<SEC-DOCUMENT>0001683168-24-004814.txt : 20240715
<SEC-HEADER>0001683168-24-004814.hdr.sgml : 20240715
<ACCEPTANCE-DATETIME>20240715074432
ACCESSION NUMBER:		0001683168-24-004814
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20240827
FILED AS OF DATE:		20240715
DATE AS OF CHANGE:		20240715

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			INTRUSION INC
		CENTRAL INDEX KEY:			0000736012
		STANDARD INDUSTRIAL CLASSIFICATION:	COMPUTER COMMUNICATIONS EQUIPMENT [3576]
		ORGANIZATION NAME:           	06 Technology
		IRS NUMBER:				751911917
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39608
		FILM NUMBER:		241115869

	BUSINESS ADDRESS:	
		STREET 1:		101 EAST PARK BLVD, SUITE 1200
		CITY:			PLANO
		STATE:			TX
		ZIP:			75074
		BUSINESS PHONE:		9722346400

	MAIL ADDRESS:	
		STREET 1:		101 EAST PARK BLVD, SUITE 1200
		CITY:			PLANO
		STATE:			TX
		ZIP:			75074

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INTRUSION COM INC
		DATE OF NAME CHANGE:	20000601

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ODS NETWORKS INC
		DATE OF NAME CHANGE:	19970507

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	OPTICAL DATA SYSTEMS INC
		DATE OF NAME CHANGE:	19950517
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>intrusion_idef14a.htm
<DESCRIPTION>FORM DEF 14A
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:INTZ="http://intrusion.com/20231231">
<head>
     <title>Intrusion Inc.</title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_029_ECD%2D2024_rempres -->
<!-- Field: Set; Name: xdx; ID: xdx_03A_INTZ_intrusion.com_20231231 -->
<!-- Field: Set; Name: xdx; ID: xdx_04A_20230101_20231231 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DEntityCentralIndexKey_0000736012 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_065_Ratio_4_xbrli%2D%2Dpure -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000004" name="dei:EntityCentralIndexKey">0000736012</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl0011" name="dei:DocumentType">DEF 14A</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="intz-20231231.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2023-01-01to2023-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000736012</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000736012</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_AnthonyScottMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000736012</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">INTZ:AnthonyScottMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_AnthonyScottMember_custom_ReportedValueOfEquityAwardsForCeoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000736012</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">INTZ:AnthonyScottMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">INTZ:ReportedValueOfEquityAwardsForCeoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_AnthonyScottMember_custom_FairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000736012</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">INTZ:AnthonyScottMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">INTZ:FairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_AnthonyScottMember_custom_FairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000736012</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">INTZ:AnthonyScottMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">INTZ:FairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_AnthonyScottMember_custom_FairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000736012</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">INTZ:AnthonyScottMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">INTZ:FairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_AnthonyScottMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000736012</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">INTZ:AnthonyScottMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_AnthonyScottMember_custom_ReportedValueOfEquityAwardsForCeoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000736012</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">INTZ:AnthonyScottMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">INTZ:ReportedValueOfEquityAwardsForCeoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_AnthonyScottMember_custom_FairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000736012</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">INTZ:AnthonyScottMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">INTZ:FairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_AnthonyScottMember_custom_FairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000736012</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">INTZ:AnthonyScottMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">INTZ:FairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_AnthonyScottMember_custom_FairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000736012</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">INTZ:AnthonyScottMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">INTZ:FairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_ReportedValueOfEquityAwardsForCeoMember_ecd_NonPeoNeoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000736012</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">INTZ:ReportedValueOfEquityAwardsForCeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_FairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember_ecd_NonPeoNeoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000736012</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">INTZ:FairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_FairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember_ecd_NonPeoNeoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000736012</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">INTZ:FairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_FairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember_ecd_NonPeoNeoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000736012</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">INTZ:FairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_ReportedValueOfEquityAwardsForCeoMember_ecd_NonPeoNeoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000736012</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">INTZ:ReportedValueOfEquityAwardsForCeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_FairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember_ecd_NonPeoNeoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000736012</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">INTZ:FairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_FairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember_ecd_NonPeoNeoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000736012</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">INTZ:FairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_FairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember_ecd_NonPeoNeoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000736012</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">INTZ:FairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Ratio">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  <ix:relationship fromRefs="Fact000016" toRefs="Footnote000041"/>
  <ix:relationship fromRefs="Fact000028" toRefs="Footnote000041"/>
  <ix:relationship fromRefs="Fact000018" toRefs="Footnote000043"/>
  <ix:relationship fromRefs="Fact000030" toRefs="Footnote000043"/>
  <ix:relationship fromRefs="Fact000020" toRefs="Footnote000044"/>
  <ix:relationship fromRefs="Fact000032" toRefs="Footnote000044"/>
  <ix:relationship fromRefs="Fact000022" toRefs="Footnote000045"/>
  <ix:relationship fromRefs="Fact000034" toRefs="Footnote000045"/>
  <ix:relationship fromRefs="Fact000024" toRefs="Footnote000046"/>
  <ix:relationship fromRefs="Fact000036" toRefs="Footnote000046"/>
  <ix:relationship fromRefs="Fact000051" toRefs="Footnote000066"/>
  <ix:relationship fromRefs="Fact000061" toRefs="Footnote000066"/>
  <ix:relationship fromRefs="Fact000071" toRefs="Footnote000083"/>
  <ix:relationship fromRefs="Fact000078" toRefs="Footnote000083"/>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="xdx_904_edei--DocumentType_dxL_c20230101__20231231_z8ewrWnm0B9d" title="::XDX::DEF%2014A"><span style="-sec-ix-hidden: xdx2ixbrl0011">SCHEDULE 14A</span></span> INFORMATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Proxy Statement Pursuant to Section 14(a) of</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">the Securities Exchange Act of 1934</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Filed by the Registrant <span style="font-family: Times New Roman, Times, Serif">&#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Filed by a Party other than the Registrant <span style="font-family: Times New Roman, Times, Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td><span style="font-family: Times New Roman, Times, Serif">&#9744;</span></td><td>Preliminary Proxy Statement</td></tr>
                                                                                                                                          <tr style="vertical-align: top">
<td style="width: 4%"><span style="font-family: Times New Roman, Times, Serif">&#9744;</span></td><td style="width: 96%">Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</td></tr><tr style="vertical-align: top">
<td>&#9746;</td><td>Definitive Proxy Statement</td></tr>
                                                                                                                                                                                                                                 <tr style="vertical-align: top">
<td>&#9744;</td><td>Definitive Additional Materials</td></tr>
                                                                                                                                                                                                                                 <tr style="vertical-align: top">
<td>&#9744;</td><td>Soliciting Material Pursuant to &#167; 240.14a-12</td></tr>
                                                                                                                                                                                                                                 </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="xdx_90A_edei--EntityRegistrantName_c20230101__20231231_zqn3fpzX4XLl"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000012" name="dei:EntityRegistrantName">Intrusion Inc.</ix:nonNumeric></span></b></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Name of Registrant as Specified In Its Charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Name of Person(s) Filing
Proxy Statement, if Other Than the Registrant)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Payment of Filing Fee (Check the appropriate box):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 4%"><span style="font-family: Times New Roman, Times, Serif">&#9746;</span></td><td style="width: 96%">No fee required</td></tr>
<tr style="vertical-align: top">
<td><span style="font-family: Times New Roman, Times, Serif">&#9744;</span></td><td>Fee paid previously with preliminary materials</td></tr>
<tr style="vertical-align: top">
<td><span style="font-family: Times New Roman, Times, Serif">&#9744;</span></td><td>Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&#160;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>101 EAST PARK BLVD, SUITE 1200</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>PLANO, TEXAS 75074</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>(972) 234-6400</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>_____________________</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>NOTICE OF ANNUAL MEETING
OF STOCKHOLDERS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>To Be Held August 27,
2024</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>_____________________</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>To the Stockholders of</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Intrusion Inc.:</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>NOTICE IS HEREBY GIVEN
</b><span style="font-family: Times New Roman, Times, Serif">that the Annual Meeting of Stockholders (the &#8220;<b><i>Meeting</i></b>&#8221;)
of Intrusion Inc. (the &#8220;<b><i>Company</i></b>,&#8221; &#8220;<b><i>we,</i></b>&#8221; &#8220;<b><i>us</i></b>&#8221; or &#8220;<b><i>our</i></b>&#8221;)
will be held at&#160;9:00 a.m., Central Time, on Thursday, August 27, 2024. The Meeting will be held entirely online via audio webcast
to allow for greater stockholder attendance and to reduce the carbon footprint that is required for travel to, and in-person attendance
at, the Annual Meeting. The Annual Meeting may be accessed at <span style="text-decoration: underline">www.virtualshareholdermeeting.com/INTZ2024</span>, where you will be able
to listen to the Annual Meeting live, submit questions and vote. We have designed the virtual Annual Meeting to provide stockholders with
substantially the same opportunities to participate as if the Annual Meeting were held in person. The Meeting will be held&#160;for the
following purposes:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 34.15pt"/><td style="width: 22.85pt">(1)</td><td style="text-align: justify">To elect six (6) directors to serve until the next Annual Meeting of Stockholders or until their respective successors are duly elected
and qualified.</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 34.15pt"/><td style="width: 22.85pt">(2)</td><td style="text-align: justify">To ratify the appointment of Whitley Penn LLP as independent auditors of the Company for the fiscal year ending December 31, 2024.</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 34.15pt"/><td style="width: 22.85pt">(3)</td><td style="text-align: justify">To approve an amendment to the 2021 Equity Incentive Plan to increase the number of shares reserved under the Plan from 125,000 to
2,500,000.</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 34.15pt"/><td style="width: 22.85pt">(4)</td><td style="text-align: justify">To approve an amendment to the 2023 Employee Stock Purchase Plan to increase the number of shares reversed under the Plan from 50,000
to 1,000,000.</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 34.15pt"/><td style="width: 22.85pt">(5)</td><td style="text-align: justify">To approve the reservation and issuance of up to $10.0 Million of Common Stock in connection with a Standby Equity Purchase Agreement
so that such issuances are made in accordance with Nasdaq Marketplace Rule 5635(d).</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33pt">To transact such other business as may properly come before
the Meeting or any adjournments thereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing items
of business are more fully described in the Proxy Statement accompanying this Notice.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The record date for determining
those stockholders who will be entitled to notice of, and to vote at, the Meeting and at any adjournment thereof is July 3, 2024. If
you owned our common stock at the close of business on July 3, 2024, you may virtually attend and vote at the Meeting. A list of stockholders
eligible to vote at the Meeting will be available for review during our regular business hours at our headquarters in Plano, Texas, for
the ten days prior to the date of the Meeting for any purpose related to the Annual Meeting. The list of stockholders will also be available
during the Annual Meeting through the Annual Meeting website for those stockholders who choose to attend.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>All stockholders are cordially
invited to virtually attend the Meeting. Whether or not you plan to virtually attend the Meeting, we hope that you will vote as soon as
possible. You may vote by internet; by phone; by mail; or, virtually during the Meeting at www.virtualshareholdermeeting.com/INTZ2024.
Stockholders are urged to complete, date, and sign the enclosed Proxy and return it promptly in the enclosed postage prepaid envelope.
Your Proxy may be revoked at any time prior to the Meeting.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 281pt"><i>By Order of the Board of Directors</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 281pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 281pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 281pt"><i>Anthony J. LeVecchio</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 281pt"><i>Executive Chairman of the Board</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Plano, Texas</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">July 15, 2024</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>Important Notice Regarding
the Availability of Proxy Materials for the Annual Meeting of Stockholders to be held on August 27, 2024: </b>This proxy statement and
the Company&#8217;s 2023 Annual Report on Form 10-K are available at www.intrusion.com.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&#160;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>INTRUSION INC.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>101 EAST PARK BLVD, SUITE 1200</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>PLANO, TEXAS 75074</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>PROXY STATEMENT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>for</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>ANNUAL MEETING OF STOCKHOLDERS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>to be Held August 27, 2024</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The enclosed proxy (the &#8220;<b><i>Proxy</i></b>&#8221;)
is being solicited on behalf of the Board of Directors (the &#8220;Board&#8221;) of Intrusion Inc. (the &#8220;Company,&#8221; &#8220;we,&#8221;
&#8220;us&#8221; or &#8220;our&#8221;) for use at the Annual Meeting of Stockholders (the &#8220;Meeting&#8221;) to be held on Thursday,
August 27, 2024 at 9:00 a.m., Central Time. Proxies, together with copies of this Proxy Statement and a copy of the Company&#8217;s Annual
Report for 2023, are being mailed on or about July 15, 2024, to stockholders of record entitled to vote at the Meeting. The Meeting will
be held entirely online live via audio webcast. You will be able to attend the virtual Meeting live, vote electronically, and submit your
questions during the Annual Meeting via live webcast by visiting: www.virtualshareholdermeeting.com/INTZ2024 and entering your 16-digit
control number included in your Notice (as defined below), on your proxy card, or on the instructions that accompanied your proxy materials.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Execution and return of the
enclosed Proxy will not affect a stockholder&#8217;s right to attend the virtual Meeting and to vote electronically. Any stockholder executing
a Proxy retains the right to revoke such proxy at any time prior to exercise at the virtual Meeting. A Proxy may be revoked by delivery
of written notice of revocation to the Secretary of the Company, by execution and delivery of a later Proxy or by voting the shares electronically
at the virtual Meeting. If you attend the Meeting and vote electronically, your proxy will be revoked automatically and only your vote
at the Meeting will be counted. Virtually attending the Annual Meeting alone, however, will not revoke your proxy unless you specifically
request your proxy to be revoked. If you hold shares through a broker, bank or other agent, you must contact that broker, bank or other
agent directly to revoke any prior voting instructions. A Proxy, when executed and not revoked, will be voted in accordance with the instructions
thereon. In the absence of specific instructions, Proxies will be voted by those named in the Proxy &#8220;FOR&#8221; the election as
directors of those nominees named in the Proxy Statement, &#8220;FOR&#8221; the approval of each of the other proposals described in this
Proxy Statement, and in accordance with their best judgment on all other matters that may properly come before the Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The enclosed form of Proxy
provides a method for stockholders to withhold authority to vote for any one or more of the nominees for director while granting authority
to vote for the remaining nominees. The names of all nominees are listed on the Proxy. If you wish to grant authority to vote for all
nominees, check the box marked &#8220;FOR.&#8221; If you wish to withhold authority to vote for all nominees, check the box marked &#8220;WITHHOLD.&#8221;
If you wish your shares to be voted for some nominees and not for one or more of the others, check the box marked &#8220;FOR&#8221; and
indicate the name(s) of the nominee(s) for whom you are withholding the authority to vote by writing the name(s) of such nominee(s) on
the Proxy in the space provided.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">RECORD DATE AND VOTING SECURITIES</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Only stockholders of record
at the close of business on July 3, 2024, are entitled to notice of, and to vote at, the Meeting. The stock transfer books of the Company
will remain open between the record date and the date of the Meeting. A list of stockholders eligible to vote at the Meeting will be
available for review during our regular business hours at our headquarters in Plano, Texas, for the ten days prior to the date of the
Meeting for any purpose related to the Annual Meeting. The list of stockholders will also be available during the Meeting through the
Annual Meeting website for those stockholders who choose to attend. On the record date, the Company had 5,436,629 outstanding shares
of Common Stock, $0.01 par value (the &#8220;Common Stock&#8221;) held of record by 102 holders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">QUORUM AND VOTING</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The presence at the virtual
Meeting, in person or by Proxy, of the holders of a majority of the shares of Common Stock outstanding is necessary to constitute a quorum.
Holders of Common Stock are entitled to one vote for each share of Common Stock held on each matter to be voted on at the Meeting including
the election of directors. All votes will be tabulated by the inspector of election appointed for the Meeting, who will separately tabulate
affirmative and negative votes, abstentions, and broker non-votes. Abstentions and broker non-votes are counted as present for purposes
of determining the presence or absence of a quorum for the transaction of business. Abstentions will be counted towards the tabulations
of votes cast on matters presented at the Meeting and will have the same effect as negative votes (other than the election of directors)
whereas broker non-votes will not be counted for purposes of determining whether a matter has been approved.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Value: 1; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>STOCKHOLDER PROPOSALS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt">Assuming the presence of
a quorum, the following paragraphs describe the vote required by the stockholders of record to approve each of the proposals set forth
in this Proxy Statement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 11.85pt"/><td style="width: 17.15pt"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify; padding-right: 1pt"><b>Proposal One. </b>The five (5) nominees receiving the greatest number of votes
of the shares of Common Stock outstanding present in person or represented by Proxy at the Meeting and entitled to vote shall be deemed
elected even if they receive the affirmative vote of less than a majority of the shares of Common Stock outstanding entitled to be voted
at the Meeting.</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify; padding-right: 1pt">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 11.85pt"/><td style="width: 17.15pt"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify"><b>Proposal Two</b>. The affirmative vote of the holders of a majority of the shares of Common Stock outstanding
present in person or represented by Proxy at the Meeting and entitled to vote is required for the ratification of the appointment of Whitley
Penn LLP as independent auditors.</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 11.85pt"/><td style="width: 17.15pt"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify"><b>Proposal Three.</b> The affirmative vote of the holders of a majority of the Shares of Common Stock
outstanding present in person or represented by Proxy at the Meeting and entitled to vote is required for an amendment to the 2021 Equity
Incentive Plan to increase the number of shares reserved under the Plan from 125,000 to 2,500,000.</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 11.85pt"/><td style="width: 17.15pt"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify"><b>Proposal Four. </b>The affirmative vote of the holders of a majority of the Shares of Common Stock
outstanding present in person or represented by Proxy at the Meeting and entitled to vote is required for an amendment to the 2023 Employee
Stock Purchase Plan to increase the number of shares reversed under the Plan from 50,000 to 1,000,000.</td></tr>
<tr style="vertical-align: top">
<td>&#160;</td><td>&#160;</td><td style="text-align: justify">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="width: 11.85pt"/><td style="width: 17.15pt"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify"><b>Proposal Five.</b> The affirmative vote of the holders of a majority of the Shares of Common Stock
outstanding present in person or represented by Proxy at the Meeting and entitled to vote is required for the reservation and issuance
of up to $10.0 Million of Common Stock in connection with a Standby Equity Purchase Agreement.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>The Board unanimously recommends a vote &#8220;FOR&#8221;
each of proposals ONE through FIVE as set forth in this Proxy Statement.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 4 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROPOSAL ONE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ELECTION OF DIRECTORS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 33pt"><span style="font-family: Times New Roman, Times, Serif">The
Board for </span>the ensuing year will consist of five directors who are each to be elected at the Meeting for a term of office expiring
at the next Annual Meeting of Stockholders or until their respective successors have been elected and qualified. It is intended that the
persons named in the following table will be nominated as directors of the Company and that the persons named in the accompanying Proxy,
unless otherwise directed, will vote for the election of such nominees at the Meeting. Each of the nominees has indicated their willingness
to serve as a member of the Board of Directors, if elected. However, in the event any nominee shall become unavailable for election to
the Board for any reason not presently known or contemplated, the Proxy holders will be vested with discretionary authority in such instance
to vote the enclosed Proxy for such substitute as the Board shall designate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33pt">The following slate of six nominees has been nominated by
the Board of Directors:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt"><b>Director</b></span></td>
    </tr>
  <tr style="vertical-align: bottom">
    <td style="padding-left: 98pt"><span style="font-size: 10pt"><b>Name of Nominee</b></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt"><b>Age</b></span></td>
    <td style="text-align: center">&#160;</td>
    <td style="padding-left: 75pt"><span style="font-size: 10pt"><b>Position(s)</b></span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt"><b>Since</b></span></td>
    </tr>
  <tr style="vertical-align: bottom">
    <td style="border-top: Black 1pt solid; width: 41%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="border-top: Black 1pt solid; width: 6%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="border-top: Black 1pt solid; width: 40%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="border-top: Black 1pt solid; text-align: center; width: 10%">&#160;</td>
    </tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td><span style="font-size: 10pt">Anthony Scott</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">71</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">President, Chief Executive Officer, and Director</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">2022</span></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt">Anthony J. LeVecchio (1)*</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">77</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Executive Chairman and Director</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">2020</span></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td><span style="font-size: 10pt">James F. Gero (1)(2)*</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">79</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Director</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">2003</span></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt">Katrinka B. McCallum*(2)(3)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">56</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Director</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">2021</span></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td><span style="font-size: 10pt">Gregory K. Wilson*(2)(3)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">52</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Director</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">2021</span></td>
    </tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-size: 10pt">Dion Hinchcliffe*</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">54</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Director</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">2024</span></td>
    </tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">* Independent Director as defined by Nasdaq
Rule 5605(a)(2).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(1) Member of the Compensation Committee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(2) Member of the Audit Committee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(3) Member of the Nominating and Governance Committee</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Board Diversity Matrix</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In accordance with the rules
of the Nasdaq Stock Market (&#8220;Nasdaq&#8221;), the following table reflects our Board diversity matrix as of May 15, 2024:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border: #BFBFBF 1pt solid; width: 39%; padding-left: 3pt; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Part I: Gender Identity</b></span></td>
    <td style="border-top: #BFBFBF 1pt solid; border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; width: 14%; padding-left: 1.1pt; text-align: center; text-indent: 0.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Female</b></span></td>
    <td style="border-top: #BFBFBF 1pt solid; border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; width: 14%; padding-left: 1.1pt; text-align: center; text-indent: 0.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Male</b></span></td>
    <td style="border-top: #BFBFBF 1pt solid; border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; width: 14%; padding-left: 1.1pt; text-align: center; text-indent: 0.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Non-Binary</b></span></td>
    <td style="border-top: #BFBFBF 1pt solid; border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; width: 19%; padding-left: 1.1pt; text-align: center; text-indent: 0.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Did Not Disclose Gender</b></span></td></tr>
  <tr>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; border-left: #BFBFBF 1pt solid; padding-left: 3pt; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Directors</span></td>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; padding-left: 1.1pt; text-align: center; text-indent: 0.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; padding-left: 1.1pt; text-align: center; text-indent: 0.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; padding-left: 1.1pt; text-align: center; text-indent: 0.45pt">&#160;</td>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; padding-left: 1.1pt; text-align: center; text-indent: 0.45pt">&#160;</td></tr>
  <tr>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; border-left: #BFBFBF 1pt solid; padding-left: 3pt; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">African American or Black</span></td>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; padding-left: 1.1pt; text-align: center; text-indent: 0.45pt">&#160;</td>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; padding-left: 1.1pt; text-align: center; text-indent: 0.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; padding-left: 1.1pt; text-indent: 0.45pt">&#160;</td>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; padding-left: 1.1pt; text-indent: 0.45pt">&#160;</td></tr>
  <tr>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; border-left: #BFBFBF 1pt solid; padding-left: 3pt; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alaskan Native or Native American</span></td>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; padding-left: 1.1pt; text-indent: 0.45pt">&#160;</td>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; padding-left: 1.1pt; text-indent: 0.45pt">&#160;</td>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; padding-left: 1.1pt; text-indent: 0.45pt">&#160;</td>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; padding-left: 1.1pt; text-indent: 0.45pt">&#160;</td></tr>
  <tr>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; border-left: #BFBFBF 1pt solid; padding-left: 3pt; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Asian</span></td>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; padding-left: 1.1pt; text-indent: 0.45pt">&#160;</td>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; padding-left: 1.1pt; text-indent: 0.45pt">&#160;</td>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; padding-left: 1.1pt; text-indent: 0.45pt">&#160;</td>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; padding-left: 1.1pt; text-indent: 0.45pt">&#160;</td></tr>
  <tr>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; border-left: #BFBFBF 1pt solid; padding-left: 3pt; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hispanic or Latinx</span></td>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; padding-left: 1.1pt; text-indent: 0.45pt">&#160;</td>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; padding-left: 1.1pt; text-indent: 0.45pt">&#160;</td>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; padding-left: 1.1pt; text-indent: 0.45pt">&#160;</td>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; padding-left: 1.1pt; text-indent: 0.45pt">&#160;</td></tr>
  <tr>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; border-left: #BFBFBF 1pt solid; padding-left: 3pt; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Native Hawaiian or Pacific Islander</span></td>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; padding-left: 1.1pt; text-indent: 0.45pt">&#160;</td>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; padding-left: 1.1pt; text-indent: 0.45pt">&#160;</td>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; padding-left: 1.1pt; text-indent: 0.45pt">&#160;</td>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; padding-left: 1.1pt; text-indent: 0.45pt">&#160;</td></tr>
  <tr>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; border-left: #BFBFBF 1pt solid; padding-left: 3pt; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">White</span></td>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; padding-left: 1.1pt; text-align: center; text-indent: 0.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; padding-left: 1.1pt; text-align: center; text-indent: 0.45pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; padding-left: 1.1pt; text-indent: 0.45pt">&#160;</td>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; padding-left: 1.1pt; text-indent: 0.45pt">&#160;</td></tr>
  <tr>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; border-left: #BFBFBF 1pt solid; padding-left: 3pt; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Two or More Races or Ethnicities</span></td>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; padding-left: 1.1pt; text-indent: 0.45pt">&#160;</td>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; padding-left: 1.1pt; text-indent: 0.45pt">&#160;</td>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; padding-left: 1.1pt; text-indent: 0.45pt">&#160;</td>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; padding-left: 1.1pt; text-indent: 0.45pt">&#160;</td></tr>
  <tr>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; border-left: #BFBFBF 1pt solid; padding-left: 3pt; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LGBTQ+</span></td>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; padding-left: 1.1pt; text-indent: 0.45pt">&#160;</td>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; padding-left: 1.1pt; text-indent: 0.45pt">&#160;</td>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; padding-left: 1.1pt; text-indent: 0.45pt">&#160;</td>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; padding-left: 1.1pt; text-indent: 0.45pt">&#160;</td></tr>
  <tr>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; border-left: #BFBFBF 1pt solid; padding-left: 3pt; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Did Not Disclose Demographic Background</span></td>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; padding-left: 1.1pt; text-indent: 0.45pt">&#160;</td>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; padding-left: 1.1pt; text-indent: 0.45pt">&#160;</td>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; padding-left: 1.1pt; text-indent: 0.45pt">&#160;</td>
    <td style="border-right: #BFBFBF 1pt solid; border-bottom: #BFBFBF 1pt solid; padding-left: 1.1pt; text-indent: 0.45pt">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b></b></p>

<!-- Field: Page; Sequence: 5 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Director Biographies</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Below is a brief account of
the business experience of each of the director nominees and executive officers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>Anthony Scott </i></b>was
appointed as our President and Chief Executive Officer on November 11, 2021, and as a director on January 21, 2022. Mr. Scott&#8217;s
prior engagements demonstrate many years of executive leadership and cybersecurity experience, including serving as Federal Chief Information
Officer for the U.S. government, Chief Information Officer for multi-billion corporations such as VMware, Microsoft and The Walt Disney
Company, as well as a private consultant helping organizations implement effective world class solutions for cybersecurity, IT governance
and crisis management. Prior to his appointment, Scott had been serving as the founder and CEO of the Tony Scott Group, LLC., a Washington
DC and Silicon Valley-based consulting and venture capital firm focused on early-stage cybersecurity and privacy technologies. Before
starting the Tony Scott Group in 2017, Scott was appointed by President Obama as the Federal Chief Information Officer for the U.S. Government
in February 2015. In that role, he had oversight, budget and management responsibilities for the more than $85 billion budget that the
Federal Government annually spends on IT. He and his team managed the government-wide response plan after the Office of Program Management
cybersecurity incident, which prompted the Cybersecurity Sprint and Implementation Plan (CSIP) that dramatically improved the information
systems security posture of the Federal Government. He also created the first &#8220;State of IT&#8221; report at the end of the Obama
administration, collaborating with members of Congress to create several legislative proposals to improve IT funding within the Federal
Government. Scott is a renowned expert on providing public and private sector executive insights concerning matters such as digital transformation,
cloud adoption, machine learning, AI, cybersecurity, governance, open data, and workforce diversity, and he has appeared frequently before
Congress as well as at numerous industry forums. Prior to working at the Federal Government, Scott was the CIO at VMware, Microsoft,
and The Walt Disney Company, as well as Chief Technology Officer at General Motors, and he has also held senior executive positions at
Bristol Myers Squibb, Price Waterhouse, Sun Microsystems and Marriott. Scott holds a Bachelor of Science Degree from the University of
San Francisco in Information Systems Management and a Juris Doctorate (law) degree from Santa Clara University. Mr. Scott&#8217;s many
years in executive leadership roles, including serving for governmental agencies, combined with his IT and cybersecurity experience make
him uniquely qualified to serve on our board and as our president and chief executive officer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>Anthony J. LeVecchio
</i></b>was appointed by the Board to serve as a Director on August 6, 2020, as Board Chair on August 20, 2020, and was appointed to serve
as our &#8220;Executive Chairman of the Board&#8221; on August 4, 2021. Mr. LeVecchio also serves on our Compensation Committee. Mr. LeVecchio
is President and Owner of The James Group, Inc., a general business consulting firm that has advised CEOs across a wide range of industries
in both public and private companies. Prior to forming The James Group in 1988, Mr. LeVecchio was the Senior Vice President and Chief
Financial Officer for VHA Southwest, Inc., a regional healthcare system. Before that, Mr. LeVecchio held financial management positions
with Philips Information Systems, Exxon Office Systems and Xerox Corporation. Mr. LeVecchio has served on the board of over 20 private
companies ranging from pre-revenue startups to companies with over $100 million in annual revenues. In this capacity, he has guided companies
through all phases of corporate growth including startup operations; achieving profitability; asset, debt, and equity financing; merger
and acquisitions and implementation of corporate governance best practices. His previous board experience includes serving as Chairman
of the Board of Legacy Texas Bank (Nasdaq) and as Co-chairman of the Board for UniPixel, Inc. (Nasdaq). Mr. LeVecchio has also served
on boards for Microtune, Inc., DG FastChannel, Inc., Maxum Health, Inc., Medical Alliance and ASDS. As a public company director, he has
experience with IPOs; secondary offerings; Sarbanes-Oxley preparedness and qualification for 404 accelerated filers; Nasdaq de-listing
and relisting; SEC stock option backdating investigations and class action lawsuit resolution; and Dodd-Frank implementation. In addition
to his business activities, Mr. LeVecchio is a lecturing professor in the School of Management at University of Texas, Dallas, and is
a member of the advisory board for The Institute for Excellence in Corporate Governance at UTD. In 2014, he was named as an Outstanding
Public Company Director by the Dallas Business Journal. He has participated as a speaker and panelist on several occasions for Bank Director
and Corporate Board Member. Mr. LeVecchio received a Bachelor of Economics from Rollins College, Winter Park, Florida, and an M.B.A. in
Finance from the same institution where he remains an active alumnus and a former member of their Board of Trustees. Mr. LeVecchio was
selected to serve as our Board Chair and on our Compensation Committee because of his standing as a financial expert and corporate governance
expert.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 6 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>James F. Gero </i></b>was
named a Director of the Company on October 27, 2003, and serves as the Chair of our Compensation Committee and as a member of our Audit
Committee and Nominating and Corporate Governance Committee. Mr. Gero is former Executive Chairman of Orthofix, N.V. (Nasdaq), and has
served on the board of Orthofix from 1995 to 2013. He also serves on the Board of LCI Industries (NYSE), where he also had previously
served as its Chairman. Previously, he was a director of REI (NYSE), American Medical Electronics (Nasdaq), DF&amp;R (Nasdaq), Spar Aerospace
(TSE), and numerous private companies including Thayer Aerospace. During his 50-year business career he was Chairman and CEO of Sierra
Technologies, a diversified technology driven company, Chairman and CEO of Varo, Inc. (NYSE), a developer and manufacturer of various
aerospace and defense products, one of the founders of Clearwire Corporation, and early on was Vice President and General Manager of Allied
Corp. (now Honeywell). Presently, he manages his investments in private equity and the public markets. Educationally, Mr. Gero has a B.S.
in Chemistry and Biology from State University of New York, an M.B.A. from the University of New Haven, and an M.S. in Strategic Planning
from Fairleigh Dickinson and an honorary Doctorate of Business degree from the University of New Haven. He has significant experience
in general management, board governance, and private investing. He is well disciplined in management, finance, operations and other functions
required in operating a business. Mr. Gero&#8217;s extensive experience serving on boards of both public and private companies and his
knowledge in the areas of strategic planning, finance, and corporate governance makes him particularly qualified for service on our Board,
Audit Committee, Nominating and Governance Committee, and Chair of our Compensation Committee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>Katrinka B. McCallum
</i></b>was appointed to our Board in February of 2021 and serves as Chair of our Audit Committee and as a member of our Nominating and
Corporate Governance Committee. Most recently, Ms. McCallum was Vice President of Customer and Product Experience at Red Hat, a leading
provider of enterprise open-source solutions, which was acquired by IBM in 2019. She joined Red Hat in 2007 as VP of Investor Relations
and has served in a variety of Vice President positions within the Products &amp; Technologies organization during her tenure there. During
her career, that spans more than two decades in enterprise software, Ms. McCallum led business units, sales and marketing organizations
as well as engineering and operations teams. She developed a reputation for driving strategy into actions that intelligently aligned the
operational backbone and accelerated the business. Ms. McCallum serves on the board of Rimini Street, Inc. (Nasdaq: RMNI) and is a member
of their audit committee. In addition, she has served on corporate boards including Micromuse, Inc. (Nasdaq) and Round Pond, a subsidiary
board of Red Hat, Inc. Ms. McCallum is a member of the North Carolina Board of Science, Technology &amp; Innovation, where she also co-chairs
the Data Economy committee. In addition, she was a member of the executive committee for the North Carolina Technology Association board.
Ms. McCallum has an M.B.A. from The Fuqua School of Business at Duke University, a B.A. in Economics from Wellesley College, and a Certificate
in Accounting from Northeastern University. And though now inactive, Ms. McCallum earned her CPA license while working as an auditor for
Deloitte and she is an active member of the National Association of Corporate Directors. Ms. McCallum&#8217;s broad array of business
experience and expertise as a strategic high growth technology leader, financial expert, as well as her general business acumen across
a broad range of public, private and non-profit organizations makes her particularly qualified for service on our Board, our Nominating
and Governance Committee, and as Chair of our Audit Committee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>Gregory K. Wilson </i></b>was
elected to our Board in May of 2021 and serves as chair of our Nominating and Corporate Governance Committee and as a member of our Audit
Committee. Mr. Wilson recently became the Chief Information Security Officer at Docupace, a company that provides a suite of digital solutions
to assist broker-dealers, registered investment advisers and other financial professionals. Docupace streamlines and automates client
onboarding, document management, advisor transitions and other critical workflows while maintaining SEC and FINRA compliance. Prior to
that, Mr. Wilson was Chief Information Security Officer at Pioneer Natural Resources from 2018 through the end of 2020, where he was responsible
for the development and execution of its information security, risk, compliance and privacy program, which included risk management, incident
response, vendor management and security governance. From 2014 until his move to Pioneer, Mr. Wilson was Head of Information Security
at 1st Global. Mr. Wilson is an experienced leader with more than 23 years of experience in IT Risk Management, Information Security,
IT Audit, Litigation Support, Privacy, Business Continuity and Disaster Recovery Planning, Training and Awareness and Compliance Management.
Mr. Wilson has expert knowledge in risk assessment and security compliance with the regulatory requirements of Sarbanes-Oxley (SOX), Payment
Card Industry (PCI), Health Insurance Portability and Accountability Act (HIPAA), Gramm Leach-Bliley Act (GLBA), US Patriot Act and General
Data Protection Regulation (GDPR). Mr. Wilson serves as an Advisor to Menlo Ventures, YL and Vation Ventures and on several corporate
Advisory Boards and Dallas Innovation Advisory Council as well as several professional and community boards. Mr. Wilson received his master&#8217;s
degree in Economics from the University of Oklahoma and his bachelor's degree in Public Administration from the University of Nebraska
at Omaha. Mr. Wilson has completed the NACD&#8217;s Director Professionalism certification and has been designated a Qualified Technology
Expert by the Digital Director Network. Mr. Wilson holds the CISSP, CISM, CGEIT, CDPSE, PSM and PMP certifications as well as his Series
7, 24 and 66. Mr. Wilson&#8217;s extensive experience serving on private corporate, governmental, and nonprofit boards as well as his
leadership and experience in Information Security strategy, risk governance, enterprise risk management, digital transformation, regulatory
compliance, incident response, mergers and acquisitions, and operations makes him particularly qualified for service on our Board.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 7 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>Dion Hinchcliffe</i></b>
was appointed to our Board in July 2024. Mr. Hinchcliffe is currently Vice President of CIO Practice at The Futurum Group and an executive
fellow at Dartmouth College&#8217;s Tuck Center for Digital Strategies. Prior to joining the Futurum Group, Mr. Hinchcliffe was VP and
Principal Analyst at Constellation Research from 2017 through May 2024 where he researched and advised clients on the issues of enterprise
technology leadership, digital transformation, and stakeholder experience. Mr. Hinchcliffe is a veteran of enterprise IT and several Internet
startups and has extensive practical experience with enterprise strategy and operational issues and, is a widely followed commentator and
industry analyst for ZDNet. Mr. Hinchcliffe is also a frequent keynote speaker and co-author of two books on intersection of technology
and business including Web 2.0 Architectures from O'Reilly as well as the bestselling Social Business By Design (John Wiley &amp; Son.)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All directors of the Company
hold office until the next ensuing annual meeting of stockholders or until their respective successors are duly elected and qualified.
All officers of the Company are elected annually by the Board and serve at the discretion of the Board. There are no family relationships
between any director or officer of the Company and any other such person.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Stockholder Approval</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 0; text-align: justify; text-indent: 0.5in">The affirmative vote
of a plurality of the 5,436,629 shares of Common Stock outstanding present in person or by proxy at the Meeting is required for the
election of each of the nominees for director.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2pt 0pt 0; text-align: center"><b>The Board recommends a vote &#8220;FOR&#8221;
the election of such nominees.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 8 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CORPORATE GOVERNANCE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The business affairs of the
Company are managed under the direction of the Board. The Board meets on a regularly scheduled basis during the fiscal year of the Company
to review significant developments affecting the Company and to act on matters requiring Board approval. It also holds special meetings
as required from time to time when important matters arise requiring Board action between scheduled meetings. The Board of Directors or
its authorized committees met 31 times during the 2023 fiscal year. During fiscal year 2023, each director participated in at least 95%
or more of the aggregate of (1) the total number of meetings of the Board of Directors (held during the period for which he was a director)
and (2) the total number of meetings of all committees of the Board on which he served (during the period that he served).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Director Independence</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each of Anthony J. LeVecchio,
James F. Gero, Katrinka B. McCallum, and Gregory K. Wilson are &#8220;independent&#8221; members of our board of directors as &#8220;independence&#8221;
is defined in Nasdaq Marketplace Rule 5605(a)(2) (&#8220;Rule 5605&#8221;). Dion Hinchcliffe, if elected, would be an independent member
of the Board under Rule 5605.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Family Relationships</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">There are no family relationships
between any director, nominee for director, or officer of the Company and any other such person.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Board Role in Risk Oversight
and Management</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board has an active role
in the oversight and management of the Company&#8217;s risks and carries out its role directly and through Board committees. The Board&#8217;s
direct role in the Company&#8217;s risk management process includes regular or periodic receipt and discussion of reports from management
and the Company&#8217;s inside and outside counsel and advisers on areas of material risk to the Company, including operational, strategic,
financial, legal, and regulatory risks.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">While overall enterprise-wide
risk management is ultimately the responsibility of the Board, the Audit Committee is delegated with the authority to oversee the identifying,
assessing, and monitoring of such risks, delegating authority for discrete risk management oversight to the appropriate committees of
the Board or to a Risk Oversight sub-committee of the Audit Committee. The Audit Committee shall report regularly to the Board at-large
on its activities in risk oversight, pass along reports from any Committees or sub-committees with oversight authority, and make recommendations
for any changes, modifications, improvements, or expansions of the Company&#8217;s risk assessment and management policies and procedures.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board has also addressed
risk through the adoption of corporate policies. The Board has adopted a Code of Business Conduct and Ethics, which the Company adopted
on September 14, 2020, as amended on March 16, 2022 (the &#8220;Code&#8221;), which is designed to ensure that directors, officers, and
employees of the Company are aware of their legal and ethical responsibilities and conduct the Company&#8217;s business in a consistently
legal and ethical manner and to avoid instances of insider trading. The Code covers areas of professional conduct that include conflicts
of interest, fair dealing and the strict adherence to all laws and regulations applicable to the conduct of the Company&#8217;s business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company has not adopted
any practices or policies regarding the ability of our employees (including officers) or Directors, or any of their designees, to purchase
financial instruments (including prepaid variable forward contracts, equity swaps, collars, and exchange funds), or otherwise engage
in transactions, that hedge or offset, or are designed to hedge or offset, any decrease in the market value of our Common Stock either
granted to the employee or director by the Company as part of the compensation of the employee or director; or held, directly or indirectly,
by the employee or director.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 9 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Committees</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board has established
Audit, Compensation, and Nominating and Governance, and Disclosure Committees to devote attention to specific subjects and to assist it
in the discharge of its responsibilities. The functions of the Audit Committee, the Compensation Committee,  the Nominating and Governance
Committee, and Disclosure Committee are described below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Audit Committee</i>. The
Audit Committee for fiscal year 2023 was composed of Ms. McCallum (Chair), who serves as our audit committee financial expert, Mr. Wilson,
and Mr. Gero The duties and functions performed by our Audit Committee are set forth in the &#8220;Report of the Audit Committee.&#8221;
Each member of our Audit Committee is an independent director, as defined by Nasdaq Rule 5605(a)(2). The Audit Committee is governed by
a written charter, which was amended and restated by the Board on September 14, 2020, and further amended on March 11, 2022, and a copy
of the charter is included under the &#8220;investor relations&#8221; section on the Company&#8217;s website, www.intrusion.com. The Audit
Committee held four meetings during fiscal year 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Compensation Committee</i>.
The Compensation Committee for fiscal year 2023 was composed of Mr. Gero (Chair) and Mr. LeVecchio, each of whom was an independent director,
as defined by Nasdaq Rule 5605(a)(2). The Compensation Committee met one time and acted unanimously by written consent during the 2023
fiscal year. The Compensation Committee is empowered to advise management and make recommendations to the Board with respect to the compensation
and other employment benefits of executive officers, key employees and directors of the Company. The Compensation Committee also administers
the Company&#8217;s equity incentive plan for officers, key employees and directors, and the Company&#8217;s incentive bonus programs
for executive officers and employees. The Compensation Committee is authorized, among other powers, to determine from time to time the
individuals to whom awards shall be granted, the number of shares to be covered by each award and the time or times at which awards shall
be granted pursuant to the equity incentive plan. The Compensation Committee is governed by a written charter that was approved by the
Board on September 14, 2020, as amended on March 11, 2022, and a copy of this charter is included under the &#8220;investor relations&#8221;
section on the Company&#8217;s website, www.intrusion.com.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Nominating and Governance
Committee</i>. The Nominating and Governance Committee is composed of Mr. Wilson (Chair), Ms. McCallum, and Mr. Gero, each of whom is
an independent director, as defined by Nasdaq Rule 5605(a)(2). The Nominating and Governance Committee is governed by a written charter
that was approved by the Board on September 14, 2020, as amended on March 11, 2022, and a copy of this charter is included under the &#8220;investor
relations&#8221; section on the Company&#8217;s website, www.intrusion.com. The Nominating and Governance Committee met one time during
2023. All of our 2024 director nominees were recommended for nomination by the Nominating and Corporate Governance Committee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Disclosure Committee</i>.
The Disclosure Committee for fiscal year 2023 was composed of Ms. McCallum, an independent director, as defined by Nasdaq Rule 5605(a)(2),
and included the Company&#8217;s CEO, CFO, and legal counsel. The Committee reviews and comments on all outgoing press releases and disclosures,
and also reviews and comments on all disclosures and reporting related to the Company&#8217;s earnings and/or financial position prior
to the Audit Committee&#8217;s review and approval of their release.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Page; Sequence: 10 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>REPORT OF THE AUDIT COMMITTEE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Audit Committee oversees
the Company&#8217;s financial reporting process on behalf of the Board. Management has the primary responsibility for the financial statements
and the reporting process, including the systems of internal controls. In fulfilling its oversight responsibilities, the Audit Committee
reviewed the audited financial statements in the Annual Report with management including a discussion of the quality, not just the acceptability,
of the accounting principles, the reasonableness of significant judgments, and the clarity of disclosures in the financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Audit Committee has discussed
with Whitley Penn LLP, the Independent Registered Public Accounting Firm to the Company, who are responsible for expressing an opinion
on the conformity of those audited financial statements with generally accepted accounting principles, the matters required to be discussed
by PCAOB Auditing Standard No. 16, Communications with Audit Committees, and such other matters as are required to be discussed with the
Audit Committee under generally accepted auditing standards. In addition, the Audit Committee has received and reviewed the written disclosures
and the letter from Whitley Penn LLP required by applicable requirements of the PCAOB regarding Whitley Penn LLP&#8217;s communications
with the Audit committee concerning independence, and the Audit Committee has discussed with Whitley Penn LLP its independence.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Audit Committee discussed
with Whitley Penn LLP the overall scope and plans for their audit. The Audit Committee meets with Whitley Penn LLP, with and without management
present, to discuss the results of their examinations, their evaluations of the Company&#8217;s internal controls, and the overall quality
of the Company&#8217;s financial reporting. The Audit Committee held four meetings during fiscal year 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In reliance on the reviews
and discussions referred to above, the Audit Committee recommended to the Board (and the Board has approved) that the audited financial
statements be included in the Annual Report on Form 10-K for the year ended December 31, 2023 for filing with the SEC. The Audit Committee
and the Board have also recommended, subject to stockholder ratification, the selection of Whitley Penn LLP as the Company&#8217;s Independent
Registered Public Accounting Firm.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5in">Respectfully submitted,</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5in">AUDIT COMMITTEE</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5in">of the Board of Directors</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5in">Katrinka B. McCallum, Audit Committee Chair</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5in">Jim Gero, Audit Committee Member</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5in">Gregory K. Wilson, Audit Committee Member</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 11 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>REPORT OF COMPENSATION COMMITTEE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Compensation Committee
is responsible for administering the compensation programs of the executive officers. The Compensation Committee sets performance goals
and objectives for the Chief Executive Officer and the other executive officers, evaluates their performance with respect to those goals
and sets their compensation based upon the evaluation of their performance. In evaluating executive officer pay, the Compensation Committee
may consider recommendations from the Chief Executive Officer with respect to goals and compensation of the other executive officers.
The Compensation Committee also periodically reviews director compensation. All decisions with respect to executive and director compensation
are approved by the Compensation Committee and recommended to the full Board for ratification.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Compensation Committee
is responsible for administering all of the Company&#8217;s equity-based plans. The Compensation Committee also periodically reviews compensation
and equity-based plans and makes its recommendations to the board with respect to these areas.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">It is the opinion of the
Compensation Committee that the executive compensation policies and plans, including, without limitation, the Amended Intrusion Inc. 2021
Omnibus Incentive Plan, as amended, and the Intrusion Inc. Employee Stock Purchase Plan, and proposed amended thereof in this Proxy, provide
the necessary total remuneration program to properly align the Company&#8217;s performance and the interests of the Company&#8217;s stockholders
through the use of competitive and equitable executive compensation in a balanced and reasonable manner, for both the short and long-term.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 281pt">Respectfully submitted,</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 281pt">COMPENSATION COMMITTEE</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 281pt">of the Board of Directors</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 281pt">James F. Gero, Compensation Committee Chair</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 281pt">Anthony J. LeVecchio, Compensation Committee Member</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 12 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>EXECUTIVE COMPENSATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Executive Officers</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets
forth the names and ages of all our NEOs, their respective positions with the Company, and the period during which each has served as
an executive officer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 31%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 5%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 53%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 8%; text-align: center"><span style="font-size: 10pt"><b>Officer</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="2" style="padding-left: 57pt"><span style="font-size: 10pt"><b>Name of Officer</b></span></td>
    <td colspan="2" style="text-align: center"><span style="font-size: 10pt"><b>Age</b></span></td>
    <td colspan="2" style="padding-left: 128pt"><span style="font-size: 10pt"><b>Position(s)</b></span></td>
    <td style="text-align: center"><span style="font-size: 10pt"><b>Since</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td style="border-top: Black 1pt solid"><span style="font-size: 10pt">Anthony Scott</span></td>
    <td style="border-top: #EEEEEE 1pt solid">&#160;</td>
    <td style="border-top: Black 1pt solid; text-align: center"><span style="font-size: 10pt">71</span></td>
    <td style="border-top: #EEEEEE 1pt solid">&#160;</td>
    <td style="border-top: Black 1pt solid"><span style="font-size: 10pt">President, Chief Executive Officer, and Director</span></td>
    <td style="border-top: #EEEEEE 1pt solid">&#160;</td>
    <td style="border-top: Black 1pt solid; text-align: center"><span style="font-size: 10pt">2021</span></td></tr>
  <tr style="vertical-align: bottom">
    <td colspan="2"><span style="font-size: 10pt">Kimberly Pinson</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">59</span></td>
    <td>&#160;</td>
    <td colspan="2"><span style="font-size: 10pt">Chief Financial Officer</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">2022</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #EEEEEE">
    <td colspan="2"><span style="font-size: 10pt">T. Joe Head</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">67</span></td>
    <td>&#160;</td>
    <td colspan="2"><span style="font-size: 10pt">Chief Technical Officer</span></td>
    <td style="text-align: center"><span style="font-size: 10pt">2003</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 33pt">The biography for Anthony Scott is provided in &#8220;<i>Proposal
One &#8211; Election of Directors</i>.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>T. Joe Head </i></b>currently
serves as our Chief Technology Officer, is a co-founder of the Company, and  served director from 1983 to 2022. Prior to co-founding
the Company, Mr. Head held the positions of Product Marketing Manager and Marketing Engineer of Honeywell Optoelectronics, from 1980 to
1983. Mr. Head holds a B.S. degree in Electrical Engineering from Texas A&amp;M University.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>Kimberly Pinson </i></b>was
appointed on June 27, 2022. Ms. Pinson brings more than 25 years of experience leading finance and related functions for global software,
technology, medical device, healthcare, and real estate companies. Prior to joining Intrusion, Inc., Ms. Pinson served as CFO for NetFortis
since 2020 as well as for EndoStim, Inc. from 2016 to 2020. Prior to joining EndoStim, Inc., Ms. Pinson served as CFO for United Orthopedic
Group, as well as in senior finance leadership roles at Quadrem, Xtria, Novo Networks, and Centex. Ms. Pinson began her career at Grant
Thornton in audit, has a BBA from the University of Texas at Dallas and was a licensed certified public accountant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All executive officers of
the Company serve at the discretion of the Board. There are no family relationships between any director or executive officer and any
other such person.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Summary Compensation Information</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets
forth certain summary information regarding all cash compensation earned by the each of the Company&#8217;s Chief Executive Officer and
Chief Financial Officer, and one other executive
officer who have served during the last two fiscal years in all capacities in which they served the Company and its subsidiaries. The
individuals listed below have been determined by the Company to be its &#8220;Named Executive Officers&#8221; for fiscal year 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 13 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"><b>2023 SUMMARY COMPENSATION TABLE (1)</b></span></p>



<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Name and Principal Position</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">Year</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Salary</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">Bonus</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center; font-weight: bold">Stock Awards</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Option Awards (2)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">All Other Compensation (3)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 25%; text-align: left">Anthony Scott</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 6%; text-align: center">2023</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">318,750</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">139,157</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 8%; text-align: right">457,907</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">President and CEO, Director</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">2022</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">425,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">425,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Kimberly Pinson (4)</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">236,250</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">70,615</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">306,865</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Chief Financial Officer</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">2022</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">135,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">78,178</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">213,178</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">T. Joe Head,</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">2023</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">270,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">26,413</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,762</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">298,175</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Chief Technical Officer</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">2022</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">270,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,558</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">271,558</td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 5%">(1)</td><td style="text-align: justify; width: 95%">No non-equity incentive plan compensation was paid, and no pension or non-qualified deferred compensation earnings were awarded to
the Named Executive Officers for the last two years. These columns have been omitted from the table.</td></tr>
<tr style="vertical-align: top">
<td>(2)</td><td style="text-align: justify">Represents the aggregate grant date fair value computed in accordance with the FASB ASC Topic 718. The FASB ASC Topic 718 full grant
date fair value will be expensed and reported as the option vests for the Named Executive Officer. A complete discussion of the assumptions
used to calculate such values can be found in the Company&#8217;s 2023 Annual Report on Form 10-K, which accompanies this Proxy Statement.</td></tr>
<tr style="vertical-align: top">
<td>(3)</td><td style="text-align: justify">This amount includes the annual employer matching contributions under the Company&#8217;s tax qualified Section 401(k) Savings Plan.</td></tr>
<tr style="vertical-align: top">
<td>(4)</td><td>Ms. Pinson was appointed Chief Financial Officer effective May 2022.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Base Salary</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1pt 0pt 0; text-align: justify; text-indent: 0.5in">The salaries of the executive officers,
including the Chief Executive Officer, are determined annually by the Compensation Committee with reference to the following without specific
weighting:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 32.8pt"/><td style="width: 32.2pt"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify; padding-right: 1pt">salaries paid to executives with similar responsibilities at companies of a comparable size and sales volume,
primarily in the high technology industry;</td></tr>
<tr style="vertical-align: top">
<td style="width: 32.8pt"/><td style="width: 32.2pt"><span style="font-family: Symbol">&#183;</span></td><td>each officer&#8217;s performance; and</td></tr>
<tr style="vertical-align: top">
<td style="width: 32.8pt"/><td style="width: 32.2pt"><span style="font-family: Symbol">&#183;</span></td><td>the Company&#8217;s overall financial results.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Compensation Committee
believes that other companies likely compete with the Company for executive talent and that the Company must offer salaries within a competitive
market range to attract and retain talented executives. However, the Compensation Committee manages salaries for the executive group as
a whole in a conservative fashion in order to place more emphasis on incentive compensation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Bonus</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To reinforce the attainment
of corporate objectives, the Compensation Committee believes that a substantial portion of the potential annual compensation of each executive
officer should be in the form of short-term, variable incentive pay. The incentive cash bonus program for executives is established annually
by the Compensation Committee based upon the Company&#8217;s achievement of sales and/or earnings targets established at the beginning
of the fiscal year. The incentive plan for executives requires a threshold level of Company financial performance before any incentives
are awarded. Once the threshold objective for sales and/or earnings for a fiscal year is reached, specific formulas are in place to calculate
the actual incentive payment for each executive for such year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 14 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Bonuses Awarded</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In fiscal years 2023 and
2022, the Company did not achieve its targeted sales and/or earnings goals and did not reach its threshold level of sales and/or earnings
for bonuses. Per the employee incentive plan, the Company did not award full-time, non-commissioned employees a bonus. This included our
current executive officers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Stock Option and Equity Incentive Programs</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The goal of the Company&#8217;s
short- and long-term equity-based incentive awards is to align the interests of executive officers with the Company&#8217;s stockholders.
The Compensation Committee determines the value allocated to equity-based incentives according to each executive&#8217;s position within
the Company, individual performance, contributions to achievement of corporate objectives and related factors, and grants equity awards
to create a meaningful opportunity for stock ownership. The Board approves short- and long-term incentives in the form of cash, stock
option grants, restricted stock issuances, and performance stock unit awards when performance meets or exceed expectations. However, such
incentive awards are never made during black-out periods or at such times when the Company is in possession material, non-public information.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Equity Awards Granted</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company grants equity
awards to the executive officers and key employees in order to retain their services and increase their performance potential to help
attain long-term goals of the Company. However, there has been no set formula for the granting of awards to individual executives or employees.
In 2023 and 2022, the Company has granted stock options to purchase 31,420 and 16,675 shares of the Company&#8217;s Common Stock, respectively.
Of these amounts, options to purchase 14.441 and 2,250 shares have been granted to the Named Executive Officers or the Board of Directors
during 2023 and 2022. During fiscal year 2023 and 2022, the Company issued no restricted stock to the Named Executive Officers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Timing of Awards</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Equity awards to executive
officers and other key employees are typically granted annually in conjunction with the review of the individual&#8217;s performance.
This review typically takes place in January. Grants to newly hired employees are typically effective at the first Compensation Committee
meeting following the employee&#8217;s first day of employment, after approval by the committee. The exercise price of all stock options
is set at the then current day&#8217;s closing price of the Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Stock Ownership Guidelines</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company does not have
any standard stock ownership guidelines. However, all executives are encouraged to retain stock options and other shares that they directly
own.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Perquisites</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company limits the perquisites
that are made available to executive officers. The Company does not have a pension program for executives or employees.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The perquisites provided
by the Company in fiscal year 2023 are as follows. All employees who participated in the Company&#8217;s 401(k) plan may receive up to
$2,700 in matching funds. All of the Named Executive Officers who participated in the 401(k) plan received matching funds. The health
and life insurance plans are the same for all employees. In general, all employees and dependents base health premiums are paid 72% by
Intrusion and 28% by the employees. All employees are also provided life insurance up to $50,000. This policy is the same for all employees,
including executive officers.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 15 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Employment Agreements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Neither the Company nor its
subsidiaries have any employment agreements with any of its Named Executive Officers other than an Executive Employment Agreement, dated
November 11, 2021, between the Company and Anthony Scott. The material terms of this Employment Agreement are as follows: a $425,000 annual
cash salary; a one-time restricted stock award equivalent to $75,000 of common stock based on the closing price as of November 11, 2021;
the ability to earn up to two times his annual salary (in cash or a combination of cash and stock option awards) under the terms of the
Company&#8217;s existing executive incentive based bonus plan; the ability to participate in the Company&#8217;s long-term incentive plan;
as well as other reasonable and customary benefits provided by the Company. In addition, the Employment Agreement requires that the Board
nominate Mr. Scott for election as a director at the Annual Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On March 27, 2023, the Board
approved an amendment to the Executive Employment Agreement. The amendment effected a change to Mr. Scott&#8217;s compensation package
(the &#8220;Amendment&#8221;). The Amendment provided for a temporary 50% reduction of Mr. Scott&#8217;s annualized base salary during
the period beginning March 24, 2023, to September 22, 2023, equal to $106,250 and granted an award of options to purchase 6,586 shares
of Common Stock of Intrusion, Inc. The options vest one-year from the date of the award and state an exercise price of $24.20 per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Long-term Incentive Plan</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">No long-term incentive has been awarded in 2023
or 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Outstanding Equity Awards at the End of Fiscal Year 2023</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>2023 OUTSTANDING EQUITY AWARDS AT FISCAL YEAR-END TABLE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following table sets forth information with
respect to the options outstanding by the Named Executive Officers held at fiscal year-end.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="14" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Option Awards</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Stock Awards</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Number of</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Number of</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Securities</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Securities</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Number of</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Market</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Underlying</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Underlying</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Option</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Option</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Shares</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Value</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Unexercised</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Unexercised</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center"><b>Exercise</b></td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center"><b>Exercise</b></td><td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">or Units</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Shares or</td><td style="font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Options</td><td style="font-weight: bold">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">Options</td><td style="font-weight: bold">&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center"><b>Price</b></td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center"><b>Date</b></td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center"><b>Not Vested</b></td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center"><b>Units Vested</b></td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Name</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">(#)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">(#)(1)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">(2)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">(#)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Exercisable</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Unexercisable</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="font-weight: bold; text-align: center">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Not Vested</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Not Vested</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 28%; text-align: left">Anthony Scott</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">6,586</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">24.20</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right"><span style="font-size: 10pt">3/21/2033</span></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 9%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Kimberly Pinson</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">417</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">834</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">69.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">11/10/2032</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">3,342</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">24.20</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">3/21/2033</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">T. Joe Head</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">36.00</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">2/06/2024</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,250</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">24.20</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">3/21/2033</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">433</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">2,190</td><td style="text-align: left">&#160;</td></tr>
  </table>


<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 5%">(1)</td><td style="width: 95%">Options become exercisable in three equal annual installments beginning on the first anniversary date of grant.</td></tr>
<tr style="vertical-align: top">
<td>(2)</td><td>The expiration date of each option occurs between ten years after the date of grant of each option.</td></tr>
<tr style="vertical-align: top">
<td>(3)</td><td style="text-align: justify">The market value was computed by multiplying the closing market price of common stock on December 31, 2023, $5.06 by the number of
restricted stock awards that have not vested.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b></b></p>

<!-- Field: Page; Sequence: 16 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Pay vs. Performance</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets forth compensation information
for our President and Chief Executive Officer and our other named executive officers, or NEOs, for purposes of comparing their compensation
to the value of our shareholders&#8217; investments and our net income, calculated in accordance with SEC regulations, for fiscal years
2023 and 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact000014" name="ecd:PvpTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_88A_eecd--PvpTableTextBlock_z7QNk8Ivjkze" summary="xdx: Disclosure - Pay vs Performance Disclosure" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Summary Compensation Table Total for CEO(1)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Compensation Actually Paid to
    CEO(2)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Average Compensation Table total for Non-CEO NEOs(3)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Average Compensation Actually paid to Non-CEO NEOs(4)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Value of Initial Fixed $100 Investment Based Total Shareholder Return(5)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Net Income (Loss)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 6%; text-align: center">2023</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eecd--PeoTotalCompAmt_c20230101__20231231_fKDEp_zjJDPtRWa0Mf" title="PEO Total Compensation Amount" style="width: 13%; text-align: right"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2023-01-01to2023-12-31" id="Fact000016" format="ixt:numdotdecimal" decimals="0" unitRef="USD">457,907</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eecd--PeoActuallyPaidCompAmt_c20230101__20231231_fKDIp_zgewu24XQcFg" title="PEO Actually Paid Compensation Amount" style="width: 13%; text-align: right"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2023-01-01to2023-12-31" id="Fact000018" format="ixt:numdotdecimal" decimals="0" unitRef="USD">319,652</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eecd--NonPeoNeoAvgTotalCompAmt_c20230101__20231231_fKDMp_zxhSDuQYiDc4" title="Non-PEO NEO Average Total Compensation Amount" style="width: 13%; text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2023-01-01to2023-12-31" id="Fact000020" format="ixt:numdotdecimal" decimals="0" unitRef="USD">302,520</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20230101__20231231_fKDQp_zbtgij7QWgL9" title="Non-PEO NEO Average Compensation Actually Paid Amount" style="width: 13%; text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2023-01-01to2023-12-31" id="Fact000022" format="ixt:numdotdecimal" decimals="0" unitRef="USD">217,347</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eecd--TotalShareholderRtnAmt_pp2p0_c20230101__20231231_fKDUp_z6oPkVWDM71l" title="Total Shareholder Return Amount" style="width: 13%; text-align: right"><ix:nonFraction name="ecd:TotalShareholderRtnAmt" contextRef="From2023-01-01to2023-12-31" id="Fact000024" format="ixt:numdotdecimal" decimals="2" scale="0" unitRef="USD">8.01</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--NetIncomeLoss_c20230101__20231231_zR24YU3xTuRj" title="Net Income (Loss)" style="width: 11%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-01to2023-12-31" id="Fact000026" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">13,891</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: center">2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eecd--PeoTotalCompAmt_c20220101__20221231_fKDEp_zLxUfY79Tee5" title="PEO Total Compensation Amount" style="text-align: right"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2022-01-012022-12-31" id="Fact000028" format="ixt:numdotdecimal" decimals="0" unitRef="USD">425,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eecd--PeoActuallyPaidCompAmt_c20220101__20221231_fKDIp_zbBAW908AQmk" title="PEO Actually Paid Compensation Amount" style="text-align: right"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2022-01-012022-12-31" id="Fact000030" format="ixt:numdotdecimal" decimals="0" unitRef="USD">423,341</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eecd--NonPeoNeoAvgTotalCompAmt_c20220101__20221231_fKDMp_z55UggQbXOm" title="Non-PEO NEO Average Total Compensation Amount" style="text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2022-01-012022-12-31" id="Fact000032" format="ixt:numdotdecimal" decimals="0" unitRef="USD">242,368</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20220101__20221231_fKDQp_zv6ahxQeAK6c" title="Non-PEO NEO Average Compensation Actually Paid Amount" style="text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2022-01-012022-12-31" id="Fact000034" format="ixt:numdotdecimal" decimals="0" unitRef="USD">241,589</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eecd--TotalShareholderRtnAmt_pp2p0_c20220101__20221231_fKDUp_zXm8IUw3woJ9" title="Total Shareholder Return Amount" style="text-align: right"><ix:nonFraction name="ecd:TotalShareholderRtnAmt" contextRef="From2022-01-012022-12-31" id="Fact000036" format="ixt:numdotdecimal" decimals="2" scale="0" unitRef="USD">91.86</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--NetIncomeLoss_c20220101__20221231_zBQeOtuCG0w9" title="Net Income (Loss)" style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31" id="Fact000038" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">16,229</ix:nonFraction></td><td style="text-align: left">)</td></tr>
  </table></ix:nonNumeric>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact000040" name="ecd:NamedExecutiveOfficersFnTextBlock"><p id="xdx_840_eecd--NamedExecutiveOfficersFnTextBlock_dU_zgeY84p5y4T8" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td id="xdx_F0E_zGI2QNjP3WH5" style="width: 5%">1)</td><td id="xdx_F1C_z3MCKw8IHSTa" style="text-align: justify; width: 95%"><ix:footnote id="Footnote000041" xml:lang="en-US">The dollar amounts reported are the amounts of total
                                                       compensation reported for our President and Chief Executive Officer, <span id="xdx_90C_eecd--PeoName_c20230101__20231231_zmMJqaYis0k1"><ix:nonNumeric contextRef="From2023-01-01to2023-12-31" id="Fact000042" name="ecd:PeoName">Anthony Scott</ix:nonNumeric></span>, in the Summary Compensation Table for fiscal years 2023 and 2022.</ix:footnote></td></tr>
<tr style="vertical-align: top">
<td id="xdx_F0F_zUALfU4JgHV4">2)</td><td id="xdx_F12_zBjpaI70K6v4" style="text-align: justify"><ix:footnote id="Footnote000043" xml:lang="en-US">The dollar amounts reported represent the amount of "compensation actually paid," as computed in accordance with SEC rules.
The dollar amounts reported are the amounts of total compensation reported for Mr. Scott during the applicable year, but also include
(i) the year-end value of equity awards granted during the reported year, (ii) the change in the value of equity awards that were unvested
at the end of the prior year, measured through the date the awards vested, or through the end of the reported fiscal year, and (iii) value
of equity awards issued and vested during the reported fiscal year. See Table below for further information.</ix:footnote></td></tr>
<tr style="vertical-align: top">
<td id="xdx_F0D_zQUQm2vAnIai">3)</td><td id="xdx_F1C_zwed8pH5GJy9" style="text-align: justify"><ix:footnote id="Footnote000044" xml:lang="en-US">The dollar amounts reported are the average of the total compensation reported for our NEOs, other than our CEO, in the Summary Compensation
Table for fiscal years 2023 and 2022.</ix:footnote></td></tr>
<tr style="vertical-align: top">
<td id="xdx_F0F_zby5jy6umS5l">4)</td><td id="xdx_F17_zArqqH50QVM8" style="text-align: justify"><ix:footnote id="Footnote000045" xml:lang="en-US">The dollar amounts reported represent the average amount of "compensation actually paid," as computed in accordance with
SEC rules, for our NEOs, other than our CEO. The dollar amounts reported are the average of the total compensation reported for our NEOs,
other than our CEO in the Summary Compensation Table for fiscal years 2023 and 2022, but also include (i) the year-end value of equity
awards granted during the reported year, (ii) the change in the value of equity awards that were unvested at the end of the prior year,
measured through the date the awards vested, or through the end of the reported fiscal year, and (iii) value of equity awards issued and
vested during the reported fiscal year.</ix:footnote></td></tr>
<tr style="vertical-align: top">
<td id="xdx_F04_zpOhUEUseEJ3">5)</td><td id="xdx_F13_zMy6tQr7uMRc" style="text-align: justify"><ix:footnote id="Footnote000046" xml:lang="en-US">Reflects the cumulative shareholder return over the relevant fiscal year, computed in accordance with SEC rules, assuming an investment
of $100 in our common shares at a price per share equal to the closing price of our common stock on the last trading day before the commencement
of the applicable fiscal year and the measurement end point of the closing price of our common stock on the last trading day in the applicable
fiscal year. For 2023, the closing price of our common stock on December 31, 2022, was $63.20 and the closing price of our common stock
on December 31, 2023 was $5.06. For 2022, the closing price of our common stock on December 31, 2021 was $68.80 and the closing price
of our common stock on December 31, 2022 was $63.20.</ix:footnote></td></tr></table>

</ix:nonNumeric><p id="xdx_852_zGoEzNyEAah4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact000048" name="ecd:AdjToPeoCompFnTextBlock"><p id="xdx_847_eecd--AdjToPeoCompFnTextBlock_dU_zg40pMNHuhOe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt"></p>

<ix:exclude><!-- Field: Page; Sequence: 17 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To calculate the amounts
in the &#8220;Compensation Actually Paid to CEO&#8221; column in the table above, the following amounts were deducted from and added
to (as applicable) our President and CEO&#8217;s &#8220;Total&#8221; compensation as reported in the Summary Compensation Table:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Summary Compensation Table Total for CEO</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reported Value of Equity Awards for CEO(1)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value as of Year End for Unvested Awards Granted During the Year</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value Year Over Year Increase or Decrease in Unvested Awards Granted in Prior Years</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value Increase or Decrease from Prior Year end for Awards that Vested During the Year</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Compensation Actually Paid</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 6%; text-align: center">2023</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eecd--PeoTotalCompAmt_c20230101__20231231__ecd--IndividualAxis__custom--AnthonyScottMember_zuB054QGdwJ6" title="Summary Compensation Total for PEO" style="width: 13%; text-align: right"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2023-01-012023-12-31_custom_AnthonyScottMember" id="Fact000050" format="ixt:numdotdecimal" decimals="0" unitRef="USD">457,907</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eecd--AdjToCompAmt_iN_di_c20230101__20231231__ecd--IndividualAxis__custom--AnthonyScottMember__ecd--AdjToCompAxis__custom--ReportedValueOfEquityAwardsForCeoMember_fKDEp_zjwjeD2IQjyi" style="width: 13%; text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_custom_AnthonyScottMember_custom_ReportedValueOfEquityAwardsForCeoMember" id="Fact000051" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">139,157</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eecd--AdjToCompAmt_c20230101__20231231__ecd--IndividualAxis__custom--AnthonyScottMember__ecd--AdjToCompAxis__custom--FairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember_zaLCFbtz5rh7" title="Adjustment to Compensation Amount" style="width: 13%; text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_custom_AnthonyScottMember_custom_FairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember" id="Fact000053" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,882</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eecd--AdjToCompAmt_d0_c20230101__20231231__ecd--IndividualAxis__custom--AnthonyScottMember__ecd--AdjToCompAxis__custom--FairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember_zELuNwxvhfG9" title="Adjustment to Compensation Amount" style="width: 13%; text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_custom_AnthonyScottMember_custom_FairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember" id="Fact000055" format="ixt:zerodash" decimals="0" unitRef="USD">&#8211;</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eecd--AdjToCompAmt_c20230101__20231231__ecd--IndividualAxis__custom--AnthonyScottMember__ecd--AdjToCompAxis__custom--FairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember_zS0MbDf508r1" title="Adjustment to Compensation Amount" style="width: 13%; text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_custom_AnthonyScottMember_custom_FairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember" id="Fact000057" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">23,980</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eecd--PeoActuallyPaidCompAmt_c20230101__20231231__ecd--IndividualAxis__custom--AnthonyScottMember_zAp8YOwT6py6" title="PEO Actually Paid Compensation Amount" style="width: 11%; text-align: right"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2023-01-012023-12-31_custom_AnthonyScottMember" id="Fact000059" format="ixt:numdotdecimal" decimals="0" unitRef="USD">319,652</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: center">2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eecd--PeoTotalCompAmt_c20220101__20221231__ecd--IndividualAxis__custom--AnthonyScottMember_zAAGl8yTdpa8" style="text-align: right"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2022-01-012022-12-31_custom_AnthonyScottMember" id="Fact000060" format="ixt:numdotdecimal" decimals="0" unitRef="USD">425,000</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eecd--AdjToCompAmt_iN_di_c20220101__20221231__ecd--IndividualAxis__custom--AnthonyScottMember__ecd--AdjToCompAxis__custom--ReportedValueOfEquityAwardsForCeoMember_fKDEp_z0LcZYizaHE5" style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_custom_AnthonyScottMember_custom_ReportedValueOfEquityAwardsForCeoMember" id="Fact000061" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">0</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eecd--AdjToCompAmt_c20220101__20221231__ecd--IndividualAxis__custom--AnthonyScottMember__ecd--AdjToCompAxis__custom--FairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember_zQbWwlWdUAB7" style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_custom_AnthonyScottMember_custom_FairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember" id="Fact000062" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eecd--AdjToCompAmt_c20220101__20221231__ecd--IndividualAxis__custom--AnthonyScottMember__ecd--AdjToCompAxis__custom--FairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember_zzamN6Hv5d54" style="text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_custom_AnthonyScottMember_custom_FairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember" id="Fact000063" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,442</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eecd--AdjToCompAmt_c20220101__20221231__ecd--IndividualAxis__custom--AnthonyScottMember__ecd--AdjToCompAxis__custom--FairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember_zeAqh9H8iJnd" style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_custom_AnthonyScottMember_custom_FairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember" id="Fact000064" format="ixt:numdotdecimal" decimals="0" unitRef="USD">783</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eecd--PeoActuallyPaidCompAmt_c20220101__20221231__ecd--IndividualAxis__custom--AnthonyScottMember_zmO8p0t73DXj" style="text-align: right"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2022-01-012022-12-31_custom_AnthonyScottMember" id="Fact000065" format="ixt:numdotdecimal" decimals="0" unitRef="USD">423,341</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
  <td id="xdx_F04_zC1kl0GphGEl" style="text-align: left; padding-left: 10pt; text-indent: -0.01pt; width: 3%">1)&#160;&#160;&#160;&#160;&#160;</td>
  <td id="xdx_F11_zFN4evH1uXa" style="text-align: left; padding-left: 10pt; text-indent: -0.01pt; width: 97%"><ix:footnote id="Footnote000066" xml:lang="en-US">Represents the grant date fair value of the equity awards to our CEO, as reported in the Summary Compensation Table.</ix:footnote></td></tr>
</table>


</ix:nonNumeric><p id="xdx_85B_zQJrbZNPVDvk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact000068" name="ecd:AdjToNonPeoNeoCompFnTextBlock"><p id="xdx_84E_eecd--AdjToNonPeoNeoCompFnTextBlock_dU_zg1juGBsMNSi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To calculate the amounts in the
&#8220;Compensation Actually Paid to Non-CEO NEOs&#8221; column in the table above, the following amounts were deducted from and added
to (as applicable) the average &#8220;Total&#8221; compensation of our Non-CEO NEOs as reported in the Summary Compensation Table:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Summary Compensation Table Total for Non-CEO NEOs</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reported Value of Equity Awards for Non-CEO NEOs(1)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value as of Year End for Unvested Awards Granted During the Year</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value Year Over Year Increase or Decrease in Unvested Awards Granted in Prior Years</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value Increase or Decrease from Prior Year end for Awards that Vested During the Year</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Compensation Actually Paid to Non-CEO NEOs</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 6%; text-align: center">2023</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eecd--NonPeoNeoAvgTotalCompAmt_c20230101__20231231_zsXkziSLtIVd" title="Average Total Compensation Amount for Non-PEO NEO" style="width: 13%; text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2023-01-01to2023-12-31" id="Fact000070" format="ixt:numdotdecimal" decimals="0" unitRef="USD">302,520</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eecd--AdjToCompAmt_iN_di_c20230101__20231231__ecd--AdjToCompAxis__custom--ReportedValueOfEquityAwardsForCeoMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_fKDEp_z2SBbLS2zMM1" style="width: 13%; text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_custom_ReportedValueOfEquityAwardsForCeoMember_ecd_NonPeoNeoMember" id="Fact000071" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">48,514</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eecd--AdjToCompAmt_c20230101__20231231__ecd--AdjToCompAxis__custom--FairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zzruFPthspP2" style="width: 13%; text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_custom_FairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember_ecd_NonPeoNeoMember" id="Fact000072" format="ixt:numdotdecimal" decimals="0" unitRef="USD">8,674</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eecd--AdjToCompAmt_c20230101__20231231__ecd--AdjToCompAxis__custom--FairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zkhmAjnIPBYh" style="width: 13%; text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_custom_FairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember_ecd_NonPeoNeoMember" id="Fact000073" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">22,910</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eecd--AdjToCompAmt_c20230101__20231231__ecd--AdjToCompAxis__custom--FairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zMuoi0zjjfF7" style="width: 13%; text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_custom_FairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember_ecd_NonPeoNeoMember" id="Fact000074" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">22,424</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20230101__20231231_zNLfL1WpVoAl" title="Non-PEO NEO Average Compensation Actually Paid Amount" style="width: 11%; text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2023-01-01to2023-12-31" id="Fact000076" format="ixt:numdotdecimal" decimals="0" unitRef="USD">217,347</ix:nonFraction></td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: center">2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eecd--NonPeoNeoAvgTotalCompAmt_c20220101__20221231_zAf8sXS6ECx8" style="text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2022-01-012022-12-31" id="Fact000077" format="ixt:numdotdecimal" decimals="0" unitRef="USD">242,368</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eecd--AdjToCompAmt_iN_di_c20220101__20221231__ecd--AdjToCompAxis__custom--ReportedValueOfEquityAwardsForCeoMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_fKDEp_z69fBhZmpkwi" style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_custom_ReportedValueOfEquityAwardsForCeoMember_ecd_NonPeoNeoMember" id="Fact000078" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">39,089</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eecd--AdjToCompAmt_c20220101__20221231__ecd--AdjToCompAxis__custom--FairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zwSZjIBCaZF3" style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_custom_FairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember_ecd_NonPeoNeoMember" id="Fact000079" format="ixt:numdotdecimal" decimals="0" unitRef="USD">36,188</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eecd--AdjToCompAmt_c20220101__20221231__ecd--AdjToCompAxis__custom--FairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zwkE4bMRWYW3" style="text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_custom_FairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember_ecd_NonPeoNeoMember" id="Fact000080" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,424</ix:nonFraction></td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eecd--AdjToCompAmt_c20220101__20221231__ecd--AdjToCompAxis__custom--FairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zoYTWs5f155j" style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_custom_FairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember_ecd_NonPeoNeoMember" id="Fact000081" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,547</ix:nonFraction></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20220101__20221231_zhdj9qXCcIb5" style="text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2022-01-012022-12-31" id="Fact000082" format="ixt:numdotdecimal" decimals="0" unitRef="USD">241,589</ix:nonFraction></td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
  <td id="xdx_F0B_zFFcqKH0yPXj" style="text-align: left; padding-left: 10pt; text-indent: -0.01pt; width: 3%">1)&#160;&#160;&#160;&#160;&#160;</td>
  <td id="xdx_F17_zQ93uikaVhV7" style="text-align: left; padding-left: 10pt; text-indent: -0.01pt; width: 97%"><ix:footnote id="Footnote000083" xml:lang="en-US">Represents the grant date fair value of the equity awards to our Non-CEO NEOs, as reported in the Summary Compensation Table</ix:footnote></td></tr>
</table>


</ix:nonNumeric><p id="xdx_857_zJ9lrHyvp7hj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<ix:nonNumeric contextRef="From2023-01-01to2023-12-31" escape="true" id="Fact000085" name="ecd:CompActuallyPaidVsNetIncomeTextBlock"><p id="xdx_843_eecd--CompActuallyPaidVsNetIncomeTextBlock_dU_zLBQJucesNW4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Relationship between Pay and Performance</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our &#8220;total shareholder
return,&#8221; as set forth in the above table, during the two-year period ended December 31, 2023 decreased by 91% compared to (a) a
decrease in &#8220;compensation actually paid&#8221; to our CEO from $423,341 in 2022 to $319,652 in 2023 and (b) a decrease in average
&#8220;compensation actually paid&#8221; to our non-CEO NEOs from $241,589 in 2022 to $217,347 in 2023. In addition, our net loss during
the two-year period ended December 31, 2023 decreased by 14%, from $(16,229) in 2022 to $(13,891) in 2023 compared to the aforementioned
changes in &#8220;compensation actually paid&#8221; to our CEO and non-CEO NEOs.</p>

</ix:nonNumeric><p id="xdx_85E_zzZdNeKBOxC2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b></p>

<!-- Field: Page; Sequence: 18 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>DIRECTOR COMPENSATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Overview of Compensation and Procedures</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Similarly, to the setting
of executive compensation, the Compensation Committee reviews the level of compensation of non-employee Directors on an annual basis.
The Company has historically used data from a number of different sources to determine the compensation for non-employee Directors. Some
examples of the data used include publicly available data describing director compensation in peer companies and survey data collected
by the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We compensate non-employee
members of the Board through a mixture of cash and equity-based compensation. Each non-employee Director currently receives an annual
cash retainer fee of $37,500. In addition, our Chairman receives an annual fee of $40,000 for his service, the Audit Committee Chair receives
an additional annual fee of $18,000, the Compensation Committee Chair receives an additional annual fee of $12,500 and the Nominating
and Governance Chair receives an additional $7,500 for their service. During 2023 the Board voluntarily exchanged a portion of their annual
fees for stock options. Each non-employee Director is also reimbursed for all reasonable expenses incurred in attending such meetings.
Directors who are also full-time employees of the Company receive no additional compensation for serving as directors. During 2023, Mr.
Scott, our President and Chief Executive Officer, served on the current Board with no additional compensation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Since the 2021 Annual Meeting
of Stockholders, it has been the Company&#8217;s practice to provide each non-employee director with restricted stock awards of the Company&#8217;s
Common Stock at the Annual Meeting in an amount equal to $70,000 determined by the closing price of the Company&#8217;s stock on the
day of such award. These awards cliff vest on the one-year anniversary of the award.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 19 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>2023 DIRECTOR COMPENSATION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Name and Principal Position</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Fees Earned or <br/>Paid in Cash ($)</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Stock Awards ($)</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Option Awards ($)</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Total</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Anthony Scott (1)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 32%; text-align: left">President and Chief Executive Officer</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">0</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Anthony J. LeVecchio</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Board Chair</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">58,125</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">70,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">24,114</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">152,239</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Jim Gero</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Board Member</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">37,500</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">70,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">15,557</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">123,057</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Katrinka B. McCallum</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Board Member</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">41,625</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">70,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">17,268</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">128,893</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Gregory K. Wilson</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Board Member</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">33,750</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">70,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">14,002</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">117,752</td><td style="text-align: left">&#160;</td></tr>
  </table>




<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"><b>____________________</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 5%">(1)</td><td style="width: 95%">No fees were paid to Company employees for serving as a Director of the Company.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Page; Sequence: 20 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>NOMINATION OF DIRECTORS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In nominating and evaluating candidates to determine
if they are qualified to become Board members, the Nominating and Governance Committee considers a number of attributes, including:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 32.8pt"/><td style="width: 32.2pt"><span style="font-family: Symbol">&#183;</span></td><td>personal and professional character, integrity, ethics and values, without regard to race, religion, gender or national origin;</td></tr>
<tr style="vertical-align: top">
<td style="width: 32.8pt"/><td style="width: 32.2pt"><span style="font-family: Symbol">&#183;</span></td><td style="text-align: justify">general business experience and leadership profile, including experience in corporate management, such as serving as an officer or
former officer of a publicly held company, or experience as a board member of another publicly held company;</td></tr>
<tr style="vertical-align: top">
<td style="width: 32.8pt"/><td style="width: 32.2pt"><span style="font-family: Symbol">&#183;</span></td><td>strategic planning abilities and experience;</td></tr>
<tr style="vertical-align: top">
<td style="width: 32.8pt"/><td style="width: 32.2pt"><span style="font-family: Symbol">&#183;</span></td><td>aptitude in accounting and finance;</td></tr>
<tr style="vertical-align: top">
<td style="width: 32.8pt"/><td style="width: 32.2pt"><span style="font-family: Symbol">&#183;</span></td><td>expertise in domestic and international markets;</td></tr>
<tr style="vertical-align: top">
<td style="width: 32.8pt"/><td style="width: 32.2pt"><span style="font-family: Symbol">&#183;</span></td><td>experience in the network security or telecommunications industry;</td></tr>
<tr style="vertical-align: top">
<td style="width: 32.8pt"/><td style="width: 32.2pt"><span style="font-family: Symbol">&#183;</span></td><td>understanding of relevant technologies;</td></tr>
<tr style="vertical-align: top">
<td style="width: 32.8pt"/><td style="width: 32.2pt"><span style="font-family: Symbol">&#183;</span></td><td>academic expertise in an area of the Company&#8217;s operations;</td></tr>
<tr style="vertical-align: top">
<td style="width: 32.8pt"/><td style="width: 32.2pt"><span style="font-family: Symbol">&#183;</span></td><td>communications and interpersonal skills; and</td></tr>
<tr style="vertical-align: top">
<td style="width: 32.8pt"/><td style="width: 32.2pt"><span style="font-family: Symbol">&#183;</span></td><td>practical and mature business judgment.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Nominating and Governance
Committee also evaluates Board members&#8217; and nominees&#8217; service on the boards of other public companies. These directors also
evaluate candidates identified by their personal contacts and other Board members.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Nominating and Governance
Committee will also consider nominees proposed by stockholders. Although the Company has no formal policy regarding stockholder nominees,
stockholder nominees are viewed in substantially the same manner as other nominees. The consideration of any candidate for director will
be based on the assessment of the individual&#8217;s background, skills and abilities, and if such characteristics qualify the individual
to fulfill the needs of the Board at that time. To recommend a prospective nominee for consideration, stockholders should timely submit
the candidate&#8217;s name and qualifications to the Company&#8217;s Secretary in writing at 101 East Park Blvd., Suite 1200, Plano, TX
75074. An amendment to the Company&#8217;s bylaws in 2023 did provide for changes to the procedures by which stockholders may recommend
nominees to the Board. The Nominating and Governance Committee annually reviews the requisite skills and characteristics of Board members,
as well as the composition of the Board as a whole. This assessment includes a consideration of independence, diversity, skills, experience,
and industry backgrounds in the context of the needs of the Board and the Company. Directors are expected to exemplify the highest standards
of personal and professional integrity and to constructively challenge management through their active participation and questioning.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Communication with the Board</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company does not have
formal procedures for stockholder communication with the Board. Any matter intended for the Board, or for any individual member or members
of the Board, should be directed to the Company&#8217;s Secretary at the address of the Company indicated above, with a request to forward
the same to the intended recipient. In general, all stockholder communication delivered to the Company&#8217;s Secretary for forwarding
to the Board or specified Board members will be forwarded in accordance with the stockholder&#8217;s instructions, unless the Secretary
believes the question or issue may be addressed adequately by the Company&#8217;s investor relations department. However, the Secretary
reserves the right to not forward to Board members any abusive, threatening or otherwise inappropriate materials. The Board believes that
more formal procedures are not necessary to permit shareholders adequate access to its members.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 21 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Policy Regarding Board Attendance at Stockholders Meetings</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Although it has no formal
policy requiring attendance, the Company encourages all directors to attend all meetings of stockholders. All of the then serving members
of the Board attended the 2023 Annual Meeting of Stockholders and the 2024 Special Meeting of Stockholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Code of Business Conduct and Ethics</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All of the Company&#8217;s
directors and employees are required to abide by the Company&#8217;s Code of Business Conduct and Ethics, which the Company adopted on
September 14, 2020, as amended on March 16, 2022 (the &#8220;Code&#8221;) to ensure that the Company&#8217;s business is conducted in
a consistently legal and ethical manner and to avoid instances of insider trading. The Code covers areas of professional conduct that
include conflicts of interest, fair dealing and the strict adherence to all laws and regulations applicable to the conduct of the Company&#8217;s
business. The full text of the Code is published on the Company&#8217;s website under the investor relations tab at www.intrusion.com.
The Company intends to disclose future amendments to, or waivers from, certain provisions of the Codes of Ethics on the Company&#8217;s
website within four business days following the date of such amendment or waiver. Upon the written request of any stockholder, the Company
will furnish, without charge, a copy of the Code. This request should be directed to the Company&#8217;s Secretary at 101 East Park Blvd.,
Suite 1200, Plano, TX 75074.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Page; Sequence: 22 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>PROPOSAL TWO</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>RATIFICATION OF THE APPOINTMENT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board has appointed Whitley
Penn LLP to serve as independent auditors of the Company and to audit its consolidated financial statements for fiscal year 2023, subject
to ratification by the Company&#8217;s stockholders at the Meeting. Whitley Penn LLP has served as the Company&#8217;s Independent Registered
Public Accounting Firm since July 2009. To the knowledge of management of the Company, neither such firm nor any of its members has any
direct or material indirect financial interest in the Company, nor any connection with the Company in any capacity other than as independent
auditors.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Although stockholder ratification
and approval of this appointment is not required by the Company&#8217;s bylaws or otherwise, in keeping with the Company&#8217;s policy
that its stockholders should be entitled to a voice in this regard and as a matter of good corporate practice, the Board is seeking ratification
of this appointment. If the appointment is not ratified, the Board must then determine whether to appoint other auditors prior to the
end of the current fiscal year. In such a case, the opinions of stockholders will be taken into consideration.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Fees Paid to Independent Registered Public
Accounting Firm </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Audit Committee has reviewed the following
audit and non-audit fees the Company has paid to Whitley Penn LLP for 2022 and 2023 for purposes of considering whether such fees are
compatible with maintaining the auditor&#8217;s independence. The policy of the Audit Committee is to pre-approve all audit and non-audit
services performed by Whitley Penn LLP before the services are performed, including all the services described below under &#8220;Audit-Related
Fees,&#8221; &#8220;Tax Fees&#8221; and &#8220;All Other Fees&#8221; below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Audit Fees</i>. Fees billed
for service rendered by our Accounting Firm for the reviews of Forms 10-Q and for the audit of the consolidated financial statements of
the Company were $186,685 for 2022 and $216,941 for 2023. Fees billed for the services rendered by our Accounting Firm for the review
of our registration statements for our offerings of Common Stock and due diligence associated with our at-the-market program was $32,500
in 2022 and $61,860 in 2023.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Audited-Related Fees</i>.
Aggregate fees billed for all audit-related services rendered by our Accounting Firm were $0 for 2022 and 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Tax Fees</i>. Aggregate
fees billed for permissible tax services rendered by our Accounting Firm consisted of $12,550 for 2022 and $2,000 for 2023. These amounts
include tax strategy services, preparation of sales tax returns, preparation of federal and state income tax returns, preparation of property
tax and franchise tax returns and international tax issues.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>All Other Fees</i>. Aggregate
fees billed for all other services rendered by our Accounting Firm consisted of $0 for 2022 and 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Representatives of Whitley
Penn LLP are expected to be in attendance at the Meeting and will be afforded the opportunity to make a statement. The representatives
will also be available to respond to appropriate questions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The enclosed Proxy will be
voted as specified, but if no specification is made, it will be voted &#8220;FOR&#8221; the adoption of the resolution of ratification.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><b>The Board recommends a
vote &#8220;FOR&#8221; this proposal.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 23 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROPOSAL THREE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0; text-align: center"><b>APPROVAL OF AN AMENDMENT TO THE </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0; text-align: center"><b>INTRUSION INC. 2021 OMNBUS INCENTIVE
PLAN</b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Overview</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At the Annual Meeting, stockholders are also being
asked to approve an amendment to the Amended 2021 Omnibus Incentive Plan (the &#8220;2021 Equity Plan&#8221;) to increase the number of
shares authorized to use post reverse stock split from 125,000 shares to the pre reverse stock split authorized plan amount of 2,500,000
shares. The purpose of the 2021 Equity Plan is to advance the interests of Intrusion and its stockholders by enabling Intrusion and its
subsidiaries to attract and retain qualified individuals to perform services, to provide incentive compensation for such individuals in
a form that is linked to the growth and profitability of Intrusion and increases in stockholder value, and to provide opportunities for
equity participation that align the interests of recipients with those of its stockholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Intrusion Inc. 2021 Equity Plan was originally
adopted and became effective on March 25, 2021, which was the date of its adoption by the Board, subject to the approval by the stockholders
of the Company. On March 27, 2022, the Board adopted an amendment to the 2021 Equity Plan, which effected the following material changes:
(1) permitted the Compensation Committee to recognize the existence of special circumstances with the approval of the Board of Directors;
and, (2) under such special circumstances, issue awards not otherwise subject to the attainment of a performance criteria to vest during
a period less than one (1) year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The 2021 Equity Plan, as amended, permits the
Board, or a committee or subcommittee thereof, to grant to eligible employees, non-employee directors and consultants of Intrusion and
its subsidiaries non-statutory and incentive stock options, restricted stock awards, restricted stock units (&#8220;RSUs&#8221;), stock
appreciation rights (&#8220;SARs&#8221;), performance awards, non-employee director awards, and other stock-based awards. If the proposal
is approved subject to adjustment, the maximum number of shares of Common Stock to be authorized for issuance under the 2021 Equity Plan
will be 2,500,000, with an annual increase on the first day of each calendar year beginning on January 1, 2025 and ending on January 1,
2030 equal to the lesser of: (A) ten percent (10%) of the increase in the number of shares of Common Stock outstanding from the first
day of the preceding calendar year to the first day of the current calendar year, as the number of shares are determined on a fully-diluted
basis; and (B) such smaller number of shares of Common Stock as may be determined by the Board.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our board of directors is recommending that our
stockholders approve the amendment to increase the number of shares of Common Stock available for issuance under the 2021 Equity Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Summary of Sound Governance Features of the
2021 Equity Plan</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The board of directors believes that the 2021
Equity Plan contains several features that are consistent with protecting the interests of our stockholders and sound corporate governance
practices, including the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
    <td style="width: 2%">&#10003;</td>
  <td style="text-align: left; width: 38%">Will not be excessively dilutive to stockholders</td>
    <td style="width: 2%">&#10003;</td>
  <td style="text-align: justify; width: 58%">No re-pricing of &#8220;underwater&#8221; stock options or SARs without stockholder approval</td></tr>
<tr style="vertical-align: top">
    <td>&#10003;</td>
  <td style="text-align: left">No
tax gross ups</td>
    <td>&#10003;</td>
  <td style="text-align: left">No reload options or SARs</td></tr>
<tr style="vertical-align: top">
    <td>&#10003;</td>
  <td style="text-align: left">Clawback
provisions</td>
    <td>&#10003;</td>
  <td style="text-align: left">No discounted options or SARs</td></tr>
<tr style="vertical-align: top">
    <td>&#10003;</td>
  <td style="text-align: left">Limits
on director compensation</td>
    <td>&#160;</td>
  <td style="text-align: left">&#160;</td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following is a summary of the principal features
of the 2021 Equity Plan. The summary is qualified in its entirety by reference to the full text of the Amended and Restated 2021 Omnibus
Incentive Plan (referred to herein as the &#8220;2021 Equity Plan&#8221;), which is set forth in <b>Appendix A</b>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><b>The Board recommends a
vote &#8220;FOR&#8221; this proposal.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Page; Sequence: 24 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.05pt 0pt 0; text-align: center">PLAN SUMMARY</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any stockholder
who wishes to obtain a copy of the actual 2021 Equity Plan document may do so upon written request to the Company&#8217;s Corporate Secretary,
c/o Intrusion Inc., 101 East Park Blvd, Suite 1300, Plano, Texas 75074.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Purpose</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The purpose
of the 2021 Equity Plan is to provide a means through which the Company may attract and retain key personnel and to provide a means whereby
directors, officers, employees, consultants and advisors of the Company can acquire and maintain an equity interest in the Company, or
be paid incentive compensation, including incentive compensation measured by reference to the value of Common Stock, thereby strengthening
their commitment to the welfare of the Company and its Affiliates and aligning their interests with those of the Company&#8217;s stockholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Administration</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The 2021 Equity Plan is
administered by the Compensation Committee of our board of directors or such other committee of our board of directors to which it
has properly delegated power, or if no such committee or subcommittee exists, our board of directors. To the extent required by
applicable law, rule or regulation, it is intended that each member of the Compensation Committee shall qualify as (a) a
&#8220;non-employee director&#8221; under Rule 16b-3, and (b) an &#8220;independent director&#8221; under the rules of any national
securities exchange or national securities association, as applicable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Compensation Committee
is authorized to interpret, administer, reconcile any inconsistency in, correct any defect in and/or supply any omission in the 2021 Equity
Plan and any instrument or agreement relating to, or any award granted under, the 2021 Equity Plan (each, an &#8220;Award&#8221;); establish,
amend, suspend, or waive any rules and regulations and appoint such agents as the Compensation Committee deems appropriate for the proper
administration of the 2021 Equity Plan; adopt sub-plans; and to make any other determination and take any other action that the Compensation
Committee deems necessary or desirable for the administration of the 2021 Equity Plan. Except to the extent prohibited by applicable law
or the applicable rules and regulations of any securities exchange or inter-dealer quotation system on which our securities are listed
or traded, the Compensation Committee may allocate all or any portion of its responsibilities and powers to any one or more of its members
and may delegate all or any part of its responsibilities and powers to any person or persons selected by it in accordance with the terms
of the 2021 Equity Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless otherwise
expressly provided in the 2021 Equity Plan, all designations, determinations, interpretations, and other decisions under or with respect
to the 2021 Equity Plan or any Award or any documents evidencing Awards granted pursuant to the 2021 Equity Plan are within the sole discretion
of the Compensation Committee, may be made at any time and are final, conclusive and binding upon all persons or entities, including,
without limitation, us, any participant, any holder or beneficiary of any Award, and any of our stockholders. The Compensation Committee
may make grants of the following Awards to eligible persons (&#8220;Eligible Persons&#8221;) pursuant to terms and conditions set forth
in the applicable Award agreement, including subjecting such Awards to performance criteria listed in the 2021 Equity Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 5%"/><td style="width: 5%"><span style="font-family: Symbol">&#183;</span></td><td style="width: 90%">Stock Option Awards,</td></tr>
<tr style="vertical-align: top">
<td/><td><span style="font-family: Symbol">&#183;</span></td><td>Stock Appreciation Right Awards,</td></tr>
<tr style="vertical-align: top">
<td/><td><span style="font-family: Symbol">&#183;</span></td><td>Restricted Stock and Restricted Stock Unit Awards,</td></tr>
<tr style="vertical-align: top">
<td/><td><span style="font-family: Symbol">&#183;</span></td><td>Performance Awards,</td></tr>
<tr style="vertical-align: top">
<td/><td><span style="font-family: Symbol">&#183;</span></td><td>Other Stock-Based Awards and Cash-Based Awards</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 25 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Eligible Shares</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Currently,
under the 2021 Equity Plan (sometimes referred to herein as the &#8220;Plan&#8221;), the aggregate number of shares of Common Stock that
may be issued or used for reference purposes or with respect to which Awards may be granted under the 2021 Equity Plan shall not exceed
One Hundred Twenty-Five Thousand (125,000) shares. The maximum number of shares of Common Stock with respect to which Stock Awards and
Stock Options may be granted under the Plan is One Hundred Twenty-Five Thousand (125,000) shares. If Proposal 3 is approved, the maximum
number of shares with respect to which Awards may granted under the Plan and with respect to which Incentive Stock Options may be granted,
cumulatively, would be Two Million Five Hundred Thousand (2,500,000) shares. If any Option, Stock Appreciation Right or Other Stock-Based
Awards granted under the Plan expires, terminates or is canceled for any reason without having been exercised in full, the number of shares
of Common Stock underlying any unexercised Award shall again be available for the purpose of Awards under the Plan. If any shares of Restricted
Stock, Performance Awards or Other Stock-Based Awards denominated in shares of Common Stock awarded under the Plan to a Participant are
forfeited for any reason, the number of forfeited shares of Restricted Stock, Performance Awards or Other Stock-Based Awards denominated
in shares of Common Stock shall again be available for purposes of Awards under the Plan. If any shares of Common Stock are (i) withheld
to satisfy tax withholding obligations on an Award issued under the Plan, (ii) tendered in order to satisfy the exercise price due with
respect to an Award issued under the Plan, or (iii) repurchased by the Company using proceeds received upon exercise of a Stock Option,
the number of shares of Common Stock so withheld, tendered or repurchased, as applicable, shall not be available for purposes of future
Awards under the Plan. If a Stock Appreciation Right or a Limited Stock Appreciation Right is granted in tandem with an Option, such grant
shall only apply once against the maximum number of shares of Common Stock which may be issued under the Plan. Any Award under the Plan
settled in cash shall not be counted against the foregoing maximum share limitations. To date, 79,226 total shares have been issued under
the Plan, 26,007 shares have been issued under Awards and 53,220 shares have been issued with respect to Stock Options. 31,701 shares
have been forfeited and returned to the Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Eligible Persons</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Any Employee of the
Company or any of its affiliates, any independent Non-Employee Director, or person who is an advisor or consultant to the Company designated
by the Committee in its discretion as eligible to receive Awards subject to the conditions set forth in the Plan (an &#8220;Eligible Person&#8221;)
shall be permitted to participate (a &#8220;Participant&#8221;) under the 2021 Equity Plan. Only Eligible Persons who are also employees
of the Company or its affiliates are eligible to receive Stock Awards and Stock Options under the 2021 Equity Plan. Eligibility for the
grant of a Stock Award or Stock Option and actual participation in the 2021 Equity Plan shall be determined by the Compensation Committee
in its sole discretion. As of July 1, 2024, approximately 49 employees, including three Executive officers, and four Non-Employee-Directors
would qualify as Eligible Persons and potential Participants in 2021 Equity Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Plan Awards</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Stock
Options.</i> The Compensation Committee may grant non-qualified stock options and incentive stock options to Eligible Persons, under the
2021 Equity Plan, with terms and conditions determined by the Compensation Committee that are not inconsistent with the 2021 Equity Plan.
All stock options granted under the 2021 Equity Plan are required to have a per share exercise price that is not less than 100% of the
fair market value of the Company&#8217;s Common Stock underlying such stock options on the date such stock options are granted (other
than in the case of options that are substitute Awards). All stock options that are intended to qualify as incentive stock options must
be granted pursuant to an Award agreement expressly stating that the options are intended to qualify as incentive stock options and will
be subject to the terms and conditions that comply with the rules as may be prescribed by Section 422 of the Internal Revenue Code of
1986, as amended (the &#8220;Code&#8221;). The maximum term for stock options granted under the 2021 Equity Plan will be ten years from
the initial date of grant, or with respect to any stock options intended to qualify as incentive stock options, such shorter period as
prescribed by Section 422 of the Code. However, if a non-qualified stock option would expire at a time when trading of shares of our Common
Stock is prohibited by our insider trading policy (or &#8220;blackout period&#8221; imposed by the Company), the term will automatically
be extended to the 30th day following the end of such period. The purchase price for the shares as to which a stock option is exercised
may be paid, to the extent permitted by law, (i) in cash or its equivalent at the time the stock option is exercised; (ii) in shares having
a fair market value equal to the aggregate exercise price for the shares being purchased and satisfying any requirements that may be imposed
by the Compensation Committee (so long as such shares have been held by the Participant for at least six months or such other period established
by the Compensation Committee to avoid adverse accounting treatment); or (iii) by such other method as the Compensation Committee may
permit in its sole discretion, including, without limitation, (A) in other property having a fair market value on the date of exercise
equal to the purchase price, (B) if there is a public market for the shares at such time, through the delivery of irrevocable instructions
to a broker to sell the shares being acquired upon the exercise of the stock option and to deliver to us the amount of the proceeds of
such sale equal to the aggregate exercise price for the shares being purchased or (C) through a &#8220;net exercise&#8221; procedure effected
by withholding the minimum number of shares needed to pay the exercise price. Any fractional shares of Common Stock will be settled in
cash.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.65pt 0pt 5.55pt; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.65pt 0pt 5.55pt; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.65pt 0pt 5.55pt; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.65pt 0pt 5.55pt; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 26 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 5.65pt 0pt 5.55pt; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Stock
Appreciation Rights.</i> The Compensation Committee may grant stock appreciation rights under the 2021 Equity Plan, with terms and conditions
determined by the Compensation Committee that are not inconsistent with the 2021 Equity Plan. The Compensation Committee may award stock
appreciation rights in tandem with options or independent of any option. Generally, each stock appreciation right will entitle the participant
upon exercise to an amount (in cash, shares or a combination of cash and shares, as determined by the Compensation Committee) equal to
the product of (i) the excess of (A) the fair market value on the exercise date of one share of Common Stock, over (B) the strike price
per share, times (ii) the number of shares of Common Stock covered by the stock appreciation right. The strike price per share of a stock
appreciation right will be determined by the Compensation Committee at the time of grant but in no event may such amount be less than
100% of the fair market value of a share of Common Stock on the date the stock appreciation right is granted (other than in the case of
stock appreciation rights granted in substitution of previously granted Awards).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Restricted
Stock and Restricted Stock Units.</i> The Compensation Committee may grant restricted shares of our Common Stock or restricted stock units,
representing the right to receive, upon vesting and the expiration of any applicable restricted period, one share of Common Stock for
each restricted stock unit, or, in the sole discretion of the Compensation Committee, the cash value thereof (or any combination thereof).
As to restricted shares of our Common Stock, subject to the other provisions of the 2021 Equity Plan, the holder will generally have the
rights and privileges of a stockholder as to such restricted shares of Common Stock, including, without limitation, the right to vote
such restricted shares of Common Stock. Participants have no rights or privileges as a stockholder with respect to restricted stock units.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Performance
Awards</i>. The Compensation Committee may grant a Performance Award to a Participant payable upon the attainment of specific performance
criteria. If the Performance Award is payable in shares of Common Stock, such shares shall be transferable to the Participant only upon
attainment of the relevant Performance Criteria. If the Performance Award is payable in cash, it may be paid upon the attainment of the
relevant Performance Criteria either in cash or in shares of Common Stock (based on the then current fair market value of such shares),
as determined by the Compensation Committee, in its sole and absolute discretion. Each Performance Award shall be evidenced by an Award
Agreement in such form that is not inconsistent with the Plan and that the Compensation Committee may from time to time approve.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Other Equity-Based Awards
and Cash-Based Awards</i>. The Compensation Committee may grant other equity-based or cash-based Awards under the 2021 Equity Plan, with
terms and conditions determined by the Compensation Committee that are not inconsistent with the 2021 Equity Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">Effect of Certain Events on 2021 Equity Plan and Award</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event of (i)
any dividend (other than regular cash dividends) or other distribution (whether in the form of cash, shares of Common Stock, other securities
or other property), recapitalization, stock split, reverse stock split, reorganization, merger, consolidation, split-up, split-off, spin-off,
combination, repurchase or exchange of shares of Common Stock or other securities, issuance of warrants or other rights to acquire shares
of Common Stock or other securities, or other similar corporate transaction or event that affects the shares of Common Stock (including
a change in control, as defined in the 2021 Equity Plan), or (ii) unusual or nonrecurring events affecting the Company, including changes
in applicable rules, rulings, regulations or other requirements, that the Compensation Committee determines, in its sole discretion, could
result in substantial dilution or enlargement of the rights intended to be granted to, or available for, participants (any event in (i)
or (ii), being referred to as an &#8220;Adjustment Event&#8221;), the Compensation Committee will, in respect of any such Adjustment Event,
make such proportionate substitution or adjustment, if any, as it deems equitable, to any or all of: (A) the number of shares of Common
Stock or other securities of the Company (or number and kind of other securities or other property) which may be issued in respect of
Awards or with respect to which Awards may be granted under the 2021 Equity Plan or any sub-plan and (B) the terms of any outstanding
Award, including, without limitation, (1) the number of shares of Common Stock or other securities of the Company (or number and kind
of other securities or other property) subject to outstanding Awards or to which outstanding Awards relate, (2) the exercise price or
strike price with respect to any Award, or (3) any applicable performance measures; it being understood that, in the case of any &#8220;equity
restructuring,&#8221; the Compensation Committee will make an equitable or proportionate adjustment to outstanding Awards to reflect such
equity restructuring.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 27 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection
with any change in control, the Compensation Committee may, in its sole discretion, provide for any one or more of the following: (i)
a substitution or assumption of Awards, or to the extent the surviving entity does not substitute or assume the Awards, the acceleration
of vesting of, the exercisability of, or lapse of restrictions on Awards and (ii) cancellation of any one or more outstanding Awards and
payment to the holders of such Awards that are vested as of such cancellation (including any Awards that would vest as a result of the
occurrence of such event but for such cancellation) the value of such Awards, if any, as determined by the Compensation Committee (which
value, if applicable, may be based upon the price per share of Common Stock received or to be received by other holders of our Common
Stock in such event), including, in the case of stock options and stock appreciation rights, a cash payment equal to the excess, if any,
of the fair market value of the shares of Common Stock subject to the option or stock appreciation right over the aggregate exercise price
or strike price thereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Page; Sequence: 28 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROPOSAL FOUR</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0; text-align: center"><b>APPROVAL OF AN AMENDMENT TO THE </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 0; text-align: center"><b>INTRUSION INC. EMPLOYEE STOCK PURCHASE
PLAN</b>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Overview</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">At the Annual Meeting, stockholders are also being
asked to approve an amendment to Intrusion Inc. Employee Stock Purchase Plan (the &#8220;ESPP&#8221;) to increase the number of shares
the plan was authorized to issue post reverse stock split from 50,000 to the pre reverse stock split authorized plan amount of 1,000,000.
The purpose of the ESPP is to advance the interests of Intrusion and its stockholders by enabling Intrusion and its subsidiaries to attract
and retain qualified individuals to perform services, to provide incentive compensation for such individuals in a form that is linked
to the growth and profitability of Intrusion and increases in stockholder value, and to provide opportunities for equity participation
that align the interests of recipients with those of its stockholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The ESPP was originally adopted and became effective
on April 12, 2023, which was the date of its adoption by the Board, subject to the approval by the stockholders of the Company. The ESPP
provides eligible employees with an opportunity to purchase shares of our Common Stock at a discount through accumulated payroll deductions.
If the proposal is approved, the maximum number of shares of Common Stock to be authorized for issuance under the ESPP will be 1,000,000.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our board of directors is recommending that our
stockholders approve the amendment to increase the number of shares of Common Stock available for issuance under the ESPP.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following is a summary of the principal features
of the ESPP. The summary is qualified in its entirety by reference to the full text of the ESPP, which is set forth in <b>Appendix B</b>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><b>The Board recommends a
vote &#8220;FOR&#8221; this proposal.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b></b></p>

<!-- Field: Page; Sequence: 29 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Summary of the ESPP</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The principal terms of the
ESPP are summarized below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The ESPP, including the right
of participants to make purchases under the ESPP, is intended to qualify as an &#8220;Employee Stock Purchase Plan&#8221; under the provisions
of Section 421 and 423 of the Code, although we may offer sub-plans or offerings that are not intended to meet the Section 423 requirements
for employees outside the United States pursuant to the terms of the ESPP. The provisions of the ESPP shall, accordingly, be construed
so as to extend and limit participation in a manner consistent with the requirements of those sections of the Code. The ESPP will not
be a qualified deferred compensation plan under Section 401(a) of the Code and is not subject to the provisions of ERISA.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Purpose</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The purpose of the ESPP is
to provide our employees with a means of acquiring an equity interest in Intrusion through payroll deductions, to enhance such employees&#8217;
sense of participation in our business, and to provide an incentive for continued employment through the opportunity to acquire equity
at a discounted price.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Shares Reserved for Issuance</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If approved, 1,000,000 shares
of the Common Stock of Intrusion Inc. will be reserved and made available for issuance under the ESPP. The ESPP does not include an evergreen
provision, thereby eliminating an annual automatic increase of shares. The closing price per share of our Class A Common Stock on July
1, 2024, was $1.08.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Offering Periods</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The ESPP is currently expected
to be administered through consecutive six-month periods referred to as &#8220;<i>Offering Periods</i>,&#8221; commencing on each January
1 and July 1, and ending on the succeeding June 30 and December 31, respectively. The Compensation Committee may change the duration and
structure of future Offering Periods in accordance with the terms of the ESPP, provided that no Offering Period may extend for a period
longer than 27 months.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On the first trading day of
each Offering Period (the &#8220;Offering Date&#8221;), each eligible employee who has properly enrolled in that Offering Period in accordance
with the rules prescribed by the Compensation Committee will be granted an option to purchase shares of our common stock to be funded
by payroll deductions, based on the participant&#8217;s elected contribution rate. Unless a participant has properly withdrawn from the
Offering Period, each option granted under the ESPP will automatically be exercised on the last trading day of the Offering Period (the
&#8220;Purchase Date&#8221;). The purchase price will be equal to 85% of the lesser of the fair market value of our Common Stock on (i)
the Offering Date and (ii) the Purchase Date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Plan Administration</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The ESPP will be administered
by our Compensation Committee. Subject to the terms of the ESPP, the Compensation Committee will have the authority to, among other matters,
determine the eligibility of participants, determine the terms and conditions of offerings under the ESPP, and construe and interpret
the terms of the ESPP.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 30 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Eligibility</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Generally, all of our employees,
and employees of any of our subsidiaries designated by the Compensation Committee, will be eligible to participate in the ESPP; provided
that employees who own (or are deemed to own as a result of stock attribution rules) stock constituting 5% or more of the total combined
voting power or value of all classes of our stock or any of our subsidiaries will not be permitted to participate in the ESPP. The Compensation
Committee may, in its discretion, exclude the following categories of employees from participation: (i) employees who are not employed
prior to the beginning of an Offering Period, (ii) employees who are customarily employed 20 hours or less per week in a calendar year;
(iii) employees who are customarily employed five months or less in a calendar year; (iv) certain &#8220;highly compensated&#8221; employees;
(v) employees who are citizens or residents of a foreign jurisdiction, if such employee&#8217;s participation is prohibited under the
laws of the jurisdiction governing such employee or compliance with the laws of the foreign jurisdiction would violate the requirements
of Section 423 of the Code; (vi) employees who do not meet any other eligibility requirements that the Compensation Committee may choose
to impose (within the limits permitted by the Code); and (vii) individuals who provide services to Intrusion who are reclassified as common
law employees for any reason except for federal income and employment tax purposes. A new plan benefits table is provided below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Share Purchase <br/>$ Amount</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Share Purchase <br/># Shares</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; font-style: italic; text-align: left">Executive Group</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 66%; text-align: left; padding-left: 10pt">Anthony Scott<br/>President and CEO, Director <br/></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td style="width: 13%; text-align: right">323</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">75</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 10pt">Kimberly Pinson <br/>Chief Financial Officer</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">323</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">75</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-weight: bold; font-style: italic; text-align: left">Non-Executive Director Group</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#8211;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="font-weight: bold; font-style: italic; text-align: left">Non-Executive Officer Employee Group</td><td>&#160;</td>
    <td style="text-align: left">$</td><td style="text-align: right">1,613</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">375</td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of July 1, 2024, approximately
49 of our employees were eligible to participate in the ESPP.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Enrollment in the ESPP</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Eligible employees become
participants in the ESPP by completing a subscription agreement or enrolling online authorizing payroll deductions prior to the applicable
Offering Date. A person who becomes employed after the commencement of an Offering Period may not participate in the ESPP until the commencement
of the next Offering Period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Contribution and Purchase Limitations</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Unless otherwise determined
by the Compensation Committee in accordance with the terms of the ESPP, no participant may (i) elect a contribution rate of more than
15% of his or her compensation (as defined in the ESPP) for the purchase of shares under the ESPP; (ii) purchase more than 1,500 shares
of our Common Stock (which limit the Compensation Committee may increase or decrease provided such limit does not exceed 10,000 shares)
under the ESPP on any one Purchase Date; or (iii) purchase shares that have a fair market value of more than $25,000, determined as of
the Offering Date, in any calendar year in which the Offering Period is in effect.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Certain Corporate Transactions</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the number of outstanding
shares of our Common Stock is changed by a stock dividend, recapitalization, stock split, reverse stock split, subdivision, combination,
reclassification, or similar change in our capital structure without consideration, then the Compensation Committee will proportionately
adjust the number of shares available under the ESPP, the purchase price, the number of shares any participant has elected to purchase,
and the limit on the number of shares a participant may purchase on any one Purchase Date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 31 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event of a Corporate
Transaction (as defined in the ESPP), each outstanding right to purchase Common Stock under the ESPP will be assumed or an equivalent
option substituted by the successor corporation. In the event that the successor corporation refuses to assume or substitute for the purchase
right, the Offering Period with respect to which such purchase right relates will be shortened and provide for a new final Purchase Date,
which shall occur on or prior to the consummation of the Corporate Transaction, as determined by the Compensation Committee. The ESPP
shall terminate on the closing of the Corporate Transaction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Term; Amendments and Termination</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The ESPP terminates upon the
issuance of all the shares of Common Stock reserved for issuance under the ESPP or an earlier termination of the ESPP by our Board of
Directors or our Compensation Committee. The Compensation Committee may generally amend, suspend, or terminate the ESPP at any time without
stockholder approval, except as may be required by applicable law or exchange listing rules.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Certain U.S. Federal Income Tax Consequences</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following is a general
summary of the United States federal income tax consequences to us and to participants in the ESPP based on tax laws in effect as of the
date of this proxy statement. This summary is not intended to be exhaustive and does not address all matters that may be relevant to any
particular participant. Among other considerations, this summary does not describe the tax laws of any state, municipality, or foreign
jurisdiction, or describe gift, estate, excise, payroll or other employment taxes. Participants are advised to consult with their tax
advisors regarding the tax consequences of participation in the ESPP. The ESPP is intended to qualify as an &#8220;employee stock purchase
plan&#8221; under Section 423 of the Internal Revenue Code and the following discussion assumes that it is so qualified.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each participant&#8217;s payroll
deductions under the ESPP will be made on an after-tax basis. Generally, the participant will not recognize any taxable income at the
time he or she is granted an option to purchase shares of Common Stock during an Offering Period or at the time the option is exercised
to purchase shares on behalf of the participant. The participant will generally only recognize taxable income (or loss) on the date the
participant sells or otherwise disposes of the acquired shares. The particular tax consequence depends on the length of time such shares
are held by the participant prior to the sale or disposition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the shares are sold or
disposed of more than two years from the first day of the Offering Period during which the shares were purchased, and more than one year
from the Purchase Date or if the participant dies while holding the shares, the participant (or his or her estate) will recognize ordinary
income measured as the lesser of (i) the amount by which the fair market value of the shares on the Offering Date exceeded the purchase
price of the shares (calculated as though the shares had been purchased on the Offering Date) and (ii) the excess of the fair market value
of the shares at the time of such sale or other disposition over the purchase price. Any additional gain will be treated as long-term
capital gain. If the shares are held for the holding periods described above but are sold for a price that is less than the purchase price,
there is no ordinary income, and the participating employee has a long-term capital loss for the difference between the sale price and
the purchase price. If the shares are sold or otherwise disposed of before the expiration of either of the holding periods described above,
the participant will recognize ordinary income generally measured as the excess of the fair market value of the shares on the date the
shares are purchased over the purchase price. Any additional gain or loss on such sale or disposition will be long-term or short-term
capital gain or loss, depending on how long the shares were held following the date they were purchased by the participant prior to disposing
of them.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are generally not entitled
to a deduction for amounts taxed as ordinary income or capital gain to a participant except to the extent of ordinary income recognized
upon a sale or disposition of shares prior to the expiration of the holding periods described above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>New Plan Benefits</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Participation in the ESPP
is voluntary and each eligible employee will have the discretion to determine whether and to what extent to participate in and contribute
to the ESPP. Accordingly, the benefits and amounts that will be received or allocated to officers and other employees under the ESPP are
not determinable at this time. Our non-employee directors will not be eligible to participate in our ESPP.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<!-- Field: Page; Sequence: 32 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>PROPOSAL FIVE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="text-transform: uppercase"><b>approval
of the reservation and issuance of up to $10.0 Million </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="text-transform: uppercase"><b>of
Securities in connection with a Standby Equity Purchase Agreement.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 23.75pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Common Stock is currently
listed on Nasdaq and, as such, the Company is subject to Nasdaq rules, which require us to obtain stockholder approval prior to the issuance
of our Common Stock in connection with certain non-public&#160;offerings involving the sale, issuance or potential issuance by the Company
of Common Stock (or securities convertible into or exercisable for Common Stock) equal to 20% or more of the Common Stock outstanding
before the issuance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Overview</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July 3, 2024, the Company
entered into the Standby Equity Purchase Agreement (&#8220;SEPA&#8221;) with Streeterville Capital, LLC (&#8220;Streeterville&#8221;)
pursuant to which the Company has the right to sell to Streeterville up to $10.0&#160;million of Common Stock (&#8220;Commitment Amount&#8221;),
subject to certain limitations and conditions set forth in the SEPA, from time to time during the term of the SEPA. The term of
the SEPA is a period of 24 months from the date of entry into the definitive documents. The Company also entered into a Registration
Rights Agreement with Streeterville pursuant to which it will register the resale of shares of Common Stock issued to Streeterville pursuant
to the SEPA.&#160;Sales of the shares of Common Stock to Streeterville under the SEPA, and the timing of any such sales, are at the Company&#8217;s
option, and the Company is under no obligation to sell any shares of Common Stock to Streeterville under the SEPA.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Upon the satisfaction of the
conditions to Streeterville&#8217;s purchase obligation set forth in the SEPA, including having a registration statement registering the
resale of the shares of Common Stock issuable under the SEPA declared effective by the Securities and Exchange Commission, the Company
will have the right, but not the obligation, from time to time at its discretion, to direct Streeterville to purchase a specified number
of shares of Common Stock (an &#8220;Advance&#8221;) by delivering written notice to Streeterville (an &#8220;Advance Notice&#8221;).
Each Advance is limited to the lower of (i)&#160;an amount equal to 100% of the aggregate daily trading volume during the three (3) consecutive&#160;trading
days immediately preceding an Advance Notice, or (ii) 4.99% of the shares issued and outstanding of Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The shares of Common Stock
purchased pursuant to an Advance will be purchased at a price equal to 95% of the lowest daily VWAP of the shares of Common Stock during
the three consecutive&#160;trading days commencing on the date of the delivery of the Advance Notice, other than the daily VWAP on a&#160;day
in which the daily VWAP is less than a minimum acceptable price as stated by the Company in the Advance Notice or there is no VWAP on
the subject&#160;trading day. The Company may establish a minimum acceptable price in each Advance Notice below which the Company will
not be obligated to make any sales to Streeterville. &#8220;VWAP&#8221; is defined as the daily volume weighted average price of the shares
of Common Stock for such&#160;trading day on the Nasdaq Stock Market during regular trading&#160;hours as reported by Bloomberg L.P.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Under applicable Nasdaq rules
and the terms of the SEPA, in no event may the Company issue to Streeterville under the SEPA shares of Common Stock equal to greater
than 19.99% of the shares of Common Stock outstanding immediately prior to the execution of the SEPA (the &#8220;Exchange Cap&#8221;),
unless (i)&#160;the Company obtains stockholder approval to issue shares of Common Stock in excess of the Exchange Cap in accordance
with applicable Nasdaq rules, or (ii)&#160;the average price per share paid by Streeterville for all of the shares of Common Stock that
the Company directs Streeterville to purchase from the Company pursuant to the SEPA, if any, equals or exceeds the lower of (a)&#160;the
official closing price of the Common Stock on Nasdaq immediately preceding the execution of the SEPA and (b)&#160;the average official
closing price of the Common Stock on Nasdaq for the five consecutive&#160;trading days immediately preceding the execution of the SEPA,
adjusted as required by Nasdaq. Moreover, the Company may not issue or sell any shares of Common Stock to Streeterville under the SEPA
which, when aggregated with all other shares of Common Stock then beneficially owned by Streeterville and its affiliates (as calculated
pursuant to Section&#160;13(d)&#160;of the Exchange&#160;Act and Rule&#160;13d-3&#160;thereunder), would result in Streeterville beneficially
owning more than 19.99% of the outstanding shares of Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Actual sales of shares of Common
Stock to Streeterville as an Advance under the SEPA will depend on a variety of factors to be determined by the Company from time to time,
which may include, among other things, market conditions, the trading price of the Common Stock and determinations by the Company as to
the appropriate sources of funding for our business and operations. The Company will use 10% of the proceeds associated with each Advance
to redeem the outstanding Series A Preferred Stock held by Streeterville.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt"></p>

<!-- Field: Page; Sequence: 33 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The SEPA will automatically
terminate on the earliest to occur of (i)&#160;the 24-month&#160;anniversary of the date of the SEPA or (ii)&#160;the date on which the
Company shall have made full issuances of Advances pursuant to the SEPA.&#160;The Company has the right to terminate the SEPA at no cost
or penalty upon five (5) trading days&#8217; prior writtine notice to Streeterville, provided that there are no outstanding Advance Notices
for which shares of Common Stock need to be issued.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As consideration for Streeterville&#8217;s
commitment to purchase the shares of Common Stock pursuant the SEPA, the Company paid Streeterville, (i)&#160;a structuring fee in the
amount of $25,000 and (ii)&#160;a commitment fee equal to 1% of the Commitment Amount, to be paid within three trading days of entering
into the SEPA.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The net proceeds under the
SEPA to the Company will depend on the frequency and prices at which Common Stock is sold. The Company expects that proceeds received
from such sales will be used primarily for working capital and general corporate purposes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Reasons for the Financing</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company believes that
the Streeterville transaction provides necessary additional sources of capital to the Company. The proceeds that the Company expects
to receive from the Streeterville transaction will allow the Company to fund its business operations. The Streeterville transaction provides
the Company with future flexibility to enhance its liquidity in an opportunistic and efficient manner, and only when the Company deems
it to be necessary. We remain focused on creating long-term&#160;value for our stockholders, and the Streeterville transaction will allow
us to be strategic in how we access and deploy capital primarily in support of the ongoing development and distribution of our products.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Reasons for the Stockholder Approval</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Common Stock is listed
on Nasdaq, and as a result, the Company is subject to the Nasdaq Listing Rules. In order to comply with the Nasdaq Listing Rules, we
are seeking stockholder approval of this proposal to potentially sell additional shares of Common Stock above the Exchange Cap.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Nasdaq Listing Rule&#160;5635(d)&#160;requires
stockholder approval prior to the issuance of securities in connection with a transaction other than a public offering involving the
sale, issuance or potential issuance of common stock (or&#160;securities convertible into or exercisable for common stock) in an amount
equal to 20% or more of the common stock or 20% or more of the voting power outstanding before the issuance at a price less than the
&#8220;Minimum Price.&#8221; The Minimum Price is defined as the lower of (i)&#160;the closing price of the common stock immediately
preceding the signing of the sale agreement or (ii)&#160;the average closing price of the common stock for the five&#160;trading&#160;days
immediately preceding the signing of the sale agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Accordingly, we are seeking
stockholder approval under Nasdaq Listing Rule&#160;5635(d)&#160;for the sale, issuance or potential issuance by us of Common Stock (or
securities convertible into or exercisable for our Common Stock) in excess of 20% of the shares of our Common Stock outstanding immediately
prior to the SEPA at an exercise price less than the Minimum Price in connection with the SEPA.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Consequences of Not Approving this Proposal</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Board is not seeking the
approval of the Company&#8217;s stockholders to authorize the entry into the SEPA. The SEPA has already been executed and delivered, and
the closing of the SEPA has occurred. The failure of our stockholders to approve this proposal will mean that the issuance of shares of
Common Stock in accordance with the SEPA will be limited to an amount up to the Exchange Cap, and we will not be able to realize the full
benefit of this important financing transaction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Potential Adverse Effects of Approving this
Proposal</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If approved, this proposal
will provide for the issuance of up to an aggregate of $10&#160;million in shares of Common Stock to Streeterville. The issuance
of shares of Common Stock to Streeterville will dilute the percentage ownership interest of all stockholders, may dilute the book value
per share of the Common Stock and will increase the number of the Company&#8217;s outstanding shares, which could depress the market price
of the Common Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 34 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>OWNERS AND MANAGEMENT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets
forth information regarding the beneficial ownership of the Common Stock as of June 25, 2024, unless otherwise indicated, by (1) each
person known by the Company to be the beneficial owner of more than 5% of the outstanding shares of Common Stock, (2) each director and
director nominee, (3) the Company&#8217;s current executive officers and (4) all current directors, nominees, and executive officers
of the Company as a group. The persons and entities named in the table have sole voting and investment power with respect to all such
shares owned by them, unless otherwise indicated.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">Amount and</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: center">Nature of Beneficial</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2">&#160;</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid">Name of Beneficial Owner or Group (1)</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Ownership</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Percent of Class (2)</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">Directors and Named Executive Officers:</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 66%; text-align: left; padding-left: 9pt">Anthony Scott (3)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">1,318,066</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 13%; text-align: right">19.99%</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 9pt">Kimberly Pinson (4)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">42,169</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">*%</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9pt">Anthony J. LeVecchio(5)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30,555</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">*%</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 9pt">James F. Gero (6)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">82,904</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1.52%</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9pt">Katrinka B. McCallum (7)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">13,809</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">*%</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 9pt">Gregory K. Wilson (8)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">9,128</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">*%</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9pt">T. Joe Head (9)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">22,938</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">*%</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left; padding-left: 9pt">All directors, director nominees, and executive officers as a group (7 persons) (10)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,519,569</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">28.06%</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">5% or Greater Stockholders</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-left: 9pt">Raymond T. Hyer (11)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,294,066</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">19.99%</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: left">* Represents beneficial ownership of less than 1% of the outstanding shares of Common Stock.</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 5%">(1)</td><td style="text-align: justify; width: 95%">The address for of the persons or entities shown in the foregoing
                              table who are beneficial owners of more than 5% of the Common is 101 East Park Blvd, Suite 1200, Plano,
                              Texas 75074, except for Raymond Hyer, whose address is 3919 E. 7<sup>th</sup> Avenue, Tampa, Florida 33605.</td></tr>
<tr style="vertical-align: top">
<td>(2)</td><td style="text-align: justify">Beneficial ownership is calculated in accordance with the rules of the SEC in accordance
            with Rule 13d-3(d)(1) of the Exchange Act. The percentage of beneficial ownership is based on 5,415,538 shares of Common
            Stock issued outstanding as of June 25, 2024. In computing the number of shares beneficially owned by a person and the percentage
            ownership of that person, shares of Common Stock subject to options or warrants held by that person that are currently exercisable
            or will become exercisable on or before August 25, 2024, are deemed outstanding. However, these shares are not deemed outstanding
            for the purpose of computing the percentage ownership of any other person. Unless otherwise indicated in the footnotes to
            this table, the persons and entities named in the table have sole voting and sole investment power with respect to all shares
            beneficially owned, subject to community property laws where applicable.</td></tr>
<tr style="vertical-align: top">
<td>(3)</td><td style="text-align: justify">Includes 6,586 shares that Mr. Scott may acquire upon exercise of options and 1,171,496 shares
            that Mr. Scott may acquire upon exercise warrants that are currently exercisable or will become exercisable on or before
            August 25, 2024. The warrants that Mr. Scott may exercise include a beneficial ownership limitation that limits the number
            of warrants that can be exercised. The warrants exercised cannot result in Mr. Scotts beneficial ownership exceeding 19.99%
            of the number of shares of the company&#8217;s comment stock outstanding.</td></tr>
<tr style="vertical-align: top">
<td>(4)</td><td style="text-align: justify">Includes 3,759 shares that Ms. Pinson may acquire upon exercise of options and 23,334 shares that Ms. Pinson
may acquire upon exercise of warrants that are currently exercisable or will become exercisable on or before August 25, 2024.</td></tr>
<tr style="vertical-align: top">
<td>(5)</td><td style="text-align: justify">Includes 1,610 shares that Mr. LeVecchio may acquire upon exercise of options and 8,334 shares that Mr.
LeVecchio may acquire upon exercise of warrants that are currently exercisable or will become exercisable on or before August 25, 2024.</td></tr>
<tr style="vertical-align: top">
<td>(6)</td><td style="text-align: justify">Includes 3,116 shares that Mr. Gero may acquire upon exercise of options and 36,459 shares that Mr. Gero
may acquire upon exercise of warrants that are currently exercisable or will become exercisable on or before August 25, 2024.</td></tr>
<tr style="vertical-align: top">
<td>(7)</td><td style="text-align: justify">Includes 795 shares that Ms. McCallum may acquire upon exercise of options 5,834 shares that Ms. McCallum
may acquire upon the exercise of warrants that are currently exercisable or will become exercisable on or before August 25, 2024.</td></tr>
<tr style="vertical-align: top">
<td>(8)</td><td style="text-align: justify">Includes 645 shares that Mr. Wilson may acquire upon exercise of options and 2,813 shares that Mr. Wilson
may acquire upon exercise of warrants that are currently exercisable or will become exercisable on or before August 25, 2024.</td></tr>
<tr style="vertical-align: top">
<td>(9)</td><td style="text-align: justify">Includes 1,250 shares that Mr. Head may acquire upon exercise of options that are currently
            exercisable or will become exercisable on or before August 25, 2024. Also includes 5,000 shares held by the Biblical Studies
            Foundation in which Mr. Head is President.</td></tr>
<tr style="vertical-align: top">
<td>(10)</td><td style="text-align: justify">Includes an aggregate of 17,761 shares that may be acquired upon exercise of options and 1,248,270 shares
that may be acquired upon exercise of warrants of officers and directors that are currently exercisable or will become exercisable on
or before August 25, 2024.</td></tr>
<tr style="vertical-align: top">
<td>(11)</td><td style="text-align: justify">Includes 1,056,976 shares that Mr. Hyer may acquire upon exercise warrants that are currently exercisable
or will become exercisable on or before August 25, 2024. The warrants that Mr. Hyer may exercise include a beneficial ownership limitation
that limits the number of warrants that can be exercised. The warrants exercised cannot result in Mr. Hyer&#8217;s beneficial ownership
exceeding 19.99% of the number of shares of the company&#8217;s comment stock outstanding.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 13pt 0pt 0.4pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Page; Sequence: 35 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CERTAIN TRANSACTIONS WITH MANAGEMENT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During 2023 and 2022, the
Company retained legal services of a third-party law firm for which the Company&#8217;s Chief Executive Officer is a senior advisor. The
Company recognized $77,415 and $268,291 in expense for the years ended December 31, 2023, and 2022, respectively in general and administrative
expense on the Consolidated Statements of Operations. The rates paid for legal services to the third-party firm were comparable to rates
paid to other law firms providing legal services to the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On January 2, 2024, the Company
entered into an invoice financing arrangement pursuant to a note purchase agreement with Anthony Scott, President and Chief Executive
Officer of the Company, according to which, among other things, Mr. Scott purchased from the Company a promissory note (the &#8220;Note&#8221;)
in the aggregate principal amount of $1,080,000 in exchange for $1,000,000 to the Company. Under the Note, the Company shall make principal
payments to Mr. Scott in the amount $40,000 per week each week prior to its maturity on June 15, 2024. Interest accrues on the balance
of the Note prior to its maturity at a rate of 7.0% per annum, compounded daily. In connection with the issuance of the Note, the Company
and Mr. Scott also entered into a security agreement, which provides, according to its terms, a security interest in all accounts receivable
or other receivables now existing or subsequently created prior to the payment of the Note, subject to prior permitted liens.
On March 20, 2024, the Company entered into an additional invoice financing arrangement pursuant to a note purchase agreement with Scott,
according to which, among other things, Scott purchased from the Company a second Promissory Note 2 in the aggregate principal amount
of $343,400 in exchange for $340,000 to the Company. The Promissory Note 2 is non-interest bearing and matures on April 19, 2024.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On October 10, 2023, the
Company entered into an invoice financing arrangement pursuant to a note purchase agreement with James Gero, Director of the Company,
according to which, among other things, Mr. Gero purchased from the Company a promissory note (the &#8220;Note 2&#8221; in the aggregate
principal amount of $500,000 in exchange for $465,000 to the Company. Under the Note 2 the Company made principal payment to Mr. Gero
in the amount of $10,000 per week each week prior to its maturity on November 2, 2023. Interest accrued at a rate of 7.0% per annum, compounded
daily. The note was repaid in full on November 2, 2023. The Company recorded $40,000 in interest expense related to the note.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">During 2023 and up until
July 1, 2024, there have been no other transactions, or currently proposed transactions, between the Company and any of its executive
officers, directors, director nominees, or 5% beneficial holders, or member of the immediate family of the foregoing persons, in which
one of the foregoing individuals or entities had an interest of more than $120,000. It is the Company&#8217;s policy that any such transaction
between these individuals and the Company would require the review and approval of our Board prior to being entered into.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING
COMPLIANCE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Ownership Reporting</i>.
Section 16(a) of the Exchange Act requires the Company&#8217;s directors and officers, and persons who own more than 10% of a registered
class of the Company&#8217;s equity securities, to file initial reports of ownership and reports of changes in ownership with the SEC.
Such persons are required by SEC regulation promulgated pursuant to the Exchange Act to furnish the Company with copies of all Section
16(a) report forms they file with the SEC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Delinquent Section 16
Reports</i>. Based solely on its review of the copies of such report forms received by it with respect to fiscal year 2022, the Company
believes that all filing requirements applicable to its directors, officers and persons who own more than 10% of a registered class of
the Company&#8217;s equity securities have been timely complied with in accordance with Section 16(a) of the Exchange Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>STOCKHOLDER PROPOSALS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Stockholders may submit proposals
on matters appropriate for stockholder action at subsequent annual meetings of the stockholders consistent with Rule 14a-8 promulgated
under the Exchange Act. For such proposals to be considered for inclusion in the Proxy Statement and Proxy relating to the 2025 Annual
Meeting of Stockholders, such proposals must be received by the Company not later than [March 3, 2025]. Such proposals should be directed
to Intrusion Inc., 101 East Park Blvd., Suite 1200, Plano, Texas 75074, Attention: Secretary (telephone: (972) 234-6400; telecopy: (972)
234-1467).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to Rule 14a-4(c)
of the Exchange Act of 1934, if a stockholder who intends to present a proposal at the Annual Meeting of Stockholders to be held in 2025
does not notify the Company of such proposal on or prior to [May 17, 2025], then management proxies would be allowed to use their discretionary
voting authority to vote on the proposal when the proposal is raised at the annual meeting, even though there is no discussion of the
proposal in the 2025 proxy statement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 36 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ADDITIONAL INFORMATION AVAILABLE</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>Upon the written request
of any stockholder, the Company will furnish, without charge, a copy of the Company&#8217;s 2024 Annual Report on Form 10-K, as filed
with the SEC, including the financial statements and schedules thereto. The request should be directed to the Secretary at the Company&#8217;s
offices indicated above.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s 2024
Annual Report on Form 10-K accompanies this Proxy Statement. The Annual Report on Form 10-K, which includes financial statements, does
not form and is not to be deemed part of this Proxy Statement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>OTHER BUSINESS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of the date of this Proxy
Statement, the Board and management are not aware of any other matter, other than those described herein, which will be presented for
consideration at the Meeting. Should any other matter requiring a vote of the stockholders properly come before the Meeting or any adjournment
thereof, the enclosed Proxy confers upon the persons named in and entitled to vote the shares represented by such Proxy discretionary
authority to vote the shares represented by such Proxy in accordance with their best judgment in the interest of the Company on such matters.
The persons named in the enclosed Proxy also may, if it is deemed advisable, vote such Proxy to adjourn the Meeting from time to time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>Please sign, date and
return promptly the enclosed Proxy at your earliest convenience in the enclosed envelope, which requires no postage if mailed in the United
States.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5in"><i>By Order of the Board of Directors</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5in"><span style="text-decoration: underline">/s/ Anthony J. LeVecchio&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5in"><i>Anthony J. LeVecchio</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5in"><i>Executive Chairman of the Board</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Plano, Texas</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">July 15, 2024</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Page; Sequence: 37 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="text-decoration: underline">EXHIBIT A</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">INTRUSION INC.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-decoration: underline">AMENDED AND RESTATED</span> 2021 OMNIBUS INCENTIVE
PLAN</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">1.</span><span style="font-size: 10pt">
</span></b></span><b>Purpose. </b>The Intrusion Inc. 2021 Omnibus Incentive Plan was originally adopted and became effective on March
25, 2021, which was the date of its adoption by the Board, subject to the approval by the stockholders of the Company. The Plan was amended
effective May 16, 2023, pursuant to approval by the stockholders of the Company, to confer authority to the Compensation Committee to
determine &#8220;Special Circumstances&#8221; as defined by the Plan. Subject to stockholder approval, this Amended and Restated 2021
Omnibus Incentive Plan amends the Plan to provide for a reallocation of Two Million Five-Hundred Thousand (2,500,000) shares of Intrusion
Inc. Common Stock to the Plan to supplement the Plan&#8217;s original stock allocation after a reverse stock split of 1 to 20, effective
March 15, 2024. The purpose of the Plan is to provide a means through which the Company and its Affiliates may attract and retain key
personnel and to provide a means whereby directors, officers, employees, consultants and advisors of the Company and its Affiliates can
acquire and maintain an equity interest in the Company, or be paid incentive compensation, including incentive compensation measured by
reference to the value of Common Stock, thereby strengthening their commitment to the welfare of the Company and its Affiliates and aligning
their interests with those of the Company&#8217;s stockholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">2.</span><span style="font-size: 10pt">
</span></b></span><b>Definitions</b>. The following definitions shall be applicable throughout the Plan:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><b>&#8220;</b><span style="text-decoration: underline">Affiliate</span><b>&#8221; </b>means each of the following: (a) any Subsidiary; (b) any Parent; (c) any corporation,
trade or business (including without limitation a partnership or limited liability company) which is directly or indirectly controlled
50% or more (whether by ownership of stock, assets or an equivalent ownership interest or voting interest) by the Company or one of its
Affiliates; (d) any trade or business (including a partnership or limited liability company) which directly or indirectly controls 50%
or more (whether by ownership of stock, assets or an equivalent ownership interest or voting interest) of the Company; and (e) any other
entity in which the Company or any of its Affiliates has a material equity interest and which is designated as an &#8220;Affiliate&#8221;
by resolution of the Committee; provided that, unless determined by the Committee, the Common Stock subject to any Award will constitute
&#8220;service recipient stock&#8221; for purposes of Section 409A of the Code or will not subject the Award to Section 409A of the Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Award</span>&#8221; means any award under the Plan of any Stock Option, Stock Appreciation Right, Restricted Stock Award,
Performance Award, Other Stock-Based Award or Other Cash-Based Award. All Awards shall be granted by, confirmed by, and subject to the
terms of, a written agreement executed by the Company and the Participant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(c)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><b>&#8220;</b><span style="text-decoration: underline">Award Agreement</span><b>&#8221; </b>means the written or electronic agreement setting forth the terms and conditions
applicable to an Award.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(d)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><b>&#8220;</b><span style="text-decoration: underline">Board</span><b>&#8221; </b>means the Board of Directors of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(e)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><b>&#8220;</b><span style="text-decoration: underline">Cause</span><b>&#8221; </b>means, unless determined by the Committee in the applicable Award Agreement, with respect
to a Participant&#8217;s Termination of Employment or Termination of Consultancy, the following: (a) in the case where there is no employment,
consulting, change in control or similar agreement in effect between the Company or an Affiliate and the Participant at the time of the
grant of the Award (or where there is such an agreement but it does not define &#8220;cause&#8221; (or words of like import)), termination
due to a Participant&#8217;s insubordination, dishonesty, fraud, incompetence, moral turpitude, willful misconduct, refusal to perform
the Participant&#8217;s duties or responsibilities for any reason other than illness or incapacity, or materially unsatisfactory performance
of the Participant&#8217;s duties for the Company or an Affiliate, as determined by the Committee in its good faith discretion; or (b)
in the case where there is an employment, consulting, change in control or similar agreement in effect between the Company or an Affiliate
and the Participant at the time of the grant of the Award that defines &#8220;cause&#8221; (or words of like import), &#8220;cause&#8221;
as defined under such agreement; provided, however, that with regard to any agreement under which the definition of &#8220;cause&#8221;
only applies on occurrence of a change in control, such definition of &#8220;cause&#8221; shall not apply until a change in control actually
takes place and then only with regard to a termination. With respect to a Participant&#8217;s Termination of Directorship, &#8220;cause&#8221;
means an act or failure to act that constitutes cause for removal of a director under applicable Delaware law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 38 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(f)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Change of Control</span>&#8221; has the meaning set forth in Section 11(b) below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(g)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Change in Control Price</span>&#8221; has the meaning set forth in Section 11(a)(ii).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(h)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><b>&#8220;</b><span style="text-decoration: underline">Code</span><b>&#8221; </b>means the Internal Revenue Code of 1986, as amended. Any reference to any section of the
Code shall also be a reference to any successor provision and any applicable Treasury Regulation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(i)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><b>&#8220;</b><span style="text-decoration: underline">Committee</span><b>&#8221; </b>means any committee of the Board duly authorized by the Board to administer the Plan.
If no committee is duly authorized by the Board to administer the Plan, the term &#8220;Committee&#8221; shall be deemed to refer to the
Board for all purposes under the Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(j)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Common Stock</span>&#8221; means the common stock, $.01 par value per share, of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(k)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Company</span>&#8221; means Intrusion Inc., and its successors by operation of law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(l)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Consultant</span>&#8221; means any Person who is an advisor or consultant to the Company or its Affiliates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(m)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Disability</span>&#8221; means, unless determined by the Committee in the applicable Award Agreement, with respect to a
Participant&#8217;s Termination, a permanent and total disability as defined in Section 22(e)(3) of the Code. A Disability shall only
be deemed to occur at the time of the determination by the Committee of the Disability. For Awards that are subject to Section 409A of
the Code, Disability shall mean that a Participant is disabled under Section 409A(a)(2)(C)(i) or (ii) of the Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(n)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Effective Date</span>&#8221; means the effective date of the Plan as defined in Section 15.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(o)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Eligible Employees</span>&#8221; means each employee of the Company or an Affiliate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(p)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Eligible Individual</span>&#8221; means an Eligible Employee, independent Non-Employee Director, or Consultant who is designated
by the Committee in its discretion as eligible to receive Awards subject to the conditions set forth in the Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(q)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Exchange Act</span>&#8221; means the Securities Exchange Act of 1934, as amended. Reference to a specific section of the
Exchange Act or applicable regulation includes such section or regulation, any valid regulation or interpretation, and any comparable
provision of any future legislation or regulation amending, supplementing or superseding such section or regulation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(r)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Fair Market Value</span>&#8221; means, for purposes of the Plan, unless required by any applicable provision of the Code
or regulations, as of any date and except as provided below, the last sales price reported for the Common Stock on the applicable date:
(a) as reported on the principal national securities exchange in the United States on which it is then traded, or (b) if the Common Stock
is not traded, listed or reported or quoted, the Committee shall determine in good faith the Fair Market Value in whatever manner it considers
appropriate taking into account the requirements of Section 409A of the Code. For purposes of the exercise of any Award, the applicable
date shall be the date a notice of exercise is received by the Committee or, if not a day on which the applicable market is open, the
next day that it is open.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(s)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Family Member</span>&#8221; means the Participant&#8217;s child, stepchild, grandchild, parent, stepparent, grandparent,
spouse, former spouse, sibling, niece, nephew, mother-in-law, father-in- law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law,
including adoptive relationships, any person sharing the Participant&#8217;s household (other than a tenant or employee), a trust in which
one or more of the foregoing described persons (and/or the Participant) have more than fifty percent (50%) of the beneficial interest,
a foundation in which one or more of the foregoing described persons (and/or the Participant) control the management of assets, and any
other entity in which one or more of the foregoing described persons (and/or the Participant) own more than fifty percent (50%) of the
voting interests.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 39 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(t)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Incentive Stock Option</span>&#8221; means any Stock Option awarded to an Eligible Employee of the Company, its Subsidiaries
and its Parents (if any) under the Plan intended to be and designated as an &#8220;Incentive Stock Option&#8221; within the meaning of
Section 422 of the Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(u)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Non-Employee Director</span>&#8221; means a director or a member of the Board of the Company or any Affiliate who is not
an active employee of the Company or any Affiliate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(v)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Non-Qualified Stock Option</span>&#8221; means any Stock Option awarded under the Plan that is not an Incentive Stock Option.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(w)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Other Cash-Based Award</span>&#8221; means an Award granted pursuant to Section 10(c) of the Plan and payable in cash at
such time or times and subject to such terms and conditions as determined by the Committee in its sole discretion.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(x)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Other Stock-Based Award</span>&#8221; means an Award under Section 10(a) of the Plan that is valued in whole or in part
by reference to, or is payable in or based on, Common Stock, including warrants and including an Award valued by reference to an Affiliate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(y)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Parent</span>&#8221; means any parent corporation of the Company within the meaning of Section 424(e) of the Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(z)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Participant</span>&#8221; means an Eligible Individual to whom an Award has been granted pursuant to the Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(aa)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Performance Award</span>&#8221; means an Award granted to a Participant pursuant to Section 9 of the Plan contingent upon
achieving certain Performance Criteria, including restricted stock that vests upon the attainment of one or more Performance Criteria.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(bb)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Performance Criteria</span>&#8221; means specific levels of performance of the Company (and/or one or more of the Company&#8217;s
Affiliates, divisions or operational and/or business units, business segments, administrative departments, or any combination of the foregoing)
or any Participant, which may be determined in accordance with GAAP or on a non-GAAP basis including one or more of the following measures:
(i) terms relative to a peer group or index; (ii) basic, diluted, or adjusted earnings per share; (iii) sales or revenue; (iv) earnings
before interest, taxes, and other adjustments (in total or on a per share basis); (v) cash available for distribution; (vi) basic or adjusted
net income or operating income; (vii) returns on equity, assets, capital, revenue or similar measure; (viii) level and growth of dividends;
(ix) the price or increase in price of Common Stock; (x) total shareholder return; (xi) total assets; (xii) growth in assets, new originations
of assets, or financing of assets; (xiii) equity market capitalization; (xiv) reduction or other quantifiable goal with respect to general
and/or specific expenses; (xv) equity capital raised; (xvi) mergers, acquisitions, increase in enterprise value of Affiliates, Subsidiaries,
divisions or business units or sales of assets of Affiliates, Subsidiaries, divisions or business units or sales of assets; and (xvii)
any combination of the foregoing. Any one or more of the Performance Criteria may be stated as a percentage of another Performance Criteria,
or used on an absolute or relative basis to measure the performance of the Company and/or one or more Affiliates as a whole or any divisions
or operational and/or business units, business segments, administrative departments of the Company and/or one or more Affiliates or any
combination thereof, as the Committee may deem appropriate, or any of the above Performance Criteria may be compared to the performance
of a selected group of comparison companies, or a published or special index that the Committee, in its sole discretion, deems appropriate,
or as compared to various stock market indices.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(cc)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Performance Period</span>&#8221; means the designated period during which the Performance Criteria must be satisfied with
respect to the Award to which the Performance Criteria relate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(dd)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Person</span>&#8221; means an individual, a partnership, a corporation, a limited liability company, an association, a joint
stock company, a trust, a joint venture, an unincorporated organization and a government or any branch, department, agency, political
subdivision or official thereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(ee)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Plan</span>&#8221; means the Intrusion Inc. <span style="text-decoration: underline">Amended and Restated</span> 2021 Omnibus Incentive Plan, as set forth in this
document as it may be amended from time to time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 40 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(ff)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Proceeding</span>&#8221; has the meaning set forth in Section 14(h).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(gg)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Reorganization</span>&#8221; has the meaning set forth in Section 4(b)(ii).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(hh)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Restricted Stock</span>&#8221; means an Award of shares of Common Stock that is subject to restrictions described in Section
8(b)(v).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(ii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Restriction Period</span>&#8221; has the meaning set forth in Section 8(b)(v)(I) with respect to Restricted Stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(jj)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Rule 16b-3</span>&#8221; means Rule 16b-3 under Section 16(b) of the Exchange Act as then in effect or any successor provision.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(kk)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Section 409A of the Code</span>&#8221; means the nonqualified deferred compensation rules under Section 409A of the Code
and any applicable Treasury Regulations and other official guidance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(ll)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Securities Act</span>&#8221; means the Securities Act of 1933, as amended and all applicable rules and regulations. Reference
to a specific section of the Securities Act or regulation shall include such section or regulation, any valid regulation or interpretation
under such section, and any comparable provision of any future legislation or regulation amending, supplementing or superseding such section
or regulation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(mm)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Stock Appreciation Right</span>&#8221; means the right to an Award granted pursuant to Section 7.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(nn)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Stock Option</span>&#8221; or &#8220;<span style="text-decoration: underline">Option</span>&#8221; means any option to purchase shares of Common Stock granted to
any Eligible Individual pursuant to Section 6.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(oo)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Subsidiary</span>&#8221; means any subsidiary corporation of the Company within the meaning of Section 424(f) of the Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(pp)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Ten Percent Stockholder</span>&#8221; means a Person owning stock possessing more than ten percent (10%) of the total combined
voting power of all classes of stock of the Company, each of its Subsidiaries or its Parent.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(qq)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Termination</span>&#8221; means a Termination of Consultancy, Termination of Directorship or Termination of Employment,
as applicable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(rr)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Termination of Consultancy</span>&#8221; means: (a) that the Consultant is no longer acting as a consultant to the Company
or an Affiliate; or (b) when an entity which is retaining a Participant as a Consultant ceases to be an Affiliate, unless the Participant
is, or becomes, a Consultant to the Company or another Affiliate before or at the time the entity ceases to be an Affiliate. In the event
that a Consultant becomes an Eligible Employee or a Non-Employee Director upon the termination of such Consultant&#8217;s consultancy,
unless determined by the Committee, in its sole discretion, no Termination of Consultancy shall be deemed to occur until such time as
such Consultant is no longer a Consultant, an Eligible Employee or a Non-Employee Director. The Committee may define Termination of Consultancy
in the Award Agreement, provided that any such change to the definition of the term &#8220;Termination of Consultancy&#8221; does not
subject the applicable Award to Section 409A of the Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(ss)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Termination of Directorship</span>&#8221; means that the Non-Employee Director has ceased to be a director of the Company;
except that if a Non-Employee Director becomes an Eligible Employee or a Consultant upon the termination of such Non-Employee Director&#8217;s
directorship, such Non-Employee Director&#8217;s ceasing to be a director of the Company shall not be treated as a Termination of Directorship
unless and until the Participant has a Termination of Employment or Termination of Consultancy, as the case may be.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 41 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(tt)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Termination of Employment</span>&#8221; means: (a) a termination of employment (for reasons other than a military or personal
leave of absence granted by the Company) of a Participant from the Company and its Affiliates; or (b) when an entity which is employing
a Participant ceases to be an Affiliate, unless the Participant is, or becomes, employed by the Company or another Affiliate before or
at the time the entity ceases to be an Affiliate. In the event that an Eligible Employee becomes a Consultant or a Non-Employee Director
upon the termination of such Eligible Employee&#8217;s employment, unless determined by the Committee, in its sole discretion, no Termination
of Employment shall be deemed to occur until such time as such Eligible Employee is no longer an Eligible Employee, a Consultant or a
Non-Employee Director. The Committee may define Termination of Employment in the Award Agreement, provided that any such change to the
definition of the term &#8220;Termination of Employment&#8221; does not subject the applicable Award to Section 409A of the Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(uu)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>&#8220;<span style="text-decoration: underline">Transfer</span>&#8221; means: (a) when used as a noun, any direct or indirect transfer, sale, assignment, pledge, hypothecation,
encumbrance or other disposition (including the issuance of equity in any entity), whether for value or no value and whether voluntary
or involuntary (including by operation of law), and (b) when used as a verb, to directly or indirectly transfer, sell, assign, pledge,
encumber, charge, hypothecate or dispose of (including the issuance of equity in any entity) whether for value or for no value and whether
voluntarily or involuntarily (including by operation of law). &#8220;<span style="text-decoration: underline">Transferred</span>&#8221; and &#8220;<span style="text-decoration: underline">Transferable</span>&#8221; shall
have a correlative meaning.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(vv)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">&#8220;Special Circumstances&#8221;</span> means such circumstances as determined and approved by the Board based upon the recommendation
of the Committee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">3.</span><span style="font-size: 10pt">
</span></b></span><b>Administration</b>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Committee</span>. The Plan shall be administered and interpreted by the Committee. To the extent required by applicable law, rule
or regulation, it is intended that each member of the Committee shall qualify as (a) a &#8220;non-employee director&#8221; under Rule
16b-3, and (b) an &#8220;independent director&#8221; under the rules of any national securities exchange or national securities association,
as applicable. If it is later determined that one or more members of the Committee do not so qualify, actions taken by the Committee before
such determination shall be valid despite such failure to qualify.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Grants of Awards</span>. The Committee shall have full authority to grant, pursuant to the terms of the Plan, to Eligible Individuals:
Stock Options, Stock Appreciation Rights, Restricted Stock Awards, Performance Awards, Other Stock-Based Awards, and Other Cash-Based
Awards. In particular, the Committee shall have the authority:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(i)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>to select the Eligible Individuals to whom Awards may from time to time be granted under this Plan;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(ii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>to determine whether and to what extent Awards, or any combination thereof, are to be granted to one or more Eligible Individuals;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(iii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>to determine the number of shares of Common Stock to be covered by each Award granted under this Plan;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(iv)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>to determine the terms and conditions, not inconsistent with the terms of the Plan, of any Award granted under this Plan (including
the exercise or purchase price (if any), any restriction or limitation, any vesting schedule or acceleration thereof, or any forfeiture
restrictions or waiver thereof, regarding any Award and, as applicable, the shares of Common Stock relating to such Award, based on such
factors, if any, as the Committee shall determine, in its sole discretion);</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(v)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>to determine the amount of cash, if any, to be covered by each Award granted under this Plan;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(vi)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>to determine whether, to what extent and under what circumstances grants of Options and other Awards under the Plan are to operate
on a tandem basis and/or in conjunction with or apart from other awards made by the Company outside of the Plan;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 42 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(vii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>to determine whether and under what circumstances a Stock Option may be settled in cash, Common Stock and/or Restricted Stock under
Section 6;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(viii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>to determine whether a Stock Option is an Incentive Stock Option or Non-Qualified Stock Option;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(ix)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>to impose a &#8220;blackout&#8221; period during which Options may not be exercised;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(x)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>to determine whether to require a Participant, as a condition of the granting of any Award, to not sell or dispose of shares acquired
pursuant to the exercise of an Award for a period of time as determined by the Committee, in its sole discretion, following the date of
the acquisition of such Award;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(xi)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>to modify, extend or renew an Award, provided, however, that such action does not subject the Award to Section 409A of the Code
without the consent of the Participant; and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(xii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>solely to the extent permitted by applicable law, to determine whether, to what extent and under what circumstances to provide
loans (which may be on a recourse basis and shall bear interest at the rate the Committee shall provide) to Participants in order to exercise
Options under the Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(c)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Guidelines</span>. Subject to Section 12, the Committee shall have the authority to adopt, alter and repeal such administrative
rules, guidelines and practices governing the Plan and perform all acts, including the delegation of its responsibilities (to the extent
permitted by applicable law and applicable stock exchange rules), as it shall, from time to time, deem advisable; to construe and interpret
the terms and provisions of the Plan and any Award issued under the Plan (and any agreements relating to such Award); and to supervise
the administration of the Plan. The Committee may correct any defect, supply any omission or reconcile any inconsistency in the Plan or
in any agreement relating to the Plan in the manner and to the extent it shall deem necessary to effectuate the purpose and intent of
the Plan. The Committee may adopt special guidelines and provisions for Persons who are residing in or employed in, or subject to, the
taxes of, any domestic or foreign jurisdictions to comply with applicable tax and securities laws of such domestic or foreign jurisdictions.
No action of the Committee under this Section 3(c) shall impair the rights of any Participant without the Participant&#8217;s consent.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(d)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Decisions Final</span>. Any decision, interpretation or other action made or taken in good faith by or at the direction of the
Company, the Board or the Committee (or any of its members) arising out of or in connection with the Plan shall be within the absolute
discretion of all and each of them, as the case may be, and shall be final, binding and conclusive on the Company and all employees and
Participants and their respective heirs, executors, administrators, successors and assigns.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(e)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Procedures</span>. If the Committee is appointed, the Board shall designate one of the members of the Committee as chairman and
the Committee shall hold meetings, subject to the bylaws of the Company, at such times and places as it shall deem advisable, including
by telephone conference or by written consent to the extent permitted by applicable law. A majority of the Committee members shall constitute
a quorum. All determinations of the Committee shall be made by a majority of its members. Any decision or determination reduced to writing
and signed by all of the Committee members in accordance with the bylaws of the Company, shall be fully effective as if it had been made
by a vote at a meeting duly called and held. The Committee shall keep minutes of its meetings and shall make such rules and regulations
for the conduct of its business as it shall deem advisable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(f)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Designation of Consultants/Liability</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(i)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>The Committee may designate employees of the Company and professional advisors to assist the Committee in the administration of
the Plan and (to the extent permitted by applicable law and applicable exchange rules) may grant authority to officers to grant Awards
and/or execute agreements or other documents on behalf of the Committee. In the event of any designation of authority under the Plan ,
subject to applicable law, applicable stock exchange rules and any limitations imposed by the Committee in connection with such designation,
such designee or designees shall have the power and authority to take such actions, exercise such powers and make such determinations
that are designated to the Committee under the Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 43 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(ii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>The Committee may employ such legal counsel, consultants and agents as it may deem desirable for the administration of the Plan
and may rely upon any opinion received from any such counsel or consultant and any computation received from any such consultant or agent.
Expenses incurred by the Committee or the Board in the engagement of any such counsel, consultant or agent shall be paid by the Company.
The Committee, its members and any Person designated pursuant to Section 3(f) shall not be liable for any action or determination made
in good faith with respect to the Plan. To the maximum extent permitted by applicable law, no officer of the Company or member or former
member of the Committee or of the Board shall be liable for any action or determination made in good faith with respect to the Plan or
any Award granted under it.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(g)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Indemnification</span>. To the maximum extent permitted by applicable law and the Certificate of Incorporation and bylaws of the
Company and to the extent not covered by insurance directly insuring such Person, each officer or employee of the Company or any Affiliate
and member or former member of the Committee or the Board shall be indemnified and held harmless by the Company against any cost or expense
(including reasonable fees of counsel reasonably acceptable to the Committee) or liability (including any sum paid in settlement of a
claim with the approval of the Committee), and advanced amounts necessary to pay the foregoing at the earliest time and to the fullest
extent permitted, arising out of any act or omission to act in connection with the administration of the Plan, except to the extent arising
out of such officer&#8217;s, employee&#8217;s, member&#8217;s or former member&#8217;s own fraud or bad faith. Such indemnification shall
be in addition to any right of indemnification the employees, officers, directors or members or former officers, directors or members
may have under any separate agreement or contract, applicable law and/or the Certificate of Incorporation or bylaws of the Company or
any Affiliate. This indemnification will not apply to the actions or determinations made by an individual with regard to Awards granted
to such individual under the Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">4.</span><span style="font-size: 10pt">
</span></b></span><b>Share Limitation.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Shares</span>. The aggregate number of shares of Common Stock that may be issued or used for reference purposes or with respect
to which Awards may be granted under the Plan shall not exceed Two Million Five Hundred Thousand (2,500,000) shares (subject to any increase
or decrease pursuant to Section 4(b) <span style="text-decoration: underline">or otherwise provided for in this Sub-Paragraph)</span>, which may be either authorized and unissued
Common Stock or Common Stock held in or acquired for the treasury of the Company or both. <span style="text-decoration: underline">Notwithstanding the foregoing limitation,
the aggregate number of shares of Common Stock that may be issued or used for reference purposes or with respect to which Awards may be
granted under the Plan shall be increased annually on the first day of each calendar year beginning on January 1, 2025, and ending on
January 1, 2030 equal to the lesser of: (A) ten percent (10%) of the increase in the number of shares of Common Stock outstanding from
the first day of the preceding calendar year to the first day of the current calendar year, as the number of shares are determined on
a fully-diluted basis; and (B) such smaller number of shares of Common Stock as may be determined by the Board</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>The maximum number of shares of Common Stock with respect to which Incentive Stock Options may be granted under the Plan shall
be Two Million Five Hundred Thousand (2,500,000) shares. If any Option, Stock Appreciation Right or Other Stock-Based Awards granted under
the Plan expires, terminates or is canceled for any reason without having been exercised in full, the number of shares of Common Stock
underlying any unexercised Award shall again be available for the purpose of Awards under the Plan. If any shares of Restricted Stock,
Performance Awards or Other Stock-Based Awards denominated in shares of Common Stock awarded under the Plan to a Participant are forfeited
for any reason, the number of forfeited shares of Restricted Stock, Performance Awards or Other Stock-Based Awards denominated in shares
of Common Stock shall again be available for purposes of Awards under the Plan. If any shares of Common Stock are (i) withheld to satisfy
tax withholding obligations on an Award issued under the Plan, (ii) tendered in order to satisfy the exercise price due with respect to
an Award issued under the Plan, or (iii) repurchased by the Company using proceeds received upon exercise of a Stock Option, the number
of shares of Common Stock so withheld, tendered or repurchased, as applicable, shall not be available for purposes of future Awards under
the Plan. If a Stock Appreciation Right or a Limited Stock Appreciation Right is granted in tandem with an Option, such grant shall only
apply once against the maximum number of shares of Common Stock which may be issued under the Plan. Any Award under the Plan settled in
cash shall not be counted against the foregoing maximum share limitations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 44 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(c)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Changes</span><b>. </b>The existence of the Plan and the Awards granted under the Plan shall not affect in any way the right or
power of the Board, the Committee or the stockholders of the Company to make or authorize (i) any adjustment, recapitalization, reorganization,
stock split, or other change in the Company&#8217;s capital structure or its business, (ii) any merger or consolidation of the Company
or any Affiliate, (iii) any issuance of bonds, debentures, preferred or prior preference stock ahead of or affecting the Common Stock,
(iv) the dissolution or liquidation of the Company or any Affiliate, (v) any sale or transfer of all or part of the assets or business
of the Company or any Affiliate or (vi) any other corporate act or proceeding. Subject to the provisions of Section 11(b):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(i)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>If the Company at any time subdivides (by any split, recapitalization or otherwise) the outstanding Common Stock into a greater
number of shares of Common Stock, or combines (by reverse split, combination or otherwise) its outstanding Common Stock into a lesser
number of shares of Common Stock, then the respective exercise prices for outstanding Awards that provide for a Participant elected exercise
and the number of shares of Common Stock covered by outstanding Awards shall be appropriately adjusted by the Committee to prevent dilution
or enlargement of the rights granted to, or available for, Participants under the Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(ii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Excepting transactions covered by Section 11(b), if the Company effects any merger, consolidation, statutory exchange, spin-off,
reorganization, sale or transfer of all or substantially all the Company&#8217;s assets or business, or other corporate transaction or
event in such a manner that the Company&#8217;s outstanding shares of Common Stock are converted into the right to receive (or the holders
of Common Stock are entitled to receive in exchange for such shares), either immediately or upon liquidation of the Company, securities
or other property of the Company or other entity (each, a &#8220;Reorganization&#8221;), then, subject to the provisions of Section 11(b),
(A) the aggregate number or kind of securities that may be issued under the Plan, (B) the number or kind of securities or other property
(including cash) to be issued pursuant to Awards granted under the Plan (including as a result of the assumption of the Plan and the obligations
under the Plan by a successor entity, as applicable), or (C) the purchase price for such securities, shall be appropriately adjusted by
the Committee to prevent dilution or enlargement of the rights granted to, or available for, Participants under the Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(iii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>If there shall occur any change in the capital structure of the Company other than those covered by Section 11 or this Section,
including by reason of any extraordinary dividend (whether cash or equity), any conversion, any adjustment, any issuance of any class
of securities convertible or exercisable into, or exercisable for, any class of equity securities of the Company, then the Committee may
adjust any Award and make such other adjustments to the Plan to prevent dilution or enlargement of the rights granted to, or available
for, Participants under the Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(iv)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Any such adjustment determined by the Committee pursuant to this Section shall be final, binding and conclusive on the Company
and all Participants and their respective heirs, executors, administrators, successors and permitted assigns. Any adjustment to, or assumption
or substitution of, an Award under this Section shall be intended to comply with the requirements of Section 409A of the Code and Treasury
Regulation &#167;1.424-1 (and any amendments thereto), to the extent applicable. Except as expressly provided in this Section or in the
applicable Award Agreement, a Participant shall have no additional rights under the Plan by reason of any transaction or event.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(v)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Fractional shares of Common Stock resulting from any adjustment in Awards pursuant to Section 11 or this Section shall be aggregated
until, and eliminated at, the time of exercise or payment by rounding-down for fractions less than one-half and rounding-up for fractions
equal to or greater than one-half. No cash settlements shall be required with respect to fractional shares eliminated by rounding. Notice
of any adjustment shall be given by the Committee to each Participant whose Award has been adjusted and such adjustment (whether or not
such notice is given) shall be effective and binding for all purposes of the Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(d)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Minimum Purchase Price</span>. If authorized but previously unissued shares of Common Stock are issued under the Plan, such shares
shall not be issued for a consideration that is less than as permitted under applicable law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 45 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(e)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Minimum Vesting Period</span>. Each Award Agreement will require that an Award be subject to a minimum vesting period of at least
one (1) year commencing from the grant date, or with respect to Awards that vest upon the attainment of Performance Criteria, a Performance
Period that is at least one (1) year. However, an Award, other than an Award based on the attainment of a Performance Criteria, may vest
during a period less than one (1) year under Special Circumstances. For the purpose of clarity, this Section 4(d) will not prevent the
Committee from accelerating the vesting of any Award in accordance with any of the provisions set forth in this Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">5.</span><span style="font-size: 10pt">
</span></b></span><b>Eligibility. </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">General Eligibility</span>. All current and prospective Eligible Individuals are eligible to be granted Awards. Eligibility for
the grant of Awards and actual participation in the Plan shall be determined by the Committee in its sole discretion.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Incentive Stock Options</span>. Only Eligible Employees of the Company, its Subsidiaries and its Parent (if any) are eligible to
be granted Incentive Stock Options under the Plan. Eligibility for the grant of an Incentive Stock Option and actual participation in
the Plan shall be determined by the Committee in its sole discretion.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(c)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">General Requirement</span>. The vesting and exercise of Awards granted to a prospective Eligible Individual are conditioned upon
such individual actually becoming an Eligible Employee, Consultant or Non-Employee Director, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">6.</span><span style="font-size: 10pt">
</span></b></span><b>Stock Option.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Options</span>. Stock Options may be granted alone or in addition to other Awards granted under the Plan. Each Stock Option granted
under the Plan shall be of one of two types: an Incentive Stock Option or a Non-Qualified Stock Option.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Grants</span><b>. </b>The Committee shall have the authority to grant to any Eligible Employee one or more Incentive Stock Options,
Non-Qualified Stock Options, or both types of Stock Options. The Committee shall have the authority to grant any Consultant or Non-Employee
Director one or more Non-Qualified Stock Options. To the extent that any Stock Option does not qualify as an Incentive Stock Option (whether
because of its provisions or the time or manner of its exercise or otherwise), such Stock Option or the portion which does not so qualify
shall constitute a separate Non-Qualified Stock Option.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(c)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Incentive Stock Options</span>. No term of the Plan relating to Incentive Stock Options shall be interpreted, amended or altered,
nor shall any discretion or authority granted under the Plan be so exercised, so as to disqualify the Plan under Section 422 of the Code,
or, without the consent of the Participants affected, to disqualify any Incentive Stock Option under Section 422.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(d)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Term of Options</span>. Options granted under the Plan shall be subject to the following terms and conditions and shall be in such
form and contain such additional terms and conditions, not inconsistent with the terms of the Plan, as the Committee deems desirable:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(i)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Exercise Price</span>. The exercise price per share of Common Stock subject to a Stock Option shall be determined by the Committee
at the time of grant, provided that the per share exercise price of a Stock Option shall not be less than 100% (or, in the case of an
Incentive Stock Option granted to a Ten Percent Stockholder, 110%) of the Fair Market Value of the Common Stock at the date of grant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(ii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Stock Option Term</span>. The term of each Stock Option shall be fixed by the Committee, provided that no Stock Option shall be
exercisable more than ten years after the date the Option is granted; and provided, further, that the term of an Incentive Stock Option
granted to a Ten Percent Stockholder shall not exceed five years.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 46 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(iii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Exercisability</span>. Unless provided by the Committee, Stock Options granted under the Plan shall be exercisable at such time
or times and subject to such terms and conditions as shall be determined by the Committee at the time of grant. If the Committee provides,
in its discretion, that any Stock Option is exercisable subject to certain limitations (including that such Stock Option is exercisable
only in installments or within certain time periods), the Committee may waive such limitations on the exercisability at any time at or
after the time of grant in whole or in part (including waiver of the installment exercise provisions or acceleration of the time at which
such Stock Option may be exercised), based on such factors, if any, as the Committee shall determine, in its sole discretion.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(iv)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Method of Exercise</span>. Subject to applicable installment exercise and waiting period provisions, to the extent vested, Stock
Options may be exercised in whole or in part at any time during the Option term, by giving written notice of exercise to the Company specifying
the number of shares of Common Stock to be purchased. Such notice shall be accompanied by payment in full of the purchase price as follows:
(i) in cash or by check, bank draft or money order payable to the order of the Company; (ii) solely to the extent permitted by applicable
law, if the Common Stock is traded on a national securities exchange, and the Committee authorizes, through a procedure whereby the Participant
delivers irrevocable instructions to a broker reasonably acceptable to the Committee to deliver promptly to the Company an amount equal
to the purchase price; (iii) having the Company withhold shares of Common Stock issuable upon exercise of the Stock Option, or by payment
in full or in part in the form of Common Stock owned by the Participant, based on the Fair Market Value of the Common Stock on the payment
date as determined by the Committee; or (iv) on such other terms and conditions as may be acceptable to the Committee (including having
the Company withhold shares of Common Stock issuable upon exercise of the Stock Option, or by payment in full or in part in the form of
Common Stock owned by the Participant, based on the Fair Market Value of the Common Stock on the payment date as determined by the Committee).
No shares of Common Stock shall be issued until payment has been made or provided for.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(v)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Non-Transferability of Options</span>. No Stock Option shall be Transferable by the Participant other than by will or by the laws
of descent and distribution, and all Stock Options shall be exercisable, during the Participant&#8217;s lifetime, only by the Participant.
The Committee may determine, in its sole discretion, at the time of grant or later that a Non-Qualified Stock Option that is not Transferable
pursuant to this Section is Transferable to a Family Member in whole or in part and in such circumstances, and under such conditions,
as specified by the Committee. A Non-Qualified Stock Option that is Transferred to a Family Member pursuant to the preceding sentence
(i) may not be subsequently Transferred other than by will or by the laws of descent and distribution and (ii) remains subject to the
terms of the Plan and the applicable Award Agreement. Any shares of Common Stock acquired upon the exercise of a Non-Qualified Stock Option
by a permissible transferee of a Non-Qualified Stock Option or a permissible transferee pursuant to a Transfer after the exercise of the
Non-Qualified Stock Option shall be subject to the terms of the Plan and the Award Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(vi)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Termination by Death of Disability</span>. Subject to the terms of the Award Agreement, if a Participant&#8217;s Termination is
by reason of death or Disability, all Stock Options that are held by such Participant that are vested and exercisable at the time of the
Participant&#8217;s Termination may be exercised by the Participant (or in the case of the Participant&#8217;s death, by the legal representative
of the Participant&#8217;s estate) at any time within a period of one year from the date of such Termination, but in no event beyond the
expiration of the stated term of such Stock Options; provided, however, that, in the event of a Participant&#8217;s Termination by reason
of Disability, if the Participant dies within such exercise period, all unexercised Stock Options held by such Participant shall be exercisable,
to the extent to which they were exercisable at the time of death, for a period of one year from the date of such death, but in no event
beyond the expiration of the stated term of such Stock Options.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(vii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Involuntary Termination Without Cause</span>. Subject to the terms of the Award Agreement, if a Participant&#8217;s Termination
is by involuntary termination by the Company without Cause, all Stock Options that are held by such Participant that are vested and exercisable
at the time of the Participant&#8217;s Termination may be exercised by the Participant at any time within a period of 90 days from the
date of such Termination, but in no event beyond the expiration of the stated term of such Stock Options.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 47 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(viii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Voluntary Resignation</span>. Subject to the terms of the Award Agreement, if a Participant&#8217;s Termination is voluntary (other
than a voluntary termination described in Section 6(d)(ix), all Stock Options that are held by such Participant that are vested and exercisable
at the time of the Participant&#8217;s Termination may be exercised by the Participant at any time within a period of 90 days from the
date of such Termination, but in no event beyond the expiration of the stated term of such Stock Options.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(ix)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Termination for Cause</span>. Subject to the terms of the Award Agreement, if a Participant&#8217;s Termination (x) is for Cause
or (y) is a voluntary Termination (as provided in Section 6(d)(viii) after the occurrence of an event that would be grounds for a Termination
for Cause, all Stock Options, whether vested or not vested, that are held by such Participant shall terminate and expire as of the date
of such Termination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(x)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Unvested Options</span>. Subject to the terms of the Award Agreement, Stock Options that are not vested as of the date of a Participant&#8217;s
Termination for any reason shall terminate and expire as of the date of such Termination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(xi)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Incentive Stock Option Limitations</span>. To the extent that the aggregate Fair Market Value (determined as of the time of grant)
of the Common Stock with respect to which Incentive Stock Options are exercisable for the first time by an Eligible Employee during any
calendar year under the Plan and/or any other stock option plan of the Company, any Subsidiary or any Parent exceeds $100,000, such Options
shall be treated as Non-Qualified Stock Options. In addition, if an Eligible Employee does not remain employed by the Company, any Subsidiary
or any Parent at all times from the time an Incentive Stock Option is granted until three months before the date of exercise (or such
other period as required by applicable law), such Stock Option shall be treated as a Non-Qualified Stock Option. Should any provision
of the Plan not be necessary in order for the Stock Options to qualify as Incentive Stock Options, or should any additional provisions
be required, the Committee may amend the Plan accordingly, without the necessity of obtaining the approval of the stockholders of the
Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(xii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span> <span style="text-decoration: underline">Form, Modification, Extension and Renewal of Stock Options</span>. Subject to the terms and conditions and within the limitations
of the Plan, Stock Options shall be evidenced by such form of agreement or grant as is approved by the Committee, and the Committee may
(i) modify, extend or renew outstanding Stock Options granted under the Plan (provided that the rights of a Participant are not reduced
without such Participant&#8217;s consent and provided further that such action does not subject the Stock Options to Section 409A of the
Code without the consent of the Participant), and (ii) accept the surrender of outstanding Stock Options (to the extent not previously
exercised) and authorize the granting of new Stock Options in substitution therefor (to the extent not previously exercised). An outstanding
Option may not be modified to reduce the exercise price nor may a new Option at a lower price be substituted for a surrendered Option
(other than adjustments or substitutions in accordance with Section 4(b)(ii), unless such action is approved by the stockholders of the
Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(xiii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Deferred Delivery of Common Stock</span>. The Committee may in its discretion permit Participants to defer delivery of Common Stock
acquired pursuant to a Participant&#8217;s exercise of an Option in accordance with the terms and conditions established by the Committee
in the applicable Award Agreement, to the extent such deferred delivery complies with the requirements of Section 409A of the Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(xiv)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Early Exercise</span>. The Committee may provide that a Stock Option include a provision to permit the Participant to elect at
any time before the Participant&#8217;s Termination to exercise the Stock Option as to any part or all of the shares of Common Stock subject
to the Stock Option before the full vesting of the Stock Option and such shares shall be subject to the provisions of and be treated as
Restricted Stock. Unvested shares of Common Stock so purchased may be subject to a repurchase option in favor of the Company or to any
other restriction the Committee determines to be appropriate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(xv)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span> <span style="text-decoration: underline">Other Terms and Conditions</span>. The Committee may include a provision in an Award Agreement providing for the automatic exercise
of a Non-Qualified Stock Option on a cashless basis on the last day of the term of such Option if the Participant has failed to exercise
the Non-Qualified Stock Option as of such date, with respect to which the Fair Market Value of the shares of Common Stock underlying the
Non-Qualified Stock Option exceeds the exercise price of such Non-Qualified Stock Option on the date of expiration of such Option, subject
to Section 14(o). Stock Options may contain such other provisions, which shall not be inconsistent with any of the terms of the Plan,
as the Committee shall deem appropriate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 48 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">7.</span><span style="font-size: 10pt">
</span></b></span><b>Stock Appreciation Rights.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Terms and Conditions of Stock Appreciation Rights</span><b>. </b>Stock Appreciation Rights granted under the Plan shall be subject
to such terms and conditions, not inconsistent with the provisions of the Plan, as shall be determined from time to time by the Committee,
including the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(i)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Exercise Price</span>. The exercise price per share of Common Stock subject to a Stock Appreciation Right shall be determined by
the Committee at the time of grant, provided that the per share exercise price of a Stock Appreciation Right shall not be less than 100%
of the Fair Market Value of the Common Stock at the time of grant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(ii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Term</span>. The term of each Stock Appreciation Right shall be fixed by the Committee but shall not be greater than ten years
after the date the right is granted.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(iii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Exercisability</span>. Unless provided by the Committee, Stock Appreciation Rights granted under the Plan shall be exercisable
at such time or times and subject to such terms and conditions as shall be determined by the Committee at the time of grant. If the Committee
provides, in its discretion, that any such right is exercisable subject to certain limitations (including without limitation that it is
exercisable only in installments or within certain time periods), the Committee may waive such limitations on the exercisability at any
time at or after grant in whole or in part (including without limitation waiver of the installment exercise provisions or acceleration
of the time at which such right may be exercised), based on such factors, if any, as the Committee shall determine, in its sole discretion.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(iv)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Method of Exercise</span>. Subject to applicable installment exercise and waiting period provisions Stock Appreciation Rights may
be exercised in whole or in part at any time in accordance with the applicable Award Agreement, by giving written notice of exercise to
the Company specifying the number of Stock Appreciation Rights to be exercised.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(v)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Payment</span>. Upon the exercise of a Stock Appreciation Right, a Participant shall be entitled to receive, for each right exercised,
up to, but no more than, an amount in cash and/or Common Stock (as chosen by the Committee in its sole discretion) equal in value to the
excess of the Fair Market Value of one share of Common Stock on the date that the right is exercised over the Fair Market Value of one
share of Common Stock on the date that the right was awarded to the Participant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(vi)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Termination</span>. Subject to the provisions of the applicable Award Agreement and the Plan, upon a Participant&#8217;s Termination
for any reason, Stock Appreciation Rights will remain exercisable following a Participant&#8217;s Termination on the same basis as Stock
Options would be exercisable following a Participant&#8217;s Termination.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(vii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Non-Transferability</span>. No Stock Appreciation Rights shall be Transferable by the Participant other than by will or by the
laws of descent and distribution, and all such rights shall be exercisable, during the Participant&#8217;s lifetime, only by the Participant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Limited Stock Appreciation Rights</span>. The Committee may include a provision in an Award Agreement providing for the automatic
exercise of a Stock Appreciation Right on a cashless basis on the last day of the term of such Stock Appreciation Right if the Participant
has failed to exercise the Stock Appreciation Right as of such date, with respect to which the Fair Market Value of the shares of Common
Stock underlying the Stock Appreciation Right exceeds the exercise price of such Stock Appreciation Right on the date of expiration of
such Stock Appreciation Right, subject to Section 14(o). Stock Appreciation Rights may contain such other provisions, which shall not
be inconsistent with any of the terms of the Plan, as the Committee shall deem appropriate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 49 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">8.</span><span style="font-size: 10pt">
</span></b></span><b>Restricted Stock. </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Awards of Restricted Stock</span>. Shares of Restricted Stock may be issued either alone or in addition to other Awards granted
under the Plan. The Committee shall determine the Eligible Individuals, to whom, and the time or times at which, grants of Restricted
Stock shall be made, the number of shares to be awarded, the price (if any) to be paid by the Participant (subject to Section 14(o)),
the time or times within which such Awards may be subject to forfeiture, the vesting schedule and rights to acceleration, and all other
terms and conditions of the Awards. The Committee may condition the grant or vesting of Restricted Stock upon the attainment of specified
performance targets (including the Performance Criteria) or such other factor as the Committee may determine in its sole discretion.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Awards and Certificates</span>. Eligible Individuals selected to receive Restricted Stock shall not have any right with respect
to such Award, unless and until such Participant has delivered a fully executed copy of the agreement evidencing the Award to the Company,
to the extent required by the Committee, and has complied with the applicable terms and conditions of such Award. Further, such Award
shall be subject to the following conditions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(i)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Purchase Price</span>. The purchase price of Restricted Stock shall be fixed by the Committee. The purchase price for shares of
Restricted Stock may be zero to the extent permitted by applicable law, and, to the extent not so permitted, such purchase price may not
be less than par value.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(ii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Acceptance</span>. Awards of Restricted Stock must be accepted within a period of 60 days (or such shorter period as the Committee
may specify at grant) after the grant date, by executing a Restricted Stock agreement and by paying whatever price (if any) the Committee
has designated.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(iii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Legend</span>. Each Participant receiving Restricted Stock shall be issued a stock certificate in respect of such shares of Restricted
Stock, unless the Committee elects to use another system, such as book entries by the transfer agent, as evidencing ownership of shares
of Restricted Stock. Such certificate shall be registered in the name of such Participant, and shall, in addition to such legends required
by applicable securities laws, bear an appropriate legend referring to the terms, conditions, and restrictions applicable to such Award,
substantially in the following form:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&#8220;The anticipation, alienation, attachment,
sale, transfer, assignment, pledge, encumbrance or charge of the shares of stock represented by this instrument are subject to the terms
and conditions (including forfeiture) of the Intrusion Inc. Amended and Restated 2021 Omnibus Incentive Plan (the &#8220;Plan&#8221;)
and an Agreement entered into between the registered owner and the Company dated _______. Copies of such Plan and Agreement are on file
at the principal office of the Company.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(iv)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Custody</span>. If stock certificates are issued in respect of shares of Restricted Stock, the Committee may require that any stock
certificates evidencing such shares be held in custody by the Company until the restrictions have lapsed, and that, as a condition of
any grant of Restricted Stock, the Participant has delivered a duly signed stock power or other instruments of assignment (including a
power of attorney), each endorsed in blank with a guarantee of signature if deemed necessary or appropriate by the Company, which would
permit transfer to the Company of all or a portion of the shares subject to the Restricted Stock Award in the event that such Award is
forfeited in whole or part.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(v)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Restrictions and Conditions</span>. The shares of Restricted Stock awarded pursuant to the Plan shall be subject to the following
restrictions and conditions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 50 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(I)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Restriction Period</span>. The Participant shall not be permitted to Transfer shares of Restricted Stock awarded under the Plan
during the period or periods set by the Committee (the &#8220;<span style="text-decoration: underline">Restriction Period</span>&#8221;) commencing on the date of such Award,
as set forth in the Restricted Stock Award Agreement and such agreement shall set forth a vesting schedule and any event that would accelerate
vesting of the shares of Restricted Stock. Within these limits, based on service, attainment of Performance Criteria pursuant to Section
9 and/or such other factors or criteria as the Committee may determine in its sole discretion, the Committee may condition the grant or
provide for the lapse of such restrictions in installments in whole or in part, or may accelerate the vesting of all or any part of any
Restricted Stock Award and/or waive the deferral limitations for all or any part of any Restricted Stock Award.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(II)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Performance Criteria</span>. If the grant of shares of Restricted Stock or the lapse of restrictions is based on the attainment
of Performance Criteria, the Committee shall establish the objective Performance Criteria and the applicable vesting percentage of the
Restricted Stock applicable to each Participant or class of Participants in writing before the beginning of the applicable fiscal year
or at such later date as determined by the Committee and while the outcome of the Performance Criteria are substantially uncertain. Such
Performance Criteria may incorporate provisions for disregarding (or adjusting for) changes in accounting methods, corporate transactions
(including dispositions and acquisitions) and other similar type events or circumstances.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(vi)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Rights as a Stockholder</span>. Except as provided in the Plan or as determined by the Committee in an Award Agreement, the Participant
shall have, with respect to the shares of Restricted Stock, all of the rights of a holder of shares of Common Stock of the Company, including
without limitation the right to receive dividends, the right to vote such shares and, subject to and conditioned upon the full vesting
of shares of Restricted Stock, the right to tender such shares. Payment of dividends shall be deferred until, and conditioned upon, the
expiration of the applicable Restriction Period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(vii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Termination</span>. Subject to the applicable provisions of the Award Agreement and the Plan, upon a Participant&#8217;s Termination
for any reason during the relevant Restriction Period, all Restricted Stock still subject to restriction will be forfeited in accordance
with the terms and conditions established by the Committee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(viii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Lapse of Restrictions</span>. If and when the Restriction Period expires without a prior forfeiture of the Restricted Stock, the
certificates for such shares shall be delivered to the Participant. All legends shall be removed from said certificates at the time of
delivery to the Participant, except as required by applicable law or other limitations imposed by the Committee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">9.</span><span style="font-size: 10pt">
</span></b></span><b>Performance Awards.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Performance Awards</span>. The Committee may grant a Performance Award to a Participant payable upon the attainment of specific
Performance Criteria. If the Performance Award is payable in shares of Common Stock, such shares shall be transferable to the Participant
only upon attainment of the relevant Performance Criteria in accordance with Section 9(b)(v). If the Performance Award is payable in cash,
it may be paid upon the attainment of the relevant Performance Criteria either in cash or in shares of Common Stock (based on the then
current Fair Market Value of such shares), as determined by the Committee, in its sole and absolute discretion. Each Performance Award
shall be evidenced by an Award Agreement in such form that is not inconsistent with the Plan and that the Committee may from time to time
approve.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Terms and Conditions</span>. Performance Awards awarded pursuant to this Section 9 shall be subject to the following terms and
conditions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(i)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Earning of Performance Award</span>. At the expiration of the applicable Performance Period, the Committee shall determine the
extent to which the Performance Criteria established pursuant to Section 9(b)(iii) are achieved and the percentage of each Performance
Award that has been earned.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 51 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(ii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Non-Transferability</span>. Subject to the applicable provisions of the Award Agreement and the Plan, Performance Awards may not
be Transferred during the Performance Period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(iii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Objective Performance Criteria, Formula or Standards</span>. The Committee shall establish the objective Performance Criteria for
the earning of Performance Awards based on a Performance Period applicable to each Participant or class of Participants in writing before
the beginning of the applicable Performance Period or at such later date and while the outcome of the Performance Criteria are substantially
uncertain. Such Performance Criteria may incorporate provisions for disregarding (or adjusting for) changes in accounting methods, corporate
transactions (including dispositions and acquisitions) and other similar type events or circumstances.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(iv)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Dividends</span>. Unless determined by the Committee at the time of grant, amounts equal to dividends declared during the Performance
Period with respect to the number of shares of Common Stock covered by a Performance Award will not be paid to the Participant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(v)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Payment</span>. Following the Committee&#8217;s determination, the Company shall settle Performance Awards, in such form (including
without limitation in shares of Common Stock or in cash) as determined by the Committee, in an amount equal to such Participant&#8217;s
earned Performance Awards.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(vi)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Termination</span>. Subject to the applicable provisions of the Award Agreement and the Plan, upon a Participant&#8217;s Termination
for any reason during the Performance Period for a given Performance Award, the Performance Award in question will vest or be forfeited
in accordance with the terms and conditions established by the Committee at grant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(vii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Accelerated Vesting</span>. Based on service, performance and/or such other factors or criteria, if any, as the Committee may determine,
the Committee may, at or after grant, accelerate the vesting of all or any part of any Performance Award.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">10.</span><span style="font-size: 10pt">
</span></b></span><b>Other Stock-based and Cash-based Awards.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Other Stock-Based Awards</span>. The Committee is authorized to grant to Eligible Individuals Other Stock-Based Awards that are
payable in, valued in whole or in part by reference to, or based on or related to shares of Common Stock, including without limitation
shares of Common Stock awarded purely as a bonus and not subject to restrictions or conditions, shares of Common Stock in payment of the
amounts due under an incentive or performance plan sponsored or maintained by the Company or an Affiliate, stock equivalent units, restricted
stock units, and Awards valued by reference to book value of shares of Common Stock. Other Stock-Based Awards may be granted either alone
or in addition to or in tandem with other Awards granted under the Plan. Subject to the provisions of the Plan, the Committee shall have
authority to determine the Eligible Individuals, to whom, and the time or times at which, such Awards shall be made, the number of shares
of Common Stock to be awarded pursuant to such Awards, and all other conditions of the Awards. The Committee may also provide for the
grant of Common Stock under such Awards upon the completion of a specified Performance Period. The Committee may condition the grant or
vesting of Other Stock-Based Awards upon the attainment of specified Performance Criteria as the Committee may determine, in its sole
discretion; the Committee shall establish the objective Performance Criteria for the grant or vesting of such Other Stock-Based Awards
based on a Performance Period applicable to each Participant or class of Participants in writing before the beginning of the applicable
Performance Period and while the outcome of the Performance Criteria are substantially uncertain. Such Performance Criteria may incorporate,
provisions for disregarding (or adjusting for) changes in accounting methods, corporate transactions (including dispositions and acquisitions)
and other similar type events or circumstances.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Terms and Conditions</span>. Other Stock-Based Awards made pursuant to this Section 10(b) shall be subject to the following terms
and conditions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 52 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(i)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Non-Transferability</span>. Subject to the applicable provisions of the Award Agreement and the Plan, shares of Common Stock subject
to Awards made under this Section 10(b) may not be Transferred before the date on which the shares are issued, or, if later, the date
on which any applicable restriction, performance or deferral period lapses.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(ii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Dividends</span>. Unless determined by the Committee at the time of Award, subject to the provisions of the Award Agreement and
the Plan, the recipient of an Award under this Section 10(b) shall not be entitled to receive, currently or on a deferred basis, dividends
or dividend equivalents in respect of the number of shares of Common Stock covered by the Award.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(iii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Vesting</span>. Any Award under this and any Common Stock covered by any such Award shall vest or be forfeited to the extent so
provided in the Award Agreement, as determined by the Committee, in its sole discretion.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(iv)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Price</span>. Common Stock issued on a bonus basis under this Section 10(b) may be issued for no cash consideration. Common Stock
purchased pursuant to a purchase right awarded under this Section 10(b) shall be priced, as determined by the Committee in its sole discretion.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(c)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Other Cash-Based Awards</span>. The Committee may from time to time grant Other Cash- Based Awards to Eligible Individuals in such
amounts, on such terms and conditions, and for such consideration, including no consideration or such minimum consideration as may be
required by applicable law, as it shall determine in its sole discretion. Other Cash-Based Awards may be granted subject to the satisfaction
of vesting conditions or may be awarded purely as a bonus and not subject to restrictions or conditions, and if subject to vesting conditions,
the Committee may accelerate the vesting of such Awards at any time in its sole discretion. The grant of an Other Cash-Based Award shall
not require a segregation of any of the Company&#8217;s assets for satisfaction of the Company&#8217;s payment obligation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">11.</span><span style="font-size: 10pt">
</span></b></span><b>Change in Control Provisions.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Benefits</span>. In the event of a Change in Control of the Company (as defined below), and except as provided by the Committee
in an Award Agreement, a Participant&#8217;s unvested Award shall not vest automatically and a Participant&#8217;s Award shall be treated
in accordance with one or more of the following methods as determined by the Committee:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(i)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Awards, whether or not then vested, shall be continued, assumed, or have new rights substituted therefor, as determined by the
Committee in a manner consistent with the requirements of Section 409A of the Code, and restrictions to which shares of Restricted Stock
or any other Award granted before the Change in Control are subject shall not lapse upon a Change in Control and the Restricted Stock
or other Award shall, where appropriate in the sole discretion of the Committee, receive the same distribution as other Common Stock on
such terms as determined by the Committee; provided that the Committee may decide to award additional Restricted Stock or other Awards
in lieu of any cash distribution. For purposes of Incentive Stock Options, any assumed or substituted Stock Option shall comply with the
requirements of Treasury Regulation Section 1.424-1 (and any amendment thereto).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(ii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>The Committee, in its sole discretion, may provide for the purchase of any Awards by the Company or an Affiliate for an amount
of cash equal to the excess (if any) of the Change in Control Price (as defined below) of the shares of Common Stock covered by such Awards,
over the aggregate exercise price of such Awards. &#8220;<span style="text-decoration: underline">Change in Control Price</span>&#8221; shall mean the highest price per share
of Common Stock paid in any transaction related to a Change in Control of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 53 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(iii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>The Committee may, in its sole discretion, terminate all outstanding and unexercised Stock Options, Stock Appreciation Rights,
or any Other Stock-Based Award that provides for a Participant elected exercise, effective as of the date of the Change in Control, by
delivering notice of termination to each Participant before the date of consummation of the Change in Control, in which case during the
period from the date on which such notice of termination is delivered to the consummation of the Change in Control, each such Participant
may exercise in full all of such Participant&#8217;s Awards that are then outstanding (without regard to any limitations on exercisability
contained in the Award Agreements), but any such exercise shall be contingent on the occurrence of the Change in Control, and, provided
that, if the Change in Control does not take place within a specified period after giving such notice for any reason whatsoever, the notice
and exercise pursuant thereto shall be null and void.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(iv)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>The Committee may, in its sole discretion, provide for accelerated vesting or lapse of restrictions, of an Award at any time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Change in Control</span>. Unless determined by the Committee in the applicable Award Agreement or other written agreement with
a Participant approved by the Committee, a &#8220;Change in Control&#8221; shall be deemed to occur if:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(i)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>any &#8220;person,&#8221; as such term is used in Sections 13(d) and 14(d) of the Exchange Act (other than the Company, any trustee
or other fiduciary holding securities under any employee benefit plan of the Company, or any company owned, directly or indirectly, by
the stockholders of the Company in substantially the same proportions as their ownership of Common Stock of the Company), becoming the
beneficial owner (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of the Company representing
50% or more of the combined voting power of the Company&#8217;s then outstanding securities;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(ii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>during any period of two consecutive years, individuals who at the beginning of such period constitute the Board, and any new director
(other than a director designated by a Person who has entered into an agreement with the Company to effect a transaction described in
subsections (b)(i), (iii), or (iv) of this Section or a director whose initial assumption of office occurs as a result of either an actual
or threatened election contest or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other than
the Board) whose election by the Board or nomination for election by the Company&#8217;s stockholders was approved by a vote of at least
two-thirds of the directors then still in office who either were directors at the beginning of the two-year period or whose election or
nomination for election was previously so approved, cease for any reason to constitute at least a majority of the Board;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(iii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>a reorganization, merger or consolidation of the Company with any other corporation, other than (i) a reorganization, merger or
consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent
(either by remaining outstanding or by being converted into voting securities of the surviving entity) more than 50% of the combined voting
power of the voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation; or
(ii) a reorganization, merger or consolidation effected to implement a recapitalization of the Company (or similar transaction) in which
no Person (other than those covered by the exceptions in Section 11(b)(i)) acquires more than 50% of the combined voting power of the
Company&#8217;s then outstanding securities; or</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(iv)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>a complete liquidation or dissolution of the Company or the consummation of a sale or disposition by the Company of all or substantially
all of the Company&#8217;s assets other than the sale or disposition of all or substantially all of the assets of the Company to a Person
or Persons who beneficially own, directly or indirectly, 50% or more of the combined voting power of the outstanding voting securities
of the Company immediately before the time of the sale. With respect to any Award that is characterized as &#8220;nonqualified deferred
compensation&#8221; within the meaning of Section 409A of the Code, an event shall not be considered to be a Change in Control under the
Plan for purposes of payment of such Award unless such event is also a &#8220;change in ownership,&#8221; a &#8220;change in effective
control&#8221; or a &#8220;change in the ownership of a substantial portion of the assets&#8221; of the Company within the meaning of
Section 409A of the Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 54 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(c)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Escrow and Withholding of Proceeds</span>. To the extent the Board determines that the escrow or withholding of any proceeds with
respect to any Awards is in the best interest of the Company in connection with a transaction that would result in a Change in Control,
the Board shall, in its good faith, make any such determination, taking into account the requirements of Section 409A of the Code, and
such determination shall be final, binding and conclusive. The Board may make any such determination with respect to any Awards and shall
not be required to treat all Awards in the same manner.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">12.</span><span style="font-size: 10pt">
</span></b></span><b>Termination of Amendment of Plan</b>. The Board may at any time, and from time to time, amend, in whole or in part,
any or all of the provisions of the Plan (including any amendment deemed necessary to ensure that the Company may comply with any regulatory
requirement referred to in Section 422 or Section 409A of the Code), or suspend or terminate it entirely; provided, however, that, unless
required by law or provided in this Plan, the rights of a Participant with respect to Awards granted before such amendment, suspension
or termination, may not be impaired without the consent of such Participant and, provided further, that without the approval of the holders
of the Company&#8217;s Common Stock entitled to vote in accordance with applicable law, no amendment may be made that would (a) increase
the aggregate number of shares of Common Stock that may be issued under the Plan (except by operation of Section 4(b); (b) change the
classification of individuals eligible to receive Awards under the Plan; (c) decrease the minimum option price of any Stock Option or
Stock Appreciation Right; (d) extend the maximum option period under Section 6(d)(ii); (e) alter the Performance Criteria for Restricted
Stock, Performance Awards or Other Stock-Based Awards; (f) award any Stock Option or Stock Appreciation Right in replacement of a canceled
Stock Option or Stock Appreciation Right with a higher exercise price than the replacement award; or (g) in no event may the Plan be amended
without the approval of the stockholders of the Company in accordance with the laws of the State of Delaware to increase the aggregate
number of shares of Common Stock that may be issued under the Plan, decrease the minimum exercise price of any Award, or to make any other
amendment that would require stockholder approval under Financial Industry Regulatory Authority (FINRA) rules and regulations or the rules
of any exchange or system on which the Company&#8217;s securities are listed or traded at the request of the Company. The Board may amend
the Plan or any Award Agreement at any time without a Participant&#8217;s consent to comply with applicable law including Section 409A
of the Code. The Committee may amend the terms of any Award prospectively or retroactively, but no such amendment or other action by the
Committee shall impair the rights of any holder without the holder&#8217;s consent.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">13.</span><span style="font-size: 10pt">
</span></b></span><b>Unfunded Status of Plan</b>. The Plan is intended to constitute an &#8220;unfunded&#8221; plan for incentive and
deferred compensation. With respect to any payment as to which a Participant has a fixed and vested interest but which are not yet made
to a Participant by the Company, nothing in the Plan gives any such Participant any right that is greater than those of a general unsecured
creditor of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">14.</span><span style="font-size: 10pt">
</span></b></span><b>General Provisions. </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Legend</span>. In addition to any legend required by the Plan, the certificates for such shares may include any legend that the
Committee deems appropriate to reflect any restrictions on Transfer. All certificates for shares of Common Stock delivered under the Plan
shall be subject to such stop transfer orders and other restrictions as the Committee may deem advisable under the rules, regulations
and other requirements of the Securities and Exchange Commission, any stock exchange upon which the Common Stock is then listed or any
national securities exchange system upon whose system the Common Stock is then quoted, any applicable federal or state securities law,
and any applicable corporate law, and the Committee may cause a legend or legends to be put on any such certificates to make appropriate
reference to such restrictions.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Other Plans</span>. Nothing contained in the Plan shall prevent the Board from adopting other or additional compensation arrangements,
subject to stockholder approval if such approval is required, and such arrangements may be either generally applicable or applicable only
in specific cases.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(c)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">No Right to Employment/Directorship/Consultancy</span>. Neither the Plan nor the grant of any Option or other Award shall give
any Participant or other employee, Consultant or Non-Employee Director any right with respect to continuance of employment, consultancy
or directorship by the Company or any Affiliate, nor shall there be a limitation in any way on the right of the Company or any Affiliate
by which an employee is employed or a Consultant or Non-Employee Director is retained to terminate such employment, consultancy or directorship
at any time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 55 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(d)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Withholding of Taxes</span>. The Company may deduct from any payment to be made pursuant to the Plan, or to require, before the
issuance or delivery of shares of Common Stock or the payment of any cash hereunder, payment by the Participant of, any federal, state
or local taxes required by law to be withheld. Upon the vesting of Restricted Stock (or other Award that is taxable upon vesting), or
upon making an election under Section 83(b) of the Code, a Participant shall pay all required withholding to the Company. Any minimum
statutorily required withholding obligation with regard to any Participant may be satisfied, subject to the consent of the Committee,
by reducing the number of shares of Common Stock deliverable or by delivering shares of Common Stock already owned. Furthermore, at the
discretion of the Committee, any additional tax obligations of a Participant with respect to an Award may be satisfied by further reducing
the number of shares of Common Stock, deliverable with respect to such Award, to the extent that such reductions do not result in any
adverse accounting implications to the Company, as determined by the Committee. Any fraction of a share of Common Stock required to satisfy
such tax obligations shall be disregarded and the amount due shall be paid instead in cash by the Participant.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(e)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">No Assignment of Benefits</span>. No Award or other benefit payable under the Plan shall, except as provided by law or permitted
by the Committee, be Transferable in any manner, and any attempt to Transfer any such benefit shall be void, and any such benefit shall
not in any manner be liable for or subject to the debts, contracts, liabilities, engagements or torts of any Person who shall be entitled
to such benefit, nor shall it be subject to attachment or legal process for or against such Person.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(f)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Listing and Other Conditions</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(i)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Unless determined by the Committee, as long as the Common Stock is listed on a national securities exchange or system sponsored
by a national securities association, the issuance of shares of Common Stock pursuant to an Award shall be conditioned upon such shares
being listed on such exchange or system. The Company shall have no obligation to issue such shares unless and until such shares are so
listed, and the right to exercise any Option or other Award with respect to such shares shall be suspended until such listing has been
effected.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(ii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>If at any time counsel to the Company shall be of the opinion that any sale or delivery of shares of Common Stock pursuant to an
Option or other Award is or may in the circumstances be unlawful or result in the imposition of excise taxes on the Company under the
statutes, rules or regulations of any applicable jurisdiction, the Company shall have no obligation to make such sale or delivery, or
to make any application or to effect or to maintain any qualification or registration under the Securities Act with respect to shares
of Common Stock or Awards, and the right to exercise any Option or other Award shall be suspended until, in the opinion of said counsel,
such sale or delivery shall be lawful or will not result in the imposition of excise taxes on the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(iii)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>Upon termination of any period of suspension, any Award affected by such suspension which shall not then have expired or terminated
shall be reinstated as to all shares available before such suspension and as to shares which would have become available during the period
of such suspension, but no such suspension shall extend the term of any Award.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(iv)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span>A Participant shall be required to supply the Company with certificates, representations and information that the Company requests
and cooperate with the Company in obtaining any listing, registration, qualification, exemption, consent or approval the Company deems
necessary or appropriate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(g)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Governing Law</span>. The Plan and actions taken in connection with the Plan shall be governed and construed in accordance with
the laws of the State of Delaware (regardless of the law that might govern under applicable principles of conflict of laws).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 56 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(h)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Jurisdiction; Waiver of Jury Trial</span>. Any suit, action or proceeding with respect to the Plan or any Award Agreement, or any
judgment entered by any court of competent jurisdiction in respect of any thereof, shall be resolved only in the courts of Collin County,
Texas and the appellate courts having jurisdiction of appeals in such courts. In that context, and without limiting the generality of
the foregoing, the Company and each Participant shall irrevocably and unconditionally (a) submit in any proceeding relating to the Plan
or any Award Agreement, or for the recognition and enforcement of any judgment in respect thereof (a &#8220;Proceeding&#8221;), to the
exclusive jurisdiction of the courts of Collin County, Texas, and appellate courts having jurisdiction of appeals from any of the foregoing,
and agree that all claims in respect of any such Proceeding shall be heard and determined in such Texas court or, to the extent permitted
by law, in such federal court, (b) consent that any such Proceeding may and shall be brought in such courts and waives any objection that
the Company and each Participant may have to the venue or jurisdiction of any such Proceeding in any such court or that such Proceeding
was brought in an inconvenient court and agree not to plead or claim the same, (c) waive all right to trial by jury in any Proceeding
(whether based on contract, tort or otherwise) arising out of or relating to the Plan or any Award Agreement, (d) agree that service of
process in any such Proceeding may be effected by mailing a copy of such process by registered or certified mail (or any substantially
similar form of mail), postage prepaid, to such party, in the case of a Participant, at the Participant&#8217;s address shown in the books
and records of the Company or, in the case of the Company, at the Company&#8217;s principal offices, attention General Counsel, and (e)
agree that nothing in the Plan shall affect the right to effect service of process in any other manner permitted by the laws of the State
of Texas.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(i)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Construction</span>. Wherever any words are used in the Plan in the masculine gender they shall be construed as though they were
also used in the feminine gender in all cases where they would so apply, and wherever words are used in the Plan in the singular form
they shall be construed as though they were also used in the plural form in all cases where they would so apply.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(j)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Other Benefits</span>. No Award granted or paid out under the Plan shall be deemed compensation for purposes of computing benefits
under any retirement plan of the Company or its Affiliates nor affect any benefit under any other benefit plan now or subsequently in
effect under which the availability or amount of benefits is related to the level of compensation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(k)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Costs</span>. The Company shall bear all expenses associated with administering the Plan, including expenses of issuing Common
Stock pursuant to Awards hereunder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(l)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">No Rights to Same Benefits</span>. The provisions of Awards need not be the same with respect to each Participant, and such Awards
to individual Participants need not be the same in subsequent years.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(m)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Death/Disability</span>. The Committee may in its discretion require the transferee of a Participant to supply it with written
notice of the Participant&#8217;s death or Disability and to supply it with a copy of the will (in the case of the Participant&#8217;s
death) or such other evidence as the Committee deems necessary to establish the validity of the transfer of an Award. The Committee may
also require that the agreement of the transferee to be bound by all of the terms and conditions of the Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(n) <span style="text-decoration: underline">Section 16(b)
of the Exchange Act</span>. All elections and transactions under the Plan by Persons subject to Section 16 of the Exchange Act involving
shares of Common Stock are intended to comply with any applicable exemptive condition under Rule 16b-3. The Committee may establish and
adopt written administrative guidelines, designed to facilitate compliance with Section 16(b) of the Exchange Act, as it may deem necessary
or proper for the administration and operation of the Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 57 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(o)<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Section 409A of the Code</span>. The Plan is intended to comply with the applicable requirements of Section 409A of the Code and
shall be limited, construed and interpreted in accordance with such intent. To the extent that any Award is subject to Section 409A of
the Code, it shall be paid in a manner that will comply with Section 409A of the Code, including proposed, temporary or final regulations
or any other guidance issued by the Secretary of the Treasury and the Internal Revenue Service with respect thereto. Any provision in
the Plan that is inconsistent with Section 409A of the Code shall be deemed to be amended to comply with Section 409A of the Code and
to the extent such provision cannot be amended to comply therewith, such provision shall be null and void. The Company shall have no liability
to a Participant, or any other party, if an Award that is intended to be exempt from, or compliant with, Section 409A of the Code is not
so exempt or compliant or for any action taken by the Committee or the Company and, in the event that any amount or benefit under the
Plan becomes subject to penalties under Section 409A of the Code, responsibility for payment of such penalties shall rest solely with
the affected Participants and not with the Company. Any payment of &#8220;nonqualified deferred compensation&#8221; (within the meaning
of Section 409A of the Code) that are required to be made under the Plan to a &#8220;specified employee&#8221; (as defined under Section
409A of the Code) as a result of such employee&#8217;s separation from service (other than a payment that is not subject to Section 409A
of the Code) shall be delayed for the first six (6) months following such separation from service (or, if earlier, the date of death of
the specified employee) and shall instead be paid (in a manner set forth in the Award Agreement) upon expiration of such delay period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(p)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Successor and Assigns</span>. The Plan shall be binding on all successors and permitted assigns of a Participant, including the
estate of such Participant and the executor, administrator or trustee of such estate.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(q)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Severability of Provisions</span>. If any provision of the Plan shall be held invalid or unenforceable, such invalidity or unenforceability
shall not affect any other provisions hereof, and the Plan shall be construed and enforced as if such provisions had not been included.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(r)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Payments to Minors, Etc</span>. Any benefit payable to or for the benefit of a minor, an incompetent Person or other Person incapable
of receipt thereof shall be deemed paid when paid to such Person&#8217;s guardian or to the party providing or reasonably appearing to
provide for the care of such Person, and such payment shall fully discharge the Committee, the Board, the Company, its Affiliates and
their employees, agents and representatives with respect thereto.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(s)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Headings and Captions</span>. The headings and captions in the Plan are provided for reference and convenience only, shall not
be considered part of the Plan, and shall not be employed in the construction of the Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(t)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</span><span style="text-decoration: underline">Company Recoupment of Awards</span>. A Participant&#8217;s rights with respect to any Award hereunder shall in all events be subject
to (a) any right that the Company may have under any Company recoupment policy or other agreement or arrangement with a Participant, or
(b) any right or obligation that the Company may have regarding the clawback of &#8220;incentive-based compensation&#8221; under Section
10D of the Exchange Act and any applicable rules and regulations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">15.</span><span style="font-size: 10pt">
</span></b></span><b>Effective Date of Plan</b>. <span style="text-decoration: underline">As amended herein by the Board on March __, 2023, the Plan became effective on March
25, 2021, which was the date of the original adoption of the Plan by the Board</span>, as subsequently approved by the stockholders of the
Company in accordance with the requirements of the laws of the State of Delaware.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">16.</span><span style="font-size: 10pt">
</span></b></span><b>Term of Plan. </b>No Award shall be granted pursuant to the Plan on or after the tenth anniversary of the earlier
of the date that the Plan is adopted or the date of stockholder approval, but Awards granted before such tenth anniversary may extend
beyond that date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"><b><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">17.</span><span style="font-size: 10pt">
</span></b></span><b>Name of Plan</b>. The Plan shall be known as the &#8220;Intrusion Inc. Amended and Restated 2021 Omnibus Incentive
Plan.&#8221;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>
<!-- Field: Page; Sequence: 58 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->
<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><b><span style="text-decoration: underline">APPENDIX B</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span style="text-decoration: underline">AMENDED AND RESTATED</span> INTRUSION, INC.
</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>2023 EMPLOYEE STOCK PURCHASE PLAN</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">1.</span>
<span style="text-decoration: underline">Establishment of Plan</span>. Approved by stockholder vote effective May 16, 2023, Intrusion proposes to grant rights to purchase shares
of Common Stock to eligible Employees of Intrusion and its Participating Corporations (as hereinafter defined) pursuant to this Plan.
Intrusion intends this Plan to qualify as an &#8220;employee stock purchase plan&#8221; under Section 423 of the Code (including any amendments
to or replacements of such Section), and this Plan will be so construed. Any term not expressly defined in this Plan but defined for purposes
of Section 423 of the Code will have the same definition herein. Subject to Section 14, a total of 1,000,000 shares of Common Stock is
reserved for issuance under this Plan. The number of shares reserved for issuance under this Plan will be subject to adjustments effected
in accordance with Section 14 of this Plan. Capitalized terms not defined elsewhere in the text are defined in Section 27. A reverse stock
split of Intrusion&#8217;s outstanding shares of common stock was effected March 15, 2024, at a ratio of 1-for-20. In view of this reverse
stock split and subject to stockholder approval, the Company&#8217;s board of directors on June 26, 2024, approved an additional reserve
of 1,000,000 shares of Common Stock under this Plan, such issuance continuing to be subject to adjustments effected in accordance with
Section 14 of the Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">2.</span> <span style="text-decoration: underline">Purpose</span>. The
purpose of this Plan is to provide eligible Employees of Intrusion and Participating Corporations with a means of acquiring an
equity interest in Intrusion through payroll deductions (or other permitted contributions), to enhance such Employees&#8217; sense
of participation in the affairs of Intrusion.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">
<span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">3.</span> <span style="text-decoration: underline">Administration</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span>
The Plan will be administered by the Compensation Committee of the Board (the &#8220;<b>Committee</b>&#8221;), by the Board, or by the
Committee&#8217;s delegate(s), as permitted by applicable law and provided herein. Subject to the provisions of this Plan and the limitations
of Section 423 of the Code or any successor provision in the Code, all questions of interpretation or application of this Plan will be
determined by the Committee or its delegate(s) and its decisions will be final and binding upon all Participants. The Committee or its
delegate(s) will have full and exclusive discretionary authority to construe, interpret and apply the terms of the Plan, and to determine
eligibility. The Committee will have full authority to determine which eligible entities will be Participating Corporations, whether an
offer to a Participating Corporation is intended to meet Code Section 423 requirements, and whether to have separate offerings and the
terms of such offerings (in accordance with the Plan), and to decide upon any and all claims filed under the Plan. Every finding, decision
and determination made by the Board, the Committee or its delegate(s) will, to the full extent permitted by law, be final and binding
upon all parties. The Board or Committee will have the authority to determine the Fair Market Value of the Common Stock (which determination
will be final, binding and conclusive for all purposes) in accordance with <span style="text-decoration: underline">Section 8</span> below and to interpret <span style="text-decoration: underline">Section 8</span> of
the Plan in connection with circumstances that impact the Fair Market Value. Members of the Committee will receive no compensation for
their services in connection with the administration of this Plan, other than standard fees as established from time to time by the Board
for services rendered by Board members serving on Board committees. All expenses incurred in connection with the administration of this
Plan will be paid by Intrusion. For purposes of this Plan, the Committee may designate separate offerings under the Plan (the terms of
which need not be identical) in which eligible Employees of one or more Participating Corporations will participate, even if the dates
of the applicable Offering Periods of each such offering are identical. In this regard, and unless otherwise specified by the Committee,
each offering of the Plan to the eligible Employees of Intrusion or a Participating Corporation will be deemed a separate offering for
purposes of Code Section 423 and the provisions of the Plan will separately apply to each Offering. The Committee may establish rules
to govern transfers of employment between Intrusion and its Participating Corporations and transfers of participation between separate
offerings made under the Plan, consistent with any applicable Code Section 423 requirements and the terms of the Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">4.</span>
<span style="text-decoration: underline">Eligibility</span>. Any Employee of Intrusion or the Participating Corporations is eligible to participate in an Offering Period under
this Plan except that the Committee may exclude any or all of the following (other than where prohibited by applicable law):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span>
Employees who are not employed by Intrusion or a Participating Corporation prior to the beginning of such Offering Period or prior to
such other time period as specified by the Committee or its delegate(s);</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 59 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span> Employees
who are customarily employed for twenty (20) or less hours per week; calendar year;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-indent: 67.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(c)</span> Employees who are customarily
employed for five (5) months or less in a calendar year;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 45pt; text-indent: 4.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(d)</span> Employees
who are &#8220;highly compensated employees&#8221; of Intrusion or any Participating Corporation (within the meaning of Section 414(q)
of the Code), or (ii) any employee who is a &#8220;highly compensated employees&#8221; with compensation above a specified level, who
is an officer and/or is subject to the disclosure requirements of Section 16(a) of the Exchange Act;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(e)</span>
Employees who are citizens or residents of a non-U.S. jurisdiction (without regard to whether they are also a citizen of the U.S. or a
resident alien (within the meaning of Section 7701(b)(1)(A) of the Code)) if either: (i) such employee&#8217;s participation is prohibited
under the laws of the jurisdiction governing such employee, or (ii) compliance with the laws of the non-U.S. jurisdiction would violate
the requirements of Section 423 of the Code;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(f)</span>
Employees who do not meet any other eligibility requirements that the Committee may choose to impose (within the limits permitted by the
Code); and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(g)</span>
individuals who provide services to Intrusion or any of its Participating Corporations as independent contractors who are reclassified
as common law employees for any reason except for federal income and employment tax purposes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0.1in; text-align: justify">The foregoing notwithstanding, (i)
Employees who, together with any other person whose stock would be attributed to such Employee pursuant to Section 424(d) of the Code,
own stock or hold options to purchase stock possessing five percent (5%) or more of the total combined voting power or value of all classes
of stock of Intrusion or any of its Participating Corporations or who, as result of being granted an option under this Plan with respect
to such Offering Period, would own stock or hold options to purchase stock possessing five percent (5%) or more of the total combined
voting power or value of all classes of stock of Intrusion or any of its Participating Corporations may not participate in the Plan and
(ii) an individual will not be eligible if his or her participation in the Plan is prohibited by the law of any country that has jurisdiction
over him or her or if he or she is subject to a collective bargaining agreement that does not provide for participation in the Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">5.</span>  <span style="text-decoration: underline">Offering
Dates</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span>
While the Plan is in effect, the Board or Committee may determine the duration and commencement date of each Offering Period, provided
that an Offering Period will in no event be longer than twenty-seven (27) months. Offering Periods may be consecutive or overlapping.
Each Offering Period may consist of one or more Purchase Periods during which payroll deductions of Participants are accumulated under
this Plan. While the Plan is in effect, the Board or Committee may determine the duration and commencement date of each Purchase Period,
provided that a Purchase Period will in no event end later than the close of the Offering Period in which it begins. Purchase Periods
will be consecutive.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.95pt 0pt 42.95pt; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span>
Until otherwise determined by the Board or Committee, the Offering Periods under the Plan shall be six-months and will commence on each
January 1 and July 1, with each such Offering Period also consisting of a single six-month Purchase Period. The Board or Committee will
have the power to change these terms as provided in <span style="text-decoration: underline">Section 5(a)</span> above and <span style="text-decoration: underline">Section 24</span> below.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">6.</span>  <span style="text-decoration: underline">Participation
in this Plan</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.35pt"><span style="text-decoration: underline"></span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span>
With respect to each Offering Period, an eligible Employee determined in accordance with <span style="text-decoration: underline">Section 4</span> may elect to become a Participant
by submitting the prescribed enrollment form (an &#8220;<b>Enrollment Form</b>&#8221;) in accordance with Intrusion&#8217;s procedures
prior to the commencement of the Offering Period to which such agreement relates in accordance with such rules as Intrusion may determine.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 60 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span> Once an Employee
becomes a Participant in an Offering Period, then such Participant will automatically participate in the Offering Period commencing immediately
following the last day of such prior Offering Period at the same contribution level as was in effect in the prior Offering Period unless
the Participant withdraws or is deemed to withdraw from this Plan or terminates further participation in the Offering Period as set forth
in <span style="text-decoration: underline">Section 11</span> below, or otherwise notifies Intrusion of a change in the Participant&#8217;s contribution level by filing an additional
Enrollment Form in accordance with Intrusion&#8217;s procedures. A Participant that is automatically enrolled in a subsequent Offering
Period pursuant to this subsection (b) is not required to file any additional Enrollment Form in order to continue participation in this
Plan and (ii) will be deemed to have accepted the terms and conditions of the Plan and Enrollment Form in effect at the time each subsequent
Offering Period begins, subject to Participant&#8217;s right to withdraw from the Plan in accordance with the withdrawal procedures in
effect at the time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">7.</span>  <span style="text-decoration: underline">Grant
of Option on Enrollment</span>. Becoming a Participant with respect to an Offering Period will constitute the grant (as of the Offering
Date) by Intrusion to such Participant of an option to purchase on the Purchase Date up to that number of shares of Common Stock
determined by a fraction, the numerator of which is the amount of the applicable contribution level for such Participant multiplied
by such Participant&#8217;s Compensation (as defined in <span style="text-decoration: underline">Section 9</span> below) during such Purchase Period and the denominator of
which is the lower of (i) eighty-five percent (85%) of the Fair Market Value of a share of the Common Stock on the Offering Date
(but in no event less than the par value of a share of Intrusion&#8217;s Common Stock), or (ii) eighty-five percent (85%) of the
Fair Market Value of a share of the Common Stock on the Purchase Date (but in no event less than the par value of a share of the
Common Stock), and provided, further, that the number of shares of Common Stock subject to any option granted pursuant to this Plan
will not exceed the lesser of (x) the maximum number of shares provided under this Plan, as may be changed by the Board or Committee
pursuant to <span style="text-decoration: underline">Section 10(b)</span> below with respect to the applicable Purchase Date or (y) the maximum number of shares which may be
purchased pursuant to <span style="text-decoration: underline">Section 10(a)</span> below with respect to the applicable Purchase Date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">8.</span> <span style="text-decoration: underline">Purchase
Price</span>. The Purchase Price per share at which a share of Common Stock will be sold to a Participant in any Offering Period will
be eighty-five percent (85%) of the lesser of:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span>
The Fair Market Value on the Offering Date;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">or (b)</span> The Fair Market Value
on the Purchase Date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 129.05pt 0pt 78.95pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">9.</span>  <span style="text-decoration: underline">Payment
of Purchase Price; Payroll Deduction Changes; Share Issuances</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 38.15pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span>The aggregate Purchase
Price of the shares purchased hereunder is accumulated by regular payroll deductions made during each Offering Period, unless Intrusion
determines that contributions may be, or are required to be, made in another form (including payment by check at the end of a Purchase
Period). The deductions are made as a percentage of the Participant&#8217;s Compensation in one percent (1%) increments not less than
one percent (1%), nor greater than fifteen percent (15%) or such lower limit set by the Board or Committee. &#8220;<b>Compensation</b>&#8221;
will mean base salary and regular hourly wages, not including bonuses and incentive compensation commissions and shift differentials;
however, Intrusion may at any time prior to the beginning of an Offering Period determine that for that and future Offering Periods,
Compensation may include any W-2 cash compensation, including without limitation base salary or regular hourly wages, bonuses, incentive
compensation, commissions, overtime, shift premiums, plus draws against commissions. For purposes of determining a Participant&#8217;s
Compensation, any election by such Participant to reduce his or her regular cash remuneration under Sections 125 or 401(k) of the Code
will be treated as if the Participant did not make such election. Payroll deductions will commence on the first payday on or following
the beginning of the Offering Period or as otherwise determined by rules established by Intrusion and will continue to the end of the
applicable Offering Period unless sooner altered or terminated as provided in this Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span>
Except as provided in <span style="text-decoration: underline">Section 9(c)</span> below or as otherwise determined by the Committee, a Participant may not make changes in the
percentage of payroll deductions during an Offering Period or Purchase Period. A Participant may increase or decrease the percentage of
payroll deductions by completing a new authorization for payroll deductions prior to the beginning of a new Offering Period, within such
timeframe as may be specified by Intrusion and pursuant to such Enrollment Form or other form as required by Intrusion, with such change
becoming effective as of the Offering Date of such new Offering Period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 61 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(c)</span>
Subject to <span style="text-decoration: underline">Section 24</span> below and to the rules of the Plan, a Participant may reduce his or her payroll deduction percentage to
zero during an Offering Period by filing with Intrusion a request for withdrawal from participation at least fifteen (15) days
before the applicable Purchase Date (or within such other time frame as specified by Intrusion), and after such withdrawal becomes
effective no further payroll deductions will be made for the duration of the Offering Period. Payroll deductions accumulated on
behalf of the Participant but not yet used to purchase shares prior to the effective date of the request will be refunded to the
Participant. A reduction of the payroll deduction percentage to zero will be treated as such Participant&#8217;s withdrawal from
such Offering Period and the Plan, effective as of the day following the filing date of such request with Intrusion.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(d)</span>
All payroll deductions made for a Participant are credited to the Participant&#8217;s account under this Plan and are deposited with the
general funds of Intrusion, and Intrusion will not be obligated to segregate such payroll deductions. No interest accrues on the payroll
deductions. All payroll deductions received or held by Intrusion may be used by Intrusion for any corporate purpose.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(e)</span>
On each Purchase Date, so long as this Plan remains in effect and provided that the Participant has not withdrawn from participation in
the Offering Period at least fifteen (15) days before such Purchase Date (or within such other time frame as specified by Intrusion),
Intrusion will apply the funds accumulated on behalf of the Participant to the purchase of whole shares of Common Stock reserved under
the option granted to such Participant with respect to the Offering Period to the extent that such option is exercisable on the Purchase
Date. The Purchase Price per share will be as specified in <span style="text-decoration: underline">Section 8</span> of this Plan. Any amount accumulated on behalf of a Participant
on a Purchase Date which is less than the amount necessary to purchase a full share of Common Stock will be refunded to Participant in
cash, without interest, at or shortly following the end of the Purchase Period or Offering Period, as the case may be, unless otherwise
determined by Intrusion. No Common Stock will be purchased on a Purchase Date on behalf of any Employee who has ceased to provide services
to either Intrusion or a Participating Corporation prior to such Purchase Date. In the event that this Plan has been oversubscribed, all
funds accumulated on behalf of a Participant that are not used to purchase shares on the Purchase Date will be returned to the Participant,
without interest.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(f)</span> As
promptly as practicable after the Purchase Date, Intrusion will issue shares for the Participant&#8217;s benefit representing the
shares purchased upon exercise of the Participant&#8217;s option.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(g)</span>
During a Participant&#8217;s lifetime, the option to purchase shares hereunder is exercisable only by the Participant. The Participant
will have no interest or voting right in shares covered by the option until such option has been exercised.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(h)</span>
To the extent required by applicable U.S. federal, state or local law, a Participant will make arrangements satisfactory to Intrusion
and the Participant&#8217;s employer for the satisfaction of any withholding tax obligations that arise in connection with the Plan. At
any time, Intrusion or the Participant&#8217;s employer may, but shall not be obligated to, withhold from the Participant&#8217;s wages
or other cash compensation the amount necessary for Intrusion or the Participant&#8217;s employer to meet applicable withholding obligations,
including up to the maximum permissible statutory rates and including any withholding required to make available to Intrusion or any Participating
Corporation, as applicable, any tax deductions or benefits attributable to the sale or early disposition of shares of Common Stock. In
addition, Intrusion or the Participant&#8217;s employer may, but shall not be obligated to, withhold from the proceeds of the sale of
Common Stock or by any other method of withholding Intrusion or the Participant&#8217;s employer deems appropriate. Intrusion will not
be required to issue any shares of Common Stock under the Plan until such obligations are satisfied.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">10.</span>  <span style="text-decoration: underline">Limitations
on Shares to be Purchased</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.9pt 0pt 42.95pt; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span>
No Participant will be entitled to purchase stock under any Offering Period at a rate which, when aggregated with such
Participant&#8217;s rights under all other employee stock purchase plans of a Participating Company intended to meet the
requirements of Section 423 of the Code to purchase stock that are also outstanding in the same calendar year(s) under other
Offering Periods or other employee stock purchase plans of Intrusion, its Parent and its Subsidiaries exceeds U.S. $25,000 in Fair
Market Value, determined as of the Offering Date (or such other limit as may be imposed by the Code) for each calendar year in which
such Offering Period is in effect (hereinafter the &#8220;<b>Maximum Dollar Amount</b>&#8221;), or such lower amount as is
determined by the Board or the Committee. Intrusion may automatically suspend the payroll deductions of any Participant as necessary
to enforce such limit; provided that when Intrusion automatically resumes such payroll deductions, Intrusion must apply the rate in
effect immediately prior to such suspension. Alternatively, in Intrusion&#8217;s discretion and to the extent permissible under
applicable law, if Intrusion does not automatically suspend payroll deductions of any Participant as necessary to enforce such limit
or if payroll deductions exceed the amount that may be purchased pursuant to the Share Limit as defined in Section 10(b) below,
Intrusion shall refund any accumulated payroll deductions that may not be applied to the purchase of shares due to the applicable
Maximum Dollar Amount or Share Limit as determined by <span style="text-decoration: underline">Sections 10(a) and (b)</span>, with such refund occurring as soon as
practicable following the applicable Purchase Date without interest.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 62 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span>The Board or Committee may, in its sole discretion, set a lower maximum number of shares which may be purchased by any Participant
during any Offering Period than that determined under <span style="text-decoration: underline">Section 10(a)</span> above, which will be the &#8220;<b>Maximum Share
Limit</b>&#8221; for subsequent Offering Periods; provided, however, in no event will a Participant be permitted to purchase more
than ten thousand (10,000) Shares during any one Purchase Period irrespective of the limits set forth in (a) and (b) hereof, or such
lower share limit (the &#8220;<b>Share Limit</b>&#8221;) as the Committee may determine from time to time. The initial Share Limit
is 1,500 shares during any one Purchase Period or such greater (not to exceed the Maximum Share Limit) or lesser number, in either
case as the Committee or Board may determine. If a new Share Limit is set, then all Participants will be notified of such Share
Limit prior to the commencement of the next Offering Period for which it is to be effective. The Share Limit will continue to apply
with respect to all succeeding Offering Periods unless revised by the Board or Committee as set forth above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(c)</span>
If the number of shares to be purchased on a Purchase Date by all Participants exceeds the number of shares then available for
issuance under this Plan, then Intrusion will make a pro rata allocation of the remaining shares in as uniform a manner as will be
reasonably practicable and as Intrusion determines to be equitable. In such event, Intrusion will give written notice of such
reduction of the number of shares to be purchased under a Participant&#8217;s option to each Participant affected.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(d)</span>
Any payroll deductions accumulated on behalf of a Participant which are not used to purchase stock due to the limitations in this <span style="text-decoration: underline">Section
10</span>, and not covered by <span style="text-decoration: underline">Section 9(e)</span>, as applicable, will be returned to the Participant as soon as practicable after the
end of the applicable Purchase Period, without interest.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">11.</span> <span style="text-decoration: underline">Withdrawal</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 36.2pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span>
Each Participant may withdraw from an Offering Period under this Plan pursuant to a method specified by Intrusion. Such withdrawal
may be elected at any time prior to the last fifteen (15) days of an Offering Period, or such other time period as specified by
Intrusion.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.95pt 0pt 42.95pt; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span>
Upon withdrawal from this Plan, the accumulated payroll deductions will be returned to the withdrawn Participant, without interest,
and the Participant&#8217;s interest in this Plan will terminate. In the event a Participant voluntarily elects to withdraw from
this Plan, the Participant may not resume participation in this Plan during the same Offering Period, but may participate in any
Offering Period under this Plan which commences on a date subsequent to such withdrawal by re-enrolling in this Plan in the manner
set forth in <span style="text-decoration: underline">Section 6</span> above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">12.</span>  <span style="text-decoration: underline">Termination
of Employment</span>. If a Participant&#8217;s employment terminates for any reason, including without limitation retirement, death,
disability, or the failure of a Participant to remain an eligible Employee of Intrusion or of a Participating Corporation, or the
failure of a Parent, Subsidiary or Affiliate to remain a Participating Corporation for any reason, the Participant&#8217;s
participation in this Plan will terminate as of the date of such termination. In such event, accumulated payroll deductions credited
to the Participant will be returned to the Participant or, in the case of the Participant&#8217;s death, to the Participant&#8217;s
legal representative, without interest. For purposes of this <span style="text-decoration: underline">Section 12</span>, an Employee will not be deemed to have ceased to
provide services or failed to remain in the continuous employ of Intrusion or of a Participating Corporation in the case of sick
leave, military leave, or any other leave of absence approved by Intrusion or as so provided pursuant to a formal policy adopted
from time to time by Intrusion; provided that such leave is for a period of not more than ninety (90) days or reemployment upon the
expiration of such leave is guaranteed by contract or statute. Intrusion will have sole discretion to determine whether a
Participant has terminated employment and the effective date on which the Participant terminated employment, regardless of any
notice period required under local employment law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">13.</span>  <span style="text-decoration: underline">Return
of Payroll Deductions</span>. In the event a Participant&#8217;s interest in this Plan is terminated by withdrawal, termination of
employment or otherwise, or in the event this Plan is terminated by the Board or Committee, Intrusion will deliver to the
Participant all accumulated payroll deductions accumulated on behalf of such Participant which were not previously used to purchase
Shares. No interest will accrue on the payroll deductions of a Participant in this Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 63 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">14.</span>  <span style="text-decoration: underline">Capital
Changes</span>. If the number or class of outstanding Shares is changed by a stock dividend, recapitalization, stock split, reverse
stock split, subdivision, combination, reclassification or similar change in the capital structure of Intrusion, without
consideration, then, as applicable, the number and class of Common Stock that may be delivered under the Plan, the Purchase Price
per share, the number of shares of Common Stock covered by each option under the Plan which has not yet been exercised, and the
numerical limits of <span style="text-decoration: underline">Sections 1 and 10</span> will be proportionately adjusted, subject to any required action by the Board or the
stockholders of Intrusion and in compliance with applicable securities laws; provided that fractions of a Share will not be
issued.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">15.</span>  <span style="text-decoration: underline">Non-assignability</span>.
Neither payroll deductions accumulated on behalf of a Participant nor any rights with regard to the exercise of an option or to
receive shares under this Plan may be assigned, transferred, pledged or otherwise disposed of in any way (other than by will, the
laws of descent and distribution, or, if permitted by the Committee or Intrusion, the designation of a beneficiary pursuant to a
method specified by Intrusion) by the Participant. Any such attempt at assignment, transfer, pledge or other disposition will be
void and without effect.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">16.</span>  <span style="text-decoration: underline">Use
of Participant Funds and Reports</span>. Intrusion may use all payroll deductions received or held by it under the Plan for any
corporate purpose, and Intrusion will not be required to segregate Participant payroll deductions. Until Shares are issued,
Participants will only have the rights of an unsecured creditor. Each Participant will receive a report containing, or otherwise
have access to, the following information promptly after the end of each Purchase Period: the total payroll deductions (or other
contributions) accumulated, the number of shares purchased, the Purchase Price thereof and the remaining cash balance, if any,
carried forward or refunded, as determined by Intrusion, to the next Purchase Period or Offering Period, as the case may be.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">17.</span>  <span style="text-decoration: underline">Notice
of Disposition</span>. Each U.S. taxpayer Participant will notify Intrusion in writing if the Participant disposes of any of the shares
purchased in any Offering Period pursuant to this Plan if such disposition occurs within two (2) years from the Offering Date or
within one (1) year from the Purchase Date on which such shares were purchased (the &#8220;<b>Notice Period</b>&#8221;). Intrusion
may, at any time during the Notice Period, place a legend or legends on any certificate representing shares acquired pursuant to
this Plan requesting Intrusion&#8217;s transfer agent to notify Intrusion of any transfer of the shares. The obligation of the
Participant to provide such notice will continue notwithstanding the placement of any such legend on the certificates.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">18.</span>  <span style="text-decoration: underline">No
Rights to Continued Employment</span>. Neither this Plan nor the grant of any option hereunder will confer any right on any Employee to
remain in the employ of Intrusion or any Participating Corporation, or restrict any right Intrusion or any Participating Corporation
may have to terminate such Employee&#8217;s employment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">19.</span>  <span style="text-decoration: underline">Equal
Rights and Privileges</span>. All eligible Employees granted an option under this Plan that is intended to meet the Code Section 423
requirements will have equal rights and privileges with respect to this Plan or within any separate offering under the Plan so that
this Plan qualifies as an &#8220;employee stock purchase plan&#8221; within the meaning of Section 423 or any successor provision of
the Code and the related regulations. Any provision of this Plan which is inconsistent with Section 423 or any successor provision
of the Code will, without further act or amendment by Intrusion, the Committee or the Board, be reformed to comply with the
requirements of Section 423 (unless such provision applies exclusively to options granted under the Plan that are not intended to
comply with Code Section 423 requirements). This <span style="text-decoration: underline">Section 19</span> will take precedence over all other provisions in this Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">20.</span>  <span style="text-decoration: underline">Notices</span>.
All notices or other communications by a Participant to Intrusion under or in connection with this Plan will be deemed to have been
duly given when received in the form specified by Intrusion at the location, or by the person, designated by Intrusion for the
receipt thereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">21.</span>  <span style="text-decoration: underline">Term;
Stockholder Approval</span>. This Plan originally became effective on the Effective Date. This Plan will be approved by the
stockholders of Intrusion within twelve (12) months before or after the date this Plan is adopted by the Board. Any amendment to
this Plan that requires approval by stockholders of Intrusion will be done in any manner permitted by applicable law. No purchase of
shares that are subject to such stockholder approval before becoming available under this Plan will occur prior to stockholder
approval of such shares and the Board or Committee may delay any Purchase Date and postpone the commencement of any Offering Period
subsequent to such Purchase Date as deemed necessary or desirable to obtain such approval (provided that if a Purchase Date would
occur more than twenty-four (24) months after commencement of the Offering Period to which it relates, then such Purchase Date will
not occur and instead such Offering Period will terminate without the purchase of such shares and Participants in such Offering
Period will be refunded their contributions without interest. This Plan will continue until the earlier to occur of (a) termination
of this Plan by the Board or the Committee (which termination may be effected by the Board or the Committee at any time pursuant to <span style="text-decoration: underline">Section
24</span> below) or (b) issuance of all of the shares of Common Stock reserved for issuance under this Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 64 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">22.</span>
<span style="text-decoration: underline">Conditions Upon Issuance of Shares; Limitation on Sale of Shares</span>. Shares will not be issued with respect to an option unless the
exercise of such option and the issuance and delivery of such shares pursuant thereto will comply with all applicable provisions of U.S.
law, including, without limitation, the Securities Act, the Exchange Act, the rules and regulations promulgated thereunder, and the requirements
of any stock exchange or automated quotation system upon which the shares may then be listed, and will be further subject to the approval
of counsel for Intrusion with respect to such compliance. Shares may be held in trust or subject to further restrictions as permitted
by any Subplan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">23.</span>  <span style="text-decoration: underline">Applicable
Law</span>. The Plan will be governed by the substantive laws (excluding the conflict of laws rules) of the State of Texas.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">24.</span>  <span style="text-decoration: underline">Amendment
or Termination</span>. The Board or the Committee, in its sole discretion, may amend, suspend, or terminate the Plan, or any part
thereof, at any time and for any reason. If the Plan is terminated, the Board or the Committee, in its discretion, may elect to
terminate all outstanding Offering Periods either immediately or upon completion of the purchase of shares of Common Stock on the
next Purchase Date (which may be sooner than originally scheduled, if determined by the Board or the Committee in its discretion),
or may elect to permit Offering Periods to expire in accordance with their terms (and subject to any adjustment pursuant to <span style="text-decoration: underline">Section
14</span>). If an Offering Period is terminated prior to its previously-scheduled expiration, all amounts then credited to
Participants&#8217; accounts for such Offering Period which have not been used to purchase shares of Common Stock will be returned
to those Participants (without interest thereon, except as otherwise required under local laws) as soon as administratively
practicable. Further, the Committee will be entitled to establish rules to change the Purchase Periods and Offering Periods, limit
the frequency and/or number of changes in the amount withheld or contributed during a Purchase Period or an Offering Period, the
Committee or Intrusion may permit payroll withholding in excess of the amount designated by a Participant in order to adjust for
delays or mistakes in the administration of the Plan, the Committee or Intrusion may establish reasonable waiting and adjustment
periods and/or accounting and crediting procedures to ensure that amounts applied toward the purchase of Common Stock for each
Participant properly correspond with amounts withheld from the Participant&#8217;s Compensation, and establish such other
limitations or procedures as Intrusion or the Committee determines in its sole discretion advisable which are consistent with the
Plan. Such actions will not require stockholder approval or the consent of any Participants. However, no amendment will be made
without approval of the stockholders of Intrusion (obtained in accordance with <span style="text-decoration: underline">Section 21</span> above) within twelve (12) months of
the adoption of such amendment (or earlier if required by <span style="text-decoration: underline">Section 21</span>) if such amendment would increase the number of shares
that may be issued under this Plan or otherwise require stockholder approval under Code Section 423. In addition, in the event the
Board or Committee determines that the ongoing operation of the Plan may result in unfavorable financial accounting consequences,
the Board or Committee may, in its discretion and, to the extent necessary or desirable, modify, amend or terminate the Plan to
reduce or eliminate such accounting consequences including, but not limited to: (i) amending the definition of Compensation,
including with respect to an Offering Period underway at the time; (ii) altering the Purchase Price for any Offering Period
including an Offering Period underway at the time of the change in Purchase Price; (iii) shortening any Offering Period by setting a
Purchase Date, including an Offering Period underway at the time of the Board or Committee action; (iv) reducing the maximum
percentage of Compensation a participant may elect to set aside as payroll deductions; and (v) reducing the maximum number of shares
of Common Stock a Participant may purchase during any Offering Period. Such modifications or amendments will not require approval of
the stockholders of Intrusion or the consent of any Participants.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">25.</span>  <span style="text-decoration: underline">Corporate
Transactions</span>. In the event of a Corporate Transaction, each outstanding right to purchase Intrusion Common Stock will be assumed
or an equivalent option substituted by the successor corporation or a parent or a subsidiary of the successor corporation. In the
event that the successor corporation refuses to assume or substitute for the purchase right, the Offering Period with respect to
which such purchase right relates will be shortened by setting a new Purchase Date (the &#8220;<b>New Purchase Date</b>&#8221;) and
will end on the New Purchase Date. The New Purchase Date will occur on or prior to the consummation of the Corporate Transaction,
and the Plan will terminate on the consummation of the Corporate Transaction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">26.</span>  <span style="text-decoration: underline">Tax
Qualification</span>. Although Intrusion may endeavor to (i) qualify an option to purchase Intrusion Common Stock for favorable tax
treatment under the laws of the U.S. or (ii) avoid adverse tax treatment (e.g., under Section 409A of the Code), Intrusion makes no
representation to that effect and expressly disavows any covenant to maintain favorable or avoid unfavorable tax treatment,
notwithstanding anything to the contrary in this Plan. Intrusion will be unconstrained in its corporate activities without regard to
the potential negative tax impact on Participants under the Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 65 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">27.</span>  <span style="text-decoration: underline">Definitions</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(a)</span>
&#8220;<b>Affiliate</b>&#8221; means any entity, other than a Subsidiary or Parent, (i) that, directly or indirectly, is controlled
by, controls or is under common control with, Intrusion and (ii) in which Intrusion has a significant equity interest, in either
case as determined by the Committee, whether now or hereafter existing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(b)</span>
&#8220;<b>Board</b>&#8221; means the Board of Directors of Intrusion.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(c)</span>
&#8220;<b>Code</b>&#8221; means the U.S. Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(d)</span>
&#8220;<b>Common Stock</b>&#8221; means the common stock, $.01 par value per share, of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(e)</span> <span style="font-size: 10pt">&#8220;<b>Corporate
Transaction</b>&#8221; means the occurrence of any of the following </span>events: <span style="font-size: 10pt">(i) any
&#8220;person&#8221; (as such term is used in Sections 13(d) and 14(d) of the Exchange Act) becomes the &#8220;beneficial
owner&#8221; (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of securities of Intrusion representing fifty
percent (50%) or more of the total voting power represented by Intrusion&#8217;s then outstanding voting securities; (ii) the
consummation of the sale or disposition by Intrusion of all or substantially all of Intrusion&#8217;s assets; (iii) the consummation
of a merger or consolidation of Intrusion with any other corporation, other than a merger or consolidation which would result in the
voting securities of Intrusion outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by
being converted into voting securities of the surviving entity or its parent) at least fifty percent (50%) of the total voting power
represented by the voting securities of Intrusion or such surviving entity or its parent outstanding immediately after such merger
or consolidation; or (iv) any other transaction which qualifies as a &#8220;corporate transaction&#8221; under Section 424(a) of the
Code wherein the stockholders of Intrusion give up all of their equity interest in Intrusion (except for the acquisition, sale or
transfer of all or substantially all of the outstanding shares of Intrusion).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(f)</span>&#8220;<b>Effective Date</b>&#8221; means the date this amendment and restatement is approved by the stockholders of Intrusion,
which shall be within twelve (12) months of the approval of the Plan by the Board.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(g)</span> &#8220;<b>Employee</b>&#8221;
means any person providing services to Intrusion or any Participating Corporation as an employee. Neither service as a director nor payment
of a director&#8217;s fee by Intrusion will be sufficient to constitute &#8220;employment&#8221; by Intrusion.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(h)</span> &#8220;<b>Exchange
Act</b>&#8221; means the U.S. Securities Exchange Act of 1934, as amended.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(i)</span> &#8220;<b>Fair
Market Value</b>&#8221; means, as of any date, the value of a share of Common Stock determined as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 6.95pt 0pt 78.95pt; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(i)</span> if
such Common Stock is publicly traded and is then listed on a national securities exchange, its closing price on the date of
determination on the principal national securities exchange on which the Common Stock is listed or admitted to trading as reported
in such source as the Board or Committee deems reliable, or if such principal national securities exchange is not open for business
on the date that Fair Market Value is being determined, the closing price as reported on the preceding business day on which that
exchange was open for business;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(ii)</span><span style="font-family: Times New Roman, Times, Serif"> </span>if
such Common Stock is publicly traded but is neither listed nor admitted to trading on a national securities exchange, the average of
the closing bid and asked prices on the date of determination (or if such date is not a business day, on the preceding business day)
as reported in such source as the Board or Committee deems reliable; or</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in"> <span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(iii)</span> by the Board or the Committee in good faith.</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 66 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(j)</span>
&#8220;<b>Offering Date</b>&#8221; means the first U.S. business day of each Offering Period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(k)</span>
&#8220;<b>Offering Period</b>&#8221; means a period with respect to which the right to purchase Common Stock may be granted under
the Plan, as determined by the Board or Committee pursuant to <span style="text-decoration: underline">Section 5(a)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(l)</span>
&#8220;<b>Parent</b>&#8221; has the same meaning as &#8220;parent corporation&#8221; in Sections 424(e) and 424(f) of the Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(m)</span>
&#8220;<b>Participant</b>&#8221; means an eligible Employee who meets the eligibility requirements set forth in <span style="text-decoration: underline">Section 4</span> and
who elects to participate in the Plan, subject and pursuant to <span style="text-decoration: underline">Section 6</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(n)</span>
&#8220;<b>Participating Corporation</b>&#8221; means any Parent, Subsidiary or Affiliate that the Board designates from time to time as
a corporation that will participate in this Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(o)</span>
&#8220;<b>Plan</b>&#8221; means this Intrusion, Inc. 2022 Employee Stock Purchase Plan, as may be amended from time to time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(p)</span> &#8220;<b>Purchase
Date</b>&#8221; means the last U.S. business day of each Purchase Period.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 114.95pt; text-indent: -6.95pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(q)</span> &#8220;<b>Purchase Period</b>&#8221;
means a period during which contributions may be made toward the purchase of Common Stock under the Plan, as determined pursuant to <span style="text-decoration: underline">Section
5(b)</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(r)</span>
&#8220;<b>Purchase Price</b>&#8221; means the price at which Participants may purchase shares of Common Stock under the Plan, as determined
pursuant to <span style="text-decoration: underline">Section 8</span>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(s)</span>
&#8220;<b>Securities Act</b>&#8221; means the U.S. Securities Act of 1933, as amended.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(t)</span>
&#8220;<b>Subsidiary</b>&#8221; has the same meaning as &#8220;subsidiary corporation&#8221; in Sections 424(e) and 424(f) of the
Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"><span style="display: inline-block; width: 0.5in; float: left; white-space: nowrap">(u)</span>
&#8220;<b>Intrusion</b>&#8221; means Intrusion, Inc., a Delaware corporation, or any successor corporation.</p>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 67 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><img src="image_004.jpg" alt="" style="height: 794px; width: 619px"/></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 68 -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&#160;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><img src="image_005.jpg" alt="" style="height: 801px; width: 619px"/></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 69; Options: Last -->
    <div style="margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-bottom: Black 1pt solid; border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&#160;<!-- Field: /Sequence --></td><td style="width: 33%; text-align: right">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!--   -->
<!-- Field: Set; Name: xdx; ID: xdx_088_labels -->
<!-- eJx9ks1ugzAQhO+R8g4rzlWI2ltuND9VpLagtI1URT0YWBKrxqZrE8Lb18YhilSaE2Bmv5lhCaI854YryQQ8sxSFDu6CgzHVLAybppmcUhITRfvwfjp9CEkJDIWTBeNRgFk+m6uyijJTMyHahPF8q1/RrGWmSnzHk3kUKvu2xA0K5lz0gVeQomkQJSSsBSZzSJAKRSWTGTpsVmujytmKcdoyUWOk4+ITGS1lvlL0IY+oDeZRwyjXT8SkfVjUxOXeiV6wTJGsoxuHbh6YBlWAewuWAdYLegp4DJw54EFeu/Os3VAmJ4iPSO5q2xIyjTEt0N+t5WDKtUyIq25GD+XsXB3V3/VcsHl7sj38Nzu3X9Txu2k9FD+S5qBk+5YpYy4BzofQnd4s/bfoilR56eT340Ntu4S31zLYzxGvanQLs9S+q+cOrenrKvEGK0VW1/nExfKn5qb1BMuao7rE6ZXnSPY38eLez1nPYQkxnEfGo1+QwiSv -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>2
<FILENAME>intz-20231231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.23a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +Kopo7xRiXgen8uEbXpMOaCIiaPty5522YkxvmRwfekavyksNL1xJSqUzrom4VsL -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:INTZ="http://intrusion.com/20231231" elementFormDefault="qualified" targetNamespace="http://intrusion.com/20231231">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://intrusion.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="intz-20231231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="intz-20231231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="intz-20231231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/ecd/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
    <element id="INTZ_AnthonyScottMember" name="AnthonyScottMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="INTZ_ReportedValueOfEquityAwardsForCeoMember" name="ReportedValueOfEquityAwardsForCeoMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="INTZ_FairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember" name="FairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="INTZ_FairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember" name="FairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="INTZ_FairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember" name="FairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>3
<FILENAME>intz-20231231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.23a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://intrusion.com/role/Cover" xlink:href="intz-20231231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosureWithAdditionalMeasures" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosureWithAdditionalMeasures" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpTable" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsToCompensation" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpAdjustmentsToCompensation" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/TabularListsByExecutiveCategory" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#TabularListsByExecutiveCategory" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/TabularListMeasures" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#TabularListMeasures" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpMeasures" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpMeasures" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpExecutiveCategoriesOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpExecutiveCategoriesOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpAdjustmentsOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#IndividualsOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/AwardTypeOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTypeOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/TradingArrangementsOnly" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#TradingArrangmentsOnly" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ForgoneRecoveries" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ForgoneRecoveries" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/OutstandingRecoveries" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#OutstandingRecoveries" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardsCloseToMnpiDisc" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardsCloseToMnpiDisc" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangementsByInd" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangemenstByInd" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/Defaults" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#Defaults" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://intrusion.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpExecutiveCategoriesOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember" xlink:label="loc_ecdAllAdjToCompMember" />
      <link:loc xlink:type="locator" xlink:href="intz-20231231.xsd#INTZ_ReportedValueOfEquityAwardsForCeoMember" xlink:label="loc_INTZReportedValueOfEquityAwardsForCeoMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_INTZReportedValueOfEquityAwardsForCeoMember" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="intz-20231231.xsd#INTZ_FairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember" xlink:label="loc_INTZFairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_INTZFairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="intz-20231231.xsd#INTZ_FairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember" xlink:label="loc_INTZFairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_INTZFairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="intz-20231231.xsd#INTZ_FairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember" xlink:label="loc_INTZFairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_INTZFairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember" xlink:type="arc" order="30" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/IndividualsOnly">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:loc xlink:type="locator" xlink:href="intz-20231231.xsd#INTZ_AnthonyScottMember" xlink:label="loc_INTZAnthonyScottMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllIndividualsMember" xlink:to="loc_INTZAnthonyScottMember" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/AwardTypeOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/TradingArrangementsOnly" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>intz-20231231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.23a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="ecd_IndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_IndividualAxis" xlink:to="ecd_IndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_IndividualAxis_lbl" xml:lang="en-US">Individual [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="intz-20231231.xsd#INTZ_AnthonyScottMember" xlink:label="INTZ_AnthonyScottMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="INTZ_AnthonyScottMember" xlink:to="INTZ_AnthonyScottMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="INTZ_AnthonyScottMember_lbl" xml:lang="en-US">Anthony Scott [Member[</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="INTZ_AnthonyScottMember" xlink:to="INTZ_AnthonyScottMember_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="INTZ_AnthonyScottMember_2_lbl" xml:lang="en-US">Anthony Scott [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis" xlink:label="ecd_AdjToCompAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToCompAxis" xlink:to="ecd_AdjToCompAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToCompAxis_lbl" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="intz-20231231.xsd#INTZ_ReportedValueOfEquityAwardsForCeoMember" xlink:label="INTZ_ReportedValueOfEquityAwardsForCeoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="INTZ_ReportedValueOfEquityAwardsForCeoMember" xlink:to="INTZ_ReportedValueOfEquityAwardsForCeoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="INTZ_ReportedValueOfEquityAwardsForCeoMember_lbl" xml:lang="en-US">Reported Value of Equity Awards For C E O Member</link:label>
      <link:loc xlink:type="locator" xlink:href="intz-20231231.xsd#INTZ_FairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember" xlink:label="INTZ_FairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="INTZ_FairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember" xlink:to="INTZ_FairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="INTZ_FairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember_lbl" xml:lang="en-US">Fair Value as of Year End for Unvested Awards Granted During Year [Member[</link:label>
      <link:loc xlink:type="locator" xlink:href="intz-20231231.xsd#INTZ_FairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember" xlink:label="INTZ_FairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="INTZ_FairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember" xlink:to="INTZ_FairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="INTZ_FairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember_lbl" xml:lang="en-US">Fair Value Year Over Year Increase or Decrease In Unvested Awards Granted in Prior Years [Member[</link:label>
      <link:loc xlink:type="locator" xlink:href="intz-20231231.xsd#INTZ_FairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember" xlink:label="INTZ_FairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="INTZ_FairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember" xlink:to="INTZ_FairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="INTZ_FairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember_lbl" xml:lang="en-US">Fair Value Increase or Decrease From Prior Year End For Awards Vested During Year [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="INTZ_ReportedValueOfEquityAwardsForCeoMember" xlink:to="INTZ_ReportedValueOfEquityAwardsForCeoMember_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="INTZ_ReportedValueOfEquityAwardsForCeoMember_2_lbl" xml:lang="en-US">Reported Value of Equity Awards for CEO [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="INTZ_FairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember" xlink:to="INTZ_FairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="INTZ_FairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember_2_lbl" xml:lang="en-US">Fair Value as of Year End for Unvested Awards Granted DuringYear [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="INTZ_FairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember" xlink:to="INTZ_FairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="INTZ_FairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember_2_lbl" xml:lang="en-US">Fair Value Year Over Year Increase or Decrease in Unvested Awards Granted in Prior Years [Member]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="INTZ_FairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember" xlink:to="INTZ_FairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="INTZ_FairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember_2_lbl" xml:lang="en-US">Fai Value Increase or Decrease from Prior Year End for Awards Vested During Year [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ExecutiveCategoryAxis" xlink:label="ecd_ExecutiveCategoryAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ExecutiveCategoryAxis" xlink:to="ecd_ExecutiveCategoryAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ExecutiveCategoryAxis_lbl" xml:lang="en-US">Executive Category [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoMember" xlink:label="ecd_NonPeoNeoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoMember" xlink:to="ecd_NonPeoNeoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoMember_lbl" xml:lang="en-US">Non-PEO NEO [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable" xlink:label="ecd_PvpTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PvpTable" xlink:to="ecd_PvpTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PvpTable_lbl" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock" xlink:label="ecd_PvpTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PvpTableTextBlock" xlink:to="ecd_PvpTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PvpTableTextBlock_lbl" xml:lang="en-US">Disclosure - Pay vs Performance Disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName" xlink:label="ecd_CoSelectedMeasureName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CoSelectedMeasureName" xlink:to="ecd_CoSelectedMeasureName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CoSelectedMeasureName_lbl" xml:lang="en-US">Company Selected Measure Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock" xlink:label="ecd_NamedExecutiveOfficersFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="ecd_NamedExecutiveOfficersFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NamedExecutiveOfficersFnTextBlock_lbl" xml:lang="en-US">Named Executive Officers, Footnote [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock" xlink:label="ecd_PeerGroupIssuersFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeerGroupIssuersFnTextBlock" xlink:to="ecd_PeerGroupIssuersFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeerGroupIssuersFnTextBlock_lbl" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock" xlink:label="ecd_ChangedPeerGroupFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ChangedPeerGroupFnTextBlock" xlink:to="ecd_ChangedPeerGroupFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ChangedPeerGroupFnTextBlock_lbl" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt" xlink:label="ecd_PeoTotalCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoTotalCompAmt" xlink:to="ecd_PeoTotalCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoTotalCompAmt_lbl" xml:lang="en-US">PEO Total Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt" xlink:label="ecd_PeoActuallyPaidCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoActuallyPaidCompAmt" xlink:to="ecd_PeoActuallyPaidCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoActuallyPaidCompAmt_lbl" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock" xlink:label="ecd_AdjToPeoCompFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToPeoCompFnTextBlock" xlink:to="ecd_AdjToPeoCompFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToPeoCompFnTextBlock_lbl" xml:lang="en-US">Adjustment To PEO Compensation, Footnote [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt" xlink:label="ecd_NonPeoNeoAvgTotalCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="ecd_NonPeoNeoAvgTotalCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoAvgTotalCompAmt_lbl" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:label="ecd_NonPeoNeoAvgCompActuallyPaidAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="ecd_NonPeoNeoAvgCompActuallyPaidAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoAvgCompActuallyPaidAmt_lbl" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:label="ecd_AdjToNonPeoNeoCompFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="ecd_AdjToNonPeoNeoCompFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToNonPeoNeoCompFnTextBlock_lbl" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:label="ecd_EquityValuationAssumptionDifferenceFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="ecd_EquityValuationAssumptionDifferenceFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_EquityValuationAssumptionDifferenceFnTextBlock_lbl" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:label="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:label="ecd_CompActuallyPaidVsNetIncomeTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="ecd_CompActuallyPaidVsNetIncomeTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsNetIncomeTextBlock_lbl" xml:lang="en-US">Relationship between Pay and Performance</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:label="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:label="ecd_TotalShareholderRtnVsPeerGroupTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="ecd_TotalShareholderRtnVsPeerGroupTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TotalShareholderRtnVsPeerGroupTextBlock_lbl" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:label="ecd_CompActuallyPaidVsOtherMeasureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="ecd_CompActuallyPaidVsOtherMeasureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsOtherMeasureTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock" xlink:label="ecd_TabularListTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TabularListTableTextBlock" xlink:to="ecd_TabularListTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TabularListTableTextBlock_lbl" xml:lang="en-US">Tabular List, Table</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt" xlink:label="ecd_TotalShareholderRtnAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TotalShareholderRtnAmt" xlink:to="ecd_TotalShareholderRtnAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TotalShareholderRtnAmt_lbl" xml:lang="en-US">Total Shareholder Return Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt" xlink:label="ecd_PeerGroupTotalShareholderRtnAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="ecd_PeerGroupTotalShareholderRtnAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeerGroupTotalShareholderRtnAmt_lbl" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net Income (Loss)</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt" xlink:label="ecd_CoSelectedMeasureAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CoSelectedMeasureAmt" xlink:to="ecd_CoSelectedMeasureAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CoSelectedMeasureAmt_lbl" xml:lang="en-US">Company Selected Measure Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt" xlink:label="ecd_OtherPerfMeasureAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OtherPerfMeasureAmt" xlink:to="ecd_OtherPerfMeasureAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OtherPerfMeasureAmt_lbl" xml:lang="en-US">Other Performance Measure, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt" xlink:label="ecd_AdjToCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToCompAmt" xlink:to="ecd_AdjToCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToCompAmt_lbl" xml:lang="en-US">Adjustment to Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName" xlink:label="ecd_PeoName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoName" xlink:to="ecd_PeoName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoName_lbl" xml:lang="en-US">PEO Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName" xlink:label="ecd_MeasureName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MeasureName" xlink:to="ecd_MeasureName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MeasureName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock" xlink:label="ecd_NonGaapMeasureDescriptionTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="ecd_NonGaapMeasureDescriptionTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonGaapMeasureDescriptionTextBlock_lbl" xml:lang="en-US">Non-GAAP Measure Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock" xlink:label="ecd_Additional402vDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Additional402vDisclosureTextBlock" xlink:to="ecd_Additional402vDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Additional402vDisclosureTextBlock_lbl" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock" xlink:label="ecd_PnsnBnftsAdjFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PnsnBnftsAdjFnTextBlock" xlink:to="ecd_PnsnBnftsAdjFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PnsnBnftsAdjFnTextBlock_lbl" xml:lang="en-US">Pension Benefits Adjustments, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjFnTextBlock" xlink:label="ecd_EqtyAwrdsAdjFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_EqtyAwrdsAdjFnTextBlock" xlink:to="ecd_EqtyAwrdsAdjFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_EqtyAwrdsAdjFnTextBlock_lbl" xml:lang="en-US">Equity Awards Adjustments, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable" xlink:label="ecd_ErrCompRecoveryTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ErrCompRecoveryTable" xlink:to="ecd_ErrCompRecoveryTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ErrCompRecoveryTable_lbl" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis" xlink:label="ecd_RestatementDateAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDateAxis" xlink:to="ecd_RestatementDateAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDateAxis_lbl" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate" xlink:label="ecd_RestatementDeterminationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDeterminationDate" xlink:to="ecd_RestatementDeterminationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDeterminationDate_lbl" xml:lang="en-US">Restatement Determination Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt" xlink:label="ecd_AggtErrCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AggtErrCompAmt" xlink:to="ecd_AggtErrCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AggtErrCompAmt_lbl" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock" xlink:label="ecd_ErrCompAnalysisTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ErrCompAnalysisTextBlock" xlink:to="ecd_ErrCompAnalysisTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ErrCompAnalysisTextBlock_lbl" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:label="ecd_StkPrcOrTsrEstimationMethodTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="ecd_StkPrcOrTsrEstimationMethodTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_StkPrcOrTsrEstimationMethodTextBlock_lbl" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt" xlink:label="ecd_OutstandingAggtErrCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingAggtErrCompAmt" xlink:to="ecd_OutstandingAggtErrCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingAggtErrCompAmt_lbl" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:label="ecd_AggtErrCompNotYetDeterminedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="ecd_AggtErrCompNotYetDeterminedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AggtErrCompNotYetDeterminedTextBlock_lbl" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName" xlink:label="ecd_ForgoneRecoveryIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryIndName" xlink:to="ecd_ForgoneRecoveryIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_ForgoneRecoveryIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:label="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_lbl" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:label="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_lbl" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:label="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_lbl" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:label="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_lbl" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName" xlink:label="ecd_OutstandingRecoveryIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryIndName" xlink:to="ecd_OutstandingRecoveryIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_OutstandingRecoveryIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt" xlink:label="ecd_OutstandingRecoveryCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryCompAmt" xlink:to="ecd_OutstandingRecoveryCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingRecoveryCompAmt_lbl" xml:lang="en-US">Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:label="ecd_RestatementDoesNotRequireRecoveryTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="ecd_RestatementDoesNotRequireRecoveryTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDoesNotRequireRecoveryTextBlock_lbl" xml:lang="en-US">Restatement does not require Recovery</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTable" xlink:label="ecd_AwardsCloseToMnpiDiscTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscTable" xlink:to="ecd_AwardsCloseToMnpiDiscTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscTable_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock" xlink:label="ecd_AwardTmgMnpiDiscTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMnpiDiscTextBlock" xlink:to="ecd_AwardTmgMnpiDiscTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMnpiDiscTextBlock_lbl" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock" xlink:label="ecd_AwardTmgMethodTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMethodTextBlock" xlink:to="ecd_AwardTmgMethodTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMethodTextBlock_lbl" xml:lang="en-US">Award Timing Method</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag" xlink:label="ecd_AwardTmgPredtrmndFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgPredtrmndFlag" xlink:to="ecd_AwardTmgPredtrmndFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgPredtrmndFlag_lbl" xml:lang="en-US">Award Timing Predetermined</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag" xlink:label="ecd_AwardTmgMnpiCnsdrdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="ecd_AwardTmgMnpiCnsdrdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMnpiCnsdrdFlag_lbl" xml:lang="en-US">Award Timing MNPI Considered</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:label="ecd_AwardTmgHowMnpiCnsdrdTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="ecd_AwardTmgHowMnpiCnsdrdTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgHowMnpiCnsdrdTextBlock_lbl" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag" xlink:label="ecd_MnpiDiscTimedForCompValFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MnpiDiscTimedForCompValFlag" xlink:to="ecd_MnpiDiscTimedForCompValFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MnpiDiscTimedForCompValFlag_lbl" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:label="ecd_AwardsCloseToMnpiDiscTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="ecd_AwardsCloseToMnpiDiscTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscTableTextBlock_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName" xlink:label="ecd_AwardsCloseToMnpiDiscIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscIndName" xlink:to="ecd_AwardsCloseToMnpiDiscIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_AwardsCloseToMnpiDiscIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt" xlink:label="ecd_AwardUndrlygSecuritiesAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardUndrlygSecuritiesAmt" xlink:to="ecd_AwardUndrlygSecuritiesAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardUndrlygSecuritiesAmt_lbl" xml:lang="en-US">Underlying Securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice" xlink:label="ecd_AwardExrcPrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardExrcPrice" xlink:to="ecd_AwardExrcPrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardExrcPrice_lbl" xml:lang="en-US">Exercise Price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue" xlink:label="ecd_AwardGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardGrantDateFairValue" xlink:to="ecd_AwardGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardGrantDateFairValue_lbl" xml:lang="en-US">Fair Value as of Grant Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct" xlink:label="ecd_UndrlygSecurityMktPriceChngPct" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_UndrlygSecurityMktPriceChngPct" xlink:to="ecd_UndrlygSecurityMktPriceChngPct_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_UndrlygSecurityMktPriceChngPct_lbl" xml:lang="en-US">Underlying Security Market Price Change</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrByIndTable" xlink:label="ecd_TradingArrByIndTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TradingArrByIndTable" xlink:to="ecd_TradingArrByIndTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TradingArrByIndTable_lbl" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrAxis" xlink:label="ecd_TradingArrAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TradingArrAxis" xlink:to="ecd_TradingArrAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TradingArrAxis_lbl" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock" xlink:label="ecd_MtrlTermsOfTrdArrTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="ecd_MtrlTermsOfTrdArrTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MtrlTermsOfTrdArrTextBlock_lbl" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName" xlink:label="ecd_TrdArrIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndName" xlink:to="ecd_TrdArrIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_TrdArrIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle" xlink:label="ecd_TrdArrIndTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndTitle" xlink:to="ecd_TrdArrIndTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrIndTitle_lbl" xml:lang="en-US">Title</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="ecd_Rule10b51ArrAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrAdoptedFlag" xlink:to="ecd_Rule10b51ArrAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Rule10b51ArrAdoptedFlag_lbl" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="ecd_NonRule10b51ArrAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrAdoptedFlag" xlink:to="ecd_NonRule10b51ArrAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonRule10b51ArrAdoptedFlag_lbl" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate" xlink:label="ecd_TrdArrAdoptionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrAdoptionDate" xlink:to="ecd_TrdArrAdoptionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrAdoptionDate_lbl" xml:lang="en-US">Adoption Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="ecd_Rule10b51ArrTrmntdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrTrmntdFlag" xlink:to="ecd_Rule10b51ArrTrmntdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Rule10b51ArrTrmntdFlag_lbl" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="ecd_NonRule10b51ArrTrmntdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrTrmntdFlag" xlink:to="ecd_NonRule10b51ArrTrmntdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonRule10b51ArrTrmntdFlag_lbl" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate" xlink:label="ecd_TrdArrTerminationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrTerminationDate" xlink:to="ecd_TrdArrTerminationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrTerminationDate_lbl" xml:lang="en-US">Termination Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate" xlink:label="ecd_TrdArrExpirationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrExpirationDate" xlink:to="ecd_TrdArrExpirationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrExpirationDate_lbl" xml:lang="en-US">Expiration Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration" xlink:label="ecd_TrdArrDuration" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrDuration" xlink:to="ecd_TrdArrDuration_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrDuration_lbl" xml:lang="en-US">Arrangement Duration</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems" xlink:label="ecd_InsiderTradingPoliciesProcLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTradingPoliciesProcLineItems" xlink:to="ecd_InsiderTradingPoliciesProcLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTradingPoliciesProcLineItems_lbl" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:label="ecd_InsiderTrdPoliciesProcAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="ecd_InsiderTrdPoliciesProcAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTrdPoliciesProcAdoptedFlag_lbl" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:label="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_lbl" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryIndName" xlink:to="ecd_ForgoneRecoveryIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryIndName_2_lbl" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryIndName" xlink:to="ecd_OutstandingRecoveryIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingRecoveryIndName_2_lbl" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscIndName" xlink:to="ecd_AwardsCloseToMnpiDiscIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscIndName_2_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndName" xlink:to="ecd_TrdArrIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrIndName_2_lbl" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>intz-20231231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.23a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://intrusion.com/role/Cover" xlink:href="intz-20231231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ErrCompDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTimingDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangements" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingPoliciesProc" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://intrusion.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:title="995410 - Disclosure - Pay vs Performance Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PayVsPerformanceDisclosureLineItems" xlink:label="loc_ecdPayVsPerformanceDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable" xlink:label="loc_ecdPvpTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPvpTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="intz-20231231.xsd#INTZ_AnthonyScottMember" xlink:label="loc_INTZAnthonyScottMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllIndividualsMember" xlink:to="loc_INTZAnthonyScottMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis" xlink:label="loc_ecdAdjToCompAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdAdjToCompAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember" xlink:label="loc_ecdAllAdjToCompMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAdjToCompAxis" xlink:to="loc_ecdAllAdjToCompMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="intz-20231231.xsd#INTZ_ReportedValueOfEquityAwardsForCeoMember" xlink:label="loc_INTZReportedValueOfEquityAwardsForCeoMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_INTZReportedValueOfEquityAwardsForCeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="intz-20231231.xsd#INTZ_FairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember" xlink:label="loc_INTZFairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_INTZFairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="intz-20231231.xsd#INTZ_FairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember" xlink:label="loc_INTZFairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_INTZFairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="intz-20231231.xsd#INTZ_FairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember" xlink:label="loc_INTZFairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_INTZFairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ExecutiveCategoryAxis" xlink:label="loc_ecdExecutiveCategoryAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdExecutiveCategoryAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllExecutiveCategoriesMember" xlink:label="loc_ecdAllExecutiveCategoriesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdExecutiveCategoryAxis" xlink:to="loc_ecdAllExecutiveCategoriesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoMember" xlink:label="loc_ecdNonPeoNeoMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllExecutiveCategoriesMember" xlink:to="loc_ecdNonPeoNeoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock" xlink:label="loc_ecdPvpTableTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPvpTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName" xlink:label="loc_ecdCoSelectedMeasureName" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdCoSelectedMeasureName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock" xlink:label="loc_ecdNamedExecutiveOfficersFnTextBlock" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdNamedExecutiveOfficersFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock" xlink:label="loc_ecdPeerGroupIssuersFnTextBlock" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeerGroupIssuersFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock" xlink:label="loc_ecdChangedPeerGroupFnTextBlock" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdChangedPeerGroupFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt" xlink:label="loc_ecdPeoTotalCompAmt" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeoTotalCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt" xlink:label="loc_ecdPeoActuallyPaidCompAmt" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeoActuallyPaidCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock" xlink:label="loc_ecdAdjToPeoCompFnTextBlock" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdAdjToPeoCompFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt" xlink:label="loc_ecdNonPeoNeoAvgTotalCompAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdNonPeoNeoAvgTotalCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:label="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:label="loc_ecdAdjToNonPeoNeoCompFnTextBlock" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdAdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:label="loc_ecdEquityValuationAssumptionDifferenceFnTextBlock" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdEquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:label="loc_ecdCompActuallyPaidVsTotalShareholderRtnTextBlock" />
      <link:presentationArc order="2120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdCompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:label="loc_ecdCompActuallyPaidVsNetIncomeTextBlock" />
      <link:presentationArc order="2130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdCompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:label="loc_ecdCompActuallyPaidVsCoSelectedMeasureTextBlock" />
      <link:presentationArc order="2140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdCompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:label="loc_ecdTotalShareholderRtnVsPeerGroupTextBlock" />
      <link:presentationArc order="2150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdTotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:label="loc_ecdCompActuallyPaidVsOtherMeasureTextBlock" />
      <link:presentationArc order="2160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdCompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock" xlink:label="loc_ecdTabularListTableTextBlock" />
      <link:presentationArc order="2170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdTabularListTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt" xlink:label="loc_ecdTotalShareholderRtnAmt" />
      <link:presentationArc order="2180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdTotalShareholderRtnAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt" xlink:label="loc_ecdPeerGroupTotalShareholderRtnAmt" />
      <link:presentationArc order="2190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeerGroupTotalShareholderRtnAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="2200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt" xlink:label="loc_ecdCoSelectedMeasureAmt" />
      <link:presentationArc order="2210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdCoSelectedMeasureAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt" xlink:label="loc_ecdOtherPerfMeasureAmt" />
      <link:presentationArc order="2220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdOtherPerfMeasureAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt" xlink:label="loc_ecdAdjToCompAmt" />
      <link:presentationArc order="2230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdAdjToCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName" xlink:label="loc_ecdPeoName" />
      <link:presentationArc order="2240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeoName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName" xlink:label="loc_ecdMeasureName" />
      <link:presentationArc order="2250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdMeasureName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock" xlink:label="loc_ecdNonGaapMeasureDescriptionTextBlock" />
      <link:presentationArc order="2260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdMeasureName" xlink:to="loc_ecdNonGaapMeasureDescriptionTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock" xlink:label="loc_ecdAdditional402vDisclosureTextBlock" />
      <link:presentationArc order="2270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdAdditional402vDisclosureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock" xlink:label="loc_ecdPnsnBnftsAdjFnTextBlock" />
      <link:presentationArc order="2280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPnsnBnftsAdjFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjFnTextBlock" xlink:label="loc_ecdEqtyAwrdsAdjFnTextBlock" />
      <link:presentationArc order="2290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdEqtyAwrdsAdjFnTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:title="995440 - Disclosure - Recovery of Erroneously Awarded Compensation">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RecoveryOfErrCompDisclosureLineItems" xlink:label="loc_ecdRecoveryOfErrCompDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable" xlink:label="loc_ecdErrCompRecoveryTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecdErrCompRecoveryTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis" xlink:label="loc_ecdRestatementDateAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdErrCompRecoveryTable" xlink:to="loc_ecdRestatementDateAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdErrCompRecoveryTable" xlink:to="loc_ecdIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate" xlink:label="loc_ecdRestatementDeterminationDate" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecdRestatementDeterminationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt" xlink:label="loc_ecdAggtErrCompAmt" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdAggtErrCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock" xlink:label="loc_ecdErrCompAnalysisTextBlock" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdErrCompAnalysisTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:label="loc_ecdStkPrcOrTsrEstimationMethodTextBlock" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdStkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt" xlink:label="loc_ecdOutstandingAggtErrCompAmt" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdOutstandingAggtErrCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:label="loc_ecdAggtErrCompNotYetDeterminedTextBlock" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdAggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName" xlink:label="loc_ecdForgoneRecoveryIndName" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:label="loc_ecdForgoneRecoveryDueToExpenseOfEnforcementAmt" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:label="loc_ecdForgoneRecoveryDueToViolationOfHomeCountryLawAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:label="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:label="loc_ecdForgoneRecoveryExplanationOfImpracticabilityTextBlock" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName" xlink:label="loc_ecdOutstandingRecoveryIndName" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdOutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt" xlink:label="loc_ecdOutstandingRecoveryCompAmt" />
      <link:presentationArc order="2120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdOutstandingRecoveryCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:label="loc_ecdRestatementDoesNotRequireRecoveryTextBlock" />
      <link:presentationArc order="2130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdRestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:title="995443 - Disclosure - Award Timing Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgDiscLineItems" xlink:label="loc_ecdAwardTmgDiscLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTable" xlink:label="loc_ecdAwardsCloseToMnpiDiscTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardsCloseToMnpiDiscTable" xlink:to="loc_ecdIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaapAwardTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock" xlink:label="loc_ecdAwardTmgMnpiDiscTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMnpiDiscTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock" xlink:label="loc_ecdAwardTmgMethodTextBlock" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMethodTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag" xlink:label="loc_ecdAwardTmgPredtrmndFlag" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgPredtrmndFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag" xlink:label="loc_ecdAwardTmgMnpiCnsdrdFlag" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMnpiCnsdrdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:label="loc_ecdAwardTmgHowMnpiCnsdrdTextBlock" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag" xlink:label="loc_ecdMnpiDiscTimedForCompValFlag" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdMnpiDiscTimedForCompValFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:label="loc_ecdAwardsCloseToMnpiDiscTableTextBlock" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName" xlink:label="loc_ecdAwardsCloseToMnpiDiscIndName" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt" xlink:label="loc_ecdAwardUndrlygSecuritiesAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardUndrlygSecuritiesAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice" xlink:label="loc_ecdAwardExrcPrice" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardExrcPrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue" xlink:label="loc_ecdAwardGrantDateFairValue" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct" xlink:label="loc_ecdUndrlygSecurityMktPriceChngPct" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdUndrlygSecurityMktPriceChngPct" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:title="995445 - Disclosure - Insider Trading Arrangements">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingArrLineItems" xlink:label="loc_ecdInsiderTradingArrLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrByIndTable" xlink:label="loc_ecdTradingArrByIndTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTradingArrByIndTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrAxis" xlink:label="loc_ecdTradingArrAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdTradingArrByIndTable" xlink:to="loc_ecdTradingArrAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllTradingArrangementsMember" xlink:label="loc_ecdAllTradingArrangementsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdTradingArrAxis" xlink:to="loc_ecdAllTradingArrangementsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdTradingArrByIndTable" xlink:to="loc_ecdIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock" xlink:label="loc_ecdMtrlTermsOfTrdArrTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdMtrlTermsOfTrdArrTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName" xlink:label="loc_ecdTrdArrIndName" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle" xlink:label="loc_ecdTrdArrIndTitle" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrIndTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="loc_ecdRule10b51ArrAdoptedFlag" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdRule10b51ArrAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="loc_ecdNonRule10b51ArrAdoptedFlag" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdNonRule10b51ArrAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate" xlink:label="loc_ecdTrdArrAdoptionDate" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrAdoptionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="loc_ecdRule10b51ArrTrmntdFlag" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdRule10b51ArrTrmntdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="loc_ecdNonRule10b51ArrTrmntdFlag" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdNonRule10b51ArrTrmntdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate" xlink:label="loc_ecdTrdArrTerminationDate" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrTerminationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate" xlink:label="loc_ecdTrdArrExpirationDate" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrExpirationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration" xlink:label="loc_ecdTrdArrDuration" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrDuration" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:title="995447 - Disclosure - Insider Trading Policies and Procedures">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems" xlink:label="loc_ecdInsiderTradingPoliciesProcLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:label="loc_ecdInsiderTrdPoliciesProcAdoptedFlag" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingPoliciesProcLineItems" xlink:to="loc_ecdInsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:label="loc_ecdInsiderTrdPoliciesProcNotAdoptedTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingPoliciesProcLineItems" xlink:to="loc_ecdInsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember" xlink:label="loc_ecdAllAdjToCompMember" />
      <link:loc xlink:type="locator" xlink:href="intz-20231231.xsd#INTZ_ReportedValueOfEquityAwardsForCeoMember" xlink:label="loc_INTZReportedValueOfEquityAwardsForCeoMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_INTZReportedValueOfEquityAwardsForCeoMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="intz-20231231.xsd#INTZ_FairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember" xlink:label="loc_INTZFairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_INTZFairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember" order="100" />
      <link:loc xlink:type="locator" xlink:href="intz-20231231.xsd#INTZ_FairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember" xlink:label="loc_INTZFairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_INTZFairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember" order="200" />
      <link:loc xlink:type="locator" xlink:href="intz-20231231.xsd#INTZ_FairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember" xlink:label="loc_INTZFairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_INTZFairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember" order="300" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:loc xlink:type="locator" xlink:href="intz-20231231.xsd#INTZ_AnthonyScottMember" xlink:label="loc_INTZAnthonyScottMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllIndividualsMember" xlink:to="loc_INTZAnthonyScottMember" order="0" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:loc xlink:type="locator" xlink:href="intz-20231231.xsd#INTZ_AnthonyScottMember" xlink:label="loc_INTZAnthonyScottMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllIndividualsMember" xlink:to="loc_INTZAnthonyScottMember" order="0" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:loc xlink:type="locator" xlink:href="intz-20231231.xsd#INTZ_AnthonyScottMember" xlink:label="loc_INTZAnthonyScottMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllIndividualsMember" xlink:to="loc_INTZAnthonyScottMember" order="0" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:loc xlink:type="locator" xlink:href="intz-20231231.xsd#INTZ_AnthonyScottMember" xlink:label="loc_INTZAnthonyScottMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllIndividualsMember" xlink:to="loc_INTZAnthonyScottMember" order="0" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2A YP# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***"<#)H
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M\=,[5!./PINA>-/#GB5S'I&K07$H&?*Y1\>NU@#C\*%KL#TW-ZBBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>5_''_D&>%_^P[!_
MZ"U>J5Y7\<?^09X7_P"P[!_Z"U 'JE%%% !7E?Q;_P"1J^'7_8=B_P#0XZ]4
MKROXM_\ (U?#K_L.Q?\ H<= 'JE9>H:]:Z9JVG:?<QS*=09HX9P!Y8<#.PG.
M02.G'.*U*Q/%F@?\)'X>GL8Y/)NAB6UGR1Y4RG*MD<CG]":3=M1I7T*,WCS2
MX967[/>.@U)-+$J(NQIF'.#NY4="?7L:A/Q"M6\07&D6^A:]=/;W MY;BWM
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 5XY^T9(\/@W298G9)$U-65E."I$;X(/K7L=9^LZ'I?B&Q^Q:O8
M07MMN#B.9<@,.A'H>3R/4T ?&/\ PGOC#_H:M;_\&$O_ ,57J/PG@OO&UCJD
M^L_$'Q#;2VQ 2&'5&0JN,^8VXG([?@<UZY_PJGP+_P!"U9?DW^-'_"J? O\
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M'<O)#:32!(I Q5CM0D#"G.>G?&13$\>^'7NX;5KFZBFF*!1/I]Q$!O)";BR
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M$2?9SC]]A.0-KCON/W:IWFK_ !#:*=K1]56&&TNIK:0Z8@DN2CKY0D4Q_*S
MM\H"D@9P*Z?4O&UYINKZG:PZ;]KCM#)+*\MV(_+C1(20@$9))\W@$]0?F (
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M&R\["WS,HQT)/%3'56_K3_@+^K)))IMO^OZU_J]W2M;WQ[!XPM-/NY?,LT6
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MQ3/".D:GH"IJ%WHUQ$Z65IID=JKQO*V'.^5RC%0,OGKT4_2O1**45R[?UO\
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M]?U_6P1YF[,PEU;PWIK7EK+I5O:V=O.EM%Y%H9/.,:B7(CC0D+&6SGH#D\5
M/$'@NYF>>YT^#=:74GD2MIS2'.%=YD(0X7Y@2XXY!)Y%7;7P=IS:%IT-CJ6H
MQ"$/)'>*Z&:59>7W[D(.[/\ =!&!C&*K7?PRT*[$0=IMD+[H4DB@F6,%$5E"
MRQL,$1KR<D=B,U6JEK_7]:DK5>1HZCK>E>%6T^!;016=X\K;K2!F"G&\MLC4
MDYR23]2:9:/X/O\ 4+7[+::=+>":9X&%F-ZR##2.#MXSN4[N^1R<U<U;P[#J
MBV86]N[)K0,L;6A1?E9=I!#*1C'H!CMCBLGPMX>LH-;O=?LUA%O/!':VBQLQ
MQ'&-K,P91ACM4'&>$'-*/Q:^?W= =_Z_$O7.K0WVIZIHMUHTES#:VT=P5D57
M%QN9@ J'C@IU..?IFL6^U/0W\&Z=KT_A>TGG:W1[6U>U\P1F5U78'6-L$EQP
MH)/. :ZF6TM+35)]7D>8230);. I95569@>!D??.23CITJI:Z' ?#UC9:?JU
M_#:16Z+!- Z!B!@JY)3DX'0C:03E31T\]/U_2Q;M?^NW^9S5QK6E7EK!%=>&
M=*N+18HC>*_*PB2=HU1$DA4N0ZDLK!,'U/%6_$VN:;X7U&UM4TS04WPM<J][
M=K:9* 1A8QY;;GVG:!QQQTJY-\/]'N;RQN9WN)GM',F)!&PE<R>86.4RA+G)
M\O9GH> !6]-9V\6H_P!KR.ZO%;-$1_#LR&)QC.?EHE9+MO\ E_7RW%K?3R_,
MYJ?6=(TK6_#EN="@@_M&*29+CRE1K0B-% ("\9!5,Y'0#FI]$O(/'>G66KS0
MW%K%:7LCQ6Q8$2%"51VRH/3Y@!C&><XJ+Q+H^AZS#;7.JWU\\=Z/L]JL,>2/
M,,<@VA4+#'DALGH"V3C&-!?[*\);4DOIH8)Y)9%A9 REF()^ZN1CH.>A[]GU
MU[_C?^E_P27LNUM?N_+J<\=3TJ[\3ZMI$>B^$C/-,8)XKJ_5+F\(4,"T/DL6
M'/<GH3[5M>$9IIEO"V@:5I4,$C6V;*X+EBC'((\I,+DL1R>IX%7(/#TEKJT]
M[;ZWJ,<,\_GRV86 Q,V ",F(N <#HU7;2PMM+MKH*[F.6:2XD,A'!8Y;H.E2
MKJ/R_'^KE6N_G_7Z&)/XM\)W:1W,[BX-M,C0%K"5WWL2JO"-A+ G(#ID>]1W
M9T)-#BN=(T+3+L:O<Q[(I(1 D\A).Z3*$@C:3RI.1ZU%H7AK0YF2:RU2^O$L
M9(D@$C+M@10'2-?D&5PX.3D]!NXK5NO#UJGA^*Q2ZO8%LW^T17$"J\R,"6R
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MZUA_\*JT1K:ZAEO-0D:Y,1DEW1(Y\O<!RD8R2KLK$Y)'?/-3&_7^MO\ @O\
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M/#VJZ?X$FT8II;71#+%$T:&#83]U]L2*>,\^6.O0]^NHI<JLUW*LKW/+]/\
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M&&/'#?=6E;?^OZW_ "(32=NW^2_1?GIVZKP/8ZU9:7<)K4MTTC2YCCN.608
M.&\^8D$\\L,9Z <5RMCX/UVSN9+BUBU"WFA,*Q-_:&5E_P!+D9R1YAW+Y3YV
MMZGC-=?X-UZ]\1Z3/>WD$4!2<P*B*1AD51)G)YQ)O ]@/K7%:=XF\0V]_-<O
MJ-K>I"(8KB%HWZO>2Q84"3".!C)(/"@8[U?V_E_7]>8UM]_]?UV.D\"Z=XFL
M9KUO$-U<2%@HQ)\R,X)RZ-Y\A (XQLC' ^45VE<7X%\7:EXGFO5OK2W@6(*0
ML<D>^)B3F-U65VR..65#U^45VE#V0^K]0HHHI#"BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5YW\0M-UN+5K
M74O#]K+//J%L^DW7E*28E<Y24^R'=R?6O1*YW4-7GL]<OX6N%BMHM*-R@8
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M*$9 ^P<!6WYQG 88!%;5_>:C#XLTFV2:)=/N$EWQ[,NSJN0=W8#T'7/MRK[
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M*&[".@+;(UR=LAY/)P,D]YUM_7]>1.MV,&H^$8KS2=)T[2K&9990L0BL]L4
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MG^SC!DD\PL&/ SA3CGITZ5,6WN@;?8Z.WU"UNKB6WBD/GQ#<\;HR,H+,H."
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %<)>>)?$>E7NM-=MI4UKIENDY2*"1'EW[]B[BY Y4
M9..]=W61>>&[&^?5&N#,PU*!+>=0V %7=@K@9!^8\^PI.]_Z\O\ @@_+^OZT
M*VA:MJ-QJM_I.JK:F[M8HIQ):JRHR2;@!AB3D%&'7GCI6%?>/KNQTE)#:0/?
MPS727<.2H58<C(ZD;BT6"<\/73Z/H:Z5+<7$M[<WUY<!%DN+@(&*H"%7"*H
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M>:H;*"T:TT>VCN;SSMV^4-N)5,'"D*N<G.<XQWJ/3/'::@FCV@\@ZK=2HEU
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M<C!JG8>"+?2;MY-,U;4;.WD6))+2,0-$ZQH$ )>-G&54 X8?A2L^5KKK_P
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M5>3OQCV[T_2_&%YJ=[I:+HZ):WVG#4/-^U9=%PN5V;.3E@.HSUIO3?\ K?\
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M#_\ !C#_ /%5H:GKNCZ)Y7]K:K8V'G9\O[7<)%OQC.-Q&<9'3U%:%% '/_\
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M2&Z1UA7!.7(.%&%)R?0^E4_^$[\'_P#0UZ'_ .#&'_XJN@HH Y__ (3OP?\
M]#7H?_@QA_\ BJN:EXET'1KA;?5-;TVQG9 ZQW5TD3%<D9 8@XR",^QK4HH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 >7V>B78^*]SIC>)_$+6EO917ZQM?DAG,K J1C!3  Q^M8.G^+
M/$$VMZ=8R?VB+5O%4T)O6G!CEC!<"#&=V!@'&,<5[ FCV$>MRZRL&-0E@6W>
M;>W,8)8#&<=2><9JC'X/T&+R=ECCR+YM1C_?/\MPV<O][W/'3VI137+?I_\
M)7_*Q,TW>W7_ "M^=SF/"$5W'XT\8B?6]2GAL94C@CN[HO%&'C#DX/ P>GH*
MR_!%[JUMXJLX-<U'5FN;Z&9D9KE+FQOL8.Z$J?W6!SMQSFNYTOP;H6BZG=ZC
M8VDJ75X"+AGNI9!)GU5V*]O3@<=*CTCP/X?T+4OM]A9-'.H98M\SNL"M]X1J
MQ(0'V HAIRWZ*WY_\#7_ ( 25[^M_P O^#_5SHJ\3UB]\27?COQ%;Z-=>(I+
MVUO+=;*.V?-C&I1"XF!X ()->V51L]'L-/O[^^M8/+N;]UDN7WL?,95V@X)P
M./3%"^)2[?\  _R&]8V7];GCGA?6M<O/'T5NFIZP96U>[6475RILY+:-B"D:
MDY+C*] ,"KUMJ6KS1:?XD;6M0,U]K[Z=+8^>?(6 R/'M5!T8 !MPYKT9?!N@
M(L2K8;?*O6U"-A-(&6=CEG!W9YSTZ>U5U\ ^'%UB35%L7%P[-)M6>01K(P(:
M14#85R"?F !_&E%-))]%_E^>J_'J)IN_G_P?RNG\K''>"M0U#7/%>I:->>()
MYK71XY8+9HI75[P,Q4RLW\13[N0?O<U>\(7'B'4O$\NDZG>RF#PV3#-*LIS?
MR/S&SX["/!(/5C[5UUIX3T.Q?3'M; 0MIB-':,DC@HK?>!.?F!ZG=GGGK5RS
MT>PT^_O[ZU@\NYOW62Y?>Q\QE7:#@G X],52T:]/QZ/\_P  :;OZ_AU7Y?B7
MJ\R_T[7=<\27\WBN[T5=(OTM[<"4"V1 J,3(A(#[B2.3]*]-KG;_ ,#>'=3U
MK^UKNPWW196D E<1RLOW2Z [6(QP2*7VD_ZZ?\%?,;UC;^NO]?(X/3_'DMQ\
M99+8ZQ$^ES2/ID=DLF2LB*&\W;G@%MRY]JQ]"US7+KQHT,.J:SYW]IWHD%U<
MJ;-[:,L-D:DY,@)7H!@5ZRG@SP_'8P6:::BPP7 NHR)'WB4,7W;\[C\Q)Y/?
MTII\%>'C"D7]GX5+Q[Y2)I RSM]Y@V[(SD\9Q[5/*[)>37W_ /!;^5D#O=_U
M_73YZ^OGG@?4M7LV\&74VM:CJ"^((YUNH+R;S0A0%@Z9Y7I@CIS7L5<[H7@7
MPYX:N1<Z5IQBF5#&CR3R2E%/4+O8[0?;%=%6K=Q136_]?U^AY_\ $:&[;5_"
MPMM7U.Q6[U%;29;.Y,89"K-G [Y4<FL7Q/>ZM8^+KJ_N=4U1=(M[B".*YTRZ
M1XK3[H9+B#()+$_>.<!ABN^UWPAHGB6XM9]5MI9I+4YA*74L6P^N$8#/N:@O
MO GAW4=7_M.YL6:X9E:11,ZQRLN-K.@.UR,#D@U$59KU;_+_ "?W^H35[^G^
M?^:^[T.C!R,BN%\::_+X1\1Z7K-Q=R+I$T$]M/$7.P2A?,C;'3)VLN?<5W59
MNN:!I?B33_L&KVBW5KYBR>6S,OS*<@Y!!I23>W]=/U^](I>?]?U8\H\4^(-:
MT7X=:!9RZ\UEKFJLUY+=3S[3&H!DV D\#)1 />NE\)>)Y_$/CA9DNI6L9_#]
MO=+!N.Q9&D8,<=,\8_"NSET'2[C58]3FLTDNXH#;QNY)"H2"0%)VCD#G&>*P
M7^%_A%Y1)_9L\;A2@,5_<1X4L6Q\L@XW,3CWJEO?U_*R_"WS^\CE;2U[?G=_
MC?Y&=\1H;MM7\+"VU?4[%;O45M)EL[DQAD*LV<#OE1R:YK7-0UBSU7QIK5OK
MNHQMH=S;?9[/SMUO(K(FY&0\<Y/(P<FO0M1\">'M6CT^.]M+B5=/4+;8O9U*
M8Z'(<%C[G)]Z2?P#X9N=;?5Y]-,MY)(DKE[B4HSJ %8Q[MA( ':E%6?S?_MO
M^3^\IZ_A^O\ FON.AA<R0HY7:64$CTKB/%+7>K>.-*\.KJE[IUG)93W<CV4W
ME22.K*%&X<X&2<=Z[JL77_"ND>)1 =2@D,L&?*FAF>*10?O ,A!P>XI25]OZ
MT?Y:/Y#6UOZZ?GK]YY,OC?Q';-X1U*2ZEN+:.TNGU- V!-#'*(S+MZ%@"&_.
MMWX::]J6J^(84NM1N+F!]#CG"R2%@7,\@W8/?  S[5WT?A70XFM&CT^-?LEJ
M]G"H9MJPOC<NW.#G Y/-9+_#'PBXMP--FC^SP"WC\J^N(\1@E@ORN,\L>OK5
M?:OZ_C_5_O(<6_Z_KT^XR?'%[X@T/7;8Z3=.\>O :=&DLGRVEQU650>VW=D#
MNHKO+"U-E86]J9I9S%&$,LSEG<@=23R2:I2>'-*E@TR&6V9TTN19;3=,Y,;J
M"H)).6X)^]FM6A:*WG^'3]2M6[_U?K^AP?Q"\23>%-3T#5#),;/?<136T;D"
M=C$6C7'<[EP.#UKA(/'.M77C1-3TTZEJ.GWDEV(;"*<*%5(8><,0/E8L?KFO
M:-3T33M9:S;4+59S9SK<P;B1LD&0&X//4\'BJ%KX,\/V-Y'=VVG+%-$T[(RR
MO@&;'F<9QS@?3MBHY79_/\?Z^70;\O+\/Z^9Y(=8U[4M(\"1"]\07,EY8W,E
MPFF7@BGF96&"68X./>I-8\4:]X8UB[1[G5%TQ-#C29;VX\R>VGD\SRY&*\;M
MP"DCU%>FW'P[\+W5GI]I)I\JPZ=&T=J([R:,QJQRPW*X)SCN34R>!?#B6EU:
MG3V>*ZMEM)Q+<2R%X@20N68G@L>>OOP*J2NG;S_$F*::OY?@S2T&62?P]IDT
MKL\DEK$SLQR6)0$DUF^.7U%?"=TNDWD5K?.R)$[S+$6RPRBNW 9AD ^IK=MK
M>*TM8K:!=D,*"-%R3A0, 9/M5?5=)L=<TZ73]2MUN+67&Y"2.0<@@CD$'D$<
MBG4]YNW?]0IIQBD^WZ'E@N[P_#[Q; -5\1V>HZ6GGB&\N,W%N1'N4"92?,1L
M9_2I[J6_8^'=%?6-=-LVC2ZE/):W&;NYD&TA _4XW'COP#79I\/_  XNBW.D
MM9S26UVX>Y9[N4R3$# W2;MQ&.,9Q[47/@'P[=:99:>]I.L5EN%LZ7<HEC#?
M> DW;B#Z$X_*I:;O\OP37YM/Y>@)?K^:?Y)KY^IYM)XXU6WE\'ZI9:C>W^FI
M97$FH^>@B>:))%1I&121N7.>O8UF6&K:]KE_I\:W?BB]C;2$N"NDWZQ-N,T@
MWMO.#P /7@5[-;>#] L_LHM]-CC6UMI+6%0S;5BD(+J1G!R1R3D^]9K_  Q\
M(N+<#39H_L\ MX_*OKB/$8)8+\KC/+'KZU7VK^OXW%9G*^(!J<WB_4;>#7]6
ML$TSP_'>0JEQ\IE#-S*OW7SCGUKT/PSJ4VL>%M*U*YC\N>ZM8YI% QAF4$UG
M:A\/_#.JW<5S>Z?)-+' EL";J8!HU^ZK /AQR?O Y[UTB(D4:QQJ$10%55&
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MA:ZL]/M)-.D$&G1M%:K'=S(8T8Y895P2#COFN@LK*UTVRALK*!(+:% D<2#
M4#L*M:7_ *Z_Y:"L[IO^OZ>IROQ1O+NR\#SRV5W/:3-<V\?G02%'4-*H.".G
M!-<[-XFO?!]KXSL)]2N+Z+2H(9+*YO'#2*\RD!&?C.&P>><&O1-:T33O$6ER
M:;JD!GM)&5F02,ARI!!W*01@@=ZSH/ WANVL5LH]-'D"Y2[(>:1V>5?NL[%B
M7QZ,2*CEW3Z_\!?Y_>4]TUT_S;_'1'F=AJE[K7PGUB1O%-_+JGA[SS]LL+LJ
M+GY=R%V'+#G'7M3=7AU>QN/"EE;:OXLU :C9S74\=KJ(6<MLC( 9L#:,G@YZ
MFO5IO"FB3G4M]@H&I0"WNU1V02( 0!@$ '!/(P?>J^J^"/#^M+8B^LI6^P1&
M&V,=U-$40@ C*,"?NCKGI3=[W]/R:?XV9*32M?O^:?\ G]YQNI6VHW>N^#]#
M_MC7]-CGL+J6;-X/M!=0I7S&&58C)KK/A]K%YKG@RSO+]_,N0TD+R[<>;L=E
M#X]P,TMY\/\ PU?V]C!<V4[I8H\=N?MLX958Y8%@^6S@=2:U%T#2TM].MX[4
M10Z<X>UCB=D6,@$#@$9X)X.15+KYO];_ ):"L]/ZZ?YZFE1112+"N=USP]?Z
MCK5KJ6GZI#9216LUJXDM3,2DC(25.]=K#8,$AASTKHJ*35P.*TCP&^@ZKY]A
M<Z8UINB*K=::9;B-4C6/"S>:,9"9SM/)/6K]WX02]M[ZUFO6^S7VHK>SHJ%2
MRJ%_=A@P(Y0'=^&.]=-13>N_]=?T%9?U]QQ4'@:[T?4)+O0=6CMBS2*D=U;O
M.$CDV%QGS Q;>I8$G^(@@]:EE\")-+//-?B6ZEO+2Z^T26X,@\CR\KD$??\
M+Y(QC/0XKL**%I:P-)W\SGM=\(V?B/44GU.222VCMGACMT=X\,Y&YBRL-V0
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M_P 3S_8_\=K9HH QO^)Y_L?^.T?\3S_8_P#':V:* ,;_ (GG^Q_X[1_Q//\
M8_\ ':V:* ,;_B>?['_CM'_$\_V/_':V:* ,;_B>?['_ ([1_P 3S_8_\=K9
MHH QO^)Y_L?^.T?\3S_8_P#':V:* ,;_ (GG^Q_X[1_Q//\ 8_\ ':V:* ,;
M_B>?['_CM'_$\_V/_':V:* ,FUU&Y2\%I?1A7;[K#O6M6/JO_(4T\_[8_P#0
MA6Q0 4444 %%%% %;4/^0=<?]<S46C?\@J#_ (%_Z$:EU#_D'7'_ %S-1:-_
MR"H/^!?^A&@"]1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <
M/XJOO#WAV\%K?:<]P/$EPL=YAR0J@+'YC#L!E!QCDYK/\.?V-8^._P"R[327
M2XMY+N/[;+>/+(^$MV);=DMD,HY)P$XZUJ>*/A[%XKU2XO+W5+N%39BVMH[9
MVC$9R69GP?G!.PX/'RBGZ+X)N--\1IK-QJ:W$N96=1#MW,\<*$YW'O"3_P "
M]J(:/7S_ .!]WZBEKM_6U_Z\CL:K:A86VJZ=<Z?>Q>;:W,;12IDC<I&",CFK
M-%)I-68T[:HYZ#P/X>MITGAL LB:?_9JGS&XM_[O7]>OO6+XHL/#W@ZP.OG3
M;FXF22W6.VAG?]X\8VH0N<%@N><9(6N[KF_%'A)/%5UIWVJ^N(+.S9Y#';.T
M<CR$;5(=2"  6X[YI2N]5O\ T_Z]0274Y$#PU#JL6G6FC>9;3RZ<ZS?:WYWO
M+(AQ_LL"<9YW8/2NLB\ ^'(6G*V3XE96VM/(5C"N) J GY%W@' P#6+H_P -
MI=+FMRVKB:.VEMC$I@((CA:4JI.[D[9 ,_[/3FO0*O1;?U_7Z&<4[OF_KO\
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M9KB?S)WBV(P(!9-N"Q#;C^==KX^NK&P\&:A>7^EV^I) ADCM[BU,\9<?=+*
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MP7=MX.>>G6G-X9T![*&S;0]--K"2T4!M(]D9/4JN,#/M6FJ(L8C55" 8"@<
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M'"E!LZ$GYGR3QM'%=M96S6=G%;M<SW+(,&:<@N_N2 !^E3T4=$NP6UN%%%%
MPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH Q]<\16^B-;Q&TO+V[N-QAM;.,/(X498X)  &1R2.HJKI7B^+4-
M0BL;K1]6TJ><-Y OX%42[1D@%&89QS@XZ&J^J?\ )2O#W_7C>?SBJ?7C_P 5
M1X7'_3S-_P"B'I+I?J_\_P#(4W9.W2QT=%%%,85GZQK%MHEB+JY6:3=(L4<4
M*;WD=CA54=R:T*YGQEUT#_L,6_\ [-2?3U7YB;LFR.W\<1M<11W_ (>UW2XI
M9%B6XO;=!'O8X4$J[$9.!DC&2*ZJN9\=G'AV+_L(6?\ Z41UTU4MK^?Z(;T?
M]=PHHHI 5M0O[;2].N+^\D\NVMXS)(^,X4#)KFF\>B(/+<>%O$<%HB[WNI+6
M/8J=2Q D+8Q_LY]JL?$/_DGNN_\ 7F_\JOZ\0/!^I$GC[!)_Z :B4N6,I=O\
MKC2O)1[_ .:1J12I-"DL;!HW4,K#H0>0:?5#1/\ D :=_P!>L7_H(J_6LE:3
M1G"7-%2?5(****DL**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH *^8/!O\ R=#<_P#85U+_ -!FKZ?KY@\&_P#)
MT-S_ -A74O\ T&:@#Z?HHHH Q]5_Y">G_P#70?\ H0K8K'U7_D)Z?_UT'_H0
MK8H **** "BBB@"MJ'_(.N/^N9J+1O\ D%0?\"_]"-2ZA_R#KC_KF:BT;_D%
M0?\  O\ T(T 7J**1CM0L%+$#.!U-#T 6BN>\):[?Z];:A)J%BME+;WKP+ &
MW,JA5(W$$@M\W..*Z&@2=PHK!\6ZS+H>EP7$5Y8V7F7,<+W-\I:*)6/+$;T_
M]"%1#5[];SP_LO\ 3;VSU NDLMO P#D1LX>-O,8!?EQ@[NO6DG?\OU!M+<Z.
MBN9/C:Q_>8LKXG(%J B9O/G$?[OYO[Q ^?;USTYJ23Q3.M_I-LGA_4F^WF16
M+F*,P%.NY6<9]<KD$<@M0G>U@NCHJ*YQO%/V>;5OM=E<H+.:*&*$(ADF:3A=
MI$A!W$C&[;COBH)_'=E;HA?3=1WA)7N$"1YMA$RJ^_Y\'!8?=+9'(S33OL#:
M6YU5%5=0U"#3-.GOK@MY,*;VVC)/L!W)Z5RNK^,M0%K!%I.C72ZA)>K:2QW*
M0N;=BH?YE$ZAB5((VOCKDYX*OK;^M1G:45E^(-1N-)\,:CJ,*QM<6MJ\RAU.
MTLJD\@'.,^_XUA2>*-4T^WFAOK>*>Y@N[:%[FTB B"3%<,8WE##J5X9L'!QC
MBFM78.ESL:*Q!XEA.K7MB+"]\NR.VXO,)Y,9\L2<_/N^Z>R]>O;--/&MM+&B
MQZ5J;7DC*(K/9&)9%92X<?/M"[58\L#QC&>*5T#TT9T]%<Y;^*VGUZ73WT>^
MAMH[)+QKR8QJ%5MW#(6WC[I'3.0<@#!,2^.+5H@?[*U,3NT7E6Y6(22K+N\M
MQ\^ IVD<D$=P*?\ 7Z"O8ZBBL#_A*[<:U9Z2]A>I=7$2RLK>7^Y#$@!AOR?N
MG)0,!W(S6_1YA=;!1110,**** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH S-:\/:7XA@CAU.V,JQDLC)(\;H2,'#H0PSWP>:IZ/X+T'0;O[78
M6<BW 4JLDUS+.5!QG;YC-MS@9Q6_10M-@>NX4444 %4]3TNRUFQ>RU"W6>W<
M@E22,$'(((Y!!Y!'(JY10U<#F;#X?^&M-O([NWL9VEB8.GGWL\RJPZ':[D9'
M8XXKIJ**!6"BBB@9'<6\-W;2V]Q$DL,JE)(W&593P017++\-/":R;_[/N&'>
M-[^X:,CT*&3:1[8Q76T4=;AY"*H50J@!0, #H*6BB@ HHHH Q[[Q+8:?>26L
MUOJKR)C)@TFZF0Y /#I&5/7L>.G6J_\ PF6E_P#/KKG_ ((KW_XS7044 <__
M ,)EI?\ SZZY_P""*]_^,T?\)EI?_/KKG_@BO?\ XS7044 <_P#\)EI?_/KK
MG_@BO?\ XS1_PF6E_P#/KKG_ ((KW_XS7044 <__ ,)EI?\ SZZY_P""*]_^
M,T?\)EI?_/KKG_@BO?\ XS7044 <_P#\)EI?_/KKG_@BO?\ XS1_PF6E_P#/
MKKG_ ((KW_XS7044 <__ ,)EI?\ SZZY_P""*]_^,T?\)EI?_/KKG_@BO?\
MXS7044 <_P#\)EI?_/KKG_@BO?\ XS1_PF6E_P#/KKG_ ((KW_XS7044 <__
M ,)EI?\ SZZY_P""*]_^,T?\)EI?_/KKG_@BO?\ XS7044 <_P#\)EI?_/KK
MG_@BO?\ XS1_PF6E_P#/KKG_ ((KW_XS7044 <__ ,)EI?\ SZZY_P""*]_^
M,T?\)EI?_/KKG_@BO?\ XS7044 <_P#\)EI?_/KKG_@BO?\ XS1_PF6E_P#/
MKKG_ ((KW_XS7044 <__ ,)EI?\ SZZY_P""*]_^,T?\)EI?_/KKG_@BO?\
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MK?4]9M=1GNKK_1F5UMPR&,LI)#<J64\\[67/&<UM444+16';6X4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJ^H6QF3]^1,C-$,G&&56."=I)()&:SN^:W03>ET>B7_B#3-,O8K2[N&2:3!
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MM%NP<GY0Q'ISTS5)7!/3^OZ_KT.XHHHI#"BBB@ HHHH Q]5_Y">G_P#70?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% &/JO_(3T_\ ZZ#_ -"%;%8^J_\ (3T__KH/
M_0A6Q0 4444 %%%% %;4/^0=<?\ 7,U%HW_(*@_X%_Z$:EU#_D'7'_7,U%HW
M_(*@_P"!?^A&@"]1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !112$A022 !W-
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M[FXO%$RB. 1B-2  O!YZ$Y]ZZ0HA<.54N!@-CD"E "@   #L*I-ZWW_K^O\
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M^"5+1V7G_P  O45YFWAG69?$FKW1TAHX[FVO(7EAFBC^T;V7ROWFYI"< _?
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M%#I<%RT*0QE96,B*0<J2!@GA2*[ZBDHVM;^M_P#,F4;W\[_I_D</X;UZ\O\
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M*DHJOZ_+_+^NLJ-G?T_7_,****"@HHHH **** "BBB@ HHHH **** "BBB@
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MARVT^6_DUS3OLL)59)5N%8*6Z X)Y-<B/ .M+?V;+J4:6H\DW"(ZC'E3-(N
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M(X-:DG@^QWMC>0*KR6M[&$D56SM;@D$'!'![&J.B?\COXH_[=?\ T6:+,_\
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M?^MCSG4/,_X2R]^P[?[>^TSYQ_K?LOV0^7[^7YFW';=GOFLV+^Q/+BW?9?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *" 001D'M110!R;_  U\*/.9187$9)SLBO[B-![!
M%D"@>P&*Z:TM+>QM(;2UA2&WA0)'&@P%4= *FHHZ6#K<**** "N:U'P!X;U6
M^EO+FQF$\IW2&"\G@#-ZE8W S[XS72T4K 4M+TFQT6R%GI]N(( Q;:"6)8\D
MDDDDGU)S5VBBF%K!1110!@ZSX-T'7[H76H6;M<!0AEAN98&8#. QC9=V,G&<
MXS5K1?#FE>'HI(],MC%YI&]WE>5VQTRSDL0.PSQ6I10M-@>NX4444 8^J_\
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MPV"IVC('/%377A.]F\+:AIT-Q##>SW\MW%,GH9_-"DE3C( !^5A[,!23TO\
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MGA%Z_C535="U.[E\00VXM#;:K9&(223,KQR!&0 J$(*G.<[LCT-#O?3^MO\
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M*** "BBB@ HHHH **** "BBB@ IKNL:,[D*JC))["G55U/\ Y!5Y_P!<'_\
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M3R_U_7W/NK('JT^W]?UYG&^#+C2[:'5'T^6VBT8W426S(RK$7:.,,$[9+G!
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MF\.7VIS2'3Q9[+FRELIOM#,IB#D'S$PIW-Q]T[<\<C%">WG;^OZ^87?]>O\
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MW)_"L&P\%:Y';:HMW-9&6XLX;>'9,Q0M&[-G;Y:B-3N'RJ#MYZTK_P!?-?\
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MVZ,V%9+MIW ^7[N&POKCD"B.KU\OT#7\_P ]#M;J]M;) ]W<PP*Q(#2R!0<
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MN#5V]N)8)_"-Q+KT^F6<L025%,*0ROY8*J=R'DG@ $>V#S7;T5,5:WR_"_\
MF)QO?Y_I_D<KX>U35KWQ%J6GWCMY6F%HW?RU F:1M\9Z?PQ[<XXRU9?C+0Y-
M?\406<-CITTK:9,$N+PD-:$N@$L8",2X[<K]:[2RTZUT_P _[-&RM/*9I69V
M=G<]R6)/0  =   , 5:II?#Y?U_7_!&^MOZ_K^KGF4_B[4HO[0LX]44WEE;:
MI(Z;$+Q^4R^06&./E.1G[P.3FM+6-1U#1X;".\\3S6MO<12SF_EMX2?, 39
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MPL%.6X&Q\<GOQT6D>&KS3SHAFN4E-E%<"9BV26E((VX500.>R^P'2A[Z;?\
M#_\  ')N[2\_^ :_]OZ-BY/]K6&+5Q'<'[2G[EB< /S\I)XP:5=>T=HK25=6
ML#'>-MMG%RF)V]$.?F/TKD%\$ZJ]I#:S/8A+1(H(761F-PBW"2L\@V#:V$(P
M-PRQ.1FKOBOPGJ>LZG#-IUZMM;O ;>X0,B_*7#EAF)R3D= 4/ .ZA=/Z^8-M
M)V\SI]3U.QT;3IM0U&ZCMK2!=TDLAP%']3Z#J:SF\8:"MS8Q'4[7RK^)I;:X
M,Z"*3#*NT,3RQ+# 'H:NZUI[:IH.H:<D@1KJVDA#L,@%E(R?SKG-2\-:MK%J
MK7"6$%R-+GLMJ3O(JNS(5(8HIQA.>./?K0M]0E=1NM_^&_X)U$6I6,]_-8Q7
MMM)>0@-+;I*IDC!Z%ESD#ZU'?ZUI6E,BZCJ=G9M("4%Q.L98#J1N(SBN9T3P
MEJNG^+)=0NM0$UDLEQ+ F]2<S,&(($088P.LC9P.!4OB_P *WOB"_M)[:2V5
M8861A*Q!R9$;C /9#^E2VU%.P=6=(FJZ=+>O91W]J]VD8E>!9E+JAZ,5SD#W
MJA<^,/#=I:0W<^O:<MM/*88YOM*%&<=1D'''?T[UR$7P^ULRW$,NKA;5X9A$
M4=3MDDA\L_+Y0; ]3(<X'RBKNG^$]=L].>6:XM[G4?ML%RL<LX$;"-0H!>.!
M,9'_ $S., 9/6G_7X_Y$IRM>VO\ P/\ ,ZM-<TZ34[BP2Z@::VA$T^V9#Y2G
MIN&[<..<D8QWIO\ PDFA?8FO?[:T[[(KB-I_M2>6'/12V<9]JJWVCW5YJ%Q=
M;H4\[3&M-NXG$A.?3[OOU]JY;5M'U'07@U&&UCO61(X5@CBED7B QL2(XV8<
M]#M(QP2N<U#DUT_K7_@?>.[O_7E_P?N/0XIHIX4FAD22)U#(Z,"K ]"".HK/
M'B/0S:RW0UG3OL\4ACDE^U)L1QU4G. >#Q[5#H^G31^#;'39RT4PL$@?U1M@
M!_$&L"R\(ZI]IM9[S^SXS;&TB$<#LRO' 7.\Y488[Q\O(&/O&M9*TW%;?\$2
MDW%2L=I!<0W5O'<6\T<T,BADDC8,K ]P1P15#_A)-"\N>3^VM.V6\GE3-]J3
M$3_W6.>#P>#6B$"Q[$ 4 8  X%>?:3X)UN#4XKJ^EL66-K88CF9@1$\A)5?+
M54!WC"#@8ZGK4]2GI&_4[A-5TZ2(2)?VK1G9AEF4@[SA.<_Q'IZ]JENKNVL+
M62ZO+B*WMXQN>69PB*/4D\"N&LO#-U!XGT:)B_E6MNTE\R1MY4C*[& !R "0
M9') Y&!G'&>H\26%[J6CM!I[0K<"6.1?-;:"%8$@-M;8>.&"DCJ*+^ZG_7]?
MY KWL_Z_K]1NH^*M$TW3X+R74;:2.XP;81SH6N,D#]WS\W7M4T/B#2YFU K>
MVPBT]MMS-Y\92,XR0Q#?*1WW8KC4\$ZY#IJP*VGRR3Q^5/YMQ(1$!<-,&0["
M7)#8.=O(!R:T9].N==N-<EM(GC_TJU>#[;#)"DS0D,5.Y<[21C< 1W&:5W?^
MO+^O,5WI_7?_ (!TZ:SI<ENEPFI6;0/$9ED$ZE6C! +@YQM&1STYJ)_$.B1S
MS0/K&GK- I:6,W*!HP#@EAG@9XYKD+WP=KLUM*T!TT3WD=W'<1F9UCA\YU?*
M$(2^-O.0N22>.E;,WAF>71-7L\VWG7MVTR,<X"DJ<$XSG"^_:GK_ %\OZ^0K
MR[?UK_7S-.3Q/H$4$4\FN:8D4P8Q2-=QA7"_>VG/..^.E3MK6E+/- VIV8FA
MB\^6,SKNCCQG>PSD+CN>*XS5_ FI:A?R3QS681III '9L@/)&P_A_P!@_I54
M?#[7"+N%]2B:W>WF$*F1=OFR0>5@@0APH]?,;@#Y12BV]T--\UGM_P '_([&
MZ\7^&[*VAN;C7=.2WFE\F.7[2I5G],@XX[^G>M=YHHX6F>1%B5=Y=F 4+USG
MTKDI/#.I0F[GM?L<DQO[>[@B>5D1A'$B%68(=O*G& >U=<FXQKO 5R/F"G(!
M]CQFJ>S_ *Z?YC3=]3GO^$[\,M:VMW'K%I)9W$[0?:5G01QN%+8<DC;PO'U'
MK6O_ &KIWVV.R_M"U^U21^:D'G+O9/[P7.2/?I7-V_AK4_L^FVUPMB(]/N9W
M1UF9C(CQR*"04&ULN.,GC//:LS3/ NM6>L6,TNI(UE#Y$LD:NO$D< BP 8MQ
M!P3GS%X)&T]:5W;^NW^8KO4Z]?$N@O:SW*ZWIK6]OM\Z47:%(L]-QS@9[9J?
M^V-,%W#:?VC9_:9X_-BA\]=\B?WE7.2/<5RMSX0U1?"&AV%A=PP:CIC1NSQL
M%60JC*1N:)P.7)!*'Z#J(=*\%:GIAMK4SVLMKYUO<S7#.1+&T0 V(H0*5..N
M5QEOEYI]6OZ_K_AMV.6FVO\ P_\ 7W^1T.@^+-,\27=_#IDBSQV;A'G2:)T<
M\] KE@.#RR@'MFMRLC2]/N]+LM0"B"6>:ZGN(E,A53O8E0S;21[X!_&M<9P,
M]:%LA]6%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 8
M^J_\A/3_ /KH/_0A6Q6/JO\ R$]/_P"N@_\ 0A6Q0 4444 %%%% %;4/^0=<
M?]<S46C?\@J#_@7_ *$:EU#_ )!UQ_US-1:-_P @J#_@7_H1H O4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110!CZK_R$]/_ .N@_P#0A6Q6
M/JO_ "$]/_ZZ#_T(5L4 %%%% !1110!6U#_D'7'_ %S-1:-_R"H/^!?^A&I=
M0_Y!UQ_US-1:-_R"H/\ @7_H1H O4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110!CZK_ ,A/3_\ KH/_ $(5L5CZK_R$]/\ ^N@_]"%;% !1
M110 4444 5M0_P"0=<?]<S46C?\ (*@_X%_Z$:EU#_D'7'_7,U%HW_(*@_X%
M_P"A&@"]1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &/JO_
M "$]/_ZZ#_T(5L5CZK_R$]/_ .N@_P#0A6Q0 4444 %%%% %;4/^0=<?]<S4
M6C?\@J#_ (%_Z$:EU#_D'7'_ %S-1:-_R"H/^!?^A&@"]1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% &/JO_(3T_P#ZZ#_T(5L5CZK_ ,A/3_\
MKH/_ $(5L4 %%%% !6%KNM3Z?=6UG;&QBDG1W\^^E,<8VX^48^\QSG&1P":W
M:QM=U;1K+R;/5HVF^TABD(LI+C<%QGA5;ID=?6DP*6GZDVH6NKK*\$DT(57D
MM;AI86RN1M!^Z>>1[@YYK8T;_D%0?\"_]"-9]I=V5WI-\VG^>ELB[5ADLVMU
MCX_A#(I.?QK0T;_D%0?\"_\ 0C3$B]1110,**** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_@7_ *$:S-.OGOM#O'.JVFI1J"J3VZ;&Z='&2-W3IC.>@K3T;_D%0?\  O\
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M!84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@#'U7_D)Z?_ -=!_P"A"MBL?5?^0GI__70?^A"MB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** ,?5?^0GI_P#UT'_H0K8K'U7_ )">G_\ 70?^A"MB@ HH
MHH *X_QS'!<"U@OFCM;+9(S7S6S2M&W "@J1LR"3D_W<5V%<[XFTV[O9+>2.
MT.H6L:.)+(71@W,<;6R.&Q@C!/?-3+H!0\-)%#H>IPVRQR6JX,=VMLT)N"4&
M2=WWB, ;AQV[&NCT;_D%0?\  O\ T(UCZ787=CI6H^?;_9+>0 P6GVDS^4 O
M/S'ID_PC(&,]S6QHW_(*@_X%_P"A&K9,=B]1112*.?E\3S?VG?V5EX=U6_\
ML,JPS30/;*F\QI)@>9,K'Y9%[4?\)#JG_0F:Y_W^LO\ Y(H\/?\ (<\6?]A6
M/_TBM:Z"@#G_ /A(=4_Z$S7/^_UE_P#)%'_"0ZI_T)FN?]_K+_Y(KH** .?_
M .$AU3_H3-<_[_67_P D4?\ "0ZI_P!"9KG_ '^LO_DBN@HH Y__ (2'5/\
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M9?\ R17044 <_P#\)#JG_0F:Y_W^LO\ Y(H_X2'5/^A,US_O]9?_ "17044
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M .$AU3_H3-<_[_67_P D4?\ "0ZI_P!"9KG_ '^LO_DBN@HH Y__ (2'5/\
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MBB@ HHHH **** "N?O/^2AZ-_P!@J_\ _1MI705S]Y_R4/1O^P5?_P#HVTH
MZ"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ KG_$/_(<\)_\ 85D_](KJN@KG_$/_ "'/"?\ V%9/_2*ZH Z"
MBBB@ HHHH **** .?L_^2AZS_P!@JP_]&W==!7/V?_)0]9_[!5A_Z-NZZ"@
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M&O0]+O?[2TFTOO+,7VB%)=A.=NX XSWZU35K^07UL<5_PEOQ#_Z)A_Y7[?\
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M;Z&U+&2-<*K8Y8 YX'7GTHZ7$FG8YW_A+?B'_P!$P_\ *_;_ .%'_"6_$/\
MZ)A_Y7[?_"L>_P#&MQX)\476C"6XU*T,%O=*US*TKQ+EC.=Q[!%# =L\=<5K
MZ=XXUJY5+RYL+..R^U0VSQ)O,N98DD!!SCC>!C'/MW7,N7FZ?TA*7]?UZB_\
M);\0_P#HF'_E?M_\*/\ A+?B'_T3#_ROV_\ A5:Q^(FKW>G3W1TJ-"]HMW;+
M(CHNTNB["Q/S_?\ OJ, CIZZNO>(O$6@V]NLEOI\TS^;)(\*2.%C0+_RS!WX
MY(+#<!@<<XIO3<::;LBG_P );\0_^B8?^5^W_P */^$M^(?_ $3#_P K]O\
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M0 4444 %%%% !1110 4444 %%%% &/JO_(3T_P#ZZ#_T(5L5CZK_ ,A/3_\
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M_?(H S_[?L_27_OD?XT?V_9^DO\ WR/\:T/(B_YY)_WR*/(B_P">2?\ ?(H
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
@@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>image_005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 2W Z4# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "O%M6U?5-$U/QW=:/<K;7C:QI\*R/&' #JJG
M((Z8/UKVFL*Y\':!>27KSV&]KZXBN;@^=(-\D>-C<-QC X& >^:%\5_ZW7^3
M$]59?UH_\T>:ZCXC\=Z=#XH3_A(K.5O#<D4[R?V<JF[210WE$;L(HYY&6/'-
M2:CXI\7O/XNU"R\16=M::#(DJ6,MFCF9#$&*%\@JI.><$Y[UZ3<^$M#N_P"U
M_/L=_P#:X1;[]ZX\T*,+T;Y<#^[BN8MOA9H]UXDUC5->TZRO1/>)/9?,^Z-5
MC"[7Z C(^Z=PIK^OP&S)O?%7BG6)M9U#2M8L='M-#MHIGL[BV$INB\0D.]B0
M47G:-OO4L.L>*_%GBLV>EZ]_8=F=(M;]HS8QS.KR9RHW=/QSTX KL-9\!^%_
M$.J6^I:KHUO<W=N $D;<,@= P! 8#T8&M.'1=.M]9FU:*V"WTT*V\D@9L&-2
M2J[<X&,GH*-/S_7_ ('I86O]?+_@_>>2^%;OQ"O@:PM$\:/%JNHWMPUMG3$N
M)BL;MO W.%QD%BS=,X'2G:?XO\9:]'X0LK358+*[U$WT-W</:1R!O).%DV X
MW<= V,^HKN)?A=X*FA>*308&C:Z-V5,DG^L/4CYN <#Y1\O'2M&Q\%^'M,GL
M9K+3E@>P:9K4)(^V(R_?PN<8/IC [8IIKK_6@WUMYGEIU3Q7K\GA5)/$?V>Y
M@UNYT^>2*T7;.T08B0KG'W01MZ9.>H%=3\9+26_T+0K2"X:WFFUJWC29>L;'
M< P^AYKH[GP#X8N['['/I:O!]M:_"F:3(G8Y+@[LC/IG'M6KJ>BZ?K*VJW]O
MYPM+A+F'YV7;(OW6X(SC/0\4NBOWO^7ZI@M&WY-?G_FCQYO&]W#XEO-5N;9/
M[;T;P]/#>6QR%$ZS+S_ND$,/8UN#4O%]G<C1[WQ-;7TFKZ7/=V]W;V*HUBRJ
MI& #AT^; )YS7?/X8T637+C67T^)K^XMOLLTI)(DB_NLN=IZ=<9[54T+P-X9
M\,O=/H^D06S761,P+,6!ZKEB<+[# ]J3UC;R_P _U:?X#V>GE^G_  5^)YSX
M.U#5-/C\'R7UXFHF;1[R[#26L8E50$*H),%O7)R-V><XK3TGQ/XGM-#B\4:G
MKVDWUG?Z?+=Q:5Y:P21,J%PD1&3+T(;/3K79Z1X&\-Z#-;RZ9I@MVM_-\K$T
MC!?,QOX+$<[1],<8INE> ?"NB:I<ZEIVB6T%U<J5D<9(P>H"DD*#W"@9IR=[
MV\_Z_P"#Y$Q5M_(XOX:^,/%FM:TL6L6NJSV%W;F=;FYT<6D4#\$)&ZL1(A!.
M"V#P*P?B/IL>H?%*[>;P@_B6*VT:.5X$OVM3$ [Y8;>7],#->J:!X%\,^%[Z
MXO=%TB&TN;C(DD5F8XSG"[B=H]A@5I)HVGIKDNM+;XU"6!;9YM[<Q@DA=N<=
M2><9HE9M-=+C5U>_D>-Q>(-8\+_#K0K?1+B:0ZQ>3&U:PA.H/9P %EBC5]N]
MAT^;&,-QQ6Q;^+?&&JZ;X>TDO+H>JZA>3PR7U_IHC=HXE#!A"QP&<$#&<<'!
MKMKCP!X6NM*N=+GTB.2QN+AKIX6D?"RGJR?-\G_ <=:P?%_PU2_\*Z=HWANV
MTN"VL;@3"ROHV:&;_>=?W@/?(.3T-%];ONOZ_K?J%NWG^O\ 7D9-EXF\0:AI
MVHZ=)XJ@MM7.MRV5I-;Z<DYD1$#%40D*,<DEB<=,YP:HV?B[QCK%CX:L(-9C
MLK^[U&\L;B[:SBDWB)3AR@)4-QT5L9]173:'\+M-/AN2P\46=C?33WS7[QVP
M=(878 ;8^0VT  <]>XKHK/P3X=T^2S>STQ(#93R7%LJ2.%B>08<A<XP1VQ@=
M@*>E]?(+]O,\Q\:7_B75]"\91G7K2'3='1;.6TDM5WW1V(QD+ @H22=H ([8
MJ;5_$FK:+8>,;G2I8(+NU33%@D%M%N^=5!W';E^N/FSCMBN_UOX=>$O$6I/J
M&JZ)!<7<D?EO+O=2P]]I'/'7J/6K5UX+\/WD5]'<:?O2_P#)^TCSI!O\K'E]
M&XQ@=,9[YI1??^MO^#^0WY' W_C#Q7X5E\2V>IZC:ZG<6^G0WUK*+00I 9)/
M+*D G*J><DD\5L>'-1\2VOQ @T'6/$%MJT!T@W9:&U2$E_, !(&>Q(&" 1VS
M70>(/"=IJT.J26ICMM6O;'[&;F1?-41@D@&-LJ1DGMGGK7-?#OX>:CX8U4ZA
MJ:Z/ T5G]C@@TL2E64MO9W:3DN31%ZZ_UO\ \ E[?UY?\$R=?AUEO&GC?S-<
M>33XM!,@LS NW:Z2 *#GC!4G(Y.<'I570O$WB/PGI^B"]O;?4-.NO#TEW;V<
M5J(S 88E8#?DEL@\D_@!7INH^#M U75VU6]T]9+YK9[1IA(ZDQ,""I ('0GG
MJ.U21^%=%BETV1;$;M-MVM;7=(Y$<3 *5()PV0 /FR:E:1M_7VO\T4WK\_\
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MTSX?>%M&L+^RT[24MH;]2ESY<L@=U/\ #OW;@/8$"IZ6\OT_SUOOT*>]_/\
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M-6=Y+U/-?]ZS !CG.5R /NXK-U'X;^#]6O/M=_H=O/<?9Q;[V9\[ ,#H?O
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M45N;9+@LV1&3G&,X/UQFJ$?@CP_'<PSK92;H)Q<0*;J4I#)DG,:%MJ9R<A0
M>^:7;^OZT_$3O9_U_6OX'!Z/JQM;[[?+=Q63_P!B!1+':!P&-XZ@+$F 6/
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MHK'OM&O[N\DGA\3:K91MC$$$=J43  X+PLW/7DGKZ<57_P"$>U3_ *'/7/\
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M$5U';JH.1\P\N)#GC'7')XZ8 -2BL.?0M1FN)94\6:S CN66*.*S*H"?NC=
M3@=.23ZDU'_PCVJ?]#GKG_?FR_\ D>@#H**S[K3KJXTZ"VBUF^M9H]NZ[A2
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M_P!B_MF^^T?\_P#L@\[[V>GE^7T^7[G3WYK/_P"$>U3_ *'/7/\ OS9?_(]
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M/B;5;*-L8@@CM2B8 '!>%FYZ\D]?3BJ__"/:I_T.>N?]^;+_ .1Z .@HK/\
M[.NO['^Q?VS??:/^?_9!YWWL]/+\OI\OW.GOS6?_ ,(]JG_0YZY_WYLO_D>@
M#H**Q['1K^TO(YYO$VJWL:YS!/':A'R".2D*MQUX(Z>G%%]HU_=WDD\/B;5;
M*-L8@@CM2B8 '!>%FYZ\D]?3B@#8HKG_ /A'M4_Z'/7/^_-E_P#(]:']G77]
MC_8O[9OOM'_/_L@\[[V>GE^7T^7[G3WYH T**Y__ (1[5/\ H<]<_P"_-E_\
MCU8L=&O[2\CGF\3:K>QKG,$\=J$?((Y*0JW'7@CIZ<4 ;%%8]]HU_=WDD\/B
M;5;*-L8@@CM2B8 '!>%FYZ\D]?3BJ_\ PCVJ?]#GKG_?FR_^1Z .@HK/_LZZ
M_L?[%_;-]]H_Y_\ 9!YWWL]/+\OI\OW.GOS6?_PCVJ?]#GKG_?FR_P#D>@#H
M**Q['1K^TO(YYO$VJWL:YS!/':A'R".2D*MQUX(Z>G%%]HU_=WDD\/B;5;*-
ML8@@CM2B8 '!>%FYZ\D]?3B@#8HKG_\ A'M4_P"ASUS_ +\V7_R/6Q8V\MI9
MQP37L][(N<SSA [Y)/(157CIP!T]>: +%%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M#S__ (:'\%_\\-6_\!T_^+H_X:'\%_\ /#5O_ =/_BZ] _X1'PS_ -"[I/\
MX!1__$T?\(CX9_Z%W2?_  "C_P#B: //_P#AH?P7_P \-6_\!T_^+H_X:'\%
M_P#/#5O_  '3_P"+KT#_ (1'PS_T+ND_^ 4?_P 31_PB/AG_ *%W2?\ P"C_
M /B: //_ /AH?P7_ ,\-6_\  =/_ (NC_AH?P7_SPU;_ ,!T_P#BZ] _X1'P
MS_T+ND_^ 4?_ ,31_P (CX9_Z%W2?_ */_XF@#S_ /X:'\%_\\-6_P# =/\
MXNC_ (:'\%_\\-6_\!T_^+KT#_A$?#/_ $+ND_\ @%'_ /$T?\(CX9_Z%W2?
M_ */_P")H \__P"&A_!?_/#5O_ =/_BZ/^&A_!?_ #PU;_P'3_XNO0/^$1\,
M_P#0NZ3_ . 4?_Q-'_"(^&?^A=TG_P  H_\ XF@#S_\ X:'\%_\ /#5O_ =/
M_BZ/^&A_!?\ SPU;_P !T_\ BZ] _P"$1\,_]"[I/_@%'_\ $T?\(CX9_P"A
M=TG_ , H_P#XF@#S_P#X:'\%_P#/#5O_  '3_P"+H_X:'\%_\\-6_P# =/\
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M5O\ P'3_ .+KT#_A$?#/_0NZ3_X!1_\ Q-'_  B/AG_H7=)_\ H__B: //\
M_AH?P7_SPU;_ ,!T_P#BZ/\ AH?P7_SPU;_P'3_XNO0/^$1\,_\ 0NZ3_P"
M4?\ \31_PB/AG_H7=)_\ H__ (F@#S__ (:'\%_\\-6_\!T_^+H_X:'\%_\
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M/^&A_!?_ #PU;_P'3_XNO0/^$1\,_P#0NZ3_ . 4?_Q-'_"(^&?^A=TG_P
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M!?\ SPU;_P !T_\ BZ/^&A_!?_/#5O\ P'3_ .+KT#_A$?#/_0NZ3_X!1_\
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M/^$1\,_]"[I/_@%'_P#$T?\ "(^&?^A=TG_P"C_^)H \_P#^&A_!?_/#5O\
MP'3_ .+H_P"&A_!?_/#5O_ =/_BZ] _X1'PS_P!"[I/_ (!1_P#Q-'_"(^&?
M^A=TG_P"C_\ B: //_\ AH?P7_SPU;_P'3_XNC_AH?P7_P \-6_\!T_^+KT#
M_A$?#/\ T+ND_P#@%'_\31_PB/AG_H7=)_\  */_ .)H \__ .&A_!?_ #PU
M;_P'3_XNC_AH?P7_ ,\-6_\  =/_ (NO0/\ A$?#/_0NZ3_X!1__ !-'_"(^
M&?\ H7=)_P# */\ ^)H \_\ ^&A_!?\ SPU;_P !T_\ BZ/^&A_!?_/#5O\
MP'3_ .+KT#_A$?#/_0NZ3_X!1_\ Q-'_  B/AG_H7=)_\ H__B: //\ _AH?
MP7_SPU;_ ,!T_P#BZ/\ AH?P7_SPU;_P'3_XNO0/^$1\,_\ 0NZ3_P" 4?\
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M_!?_ #PU;_P'3_XNO0/^$1\,_P#0NZ3_ . 4?_Q-'_"(^&?^A=TG_P  H_\
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M0/\ A$?#/_0NZ3_X!1__ !-'_"(^&?\ H7=)_P# */\ ^)H \_\ ^&A_!?\
MSPU;_P !T_\ BZ/^&A_!?_/#5O\ P'3_ .+KT#_A$?#/_0NZ3_X!1_\ Q-'_
M  B/AG_H7=)_\ H__B: //\ _AH?P7_SPU;_ ,!T_P#BZ/\ AH?P7_SPU;_P
M'3_XNO0/^$1\,_\ 0NZ3_P" 4?\ \31_PB/AG_H7=)_\ H__ (F@#S__ (:'
M\%_\\-6_\!T_^+H_X:'\%_\ /#5O_ =/_BZ] _X1'PS_ -"[I/\ X!1__$T?
M\(CX9_Z%W2?_  "C_P#B: //_P#AH?P7_P \-6_\!T_^+H_X:'\%_P#/#5O_
M  '3_P"+KT#_ (1'PS_T+ND_^ 4?_P 31_PB/AG_ *%W2?\ P"C_ /B: //_
M /AH?P7_ ,\-6_\  =/_ (NC_AH?P7_SPU;_ ,!T_P#BZ] _X1'PS_T+ND_^
M 4?_ ,31_P (CX9_Z%W2?_ */_XF@#S_ /X:'\%_\\-6_P# =/\ XNC_ (:'
M\%_\\-6_\!T_^+KT#_A$?#/_ $+ND_\ @%'_ /$T?\(CX9_Z%W2?_ */_P")
MH \__P"&A_!?_/#5O_ =/_BZ/^&A_!?_ #PU;_P'3_XNO0/^$1\,_P#0NZ3_
M . 4?_Q-'_"(^&?^A=TG_P  H_\ XF@#CM*^.W@C5+U+9KJZL6<[5>[AVIGW
M8$@?4X%>DJP90RD$$9!'>O-?BEX&\.3?#W5KF'1[*UNK.!KB&:W@6-E*\XRH
M&01Q@_T%:7P=O)[[X3Z#-<2&201R1!C_ '4E=%'X*H'X4 =S1110 4444 %%
M%% !7B_A#_DYGQ?_ ->!_G;U[17B_A#_ ).9\7_]>!_G;T >T4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &5XFO)]/\
M+:M>VLGEW%O9RRQ/@':RH2#@\'D=Z\RN?B%X@TT^";V64W5G=Z6;S5D6),LH
MV!I!A<C;NW8&!@&O4?$%A+JOAS4].@9%FNK62%&<D*&92!G /'-<EI'@6^L[
M[PM)=R6<L&EZ1)872!F/F,P4?*"O*_*>N/I1'?[ORE_P!NW+_7E_P1D6I:_X
MB\3>+-(TOQ +".V2S>QN%M(YQ$'4L^ <;MV.Y..U9?@*?QKJ]]J=WJ7C+[3:
M:5?SV4EI_9D*?:-B\-O7!7D@XYZ=:V? 7@2]\':YK\TMY%<6%V8EL@&)DCB0
M, C9&. 0!@G@=JT/!_AB]\/P:^EW+;N=1U.>\B\IF.U'Q@-D#!XYQGZT/1:=
MOQ_SL&^_?\#RRQ\;^)1X23Q%)\2],FOE!?\ L&2RM_,D(<@1Y4A\D<\+WKTV
MSU[4KCXG?V3)(8[$Z(EX;8HN4E,F"=V,].,9Q7/Z?\*'TWP=IRV0TZT\6Z>Y
MEBU"%#LE;<3MD.T,ZE3CD'':MG7/#?B=M?M?$_A^YTF+5_L(L[NVOA(]NR[M
MV590&R#GMSQTJKI/^NW^?W$O6_\ 77_+[RC=>+=>M-!\=7MLHO;G2;YHK.(Q
MC")L0G(4 MC<S<\^]5?AQXJU+7+]PWC/3-?M6@+O"UI]DN[>3CA8P,.GJWO6
MWI'A/7]-\-ZJJZY#!XAU.Z-Y+=0P!X8W.T;%5\Y7"XR>>:R=!\ :V?&EOXFU
M]?#UK<6L<B(FBP2)]H9UV[I2W4@9[5/EY?I_G\^NPY.ZT[_JC-T3QQXEUCPU
MX>TZVO8/[=UFXNU-]/"I6"*)FRP1<!FQ@ =/6N@TO4O$OASQ;8>'O$>K0:S#
MJ<,KVM\MJMO(DD8!9&525(P>".>*SM-^&VL:9X7T9;74;.W\0Z/<7$UO-M:2
M"196),;Y ."",D#(QQ6SHOAGQ%=^)+?Q#XNO--DN[.%X;.UTQ'$,>_&YRS_,
M6( &.@INU_Z[:6^?ZCEN[?+[W^AR&A?$?7+GP3XD.H7&S5[:VN;K3KKRD EC
M1F7A=NTE& SQT(S7I4-_<OX(CU%I<W9TX3F3:/O^7NSC&.O;I7"WOPKO[SX;
M)H@N[6'6H)[B2WN49O+V2NVY&.W.&1L'CJ!UQ7?Q:7.GA%-)+1_:%L1;%@3M
MW;-N<XSC/M4S^"5M]/R_S_$-/:+M=_G_ );>1Y8OQ%\1V4/@J_GF-W:76GR7
M6K(L* L@8 R#"Y&T'=@8& :ZA?&MS9ZUXWN+B<7.F:1:6]S:Q(J@?-$6.& R
M=QQU)Q3?#_@#4--N?"[7LEE+#I>ESV-TBLS>8SD?=!497 .<X^E1>&?AC)I$
MGBNRO[N.YTC5HDM[558F6*%58!6R,?*& !!/3M5RZV_O?FK?\ F&ROY?\'_@
MDNFV_P 2&DTW69-;TZ[M[MHVN-)^R")((F )*2Y+,P'KUS7H=>?6/A[X@QRV
M.FW/B+3(]'LF3%S:P.+NX1>B.&R@R.I&>E=C9?VQ_:>H?;_L/V#<GV'R-_F[
M<?-YN>,YZ;>U#MTV_K^OO$K]=_Z_K[C0HHHJ2@HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH Y;XD_\DU\1_\ 7A+_ .@UD?!+
M_DD.A?\ ;Q_Z425K_$G_ ))KXC_Z\)?_ $&LCX)?\DAT+_MX_P#2B2@#T"BB
MB@ HHHH **** "O%_"'_ "<SXO\ ^O _SMZ]HKQ?PA_R<SXO_P"O _SMZ /:
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** #H,FJ*ZWI3Q6LJ:G9-'=OY=LXN%(F?GY4.?
MF/!X'I5ZO"]5\)^(1J^J1P65VUIX<EDU31RB-BYDDD64QK@<X"NN!D_-]*+Z
MZ_UW"VFG]=OQ/9TUG2Y;L6D>I6;W)D:(0K.I?>H!9=N<Y ()';--&NZ0;?[0
M-5L?)\[[/YGVA-OFYQLSG&[/;K7F=WH6N:9\.=,UVTL;B;Q';7K:K):JI,C-
M,6$D> ,\*X&,?PU3\*>"M7TGQ=INC7$%R^C6^W69;EP=C71B\MH\],[R6QFF
MEK9_UU_S^8F]+K^NG^7R9ZTFLZ7(MFR:E9L+W/V4K.I\_ R=G/S<>F:FMKVU
MO$D>UN89UBD:.0Q2!@CKU4XZ$=Q7AMWX7\26E]?2P:?>2)X2F\_151&Q=B2;
MS&5>/FPGR8&?Z5Z/X56?POX;T+3[RPU"XO=0=I+J2&'>L$LF9':4Y&T9)&:$
MKJ_]:_TQO1V_K3^E^/8Z1=9TIM/74%U*S-D[!%N!.OEEBVW ;.,[N,>O%9NG
M>*8)QJ3ZD;'3XK2^-G'(=0BD$AXQG!^1B3]P_-7%1>&-3_X3]-":SF'AJ"_;
M7$G(/EER.(<],B4L^/3%8M[X;U*[T3Q':3:/>21W7BY)O+-N_P"\@W+EQQRF
M,_-TH6MO/_-+_/Y(;T3\O\F_T7S9Z8WCSPN-8L=*36[*6YO03#Y<ZLIP<8W
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M#!N0^,;O?-5I[WK_ )BZ(Z:BBBI&%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <M\2?^2:^(_^
MO"7_ -!K(^"7_)(="_[>/_2B2M?XD_\ )-?$?_7A+_Z#61\$O^20Z%_V\?\
MI1)0!Z!1110 4444 %%%% !7B_A#_DYGQ?\ ]>!_G;U[17B_A#_DYGQ?_P!>
M!_G;T >T4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_KP/\[>O:*\7\(?\G,^+_P#KP/\ .WH ]HHHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@#EOB3_R37Q'_P!>$O\ Z#61\$O^20Z%_P!O'_I1
M)6O\2?\ DFOB/_KPE_\ 0:R/@E_R2'0O^WC_ -*)* /0**** "BBB@ HHHH
M*\7\(?\ )S/B_P#Z\#_.WKVBO%_"'_)S/B__ *\#_.WH ]HHHHH **** "BB
MB@ HILLB0Q/+*P2-%+,Q/  ZFL_0M?TOQ+I::GH]V+JS=F59 C+R#@C# $?E
M0!I4444 %%%% !16?>ZYIVGZII^FW5QY=WJ#.MK'L8^85&6Y P,#U(JMXC\5
MZ)X2LX;O7+W[)!-)Y2/Y3OEL$XPH)' - 6-FBL+5O&.@:'>Z;9ZCJ"PW&I,%
MM$$;OYA) '*@@<L.3BMV@ HHJ">\M[99&FF1?+C,KC.6"#J<#G%#=@)Z*IZ7
MJEGK6EV^I:?-YUI<)OBDVE=R^N" 1^(JY0U8-PHHHH **Q?$/BS0O"L=O)K>
MH):"X?RX049V=O8*"?3GIS5[4]5L-&TZ74-2NXK6TB&7EE. ,]/_ -5'2X=;
M%RBL'PWXT\.^+HYGT+5(KOR?]8H5D=?<JP!Q[XQ6W%+'-&)(I%D0]&0Y![=:
M+!<?115'6-8L-!TN;4M3G\BSAQYDFQFQD@#A03U([4 7J*JZAJ5II>EW&I7D
MOE6EO$999-I;:@&2< $G\!3[.[@O[*"\MG\RWGC66-\$;E89!P>1P: )Z**H
M:?K6GZI=W]K9W'FS6$ODW*[&7RWQG&2 #QZ9H OT51CUFPFUN?1XY\W\$*SR
M1;&^5&) .<8/(/&<U>H **** "BBJ6K:M8Z%I=QJ>IW"V]G;KNEE8$[1TZ#)
M/T%%[!N7:*KV-];:G86]]9RB6VN(UEBD (#*1D'FK%-JVC#<****0!113#+&
M)A"9$$I4L$W#<0.IQZ<B@!]%8_B+Q3HGA.Q6]US4([.!VV(65F+'T"J"3^ J
MAJ/Q$\)Z5HMEK%WK$:Z?>DK;SQQO('(ZC"*2"/?% '3T5B^&_%NA^+[2:[T*
M^^UP0OY;MY3QX;&<8< ]#6AJ6I66CZ?-?ZC<QVUI"NZ260X"BAZ;@M=BU16!
MI'C?PUKNCW.K:=J\$MC:@F>5LIY0'=@P!'3N.:=HGC/P[XBTRXU'2M5@GM+;
M/GR'*>4 ,Y8, 0, \D4; ;M%8'AWQMX;\5RW$6B:K#=RVY_>(JLK >H# 9'N
M,BKL.OZ7<:]<:'#=J^I6T2S30*I^1#T).,9]LYH TJ*** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0*)2/0OC./QI?[)TW;=K_9]IMO#FZ'DKB<XQE^/FXXYI?U^6GII^)77^O/\
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MP& /8C@9IUM-<67PW\77MI=>.X+B.U_=OXDD*R(0"=T)'(Z\GZ5VWC+PC?\
MB2[TB]TO7?[(O=,DDDCF^R+<9W+M/RLP'3/7/6J9\&^)+[P]K.D:]XR_M--0
MMS#$_P#9<</V<G.6PC?-VX)'2IUY7WU_3^N@]+K^NYSYL-2\$66@Z_#XIU[4
MHKNYMH+RSU.Z%PC++QE,@%2"<]>U;OQ=O;NP\!R36=U?6TIN[="]A(4F*F0
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MK:FW&<G=Z]!2^TWY/[^GZ@U[J7I]W]6/)K7XC:E!\,=4M'TSQ7<WP%VJ:Q'
MSPQ_.VT^=NR O SVQ6CX\U&].K^$[8WGBSR)],>2:+P[*WVB1P$PQ&<$<G)/
MK7<6?@7[)\/+[PI_:._[4MPOVKR,;?-9F^YNYQN]><=JKZ]X%U6_U#1=0T;Q
M-_9%WIEHUJ)?L"W'F*VW)PS8'W?>A_Y?^DM?G_F5+=V\_P U^A-\.$QHER^[
MQ:=UP1M\3G]^,*/N?[']<UDSVFI>._%>O61\1:MH^GZ/+';PQZ7,(7DD*;F=
MWP21S@+[5U?AK2]?TN&X77O$G]MR.P,3_88[;RQW&$)SGWK*UOP5J%SK-QJ_
MASQ+<:%=WBJEX%MDN(Y@HP#M;[K8XW ]!3>]_P"OZ_K42V9F:W<^)M&T+P]X
M>EUH2:KJE]]DDU2.$!DB 9B0#QOV@#/XU&+/4O /B;088_$>K:OIVK7+6D\.
MJ3"=XWV%E=&P"!\N".G-;,OP^LYO"EKHKZEJ+7%I-]I@U%IMT\<V2=X)X[D8
MZ8-1Z/X(U&/6K75O$WB:?7KJRW?8U-JEM%"6&"VQ/O-C(R3WH6^O]*VW]>HG
MMI_3O_7Y'G>A>,M5T'4?%MUJ.J75S;S+?-8)<3LZQRP28"(&Z9#KP/2JJ:GK
M>F?"_7TU+Q'JWVFTUN"WDO?M<AFC0^7O"MDD#EN!7<WGPCM[ZUMH)]4)\G69
M=39A;??21LM"?FZ<#YO;I5^Z^'/VFQU>V_M7;_:&L1ZIN^SY\O:5/EXW<_=Z
M\=>E$=DGY+[G'_@_<.76WF__ $K_ ('WG.?#[5$N?&GD>&_$^N^(-!-H[7LV
MJEW$,P(V!&=%()&>/\B*P\<H_P 15U-O$<4FG7E^^DII?VH'RE  2?R\Y!:1
M6&<=&%>L:E;7%YI=U;6MS]EN)8F2.?9O\MB,!MN1G'7&:Y*;X6>&CX6_LFVT
MZQM[U;<1QZFMHGGI( ,2[N&)R,]?QH3U3?3]=_PT"VC7?^OSU,#7/$NJZ#\7
MKBX-S,^@6]C;B^MRY*0K([+YP7. 0P7)]"?2ETZ/7?$6A>*VT[6;Q=1L=>FD
ML&-RY0A I$)&>8SR-O3G-==!X04^(+_5;^[2[6^TV.PG@,&T-MSN;.X_>W'C
MMZFF> _!2^!]*O+!-0DO4N+M[A7D3:R @ *3D[B O7C/I0M%;R_&]_Z\G8+]
M;=5^7]+\3,\':QJ/C?5AXA<7=AI-I%]GALRY3S;@_P"M9U'W@I^5<]P37>UA
M^$_#O_"+Z,VG_:OM.ZYFG\SR]G^L<MC&3TSC-;E#?;^OZ8OZ_P OP"BBBD,*
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** .6^)/_)-?$?_ %X2_P#H-9'P2_Y)#H7_ &\?^E$E:_Q)_P"2:^(_
M^O"7_P!!K(^"7_)(="_[>/\ THDH ] HHHH **** "BBB@ KQ?PA_P G,^+_
M /KP/\[>O:*\7\(?\G,^+_\ KP/\[>@#VBBBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M(>7(RY$0CD-S\Q((8D@ 8"]:M:9.HU2.&TU&[_M"76[M);1)6"?9R[[VV#C
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MY?"-XFISZA8ZK##/]K-U;>;:&01EHQ'(K_.-ZD*",;2".IIJ>#+JS-K=:=K
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M6:T>W4L+6<95& *@'J,#GGO3)-"GO-'N+?2-&OK2<Z+/#J7FP-%]INCLV\L
M)GR'^<$C!Z\UZK)96DUW#=RVL,ES &$,S1@O&&Z[6ZC.!G%3T)V_K^OZL/\
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M>+^$/^3F?%__ %X'^=O7M%>+^$/^3F?%_P#UX'^=O0![11110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% '+?$G_DFOB/_ *\)?_0:R/@E_P D
MAT+_ +>/_2B2M?XD_P#)-?$?_7A+_P"@UD?!+_DD.A?]O'_I1)0!Z!1110 4
M444 %%%% !7B_A#_ ).9\7_]>!_G;U[17B_A#_DYGQ?_ ->!_G;T >T4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!RWQ)_Y)KXC_Z\)?\
MT&LCX)?\DAT+_MX_]*)*U_B3_P DU\1_]>$O_H-9'P2_Y)#H7_;Q_P"E$E '
MH%%%% !1110 4444 %>+^$/^3F?%_P#UX'^=O7M%>+^$/^3F?%__ %X'^=O0
M![11110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '+?$G_ ))K
MXC_Z\)?_ $&LCX)?\DAT+_MX_P#2B2M?XD_\DU\1_P#7A+_Z#61\$O\ DD.A
M?]O'_I1)0!Z!1110 4444 %%%% !7B_A#_DYGQ?_ ->!_G;U[17B_A#_ ).9
M\7_]>!_G;T >T4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M!RWQ)_Y)KXC_ .O"7_T&LCX)?\DAT+_MX_\ 2B2M?XD_\DU\1_\ 7A+_ .@U
MD?!+_DD.A?\ ;Q_Z424 >@4444 %%%% !1110 5XOX0_Y.9\7_\ 7@?YV]>T
M5XOX0_Y.9\7_ /7@?YV] 'M%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 <M\2?^2:^(_\ KPE_]!K(^"7_ "2'0O\ MX_]*)*U_B3_ ,DU
M\1_]>$O_ *#61\$O^20Z%_V\?^E$E 'H%%%% !1110 4444 %>+^$/\ DYGQ
M?_UX'^=O7M%>+^$/^3F?%_\ UX'^=O0![11110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% '+?$G_DFOB/_KPE_P#0:R/@E_R2'0O^WC_THDK7
M^)/_ "37Q'_UX2_^@UD?!+_DD.A?]O'_ *424 >@4444 %%%% !1110 5XOX
M0_Y.9\7_ /7@?YV]>T5XOX0_Y.9\7_\ 7@?YV] 'M%%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 <M\2?\ DFOB/_KPE_\ 0:R/@E_R2'0O^WC_
M -*)*U_B3_R37Q'_ ->$O_H-9'P2_P"20Z%_V\?^E$E 'H%%%% !1110 445
M5U.YFL]+NKFWA,TT43.D8S\Q X''- %JO%_"'_)S/B__ *\#_.WKT:75=7TZ
M6SM[^"&5IYT3[7;1,(MI^]N4DF,@="20?7/%><^$/^3F?%__ %X'^=O0![11
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M2O-O"'_)S/B__KP/\[>F![11112 **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!RWQ)_P"2:^(_^O"7
M_P!!K(^"7_)(="_[>/\ THDK7^)/_)-?$?\ UX2_^@UD?!+_ ))#H7_;Q_Z4
M24 >@4444 %%%% !574KF2RTRYNHH3,\4;.(Q_%@9Q5JJVH_:_[-N?L.W[7Y
M3>3NQC=CCKQ28''Z;?Z?_P ).MSITEJUN939I;PW6XG>%<R+'C ' X!QC)ZU
MR'A#_DYGQ?\ ]>!_G;UVNEN&U:#^SO[1-P'_ -+-T(MNS'S9QWSC&WO[5Q7A
M#_DYGQ?_ ->!_G;U71"ZGM%%%%(84444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% '+?$G_ ))KXC_Z\)?_ $&LCX)?\DAT+_MX_P#2B2M?XD_\DU\1
M_P#7A+_Z#61\$O\ DD.A?]O'_I1)0!Z!1110 4444 %4=:2*71+Y)[@V\30.
M'F SL&.3[U>JCK3PQZ)?//;FXA6!R\0.-XQT]OK2>PUN<O8AI=1TY;FPMM/C
MCE!AEBL'B,AP?D!/^KSZ'J..M<;X0_Y.9\7_ /7@?YV]=E9;HM0TYKJ_AOXY
M90(HH]0:4QM@X8 C]X!ZGIU[5QOA#_DYGQ?_ ->!_G;U3V)1[11112&%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110!RWQ)_Y)KXC_P"O"7_T&LCX
M)?\ )(="_P"WC_THDK7^)/\ R37Q'_UX2_\ H-9'P2_Y)#H7_;Q_Z424 >@4
M444 %%%% !1110!!#96MO(TD-M#'(WWF2, GZD5X]X0_Y.9\7_\ 7@?YV]>T
M5XOX0_Y.9\7_ /7@?YV] 'M%%%% !1110 4444 %%%% !1110 4444 %%%%
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M'(SQ7H_P[OK-/ OAFQ:Z@6\DTV.1+<R 2,H RP7J0/6DE=7]/U_R$]/Z]/\
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MXDTBUU#3;"6]3[1J9<6:HK.)=HRV&4$# ]2*U:^=-+T^.\B^&%I8>(;TO/\
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M^7^9[;#-'<01SPNKQ2*'1U.0P(R"*?7%?".>>X^%FA/<$EA"R*3_ '5=@OZ
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M9PT#1ELX+-=(L!:V\OG0PBV39%)DG<JXP&R2<CGFG3:'I%SJ4>I3Z78RW\>
MET]NC2KCT<C(_.K]% &??:%I&IW"3ZAI5C=S1J422XMTD95/! )&0#44?AW3
M(=4L]0AMHX9+.W:VMTBC5$C0D$@ #..!QG ]*U:* *M_IMAJMJ;;4;*VO+<D
M$Q7$2R(2/9@13&T;2WMK:V?3;-K>U=7MXC I6%E^Z4&,*1V(Z5=HH K1:?90
M7L][#9V\=W<!1-.D2AY0.!N8#)QVS4=SI&F7MY#>7>G6D]U "(II8%9XP>H5
MB,C\*NT4 9Z:%H\=K:VJ:58K;VDGFVT2VZ!(7R3N08PIY/(YYI7T/2)-475)
M-+L7U!!A;MK=#*/H^,_K5^BBX#9(TEC:.1%=&&&5AD$>A%4]/T;2M)MY+?3=
M-L[.&0Y>.V@6-6/3)"@ U>HH S+;PWH5DUNUKHNG0-;NSP&*U13$S##%<#@D
M 9(ZU-_8^EB&[A_LVS\J\8O<IY"[9V/4N,?,3ZFKM% &:GA[1(]+;2TT?3UT
M]SEK06R"(G.<E,8Z\]*T0     !P *6B@#.M?#^BV-_)?V>D6%O>29WW$-LB
M2-GKE@,G-.&AZ0MG<68TNR%K<NTD\(MTV2L>K,N,,3W)J_10!GV>A:1IWF?8
M=*L;7S4$<GD6Z)O4# 4X'( Z"J-WX5L4\/:EI>AP6>BO>Q-&9K6U5=I88W;5
MVY./>MZBAZ[C3MJBEI&F6^BZ/9Z9:@B"UA6%,]<*,9J[113;;=V2E9604444
MAA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!RWQ)_
MY)KXC_Z\)?\ T&LCX)?\DAT+_MX_]*)*U_B3_P DU\1_]>$O_H-9'P2_Y)#H
M7_;Q_P"E$E 'H%%%% !1110 4444 %>':%>P:1^T_P"(([Z18#?6ODP%S@.S
M+"X /N%/X\=:]QKB?'GPPT/Q[Y4]ZTUK?PKLCNH"-VW.=K \$<GT(]: .VHK
MQ7_AG>S_ .AJU/\ [X'^-'_#.]G_ -#5J?\ WP/\: /:J*\5_P"&=[/_ *&K
M4_\ O@?XT?\ #.]G_P!#5J?_ 'P/\: /:J*\5_X9WL_^AJU/_O@?XT?\,[V?
M_0U:G_WP/\: /:J*\5_X9WL_^AJU/_O@?XT?\,[V?_0U:G_WP/\ &@#VJBO%
M?^&=[/\ Z&K4_P#O@?XT?\,[V?\ T-6I_P#? _QH ]JHKQ7_ (9WL_\ H:M3
M_P"^!_C1_P ,[V?_ $-6I_\ ? _QH ]JHKQ7_AG>S_Z&K4_^^!_C1_PSO9_]
M#5J?_? _QH ]JHKQ7_AG>S_Z&K4_^^!_C1_PSO9_]#5J?_? _P : /:J*\5_
MX9WL_P#H:M3_ .^!_C1_PSO9_P#0U:G_ -\#_&@#VJBO%?\ AG>S_P"AJU/_
M +X'^-'_  SO9_\ 0U:G_P!\#_&@#VJBO%?^&=[/_H:M3_[X'^-'_#.]G_T-
M6I_]\#_&@#VJBO%?^&=[/_H:M3_[X'^-'_#.]G_T-6I_]\#_ !H ]JHKQ7_A
MG>S_ .AJU/\ [X'^-'_#.]G_ -#5J?\ WP/\: /:J*\5_P"&=[/_ *&K4_\
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M/\: /:J*\5_X9WL_^AJU/_O@?XT?\,[V?_0U:G_WP/\ &@#VJBO%?^&=[/\
MZ&K4_P#O@?XT?\,[V?\ T-6I_P#? _QH ]JHKQ7_ (9WL_\ H:M3_P"^!_C1
M_P ,[V?_ $-6I_\ ? _QH ]JHKQ7_AG>S_Z&K4_^^!_C1_PSO9_]#5J?_? _
MQH ]JHKQ7_AG>S_Z&K4_^^!_C1_PSO9_]#5J?_? _P : /:J*\5_X9WL_P#H
M:M3_ .^!_C1_PSO9_P#0U:G_ -\#_&@#VJBO%?\ AG>S_P"AJU/_ +X'^-'_
M  SO9_\ 0U:G_P!\#_&@#VJBO%?^&=[/_H:M3_[X'^-'_#.]G_T-6I_]\#_&
M@#VJBO%?^&=[/_H:M3_[X'^-'_#.]G_T-6I_]\#_ !H ]JHKQ7_AG>S_ .AJ
MU/\ [X'^-'_#.]G_ -#5J?\ WP/\: /:J*\5_P"&=[/_ *&K4_\ O@?XT?\
M#.]G_P!#5J?_ 'P/\: /:J*\5_X9WL_^AJU/_O@?XT?\,[V?_0U:G_WP/\:
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MBO%?^&=[/_H:M3_[X'^-'_#.]G_T-6I_]\#_ !H ]JHKQ7_AG>S_ .AJU/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
*%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm140376562888928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">DEF 14A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Intrusion Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000736012<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2</span><table class="report" border="0" cellspacing="2" id="idm140376555505840">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTableTextBlock', window );">Disclosure - Pay vs Performance Disclosure</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_88A_eecd--PvpTableTextBlock_z7QNk8Ivjkze" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Pay vs Performance Disclosure">
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Summary Compensation Table Total for CEO(1)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Compensation Actually Paid to
    CEO(2)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Average Compensation Table total for Non-CEO NEOs(3)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Average Compensation Actually paid to Non-CEO NEOs(4)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Value of Initial Fixed $100 Investment Based Total Shareholder Return(5)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Net Income (Loss)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 6%; text-align: center">2023</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eecd--PeoTotalCompAmt_c20230101__20231231_fKDEp_zjJDPtRWa0Mf" style="width: 13%; text-align: right" title="PEO Total Compensation Amount">457,907</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eecd--PeoActuallyPaidCompAmt_c20230101__20231231_fKDIp_zgewu24XQcFg" style="width: 13%; text-align: right" title="PEO Actually Paid Compensation Amount">319,652</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eecd--NonPeoNeoAvgTotalCompAmt_c20230101__20231231_fKDMp_zxhSDuQYiDc4" style="width: 13%; text-align: right" title="Non-PEO NEO Average Total Compensation Amount">302,520</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_980_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20230101__20231231_fKDQp_zbtgij7QWgL9" style="width: 13%; text-align: right" title="Non-PEO NEO Average Compensation Actually Paid Amount">217,347</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eecd--TotalShareholderRtnAmt_pp2p0_c20230101__20231231_fKDUp_z6oPkVWDM71l" style="width: 13%; text-align: right" title="Total Shareholder Return Amount">8.01</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--NetIncomeLoss_c20230101__20231231_zR24YU3xTuRj" style="width: 11%; text-align: right" title="Net Income (Loss)">(13,891</td><td style="width: 1%; text-align: left">)</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: center">2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98E_eecd--PeoTotalCompAmt_c20220101__20221231_fKDEp_zLxUfY79Tee5" style="text-align: right" title="PEO Total Compensation Amount">425,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98D_eecd--PeoActuallyPaidCompAmt_c20220101__20221231_fKDIp_zbBAW908AQmk" style="text-align: right" title="PEO Actually Paid Compensation Amount">423,341</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98B_eecd--NonPeoNeoAvgTotalCompAmt_c20220101__20221231_fKDMp_z55UggQbXOm" style="text-align: right" title="Non-PEO NEO Average Total Compensation Amount">242,368</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20220101__20221231_fKDQp_zv6ahxQeAK6c" style="text-align: right" title="Non-PEO NEO Average Compensation Actually Paid Amount">241,589</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eecd--TotalShareholderRtnAmt_pp2p0_c20220101__20221231_fKDUp_zXm8IUw3woJ9" style="text-align: right" title="Total Shareholder Return Amount">91.86</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--NetIncomeLoss_c20220101__20221231_zBQeOtuCG0w9" style="text-align: right" title="Net Income (Loss)">(16,229</td><td style="text-align: left">)</td></tr>
  </table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NamedExecutiveOfficersFnTextBlock', window );">Named Executive Officers, Footnote [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_840_eecd--NamedExecutiveOfficersFnTextBlock_dU_zgeY84p5y4T8" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td id="xdx_F0E_zGI2QNjP3WH5" style="width: 5%">1)</td><td id="xdx_F1C_z3MCKw8IHSTa" style="text-align: justify; width: 95%">The dollar amounts reported are the amounts of total
                                                       compensation reported for our President and Chief Executive Officer, <span id="xdx_90C_eecd--PeoName_c20230101__20231231_zmMJqaYis0k1">Anthony Scott</span>, in the Summary Compensation Table for fiscal years 2023 and 2022.</td></tr>
<tr style="vertical-align: top">
<td id="xdx_F0F_zUALfU4JgHV4">2)</td><td id="xdx_F12_zBjpaI70K6v4" style="text-align: justify">The dollar amounts reported represent the amount of "compensation actually paid," as computed in accordance with SEC rules.
The dollar amounts reported are the amounts of total compensation reported for Mr. Scott during the applicable year, but also include
(i) the year-end value of equity awards granted during the reported year, (ii) the change in the value of equity awards that were unvested
at the end of the prior year, measured through the date the awards vested, or through the end of the reported fiscal year, and (iii) value
of equity awards issued and vested during the reported fiscal year. See Table below for further information.</td></tr>
<tr style="vertical-align: top">
<td id="xdx_F0D_zQUQm2vAnIai">3)</td><td id="xdx_F1C_zwed8pH5GJy9" style="text-align: justify">The dollar amounts reported are the average of the total compensation reported for our NEOs, other than our CEO, in the Summary Compensation
Table for fiscal years 2023 and 2022.</td></tr>
<tr style="vertical-align: top">
<td id="xdx_F0F_zby5jy6umS5l">4)</td><td id="xdx_F17_zArqqH50QVM8" style="text-align: justify">The dollar amounts reported represent the average amount of "compensation actually paid," as computed in accordance with
SEC rules, for our NEOs, other than our CEO. The dollar amounts reported are the average of the total compensation reported for our NEOs,
other than our CEO in the Summary Compensation Table for fiscal years 2023 and 2022, but also include (i) the year-end value of equity
awards granted during the reported year, (ii) the change in the value of equity awards that were unvested at the end of the prior year,
measured through the date the awards vested, or through the end of the reported fiscal year, and (iii) value of equity awards issued and
vested during the reported fiscal year.</td></tr>
<tr style="vertical-align: top">
<td id="xdx_F04_zpOhUEUseEJ3">5)</td><td id="xdx_F13_zMy6tQr7uMRc" style="text-align: justify">Reflects the cumulative shareholder return over the relevant fiscal year, computed in accordance with SEC rules, assuming an investment
of $100 in our common shares at a price per share equal to the closing price of our common stock on the last trading day before the commencement
of the applicable fiscal year and the measurement end point of the closing price of our common stock on the last trading day in the applicable
fiscal year. For 2023, the closing price of our common stock on December 31, 2022, was $63.20 and the closing price of our common stock
on December 31, 2023 was $5.06. For 2022, the closing price of our common stock on December 31, 2021 was $68.80 and the closing price
of our common stock on December 31, 2022 was $63.20.</td></tr></table>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoTotalCompAmt', window );">PEO Total Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 457,907<span></span>
</td>
<td class="nump">$ 425,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoActuallyPaidCompAmt', window );">PEO Actually Paid Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">$ 319,652<span></span>
</td>
<td class="nump">423,341<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToPeoCompFnTextBlock', window );">Adjustment To PEO Compensation, Footnote [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_847_eecd--AdjToPeoCompFnTextBlock_dU_zg40pMNHuhOe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To calculate the amounts
in the &#8220;Compensation Actually Paid to CEO&#8221; column in the table above, the following amounts were deducted from and added
to (as applicable) our President and CEO&#8217;s &#8220;Total&#8221; compensation as reported in the Summary Compensation Table:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Summary Compensation Table Total for CEO</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reported Value of Equity Awards for CEO(1)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value as of Year End for Unvested Awards Granted During the Year</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value Year Over Year Increase or Decrease in Unvested Awards Granted in Prior Years</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value Increase or Decrease from Prior Year end for Awards that Vested During the Year</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Compensation Actually Paid</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 6%; text-align: center">2023</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eecd--PeoTotalCompAmt_c20230101__20231231__ecd--IndividualAxis__custom--AnthonyScottMember_zuB054QGdwJ6" style="width: 13%; text-align: right" title="Summary Compensation Total for PEO">457,907</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eecd--AdjToCompAmt_iN_di_c20230101__20231231__ecd--IndividualAxis__custom--AnthonyScottMember__ecd--AdjToCompAxis__custom--ReportedValueOfEquityAwardsForCeoMember_fKDEp_zjwjeD2IQjyi" style="width: 13%; text-align: right">139,157</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_98D_eecd--AdjToCompAmt_c20230101__20231231__ecd--IndividualAxis__custom--AnthonyScottMember__ecd--AdjToCompAxis__custom--FairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember_zaLCFbtz5rh7" style="width: 13%; text-align: right" title="Adjustment to Compensation Amount">24,882</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eecd--AdjToCompAmt_d0_c20230101__20231231__ecd--IndividualAxis__custom--AnthonyScottMember__ecd--AdjToCompAxis__custom--FairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember_zELuNwxvhfG9" style="width: 13%; text-align: right" title="Adjustment to Compensation Amount">&#8211;</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eecd--AdjToCompAmt_c20230101__20231231__ecd--IndividualAxis__custom--AnthonyScottMember__ecd--AdjToCompAxis__custom--FairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember_zS0MbDf508r1" style="width: 13%; text-align: right" title="Adjustment to Compensation Amount">(23,980</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eecd--PeoActuallyPaidCompAmt_c20230101__20231231__ecd--IndividualAxis__custom--AnthonyScottMember_zAp8YOwT6py6" style="width: 11%; text-align: right" title="PEO Actually Paid Compensation Amount">319,652</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: center">2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98A_eecd--PeoTotalCompAmt_c20220101__20221231__ecd--IndividualAxis__custom--AnthonyScottMember_zAAGl8yTdpa8" style="text-align: right">425,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eecd--AdjToCompAmt_iN_di_c20220101__20221231__ecd--IndividualAxis__custom--AnthonyScottMember__ecd--AdjToCompAxis__custom--ReportedValueOfEquityAwardsForCeoMember_fKDEp_z0LcZYizaHE5" style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_984_eecd--AdjToCompAmt_c20220101__20221231__ecd--IndividualAxis__custom--AnthonyScottMember__ecd--AdjToCompAxis__custom--FairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember_zQbWwlWdUAB7" style="text-align: right">0</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eecd--AdjToCompAmt_c20220101__20221231__ecd--IndividualAxis__custom--AnthonyScottMember__ecd--AdjToCompAxis__custom--FairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember_zzamN6Hv5d54" style="text-align: right">(2,442</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_988_eecd--AdjToCompAmt_c20220101__20221231__ecd--IndividualAxis__custom--AnthonyScottMember__ecd--AdjToCompAxis__custom--FairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember_zeAqh9H8iJnd" style="text-align: right">783</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eecd--PeoActuallyPaidCompAmt_c20220101__20221231__ecd--IndividualAxis__custom--AnthonyScottMember_zmO8p0t73DXj" style="text-align: right">423,341</td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
  <td id="xdx_F04_zC1kl0GphGEl" style="text-align: left; padding-left: 10pt; text-indent: -0.01pt; width: 3%">1)&#160;&#160;&#160;&#160;&#160;</td>
  <td id="xdx_F11_zFN4evH1uXa" style="text-align: left; padding-left: 10pt; text-indent: -0.01pt; width: 97%">Represents the grant date fair value of the equity awards to our CEO, as reported in the Summary Compensation Table.</td></tr>
</table>


<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgTotalCompAmt', window );">Non-PEO NEO Average Total Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">$ 302,520<span></span>
</td>
<td class="nump">242,368<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt', window );">Non-PEO NEO Average Compensation Actually Paid Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">$ 217,347<span></span>
</td>
<td class="nump">241,589<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToNonPeoNeoCompFnTextBlock', window );">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_84E_eecd--AdjToNonPeoNeoCompFnTextBlock_dU_zg1juGBsMNSi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">To calculate the amounts in the
&#8220;Compensation Actually Paid to Non-CEO NEOs&#8221; column in the table above, the following amounts were deducted from and added
to (as applicable) the average &#8220;Total&#8221; compensation of our Non-CEO NEOs as reported in the Summary Compensation Table:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Summary Compensation Table Total for Non-CEO NEOs</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Reported Value of Equity Awards for Non-CEO NEOs(1)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value as of Year End for Unvested Awards Granted During the Year</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value Year Over Year Increase or Decrease in Unvested Awards Granted in Prior Years</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Fair Value Increase or Decrease from Prior Year end for Awards that Vested During the Year</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Compensation Actually Paid to Non-CEO NEOs</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="width: 6%; text-align: center">2023</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eecd--NonPeoNeoAvgTotalCompAmt_c20230101__20231231_zsXkziSLtIVd" style="width: 13%; text-align: right" title="Average Total Compensation Amount for Non-PEO NEO">302,520</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eecd--AdjToCompAmt_iN_di_c20230101__20231231__ecd--AdjToCompAxis__custom--ReportedValueOfEquityAwardsForCeoMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_fKDEp_z2SBbLS2zMM1" style="width: 13%; text-align: right">48,514</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eecd--AdjToCompAmt_c20230101__20231231__ecd--AdjToCompAxis__custom--FairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zzruFPthspP2" style="width: 13%; text-align: right">8,674</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eecd--AdjToCompAmt_c20230101__20231231__ecd--AdjToCompAxis__custom--FairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zkhmAjnIPBYh" style="width: 13%; text-align: right">(22,910</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eecd--AdjToCompAmt_c20230101__20231231__ecd--AdjToCompAxis__custom--FairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zMuoi0zjjfF7" style="width: 13%; text-align: right">(22,424</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%">&#160;</td>
    <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20230101__20231231_zNLfL1WpVoAl" style="width: 11%; text-align: right" title="Non-PEO NEO Average Compensation Actually Paid Amount">217,347</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: center">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(238,238,238)">
    <td style="text-align: center">2022</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eecd--NonPeoNeoAvgTotalCompAmt_c20220101__20221231_zAf8sXS6ECx8" style="text-align: right">242,368</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_989_eecd--AdjToCompAmt_iN_di_c20220101__20221231__ecd--AdjToCompAxis__custom--ReportedValueOfEquityAwardsForCeoMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_fKDEp_z69fBhZmpkwi" style="text-align: right">39,089</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_987_eecd--AdjToCompAmt_c20220101__20221231__ecd--AdjToCompAxis__custom--FairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zwSZjIBCaZF3" style="text-align: right">36,188</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_982_eecd--AdjToCompAmt_c20220101__20221231__ecd--AdjToCompAxis__custom--FairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zwkE4bMRWYW3" style="text-align: right">(2,424</td><td style="text-align: left">)</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_980_eecd--AdjToCompAmt_c20220101__20221231__ecd--AdjToCompAxis__custom--FairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zoYTWs5f155j" style="text-align: right">4,547</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">$</td><td id="xdx_98F_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20220101__20221231_zhdj9qXCcIb5" style="text-align: right">241,589</td><td style="text-align: left">&#160;</td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
  <td id="xdx_F0B_zFFcqKH0yPXj" style="text-align: left; padding-left: 10pt; text-indent: -0.01pt; width: 3%">1)&#160;&#160;&#160;&#160;&#160;</td>
  <td id="xdx_F17_zQ93uikaVhV7" style="text-align: left; padding-left: 10pt; text-indent: -0.01pt; width: 97%">Represents the grant date fair value of the equity awards to our Non-CEO NEOs, as reported in the Summary Compensation Table</td></tr>
</table>


<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsNetIncomeTextBlock', window );">Relationship between Pay and Performance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_843_eecd--CompActuallyPaidVsNetIncomeTextBlock_dU_zLBQJucesNW4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Relationship between Pay and Performance</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our &#8220;total shareholder
return,&#8221; as set forth in the above table, during the two-year period ended December 31, 2023 decreased by 91% compared to (a) a
decrease in &#8220;compensation actually paid&#8221; to our CEO from $423,341 in 2022 to $319,652 in 2023 and (b) a decrease in average
&#8220;compensation actually paid&#8221; to our non-CEO NEOs from $241,589 in 2022 to $217,347 in 2023. In addition, our net loss during
the two-year period ended December 31, 2023 decreased by 14%, from $(16,229) in 2022 to $(13,891) in 2023 compared to the aforementioned
changes in &#8220;compensation actually paid&#8221; to our CEO and non-CEO NEOs.</p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TotalShareholderRtnAmt', window );">Total Shareholder Return Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">$ 8.01<span></span>
</td>
<td class="nump">91.86<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (13,891)<span></span>
</td>
<td class="num">(16,229)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoName', window );">PEO Name</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">Anthony Scott<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAxis=INTZ_ReportedValueOfEquityAwardsForCeoMember', window );">Reported Value of Equity Awards for CEO [Member] | Non-PEO NEO [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="num">$ (48,514)<span></span>
</td>
<td class="num">(39,089)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAxis=INTZ_FairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember', window );">Fair Value as of Year End for Unvested Awards Granted During Year [Member[ | Non-PEO NEO [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,674<span></span>
</td>
<td class="nump">36,188<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAxis=INTZ_FairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember', window );">Fair Value Year Over Year Increase or Decrease In Unvested Awards Granted in Prior Years [Member[ | Non-PEO NEO [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(22,910)<span></span>
</td>
<td class="num">(2,424)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAxis=INTZ_FairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember', window );">Fair Value Increase or Decrease From Prior Year End For Awards Vested During Year [Member] | Non-PEO NEO [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(22,424)<span></span>
</td>
<td class="nump">4,547<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=INTZ_AnthonyScottMember', window );">Anthony Scott [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoTotalCompAmt', window );">PEO Total Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">457,907<span></span>
</td>
<td class="nump">425,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoActuallyPaidCompAmt', window );">PEO Actually Paid Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">319,652<span></span>
</td>
<td class="nump">423,341<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=INTZ_AnthonyScottMember', window );">Anthony Scott [Member] | Reported Value of Equity Awards for CEO [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[7]</sup></td>
<td class="num">(139,157)<span></span>
</td>
<td class="nump">(0)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=INTZ_AnthonyScottMember', window );">Anthony Scott [Member] | Fair Value as of Year End for Unvested Awards Granted During Year [Member[</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">24,882<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=INTZ_AnthonyScottMember', window );">Anthony Scott [Member] | Fair Value Year Over Year Increase or Decrease In Unvested Awards Granted in Prior Years [Member[</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,442)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=INTZ_AnthonyScottMember', window );">Anthony Scott [Member] | Fair Value Increase or Decrease From Prior Year End For Awards Vested During Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">$ (23,980)<span></span>
</td>
<td class="nump">$ 783<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The dollar amounts reported are the amounts of total
                                                       compensation reported for our President and Chief Executive Officer, <span id="xdx_90C_eecd--PeoName_c20230101__20231231_zmMJqaYis0k1">Anthony Scott</span>, in the Summary Compensation Table for fiscal years 2023 and 2022.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">The dollar amounts reported represent the amount of "compensation actually paid," as computed in accordance with SEC rules.
The dollar amounts reported are the amounts of total compensation reported for Mr. Scott during the applicable year, but also include
(i) the year-end value of equity awards granted during the reported year, (ii) the change in the value of equity awards that were unvested
at the end of the prior year, measured through the date the awards vested, or through the end of the reported fiscal year, and (iii) value
of equity awards issued and vested during the reported fiscal year. See Table below for further information.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">The dollar amounts reported are the average of the total compensation reported for our NEOs, other than our CEO, in the Summary Compensation
Table for fiscal years 2023 and 2022.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">The dollar amounts reported represent the average amount of "compensation actually paid," as computed in accordance with
SEC rules, for our NEOs, other than our CEO. The dollar amounts reported are the average of the total compensation reported for our NEOs,
other than our CEO in the Summary Compensation Table for fiscal years 2023 and 2022, but also include (i) the year-end value of equity
awards granted during the reported year, (ii) the change in the value of equity awards that were unvested at the end of the prior year,
measured through the date the awards vested, or through the end of the reported fiscal year, and (iii) value of equity awards issued and
vested during the reported fiscal year.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top">Reflects the cumulative shareholder return over the relevant fiscal year, computed in accordance with SEC rules, assuming an investment
of $100 in our common shares at a price per share equal to the closing price of our common stock on the last trading day before the commencement
of the applicable fiscal year and the measurement end point of the closing price of our common stock on the last trading day in the applicable
fiscal year. For 2023, the closing price of our common stock on December 31, 2022, was $63.20 and the closing price of our common stock
on December 31, 2023 was $5.06. For 2022, the closing price of our common stock on December 31, 2021 was $68.80 and the closing price
of our common stock on December 31, 2022 was $63.20.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[6]</td>
<td style="vertical-align: top;" valign="top">Represents the grant date fair value of the equity awards to our Non-CEO NEOs, as reported in the Summary Compensation Table</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[7]</td>
<td style="vertical-align: top;" valign="top">Represents the grant date fair value of the equity awards to our CEO, as reported in the Summary Compensation Table.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToNonPeoNeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToNonPeoNeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToPeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToPeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsNetIncomeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsNetIncomeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NamedExecutiveOfficersFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NamedExecutiveOfficersFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgCompActuallyPaidAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoActuallyPaidCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoActuallyPaidCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TotalShareholderRtnAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TotalShareholderRtnAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=INTZ_ReportedValueOfEquityAwardsForCeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=INTZ_ReportedValueOfEquityAwardsForCeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=INTZ_FairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=INTZ_FairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=INTZ_FairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=INTZ_FairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=INTZ_FairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=INTZ_FairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=INTZ_AnthonyScottMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=INTZ_AnthonyScottMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>20</ContextCount>
  <ElementCount>17</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>6</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="intrusion_idef14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://intrusion.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="intrusion_idef14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="DEF 14A" isProxy="true" isUsgaap="true" original="intrusion_idef14a.htm">intrusion_idef14a.htm</File>
    <File>intz-20231231.xsd</File>
    <File>intz-20231231_def.xml</File>
    <File>intz-20231231_lab.xml</File>
    <File>intz-20231231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>image_004.jpg</File>
    <File>image_005.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="40">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "intrusion_idef14a.htm": {
   "nsprefix": "INTZ",
   "nsuri": "http://intrusion.com/20231231",
   "dts": {
    "inline": {
     "local": [
      "intrusion_idef14a.htm"
     ]
    },
    "schema": {
     "local": [
      "intz-20231231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "intz-20231231_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "intz-20231231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "intz-20231231_pre.xml"
     ]
    }
   },
   "keyStandard": 17,
   "keyCustom": 0,
   "axisStandard": 3,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 5,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 20,
   "entityCount": 1,
   "segmentCount": 6,
   "elementCount": 102,
   "unitCount": 4,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ecd/2024": 40,
    "http://xbrl.sec.gov/dei/2024": 4,
    "http://fasb.org/us-gaap/2024": 2
   },
   "report": {
    "R1": {
     "role": "http://intrusion.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "intrusion_idef14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "intrusion_idef14a.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "2",
     "firstAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "intrusion_idef14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2023-01-01to2023-12-31",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "intrusion_idef14a.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r67",
      "r77",
      "r87",
      "r112"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r70",
      "r80",
      "r90",
      "r115"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r101"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r108"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r71",
      "r81",
      "r91",
      "r108",
      "r116",
      "r120",
      "r128"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "auth_ref": [
      "r126"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "INTZ_AnthonyScottMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://intrusion.com/20231231",
     "localname": "AnthonyScottMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Anthony Scott [Member[",
        "verboseLabel": "Anthony Scott [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "auth_ref": [
      "r119"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r28",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r105"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Relationship between Pay and Performance"
       }
      }
     },
     "auth_ref": [
      "r104"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://intrusion.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r98"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r67",
      "r77",
      "r87",
      "r112"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r64",
      "r74",
      "r84",
      "r109"
     ]
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r108"
     ]
    },
    "INTZ_FairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://intrusion.com/20231231",
     "localname": "FairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value as of Year End for Unvested Awards Granted During Year [Member[",
        "verboseLabel": "Fair Value as of Year End for Unvested Awards Granted DuringYear [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "INTZ_FairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://intrusion.com/20231231",
     "localname": "FairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Increase or Decrease From Prior Year End For Awards Vested During Year [Member]",
        "verboseLabel": "Fai Value Increase or Decrease from Prior Year End for Awards Vested During Year [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "INTZ_FairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://intrusion.com/20231231",
     "localname": "FairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Year Over Year Increase or Decrease In Unvested Awards Granted in Prior Years [Member[",
        "verboseLabel": "Fair Value Year Over Year Increase or Decrease in Unvested Awards Granted in Prior Years [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r71",
      "r81",
      "r91",
      "r116"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r71",
      "r81",
      "r91",
      "r116"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r71",
      "r81",
      "r91",
      "r116"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r71",
      "r81",
      "r91",
      "r116"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r71",
      "r81",
      "r91",
      "r116"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r71",
      "r81",
      "r91",
      "r108",
      "r116",
      "r120",
      "r128"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "auth_ref": [
      "r126"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r63",
      "r131"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r63",
      "r131"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r63",
      "r131"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss)",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r19",
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r53",
      "r54",
      "r55",
      "r56",
      "r57",
      "r58",
      "r59",
      "r60",
      "r61",
      "r132"
     ]
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r108"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r69",
      "r79",
      "r89",
      "r114"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r72",
      "r82",
      "r92",
      "r117"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r72",
      "r82",
      "r92",
      "r117"
     ]
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "auth_ref": [
      "r95"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r95"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure - Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r95"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "auth_ref": [
      "r64",
      "r74",
      "r84",
      "r109"
     ]
    },
    "INTZ_ReportedValueOfEquityAwardsForCeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://intrusion.com/20231231",
     "localname": "ReportedValueOfEquityAwardsForCeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reported Value of Equity Awards For C E O Member",
        "verboseLabel": "Reported Value of Equity Awards for CEO [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r65",
      "r75",
      "r85",
      "r110"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r66",
      "r76",
      "r86",
      "r111"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r73",
      "r83",
      "r93",
      "r118"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r28",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r68",
      "r78",
      "r88",
      "r113"
     ]
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r107"
     ]
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r132": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001683168-24-004814-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001683168-24-004814-xbrl.zip
M4$L#!!0    ( (\][UA%%"W;NZX! "+\ 0 -    :6UA9V5?,# T+FIP9^Q[
M=5 <7[CE$-S=-7C0X*X)'@+!87"WP=TEN$-P"^X0PL#@[N[N[NZZ_-[:'[NU
M]=[N5KU76WNG3DUU==>M.O=^<[YSNJ??YM_6 1BRDC*2 "@H*(#^^P?PM@3X
M D" @X.'@T6 AX='1$1 0L%!14%&1B'$PD;'(24B)R,E(B&AH&:AHZ!DHB(A
MH>?YQ/29C9.3DYR.3XB779"%@Y/]GTF@$! 149!1"%!1"=@_DGQD_S>/MW8
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M9#.,A:>.:%;EZ]*\00Z=<//<HHHB?&=RFL24[C=K<(4,LUSV)[/(FJ"3^B!
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M=*N'X6R6+@&6%EZ"7R#20U%P<F'ZX;_S/47:CXH4 <84TK:A;VF+\U=J(S>
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MVQ6DD.I/<LY;[GS>\HM(*HPVL'.0]09X4,&,Q<B&+47V 7X9_\Y^1^YTWWL
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MGI):AN)K7$A2=; B3HW'#6V=TQB2Y8_['M.&.D8S"Q<;HR8+E8=2YFZV7H!
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MK_P)<@-P1Y63#68,H=-VUK(O*8R['%PZ\5!AK<OUH#\=/S('NQ^JZ@)$YM\
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M0 G'E)#_M%"($CA<$NF!E@X713TS&<\B%G(E@"*J5[:=C;D'T;MY^$=OI#E
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MEXK(E,HX1,6;SU%B1V[I$E50"K-[5(7D2V] Q*_Y;>E:I.MQ#+U8?IHAZSP
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MW!9-=1X]'K*V2U8=54-GB=)2;PE? \:R:&%EK0B78P2*E-NH5Q#9+L/QC3]
M/S7$'E&[)-O4U?3Z!H:5H;@I0JCBG5@^ECE*<>_Y].X$.S?[25VX;4'C5:'Y
MR)0*^<_M)#&:%4MR7,^\%+?$KM*CID?*''F70*'SAK)-E6C3:H[,,F3TV@E
M)A,ZULB H!"UQ0ZSHE%N2L8; /70SUMS&6CG2@A7Q;[-5@W[DY*%BQU!AS'[
M=0B>N+3UF/'X.%ZZOC7T=M61?<U?50DC5 07R]39MKDU=(*&O:\<ETB_E_MP
MK/MS('W(_0('#"=IKULD\*L7178HV??"7%H5N:%:)!8>'N\M!#=8<_V]A6^C
MWL2)G7.\<U)?C5((HTZ.)1HM>\=&F'&4RG"P$@ ^JJ@][Z;QH;-)S_.U[0VP
M'K!7IF7B*894:J(!0BS#3!/(<SCL,/!,GHA1G?8?T00X2PTH;4% ]Y^Z1S?*
MN_FXEGHHEPKRCK<0E<5ZNN/AA3[%^;H??"*$[9,%Q,6M:=:W-*7"/F#E8:]<
MM/#PA([EKP<[?Q3 DHV)8_$N,BC 97;&]'9G\1;:E^(?\7;J2=[OH.V8+59A
M>OKLV&&.M\OAR)" J9>@*S\IKM=I6&2Q+@R^L;T1UNVOW&J)DLNV;.E#.]/T
MO,CIC8MH%ST,58/$M8!->F"/HA\</QL-TPY4!RNOC(S!=6W1$%\=Z(&^S_NC
MMW1&O0'J&&MGK&N2E"SSQDF2I!)'PE!/:"(F(I(7+PR@2+TG0-4+S)Q2XS7Z
M43"Z2HOP#QYP#$V,X[=6&NILG^\\@:<*=H.?*S]-&5,FROO<0C; L@87<04N
M"(2WOQ$H38K[OUULD+G^XR!?$\AVJ60'>/?NW<J4+4/)Q"EAWMNQO\*%&X$#
MAX4D&92(>I[TN )E6Q&3_-S@98W#-\#",S=[Z])_/D!E!PG&TN[T7!]KD%<+
MS$L*X$,E45/;6@WN/<IABZM+4."^UL,=KQ%DXF]-1=SG\IB>90WTS@](Q#2M
MZ'GW<AY@)[V.QJ@N V5<]5J8&AY-.[N(2$7,!0\7RS=+%(452ZP6TE8R3_'<
MJ"N(2H]A3EZ(;C='916Y&-I+]CCY'ZSK;^9>],A/4D/K[U$ES@BT]S9.Z[FJ
ME2RFP 6-343<R!TW)6>-Z05N.. P9XE/E,AB7]8E\F\[R_8A98:_#/GB+EX@
M?<[E?2/]4:G="%;>GQ8H6%9]8(GKXAH:\W6C90-97/5)PJ1'8T'"!%^XTS4=
MNM4&@[2&Q;S**:G/U0M^WU??Z%<F#]N&,EK)V2IIH\;T'.M$;K.6-/$5'M<M
M!!WM?EHM>@&]*OKHG#E!ZHZ<ZHR'=_K;Z5;K\C(66>+$E=^U71YM0%9TS3%H
MCMD:$:*DLGX00ZDXW'I>MGKA5TK'!5\).HHSZT]Z3!2T@=^2A,5VC :8E-^)
M?!>D^-UD--+EB8J%X?@17%[G"R;8X?4F^EQ=%\I;8I<&+&F,T]?:_N"KLUAW
MAV0SHB0D)ME,%]59_"PYQ]8F7V(ZZD/6ZX@?%F7UR1&.:53M+R^??TCPQ3:F
M=&&]YVMGU<'A!X$L9<IX>9^U:'_XWT>9.ZNG>4%.3OC5'/W67^0*?5RYNR0O
M!ZG];LISR<[5=B,VE]O5@7D\*&+=9&RE)(EQ.A3^"7W4@'=6#A;!O%$N"P&H
MO@Z> @NI=[E>2]MKVR-_A[N)76;=;LJ.OK6?RR^UM\TZ_)R&WFX"0T]<"R/-
MG7]:!/W8=O;NAA?NKH!(;G1 [&^_.SJ8-PBR+3CW>5_*%I9&-O"94.A;V,=P
MB]N;+Z_B+HO+1&T^HZT_G:&K^=XUTGJFLZ0I:T9^IW^(^85/,^'#=DEU&\=:
M5\Y:CLK\*^%_>OO7?W#NH)OG;_*WY'L1V+Q" SNQ>9XO550/C;.6/U35_3".
M7F"=B;D6G_/YQY(KJZX["5<.4QUVT0+H VJ(%]@NB()R_$YEKP($O6A_N>[,
M/;RJVAGSOSA&E0=LD04(JODXWA@X[M7C(9"Z6_)WFSUE> X^%:*MG(CE9<5\
MHN^\J(/Y"&B/\G\[07\'XNN[1,B._'&RH<05$XJH3#%N>P#ZK5%F>PLNFW"H
M8C.?M1JKVCV+U>1!G/#DMC073P\B(LM,;-4@MEWF+ (:6.08+DDAZW-X46Y?
M=^T+ER?MI(U733Y#[O=M2$K.'B4[7RD"YH40.RYBZQ;P[(*@:@1S0S9M;3,P
M89)OW.\Q2('-2ZW>]+0O:QTBN1%R:49M%W5X]L.^I,2G4W^A^ W?".-'+[>A
M@J=:R4GJ;CU;^*,I3<F]AC%ZON$_W7Q;:H% %8J5AFW1FE][(U8/1)Z>UUTW
MNW4[]4G+?0EV=Z1%UYD^TPSO)?X.]5HH"&;@1W"X!CIL>PX*X\\U=U:%_S>G
MQG/MYJIQZ\63IQZLT5_F\WO0'!J<(;<I%)Y+2ER DEX8>^M_"B0Q'E_;(1Y>
MFZ>9_U4S57'LP3K#EB;-446(G"E+'+N82B; H<\\,34?C^3C;.M9#"P;@P:#
MAO);6Y/L<'ECF'EX!0@^VF1;YF94)L7I$8R\ :H.7EFWT71W7GS? &G7DTQU
MK1<-/V_M^(4YOUPZ_;*C"UT:I3/K-@'/&;*E;/.E'YJ21]\^ED1[^%28*7N
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M,Y[O/:SVQ-LYQL9C^?(;2!)D(*9_$+ /*)*KN0$GD<J65%"B 1KN8QA0X58
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MA%LN,KE')52[_FZP#FF%C-\ V^;J59VP1AN)#]"W3+T3@'W(\]"ZD?SUK=R
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MMU\32DMI[Q,A5(Q-[[F P:3A@YAW,TQ0@P+]P'(UBZ;][T+(.*.]=3JKS)<
M,L2L6J=WK:7!WGVMNU=H@'#X+VFZ+/"TZ:ZO3<3I[M?1*W#]F4&2V$N0_.;+
M-5FQ5=X!PGKL-,NV=^YT:G0BL A91C^$[*#][W1&MFB+AVJX)#]G+^RUG =Z
M7H,6PHYDAXTSCN?=MQ'[#DXYE=ZYL:X&8=98!"2(N#^,PD9'WG5J2]=RI '!
M726-INZD#\RC:FFN_-M\,])L1A-/QQSD^F!FWK:S![?"PNVT9>'5U4D3_OK+
MNZGS+W9_'O/PL< %61YJQ2DWQ[#:%+'&^TVY&/KR53;,Z8L+*-0.L@N"AQOE
M;/';G 7;]WNQTU9%BW1%R+45GX3]/]Q1P&AFDVT2$WDA9>&=V<D+<;*BN.J>
M6@MWXWZ0:_%0 -"S:R %^R0M+X8L,.B[S>8%=[UYX63D;)$D8(PCF#Y-C4W=
M0_$;-V=:&3%04D(]SA;LL."P]],\"9.F1\>GVRXJD/C7NV-/@]7>%@<EN46Y
M >>9@=L#MQY-.VUUU\4"-( -UM\Y*.[G@09P!WI)QN H>C%%2[_CF#SC6JY(
M9 D!-F8?*3$*K"T="OCZX@T<*NXC'%:*)40'E4'0U"UK2^MZM52ZW^;[[XMN
M)[&!+D/0^M$;NBS;AO2%' O(,Q/3!WPT^WFQJIEZGMRS8\$]KV)4#N4^G/*J
M[9U3JM/OT+Q;%&[X@;AX;]?Y'GL:[TD![Q7W??K[ZP=K4OV_+L#@OY2;&(IL
MTC1H/F);A-\H.N68>$>JS8('/"KA,R<6M)]?K)A[ T+4_:RTJT9^BUQ?7^\:
M2#>F7ACRF?DQ"29ZAH8X2YQVX:_HW,=@S)OPL^CDL_K5#*K)FH%A)D7'E(QR
M*P?3/2LJ_6?V:[71'[EH$^)7N7\1X#4[%-F=*!9<QM4@G@\&E+6D\\9D^(<%
M]1[MZ3)0 ^B<-YII_.F^/>TL?HOL;W9X(4:F0F-CD>3L99-VNKVG-_5#EM[D
MG;JVO;$Q4"05Y(,%97E J_A\6I\Y\PL 1JNMSIJI>&>647RTPY[:FGG#U+]]
M4^*R@#<N2NC6Y9L4[;."NU$SLIJ$;QVIK]]$T/6Z9+'SS?X:4_.@Z6%8ST</
M?K*!W!VORB_28J^%7U6F+?;>= _#VZ5)B4&R$U-&WIH*%0&">_98O/DLRK9]
M+"&1B]YDF5\8"SQ]-A'&_XZ2=$;*-'MR[G,H -)X=<>@OWZ97/RS=:QFWJTS
M^<2[]$#1Y.DM[]Z/S_B6SPL[>]\'74>P))R6J9=ZH@$_%AC&S\KVH(V$%XJ)
MN0_T'_</7*A] QI$.:ODG2?<-<#:S 2;+9QVR\Z.)63D>N+G_*WBIW<?RR:+
MQ.0K6U9:EGS,:IJO7Z*<JS\O"< WGN)KLOW5\1TJZW6>OA5K8EQ4Y6<[0!A7
M)"GT0/\;-<4NU](P<8_%PQ1(87F;,U_.4^4%-@(SSYM].4&.A,71%'^*Y54\
MQ=O,,+6>%AWV6*&A19]0Q]XA39J>&DWN2E/U@/N6$?S'$+-Y\>S6_<_N[F8&
M]GB-G]BAU3AJ,J>0_R-+NN.WIM1!'"U*HJ_KON;PM*D*?6"6-U5'!FT]E10H
M[=U7K>X8UN-7VII:C=-[V+,4(R#$G+:ZTRW,+.N^U'^<U>A@UMX^JS_^&W2@
M#59-&EKKIL&KLL%LT76%4G5>--3$?"HMV_=0UW;_Y/>1)7+S=8-RY-A^N-I'
M(5P>S07)'V\C#VH6<6PSV.IJ,O5JDR"\&F^Y/'C Q*6/@X;K"_F;<)?GE?7O
MQNHKK.NL07$OARKZ!Z)+MHBF6##C"5_JI9PY':,!'!=7[R<.MN]@&RT'"CG8
M+$_KS&BAQY?*G;ZF52Y>3[?)Y&6JCZB 6%G^O;,,0IZ5FW/Z'H8-&\%YEPF:
MUX_*;)&@EG=]ZU5"-_VN1/*//B?XP4SDS)J?)F?>5\C',>27H48C@0RVE*Z[
M@U:E=B53\?.:LF.T09;3N-($GY_+[.8=)D=L'A'#*2T;$DML#F^;1]OJ?AO2
M*A&XC$E;')8.F6"KU4U8C&]4J?*M!,UV[ZOBO0]YKN,)?[Y)LU)NM@Q[;ZK-
M<6Y_5*<3U 5S822OL/>O)!(7E+CX#EZ<.JZ\X3VY[EUWX/4+]()%WREY==HZ
MSNH?EM=.G $I&L=!HU95]8+A+TIF?APDTJ=LU PJ&%1-^$,0X-V&*(>LN=F
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MO9;A9V/:ZKNM9U.G%,EG%_2ZC(\:1\YP^4X9C(#O!I_F>H$.)%36IHUM?A*
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M?[RDOJ .C;*JLTJK&)OLYY@+IX13DZ0CIY6E#$C:WBLJ,//K8=T8NB[.:[O
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M9\=VXXV;J,[4)QDD))[G-J"N& 1/U8%?V3B%=GA[_=U<9U%5B@#AVP3B3J\
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MSD.C0(7[MR ^O#65!G<,97[XB)W948(69-%AWU]7 :H^S%PO1R0)DN[/2:K
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M!#MM=]1S5:ITEQ>QC"*N>Y]%!IDUDE0[M\3B;#=[Y>5-+SW+//\&]DO&O"7
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MHAEGJ_W<VX>[6]F%38ZW\BZ+\I0;VUQ?V-ZC\U_+YEK/[,<RIWRI$?ZIA)J
MJ4RSVWTG14>'OW/\]QD<N/M$QS2\;!RH\\K@*;#T?Y^OK8SZ\R4J9GS#H?P
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MI^4 Z+QN3\^!J*K.11:2.C#5YXJ?F3#!FG,;F'_8(M:^,?>ZD>B+5E?WOAU
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MM3>R^!^4I^G#[]=8-6\PZ'5JI&OHF23OI-D26:)#G,EC ]\2%J0DUO*] ,!
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MB&GP(&980*DOC()NY9D, =G<)>E%E5[Y%&\W9!FR_-W+'&^T%!WI5M"5)*V
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MWHEAO&ILQ^W4R.SVVV"-^HN7PE>IX.VJDPD)3%F.SL579VS2]6L\>@%@O0
M$*";@@*,XLJ00+GWNY4 "N+^M-!=YUN[HWN><9>WAPL8[+6I64@C>+BA(7K6
MNX 05/'D\?Y-H,'X?"XI<#"=(<JRV8J55!3&9&E<XMUK^@O"C2SZ:?$S7GM&
M#R0\"Z/O_=ID(/NJ%F->SOA;1:WH(+@[/=_W^$DSKXQ6TN#TR>D%@' JD--'
MRN9YW8A5ML1&!&R R#5+UE%]$.JE*E)H&4B[$> ?+5VNORYKV:(13OGJTS3Q
MR=\^M.U,X%OQ],(R)[M%MIFS(WHJ&8JMGL!Z+%R[UZYT+OU.:+1V1A7B$9&
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MY[W5G#FZGSHN]]//,_D3JAOWJ2YVC*6^ZET/'*HIBJY03Z,8:IE*Q0$K"*G
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M+]>+I=<A!,@<?$$UJ,;0"2GMQ(=-$XFGW7EI-%[]'PX3',F9KJ9G_5?#>\^
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M,E.DAE'$[TVS8_B8I/%I#E(QR8!VOA'<(2M;,%Y5\BUHC780CE/XK3X"21T
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M0]5.VW'.-,H-74#]2BR;CVO^JOH\2#Q#0(=5D+U%]:)E5&#T/#+CU!ORQ\4
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MS!@,$41[?NTG^Q$9[>6+;B L[1Z[@M;H<?S W_  .^)CM(T4E;@XK_?[SP"
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MQYS8;;OAZQ:_E8&;"VE)I 54/>[4YCRTHC$Z@_N^*#0W/B)1A&K5SM+$BYY
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M;U%'B<9I'X2:4$X:B"F!9GYQS5JW=LA39R:&\3*!LHR/$=O7DI-%2>8[XVH
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M@ORW'TSYG_&O'PJ8J7\#4$L#!!0    ( (\][U@+//*RQMX  "DZ 0 -
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M5RJ[3^PU>19+TNS8(I;47_\F>XCE1?NI1ISBXA7.;5\6E/EP?).M@P9:W='
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M!;#RX>FSWAZJRN](ZT[= +;:0]+(4L%9WKU5L /<O=.%R/>POE]F0"\01YS
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MF*V><F_<=GQ0.?%SGZU&-.-^AE$G9 Y 0:.]<3)RAG\@:S9W.UI(6Q"= LB
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M2\C;>T!#S-VK>'^I1^&OLO]W^X]2$XGX[\6HOU3NO][^7\B(@*L:MPDFI/>
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M%-%(TKA+[0K!#.'](Q[N+S?*%7D*42_C*:P_25(0*+P1$Z.@O  A+\L@G8S
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M*XC[KQ<+"B]7#^T1HV%?C#@>LH*EL>T;VD\2GB?)Y5F\-TTC4E%>61$PH7O
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M07(;E+=PJ5&/P"-A+&MYIKA,F8'P[OY7]P!276TP:>_+#$^_:Q5;B!WN[P\
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M9!KO'68>3#U5,\B,_0FSA.40VU,-75 "!/Y%C!933*PVMP?M@X4\'9J4W_9
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M??N$8\5Z:\N4D%+20I%5T-%YR!OFD3'WW/1O"0DCKPO<G Q:&"KE/;'1)<Q
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M+AV<K?;4J5+&]"\M3\?OVR7M!P 57YMVRSP;WE@S/$Q:.&*+$2[JS@C0'G@
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M[?#5*EC;VH@@>&+>U553)SQY$R/#X#]K6,V3)D$P3F#R#P!$\P=\=TAWB#T
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M?H.9'=M?09@H8/:WSLG^+V_:RI".O=?OK*=4HI;([DG6?X"6T\?!$\,+CW^
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M GDEP*]/?T^JH&JP>?]3,*GYC/LQ+@)E[)STSGS2A0?T0*7:G]E,^7@XSF0
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M_01UQ&K6^9_8JM+4Z%6!LMF 4^2(.".URE"_3LQ6F(,42?FLQEZ1G=NO^W\
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M2F)='CS4_/Z1;F,7E?.D&1*E".7 \RZQ=ZN=)#5IA(LH(E3X[-QEF4<.#P;
M&E*!>>V-S=U-\*73#<[8 .SE&%MBF!2N).T+B"-=5VC-KPNQ!#PG%8\2GK9
MN"RXRZN=>@R!#/>@A;<!*.56)>W:+S7.I5/+_+]H1_0O*7.CN;<#6.&GL\7Q
M^DG&?+DX&G)I;,FP&LKYQQSZ=Y*EYV03-HYWQ/S#)5@)0X6%)WW@!/[H*V>0
MD3"#A%9;NQD+E*L37/WD/=LSM@K8$O_;E\#0D#&U5*F_^?[;+UJSB>4X-]L,
MEYW5K^%R0PPBNV39#_5XS^MQI#B7CS^U,R9)ES"6@-/L6/.HG_'DK!-6_/$4
M$,_Y,[_T^_Y8-:9!>6MNXX(S%LKV(*$MH%1CNJXBY'M"9IUD;V>7&%<BT?NK
M[U?,6,N,RMEUG=UCU+)^OZBM0[(R?,.( 83UY>N^?;+KCBTL>%WL?R+#8GG_
M26%T\_[JOU:.:;%LHC!7E3.LWIE=C1O/_#REG@N39IV%!:''^&W*?[=9LCW0
M]-9&98[+J@L^=__P**Y2!?H<8[>?TBX>D;<"W2/I&79"_RS.:7DIU^F'^!W"
M'<-_N14'\EF1P5_%EQTB69<BH:Y^KZX>++OCB';E\E$UY+(/;0C(@/8:%2-U
ME6U7ZSY@K-RUL4EZY$PHT([-?=(" FC"]L)G7MQ^G\I6J3BE<PEHCO/QL(+D
M_9Z]TD^6G7\=C]8?^F!V%D/.HO1;A)*-0[D7:V&4JF"'+FB\@U/^^F$XFM>R
M)^I@D&K1C_(SR%]C%^Y'2K(A)5HCGY_I!ZT5(\%4D4[=CA,?T&ND$A$TG:8G
MS?5]%;*9E8_>HG>( %P-6O]5;LIX/$5OS9@?_S[!6C7+5''U'46 E%KV/@_A
M3"FS >GJ8O[XQHAX^RG8RZ> ;,N&!*1$6;-5?M5<S0!/T8]. 2$]7_8A;C[V
M\SQO&Z,Z',^F9EHRF#DQ1G23$@O=B.)%Q8ZT(>T.:3MQE)N*G6;&W'+[5P2[
M3@\,A)Z?6$VA'A%Y[AH;60Z41REZE\Z>T*($_ML$B-3)\A$T=U3JK^_7);^(
M.6<$(1[;&.>%W&Z\)_7Y@"7^S[_\)8,V.Q8OE(5VW;@7?^A$=T]\4(NB>!5*
MS>8?#-LC5Z&_7)S5SDZ-<8AUR@C91ZV-VVR/9ZJPU?9$_52R$4.H$#I8CPJ&
M5H\^M#[W"J/+K?YV"_6^\R&I70V!"\]S5\^.I<15Y_M!)X)Z\*ES/):ZB',[
M&IH6N'.0UTBZ3+^AG\4RQRMB-#CQN;3OCXR(C^^S-K_0!B7@;3A#'3C-G+KM
M?C:OU\L5>9 [O&5?*15<.6CM4 ??E2QHI.5/VSA[E+PS?\-EWWQI9*_#49?\
M?(^]U97I10[>WG+-?W M!3P+PW$R=EUN9RLN20Z)$6T*0;*F2_]_[7UW4)-K
MMV\0!044==-!4 *BTJ1(KRH=I+?0!0T!0I$62@A%BH!4 0$)TGM1"*$$L-"K
M$ @2.B@]]&: <-CGSKFS_6;NGCMGOG/WOGO,S"]_/>\[OWG6>E=YGC5KI4#E
ML@!5IF7L$QK4IFV&3&?>LN>0(_VP7%\*, -K_#LO68B#[MG]E_+F/PS \Q=7
MQ[H!-_W#?WP$4IY:I/>F("WOB^,UE9WN !N:7B9!)N<&L\(^"C?]+QG-%2O$
MRO^<Y;#FD_&]ZB#1,LUH4+ ODW>I\--RGVI+9(50'+TGI?TX6<<B_'Q/LAQ3
M3-?BY!B$_^)0P TY@Q=D>LGM5/<W6^Q\_3'&N;I*N]QM"Z\A)-H:;VP -KOJ
M F&=A.=Z/FNT31:M3CO9IJ8S(179R2)0)_3>KV->H\K6GB\?SNE8-/WDI3<A
MI5<I" WV.G)>TU9<K=;)*-4?-MF.P(A'=:(H!K^)E\TRR+G?UV#U^H26. $8
MJ5BV%: 'KFJ'X,->4L39O@:-J^PIH[;VU<4OWX\3=P]FLF._Z_CE5I%ZU]1I
MOL9FD9OK@S@"5JJGA15 LKO9-B>6YC\V=6RJT=G8T'XO KQMF_Y ]N'Z3N'J
M#M30WYAKA*H;OC?Z#9(SR"W(72>(8EGL MZN+K]\^WK0UF;:KOKMQOM$=GG!
MT._5 T<2EU+HO JT.!QBM-C-L'OOB[8QNO5W$P%!0+#S^8X2W[!$GSU)FZ&=
M8Q6]85:-,-F;BZ!W]F"J!U>[3&W@8VJ/OP*CWQ@7#QA\]T8(\<M7K*Q)3)V'
MO%NLCVGFPT/0R'U]@,:U+';[+9TUOI)];Y],H3FN[42+)#H]YUGUCTIT>DQ_
M+//H]O^3OEZ\5G\R%U:!/4B)3H?LOV I.$/[0S*3\71M$,EKET _2[I\ DA,
MW40<PS@67!38!_ZX^A\$2OX_.2HI0_Q94S6 [SDZ787_C9_K<4:J_Z5@!^"G
M],?5_R"PH?]L3#.*]'\^IWI%MOA[A=1_X5^4SG+@9ZW<(2/\<?4_"7]%C=@_
M";\,X2]#^-?CER'\90C_$8;0$$7=@JT^C.JD3[T>W?'1-X["H?>!IR@#+E'K
M65<E)T-<90<5I2C9FWO3+CV<@U95U$%.SMX",I_(. 3<8Q3Z*]#WOD_^48$M
M"*]8KI5G0;F1,4[<R;KO35=3#3)J/^U\;7$5B=7T*J?^J;_LHD#![^*A^:L'
M6?U=AV,5"G*BD5VP\D_I3^]S3[J*S;U!#LL:-U5%Z;Q#]D$G#3IT:]ZP7<$G
MDB.KI31'<%$NQ;W^LPI?6MV]QF"4\Y;R,(6%-\2%Z!&RGSS=4EG>9"H!M*V#
MW+J5;VPRR(2-?R."G/;\X;;33C]O^4=Q&@#Q_]T):W]W_'O:*-\ISWW,8C&
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M;VMMXK8Q&#UK-R*4E'D"N" UOC0(0M6]&LW#B)N]F*3OB6*_2TD>Z!:-1'7
M_AA!>]6;A0V_)?61!L3)3CGU?HER[O$?;?>?8_4[-*;_*9"PN%S_2U!_*B@#
MS]Q(BZL_>&K%-D4OL5N+5-HFKAL7QU1OM&=;R>S-S]('=;=<$H_VV",.^EUT
M?K9W(V_(XWM=90UV+D;')IF7,J+#-4!!FX@ALN?$H-I^RG2\C,RRAT3GZYO#
M2))/SMS*&6+19[6>"03N!_HB,_R,67^2E/9CW=\3R1NA?X/<^6^;BRM>3"K#
MO.02^](.A,^K?N!95H+M_YO/-^B>XOBNX_BK4P6$X.ZLW70W3!*B7O:H,I''
M#T7OE5(<9$Q7CU!$3UY''4(0@O8T^MX%J2]3";BZ3L[ZQH.L.1M:QG?V;HJ/
MW3IH2I_1'NXFSIP KAS)H0^T\R"^(Z/<]M%NXY @;W/X6WFN%CG;[6?:;NVR
MMV)J C*C''<.O^+1N]\R5P[8>Y5@4R]VW?WF,LRTAOUM_&9>RFN_#X-+\J\Q
M3!%H#!+,@((A;?T.>9 B6'IK2@ 9"H/;Y>??Y66M:?"3E,E/-5YKNFL@Q"39
MSLSU^/=^U5-'R.>=6^O'4!*XIE?&:*D)HB?:P9H1R"Q#UJM;/5+=37 X :B@
MZZ80UE?*'V]]=;HDC(D/B5_4@ETJX9XOFM9P(4 1>K?S8(5?J0OJ/ON8<F"\
M@,F6JK;8FV@4W%&OVB7BG>D*_OD7DZ4:Y2Z7&A'Z+@$+$[8S$VI,?1 /%R)>
M<)>?=^G8>631+XE^CFB*VY&_!DD6AL4:#B4:#G#590C,CQ?=J:"X"Q@]<%])
M:\'*/-L/H#OP>\(1 4XQ23%^*9C#&)IOOU_):?G,X#O,&:4N[O4C@#\@S!]O
M1<0O- YKZ>M7#7ATO]302>^LKGG ]1[*CU+Q!Z@=G?/?\[>9H\YDG>BGWWDW
MH5C,ZEF=:5Z##NFDC15<?6_S.O[(>AMYQX718<LAF20%![?N>S'6N#?F(2-Y
M#"+M86V/@0)FAY_C5R)[F[U3$6:(U&S+;>W3#8W-@JYQUM=$SC),T!5>8SW[
M1+5#9BBI5RR'(GYC4O;^/&0F>$I3C5W#E2;RK&W2Q?@&K(SQ*YAWBSCU;%2$
MZ!3=LF_HR\EPV3$5GZ*RH;@NNJ3#XK.:LF0\(RAS K.:5_,,8HN3?>?QE%F
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M!]Z2"\]5*Q8HNIGRF!A,PS]FEO4*SL%\#$EINC9PCS>YKFF@^K!H5*8FV<_
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MYJRC#)J< '*3=9@7LOGI3=C7&^Z.>WNG/4EJ[5$WDLP/LOC"_E:(&3!?H:M
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MGCM]F.587)MG?M_R2OQ!">8)G"[2B^U<J==L)QRXUG#7]'Q/X'?.S2YBNPB
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M] '*^,-@:F 9'L$0>$5)Z8RH\IA*QU,8B]\!#\AAK4):5"/_0JFRIM3<9M=
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M2'*(8D\H*CEX;QY:802+]CPU-A"$=1/W03!'LDD^$UCUU\4&P0Z!"A==;QV
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M!+X==R)8E^\E'@3I3F/#/=JLK^&D='5:*H?H[D*TP?T7F!,2BRT)S+085&Q
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MT<A&ES?U?47#:.A2$($T]K$!;A]-$62T)DFFSL&=B<^&M@,W-Q"ME_&0UTF
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MTTL9V*OX4$/%FI8P>-C&8.YL7%<2%)6JAVOFH=S^NFRMBQ:0/D9" N9)H(V
M_(.P;):P1X&._7PK@*[O7;^-_CSM5;Z+TLO!EIQ>!G F@F^UI@?,:\YY#/$Z
MP^T?:=LO6D3)@">)GDOF1T>Y?,U6/, P4PK#0QB74IE@W\>[.['P'#@A7=V
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M%,UW"W?,!SIG2O*Y3D?E0Q/[LM$?_HKH-W<E432";6-976$S^>IY"JKN;[8
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MZQ.AU +U*4?# ]$:E2Z$ULBO9;;>MM"6$ ^DBI(JEJD"JDU#AAKU#$!R9)5
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M-_ ]JCZNEEB&-1FXU#5M =2H#<,G6VNF+2X#016 "7$"(E$U"<6OXTCGX@9
M6:=.Z$?F9\^AQ+9H.*?^HGLC4^[&2Q#J&C7)P<!WJ%X0?/%7#*16W2K)8\=2
M$/*5=D!1_]3;+>H!JZIN4'"XK#N%:BM9C5Q!!<ME#+H*9^"B"6FM/N0"EZ[?
MQN0IOQMA,?:2$24(7#+[@ESK6(72P829GK#<J-?!YY3SSS6YN!WY"2V/:DHF
M>/H=]H3+2)RM)?*VEO0M)=HTUI^@)1V+Z!#3($(C1(F:*K?@]X2$%B^[X=E^
M*W+Z/"#C3[5<V93$4BY81/:5.]8 V(>P.@F 1PX0"L9[N%D')7T=#K[H.4F!
M"08[X&S/&5 3&*H.]2FV[$# K/\ WELE\]B_\G&+UW[P0^:*[./M<Y,]:'$)
MIXMA-0AM)-#(?(\5I8SSGA]XD?3%<KE12D0P]_;J:6!/2CV(&4Q9,,2!!0H]
M6TNX39\+Y^JA5[N#0@5VO#<''(@O<^5@RI=/?Q@Z5%"?3#86D=R3L4"U2I==
M2PK[:-[>&,LL:HQE%E5(4\VOC)DUOYJ%J;$5]RGY.>.R;%*&)OW\&@R/2"T6
MTK^$A9-N7\M<1$-DQPI[V1@*K$Z3QI^I\EJ%57G&1S :8Y019BA8#BH7E&<H
MG,,,7,K[40)'6F_1Q?:AP)CT=#+NI$$;0;NCZGF3-!X9JG%T2J)Z0U&(D1.@
M)CM6H$H-9TKTN1@4)LO]\I+:2#9)E3\[7]^?4V)Q8"F>HIG*'@504GVKJ-+2
MW)+6? \W@=^PMO ;/H/?L++P&SX?>?!6RP5;+4]DDJ8$SM;GHZ/ZV;=L%L%Y
M?>]C WLU9PS*N%I]O<FFQGJ+)B"GR3<]&6$]U%MT%UD3 *\%8BL.XMI+[*?
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M(D^64BPJ+8#%29!O4-/<5%<8^)'@+Z2XG.]91+QTM#)"")*$:W.+5BEF@$*
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MFZ7*]CRPH[&IWP_#J&<TS%S_:*RWC\Z^?OMZ*Y;-) S]Z8TQV_=PF8P/0)]
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MH$22&.V3TOU94_0_OQ4?HWB(:>XOSM''""(?23P6A[%YXC+Y%/TF^</X,:[
M_!A>=4H;[#] ;WF6;* CO)["W4Z?(&@"+V;2P]W'*6S1OZ(^L&@X3 NV,,"
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MQJQZ"BNCA%?TR!BK5K1%Y*HWB"Y2&0!M.@R:2==+?V$?C/,ML>L0(=4:;#5
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M")_5=\CCA[Q);?E$5%,C\ 7/AZM(\.'0=F&X=%T8GCD[$:0%5Z[OX]#/P77
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MFI>F7RL,=1GD" AXE8'9RG(M^21=T3E;E!1M1=)NS(KTF))!%ZUF#=2!X<Q
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MU%L]7_?'69=EJD"RW.03H%(D)BI0ZX#P"4 P7*DJW7\+8G$[UL3*Q2%R2P7
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M"Z^9ZQXT35(B^O!\1ASHNL^J&">,!6\6S[I2.4=9LN::^4F]PY^0%-D?,5-
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M$EG$O&!IZ<RH*[: !@L'IJ[C02_NO>K%>V]>MFW%PH/:FS'_%BQ*^<$D:K>
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MCKV7^PO(#2!0?W[42,.]QW 3D1@4$P@%!B-,/5AFG.0WK$BR+K';$!O#1:6
M$BF EX\V]);[A*)BAVC;V!2D]867WK)1+2Y0I!CYEV:.:1MEM="3Q&O,C"_[
MCO2_NI$SFT9P_NE$_6,&LJCG28U"<A<(&S SNK4':<>-+YUGCR'.<&>#9_JZ
MNM4U@'6R)3)J'Y.RUTP4/^-"C>])S8<_]G_R/6@6< QQ=;6/$F;1.Z-1<HU@
MZ/*Y32XSJ1RQ=6JK/-/-QS!7!)0%VR/3)'V,DR%S,X>#YK+-?NSM$"G"S< ^
MCZUFX!2,IH$DZY#:AXTCO$U4WA9*SHJ9A\DKLG#YTA61O;*4F*5O4B BVG$/
M31*Q&1EVTE[NOL95^DQZ14'0YN$HH7LBZKW<2#8]W"0/5^G\Z.ST_/+XY'=U
M>/K^[,_C@Y/#HV?AO?A[ZO N,$\X+RIJJ)'^NJ6D!:?L2TNFG:&8=OH<!O .
M[HI2ZQ1)@\+D2\S<])IL,LXNXL5?(9@\$)4:$*1%!WP?3J&Z\W#"J2/.**54
MJ90@)KEQ- =;[&)Q&MX7O"H"&7?/>."@A[ ?>,%L E>A@Y:MF+S([:M-5XKK
MV83[J-;[3P5;2-TOB@R;A <W$M\\R*>I^(E CLEQ*#X.GCKRF6O:_CM><C#C
MYT"=[_0DS<CHB1P]*J;4DN@T>DO:%B;'34B]2,FV(OYEPQUF(XE)!GMGNN_@
M(:95(YMNE)88UT0_F'/M62,RZ,E"IX2];:F3.9$&F]Q>!VC1ACPQ%83_'G0O
M(G,OU$+WPI/+V D5;4ALI9":GJ M*;KW<H!O@L1\5G]Y>OC//T[_?'=T'IV=
MGYZ=7AS\>?$L&+E?,$713##[P<JW"+*EHJP,,/N+,N@[B^9" -G.1P[D[/P-
MI'@GB+6L43Q87AS -%,WMK*RYA7G:N\E+U[[W%"Y+K]ATO9OY.%@YPK/6/#K
M3)<WS4Y?"LZ6DDQ0L=']Z<XYCND>\6>DLXOIAD_"_=V/#F@IZCTO!5=R$4#/
MUN9P/2.K/6 3/J/&:.V$2M;HFOX_[$C9)8UX___=BB["X<HQJ5K8M)A8 &P(
M3 [,GX+7=)P-MN*6PH*MMLJ"L';@H")(Y3S#6-P @PY@96Y4>J*G8]!,?XXV
MWKS:V8QV=O=>O-S;)MJ:@.4SO9-O%'[3VWOY:O,[,FS./-EL"79O8["IVO0=
M3!AYLPM[G2(G]F\-,FQ4Y;-AR8XVJK=BBY_!R@6@G,DOZB _(7E*K0'R1AI2
MPUPSQ#MVC1R%U&<DFGT+)T!8Y1S(\0YS7)@:278A%\@2XRV!>X*BX=90)76.
M8C-WQNC):8'=G9">T.57W"F3D,Z@\=Q4ZR9WC4$=/+MID&4_ 4NF2"C/078C
MY"MQ!+(4?Y+/KL9B3)(#C68P*TOI+H7>(3=FYN[VE*Y]:5C!BDJGIX!/?KE.
M=7B"5(>]=:K#DU^/3EWPX-V[8[3[P= _/OGM]/S] 7D!#OYU</SGP=L_GXE]
MW__U@\D]IO;#.B/;1)<4YB"_D9,_<<T&17N&C=.8=+I\5J&A7%QIC'"A[M!E
ME:,_T,@Z-M90/(".=PW+??'/& OFT& =*M]BC27USI1HB8L?0_ N+X JH09C
M/:3:09(252[Y ;RR%BW+]MZQFE'8TM+V"F9SK/1*O*B_V]:SH(;+CI-2W2=%
M-B'^(J7-YH8[OK[-.S_OJ#EF:I.(VPXUCE#+4:CEH%7.@,NL];!&),5^F-5A
M>Z?4)_(M'(\/F7[Y!UBA;S]<')\<73P/(_3 6H:NM;LY*&4/BKD,NY$Y#FKU
M45/;F=Q*AP]7C,FV:^PW^:NH*!IH:E"D?: .9 5I9@C.]/(179S-1Q7V#!<F
M(-HX6&O,..IO%7<.J;VBZ[88P%PXR7X5[7?@L\I^02,GPW_GP%5QP8K85S[B
M+0'E8$*A$*9LF.H(Q[7%(\8[9.M%;17IA#D<38WFQ=F^A7:+[TN$@,<.5?JF
M+K_0(.U%W2DF8 ,3_O=L>$6'*AJZ'^D(;)B,QQ3GQ):Z;%MJR_Y0SL9U<D?F
M6%IQ7T)B$Y3]QD6WM!IOSA@6YOT/CH9CM7 )2%# _W\3W.0^T7\VH1XXV+4P
MYBN)4/UP[KA\=,I,,0+7MK55=(>Q'IT4DQ3/C#KH@0S(!KIQ&CJC9L#:7#P;
M%<BPGVI)%=9P0M<)RGOSZP\9-MABIE"NL'2E_]VS[NBW=]$I=:(5(F8N!G]8
M,&OT2:_F4I:Y,S[:&Q'C$(/J";NCR.4W23/]PZ]_*_\6M2'(\LS6__LE_VLA
M]99!^&V']HBD7GN;2VX^'"=I<9UDP87[;N[8#[_ZGMY'&Y2S-B1I<U57OAYN
M-8>;YV9\M78S/H&;<7_M9OPLM_D2NGVR,[X^3!\LQ"_5]=MP=>=I6D?_YX_C
MM\>7T<%<M> 19S:/YSS&:\P5.3ZY//]P@:[:XY.N')?'?-_76M?")WOP_NCD
MW=$[:K9W?G1Q>7!Y]$X.&05Z+SI]?W+\]L,%[L_1R>7QOX[4V9\')T^[4TNU
M=!M8TYRS^?/\%Q('"'X[3,OI)('?I1EN]8O^)!]\M!*#W@8B8Y(GE8%%O47\
MU!<HH( #9OEMD4RQE8"Y<W-!L)6]F<A^^)]]C$AC/NQ6A!^C*R1,#I 3OL[2
M_JS$3]#_ WHRZHF4_9S#=4PS0OE*AOG4=.;NZP$VW]+499F J:7H0TE]?,_Z
MS9(R<.%AOA*-A%,P> ^HA0>E)13--9FB\E3@'0N]/E(O828-4Z-T;C<]"ER_
M-/4 05;_XF^)&=D,W6AAO-H\H[.2'8$(DX?1$?3_J"'V,L:<89.:?S'5Y+ ^
M3(O![!IKXP>Z-)GZ";J=1JEK]D?+PLP/NSE!?HU,7SH\'_#*Z8S.-7G$J:2R
MISK.F+:JM._A; /7%SJAGN- M[PNV(_+VSQZ+^V??X-A7OP!O 2S:2['^:RD
MEHL[L102;'HX 9;N%-%=O>>S/X%R-IU.V(-K/G;ME84>!5O FULR0M<J3I@[
M@/,#< .Y/WH/1\:*)$L4BI-K>@&@@X?O9Z>4EOZV)-0C'K>LH,2"1F4MAQN
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M9N032J+"GO/.6EL3V1+0BE<(KKB;A-IH[N<(:^:]U&D+5$_ (M$DSZZP\&5
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M"-:^,$T(#5T(J,QA6L!5*]$EHTLA#E,3+F!Q)(W]QVK(UI17B!@S7K,][B;
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M4#X_X!P? .=X<L Y?K&;<!_,H#_4#B+KA\XDR.& \[JQKG&=J\X"?.Z>HEU
M7A'94-8G@@.+FO2).S6=PS!T!D+%E77UD&^'NEO9Z]%G7905D/-@-L<S[-&
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M=/+-K6H2=%SC:U:3]19Y!LF2#$FUNW(95%?Q \(J6")_6V[*6 &8ZQX$O:J
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M+G^C!9)XFS:'<@/<SUR"UV/1FZ,]_O<F/?)1@MB._(+&#7T#<36Y@YL4S<$
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M\A02!ATAZ=!#+<Y]1B3HSHHX8_AA'GOBA)/%A?#\C28\R50[9$C8VJT/=)R
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MUS0CU;3:<5CJN+5UL@A_%+<S73R">PKD?5D"][4__WJ0RLNG!Y#* X!4OCV
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M0Z*; 8"EG7@8PJ;!VM+.X49-S_UL\'/D?J+EXY6*5H7XXBX<+"?YSL?30L%
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M[@AV#S:_6WOX=>P2H95Q"770^)= ,NE6SB0[W5A#HRJ$H@ Q4N!C,+46GB>
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M]$12>XF+J@7F?),JC9G(B1WD_1IY7TW(^[)%5Q0S0YX+0B6YPA68B"XLSEI
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MJ1&O\LXX=7:LFZ9D%%9 +MS;D_4E_.;%TY.CWP,XMD,^#;A#I/UF'"E?5D2
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M#(=I> 8=]) .>,(FJV'4Q:'E6?KL?'Z+L_,WU(;(<1ES6O;^^)PT':^Q0:M
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ML1*(S[S0'D 30^9HFA":SP<4>0=UT$"?Q)FA]+G9KL]W.$@.?GK*3[]-O9H
M+4OS$=#(Q38^"*RN<C_(U ]R+MI4KBW!/+7[X5<XZ7X4/7"*+0T9QB U%] !
M9Y"H+49ZJF$SZ."/H-(6BG:&2%JHR0_^W2LVI-7T#^5M3=#^=^HID(#MR>ZD
MD7/0D<?H6A^ZU\<)R9/9Z$@;&X6?#W\NN6HW::S\RE#/(<UUY.Y'B/OX@I E
MO%E2MU"%"A_]@D(XHX\UI($6(R+(MD;Z^7EPJJ=%RA/A)0BE!*J^Z]T.&B.I
M,6Y38?>Q^&3^'P*^+L*0WIL:3/?3L]CQL[\%$PU$ ,P50LU>J9S-#EIBA415
M8N@-=@P#,,D3KY*#;$J%*?R-]3F0ZT>+A2HOEUB7CZTF_<^/RN/3XYSOXHS9
MI]^]T4W-9D%;*'2)&[#F/.47O0=J#>X/A5[>)[BBIQ:5=A27/16@6->BX>@4
M0.P1'./?#]06CEA;M\&H<Q.7=]C;@J-RJG::==.[JQ .FD!(;1  ;*\5'PJ,
M8%_#"!OH@I)2XINYHF,\R=<M&,9@=3=0O B1>!AJ=;Y&_&\3AI%"?.V>[LM]
MO]T.B(F7!\3$ R FGA\0$P^^/1[Z4+U-O>E;Y[4[VWL_=<_^L#9[FG!OUCJF
M4]TB".IKZ-3%A $PM0Z.H**(N%*%014,%3C+<WMN=_8PIT2<?2_^5XX<07#$
M6FV&"()<_HFN<"4GW8*L&/X.CU!M2J#W#A:*-/A4WP'/C?5>[/RBK66M!6R.
M<>7)HA/-<,9).I6I%")(.XE$96#5!F)FRT\5UK,>I&YGKG O=1@-&DN<"A1!
M&3G(31O%.K[RUHKWW(7'KQ!8\.D%0B_A?8,M6NOL-W#]-US39A?JY+MO7Q%Q
MUGG)# X.3G4=].JPMO?914:OK7<3TVO,*A@CCGGV7\=/3R \E%U '^=,$94Y
M=P][8!_6[^[7S_6]"2VCD>FO5S<1GTPO,_6_+072[TDT//T,/QT#?/V?KQD$
MIE::*Q$UJHF3QQX5O><PQ].^#WH5]]G)<RNNQ!_W O[BP6@\YXQ*A*B)ET3G
M''U5;=K+INST$U5/Y-\VUD4[>;Y\\CQYYVF[!7(!'F<:1-X#*@QH9G(E28OL
MZ.73_\;2":S"X2<2&\]%2[EX[$GH;A&5#'IZ# "\Z$ Q_]R/B9-,$(E-Q??Z
M@@(DFM1D'K-KU+4+QQ88FZBOI,AC/*2B[\NAEWQ2'%=$L*P5L^Z4>2/M=^#9
MND%%F%7/8[X(:!"TS3EU-Z81QF2N3W'"3(QF*<J9J E-M"5GZ#*7_7"0R"U5
M=L2P,VR0(?1&^I98&6KF)6<GP1U'*;1W20Z,PN;=174!WY'9C7((\"BTL&>0
M5JM+Z9J#R!8M:%,"9B(!@ZNNFYM.FK)O&]#D%)*!C'>@93/QLKVF,./%3*W]
MX+45KVI(%B"[W<?9U"]DRT<AR6<OH""+Z6"H[!X6EK/LTPDU[)2W6:LJIZJ+
M78F@+SV": '1)4D,Y,/I.:O/&]!H^IIM&PYULYI<#T/SW'OB,M]G".#1GJHK
M.57]L1F6^Z;/2U^8ZW$D5%4 G0:H?++JX[K@:3G+)6]U5E!@>1MR)J@"". =
M057PP0:[<VDY=3:8$A=F+%&"8GS8A"P?9IPB3<O=0P(V@^N(?)@D1=A1/'T1
MWX[TXI(=9:0R6A=7A"%?J6_<N;TJP^8=/BNZ68$%Q17+F-V@I&Q T )WEET1
M-($["-V="]U92NC87C767MWBG*NB*&WADGO^_(5VSP\K=_<K5R56[H>BZLQ/
M1?=[.63_ "]ZM'PYMWP"A;!$K!4::NAQXV:FWN4Q&DD%+XN>_;;^SW?>^?";
M;Q^^\^')/BUMM3)HX :+44'QX[RN%C52%2Y+HBZNV(>C:C]JOD>U/4!,[S>K
ME!7FE$^NK:^&B&WLT]QX"Z1=&5EV5P^*:>6N:N 8J;?>/6Q*%(]?QM@A<'T8
MN!>8?1G,F/?,9EL"/)&=A';3+5Q7^21>M3R'W]45X3[;SL%Q=QQQ1>SU[;HD
M(IVY/76:LN^-GA7$$< ^R_0^@]^2%^9W"FVM<'[5F_GI!.8HN$2>!TVJ]/05
M@W%CO(3M&P]P3]/A>[.=_O_VKJTY56P)O^=7I/)T3C&S!02$.353)2)>P N"
MHK[L D'N-[D(_/JCXHWH3C*SLR>9/3S%2J+(^K[NU8ON_OIL3[?/E=:28]B[
M2[QX7T]_G!Y0O=4>]Q7!>SH= ZDCW=UO\/T-IGJ(RG?'^Z)(]>&:6?)1NEP*
MK:+CZ3AZ\\J0'\N&_)\KVSC\QY'Y4HF"O[S,T/\^7)/Y+YKI_H3^TY#W\0>Q
M][(=O-K=IWF>LI\;&.G'D.OS+>QG_[@WE/!@50G/!Y3P(%4)SX>;Q^<Y_IAW
M,HXE=?3[)]>UL0FCXOQ:#K>.PPV>-U14!]=W1\YZ";D;J?E3E=!I-NGS!JG+
M&>.VL:$4I1T;[$IRL@^7)MF[%3IWXI?O:5]_1"_%455!SRLTL>_0I"@"NV:'
M?HPT#[/L3X+-N]^=<L-%"NDJX7=ZXW5&>)_ 48N4\/[E^ISFVN=R*J!> <JY
M#]2ILOQ>Q=^=*>M;O9 7+^ L_GZ8TU422#ITW>TVXIT/V 'XI^WOK#AX:*39
M7?'0S7=X7'Z9F7X>ZE<XAI.2Q4&B\WN,'ZLL_VV$<E\BU//DQ?V"TE.U:+F&
M]%R%>NDA*SS\68KA-&K%N!I#+H4/4JG#[/#F0TKCAC2?6V_R\T#LW8-XMW#W
M@C;C2F!A7Z&[^O((@S!\<1W%_GYI0C[MYZ?)>44.XA;9"J574/+OI!A.R_SP
M[1C;EEX,L9\)KKQKB U!R'4&X;1(OQ8YAI\6J. %H&Y#ZH=G(?6QG[R(I,N"
MQ4<3V@N O$FIY?D VG)4_5W23^BEQ+LRW%?XL+GG7DLB#?<M]YBDB(Y<*/4'
MEB0(OJ%8]2+\#]\5/>$5]F_#/KR#?5F_]&TY_4LJOUZE\G\L9-$]R,Z1ZY\X
M[EX)*OS%(^_#>QYY*XPO&,=W,#Z'M;<6^2SBW5G@(Z7:TK90!RM/<2O/@;H6
MSCCF@#Z;LZP^KOJX3YO<:U3)O0]([J%5<N\CS.,6O_+M@W=NO^"8X6B/X6;U
M^Y/A[&[H*P@B7TQ?>]I+T/W^=.:XKNY1^>VQ02!^>N8M!A%^^E1[KZ:"G\#I
MX)73^7N=SO\>1\5\R=\>NX:R"__V !PO77FB?Y(G^D0N$'W)!>(@]*XN\)^W
M8!]\X1_CU?^6[8&X<E?L_NEZM5O\&W>+'^:\;RG(J]%I"5)EY[9ZU.'%5Q G
MOQX$EXM!2OLO<'B;VL^4J0W%L-7DQAI=[XPM5)A(W4#O)S9IM'FS9="4&  ;
MBD;J$SEI#UTZ948V'<%K..,9G^+$OH1#;EH+\V%_Y2\&DD2*V9B"$'@[6&&Y
MR,#69&EKA@=A!E>;=-W&1DO,$3Y;21E$R?@PY( 1AV!YDN0$S6"<1\;VJF.T
M );2IUH":EA/L%<]AT9<=E9+K R=:8H7Q!SCMU MV\P<W98SMN4.40$-@KE,
M2CTRHF,MB59IEZ70%J-HG@"'7@.)\$X:#P'0]%@A"Y<#IRY2_EP1"5YM*1;#
MP(K;2Y*4$AVQ X]\+)&8.=#0%NNQTHF2N3B&FDHLPOQP!&,]2]BMNFPLE:0_
MEP$-,R.!8!HY&&=*B/.U!AFTFMQ@W8N]QE8%EQO-B6PM1#L!I2Y= N:-!D9
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MN<N/%W5<9=4<<L<+SDK=]KKC00"W-?BD0+XF>TJV_ZE'COW'_P%02P,$%
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MI HU,XTL"C"0:,#AGF)!E<Q\S+N>AA:OA7,='90TVV&B 0I"&"9FVL"1@^4
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M\C]02P$"% ,4    " "//>]8110MV[NN 0 B_ $ #0              @ $
M    :6UA9V5?,# T+FIP9U!+ 0(4 Q0    ( (\][U@+//*RQMX  "DZ 0 -
M              "  >:N 0!I;6%G95\P,#4N:G!G4$L! A0#%     @ CSWO
M6 ^%Y.I%8P$ )\8) !4              ( !UXT" &EN=')U<VEO;E]I9&5F
M,31A+FAT;5!+ 0(4 Q0    ( (\][UA\(L%\& 0  )<1   1
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7;%!+!08     !P ' ,$!  #4&@0    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>intrusion_idef14a_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:INTZ="http://intrusion.com/20231231"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="intz-20231231.xsd" xlink:type="simple"/>
    <context id="From2023-01-01to2023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000736012</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000736012</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_AnthonyScottMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000736012</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">INTZ:AnthonyScottMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_AnthonyScottMember_custom_ReportedValueOfEquityAwardsForCeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000736012</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">INTZ:ReportedValueOfEquityAwardsForCeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">INTZ:AnthonyScottMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_AnthonyScottMember_custom_FairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000736012</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">INTZ:FairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">INTZ:AnthonyScottMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_AnthonyScottMember_custom_FairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000736012</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">INTZ:FairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">INTZ:AnthonyScottMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_AnthonyScottMember_custom_FairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000736012</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">INTZ:FairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">INTZ:AnthonyScottMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_AnthonyScottMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000736012</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">INTZ:AnthonyScottMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_AnthonyScottMember_custom_ReportedValueOfEquityAwardsForCeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000736012</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">INTZ:ReportedValueOfEquityAwardsForCeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">INTZ:AnthonyScottMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_AnthonyScottMember_custom_FairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000736012</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">INTZ:FairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">INTZ:AnthonyScottMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_AnthonyScottMember_custom_FairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000736012</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">INTZ:FairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">INTZ:AnthonyScottMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_AnthonyScottMember_custom_FairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000736012</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">INTZ:FairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">INTZ:AnthonyScottMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_ReportedValueOfEquityAwardsForCeoMember_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000736012</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">INTZ:ReportedValueOfEquityAwardsForCeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_FairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000736012</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">INTZ:FairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_FairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000736012</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">INTZ:FairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_FairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000736012</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">INTZ:FairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_ReportedValueOfEquityAwardsForCeoMember_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000736012</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">INTZ:ReportedValueOfEquityAwardsForCeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_FairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000736012</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">INTZ:FairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_FairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000736012</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">INTZ:FairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_FairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000736012</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">INTZ:FairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Ratio">
        <measure>pure</measure>
    </unit>
    <dei:AmendmentFlag contextRef="From2023-01-01to2023-12-31" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="From2023-01-01to2023-12-31" id="Fact000004">0000736012</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="From2023-01-01to2023-12-31" id="xdx2ixbrl0011">DEF 14A</dei:DocumentType>
    <dei:EntityRegistrantName contextRef="From2023-01-01to2023-12-31" id="Fact000012">Intrusion Inc.</dei:EntityRegistrantName>
    <ecd:PvpTableTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000014">&lt;table cellpadding="0" cellspacing="0" id="xdx_88A_eecd--PvpTableTextBlock_z7QNk8Ivjkze" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Pay vs Performance Disclosure"&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Summary Compensation Table Total for CEO(1)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Compensation Actually Paid to
    CEO(2)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Average Compensation Table total for Non-CEO NEOs(3)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Average Compensation Actually paid to Non-CEO NEOs(4)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Value of Initial Fixed $100 Investment Based Total Shareholder Return(5)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Net Income (Loss)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 6%; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eecd--PeoTotalCompAmt_c20230101__20231231_fKDEp_zjJDPtRWa0Mf" style="width: 13%; text-align: right" title="PEO Total Compensation Amount"&gt;457,907&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eecd--PeoActuallyPaidCompAmt_c20230101__20231231_fKDIp_zgewu24XQcFg" style="width: 13%; text-align: right" title="PEO Actually Paid Compensation Amount"&gt;319,652&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eecd--NonPeoNeoAvgTotalCompAmt_c20230101__20231231_fKDMp_zxhSDuQYiDc4" style="width: 13%; text-align: right" title="Non-PEO NEO Average Total Compensation Amount"&gt;302,520&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20230101__20231231_fKDQp_zbtgij7QWgL9" style="width: 13%; text-align: right" title="Non-PEO NEO Average Compensation Actually Paid Amount"&gt;217,347&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eecd--TotalShareholderRtnAmt_pp2p0_c20230101__20231231_fKDUp_z6oPkVWDM71l" style="width: 13%; text-align: right" title="Total Shareholder Return Amount"&gt;8.01&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eus-gaap--NetIncomeLoss_c20230101__20231231_zR24YU3xTuRj" style="width: 11%; text-align: right" title="Net Income (Loss)"&gt;(13,891&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: center"&gt;2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98E_eecd--PeoTotalCompAmt_c20220101__20221231_fKDEp_zLxUfY79Tee5" style="text-align: right" title="PEO Total Compensation Amount"&gt;425,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eecd--PeoActuallyPaidCompAmt_c20220101__20221231_fKDIp_zbBAW908AQmk" style="text-align: right" title="PEO Actually Paid Compensation Amount"&gt;423,341&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98B_eecd--NonPeoNeoAvgTotalCompAmt_c20220101__20221231_fKDMp_z55UggQbXOm" style="text-align: right" title="Non-PEO NEO Average Total Compensation Amount"&gt;242,368&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20220101__20221231_fKDQp_zv6ahxQeAK6c" style="text-align: right" title="Non-PEO NEO Average Compensation Actually Paid Amount"&gt;241,589&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eecd--TotalShareholderRtnAmt_pp2p0_c20220101__20221231_fKDUp_zXm8IUw3woJ9" style="text-align: right" title="Total Shareholder Return Amount"&gt;91.86&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eus-gaap--NetIncomeLoss_c20220101__20221231_zBQeOtuCG0w9" style="text-align: right" title="Net Income (Loss)"&gt;(16,229&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ecd:PvpTableTextBlock>
    <ecd:PeoTotalCompAmt
      contextRef="From2023-01-01to2023-12-31"
      decimals="0"
      id="Fact000016"
      unitRef="USD">457907</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2023-01-01to2023-12-31"
      decimals="0"
      id="Fact000018"
      unitRef="USD">319652</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2023-01-01to2023-12-31"
      decimals="0"
      id="Fact000020"
      unitRef="USD">302520</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2023-01-01to2023-12-31"
      decimals="0"
      id="Fact000022"
      unitRef="USD">217347</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="From2023-01-01to2023-12-31"
      decimals="2"
      id="Fact000024"
      unitRef="USD">8.01</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-01to2023-12-31"
      decimals="0"
      id="Fact000026"
      unitRef="USD">-13891</us-gaap:NetIncomeLoss>
    <ecd:PeoTotalCompAmt
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000028"
      unitRef="USD">425000</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000030"
      unitRef="USD">423341</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000032"
      unitRef="USD">242368</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000034"
      unitRef="USD">241589</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="From2022-01-012022-12-31"
      decimals="2"
      id="Fact000036"
      unitRef="USD">91.86</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000038"
      unitRef="USD">-16229</us-gaap:NetIncomeLoss>
    <ecd:NamedExecutiveOfficersFnTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000040">&lt;p id="xdx_840_eecd--NamedExecutiveOfficersFnTextBlock_dU_zgeY84p5y4T8" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td id="xdx_F0E_zGI2QNjP3WH5" style="width: 5%"&gt;1)&lt;/td&gt;&lt;td id="xdx_F1C_z3MCKw8IHSTa" style="text-align: justify; width: 95%"&gt;The dollar amounts reported are the amounts of total
                                                       compensation reported for our President and Chief Executive Officer, &lt;span id="xdx_90C_eecd--PeoName_c20230101__20231231_zmMJqaYis0k1"&gt;Anthony Scott&lt;/span&gt;, in the Summary Compensation Table for fiscal years 2023 and 2022.&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td id="xdx_F0F_zUALfU4JgHV4"&gt;2)&lt;/td&gt;&lt;td id="xdx_F12_zBjpaI70K6v4" style="text-align: justify"&gt;The dollar amounts reported represent the amount of "compensation actually paid," as computed in accordance with SEC rules.
The dollar amounts reported are the amounts of total compensation reported for Mr. Scott during the applicable year, but also include
(i) the year-end value of equity awards granted during the reported year, (ii) the change in the value of equity awards that were unvested
at the end of the prior year, measured through the date the awards vested, or through the end of the reported fiscal year, and (iii) value
of equity awards issued and vested during the reported fiscal year. See Table below for further information.&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td id="xdx_F0D_zQUQm2vAnIai"&gt;3)&lt;/td&gt;&lt;td id="xdx_F1C_zwed8pH5GJy9" style="text-align: justify"&gt;The dollar amounts reported are the average of the total compensation reported for our NEOs, other than our CEO, in the Summary Compensation
Table for fiscal years 2023 and 2022.&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td id="xdx_F0F_zby5jy6umS5l"&gt;4)&lt;/td&gt;&lt;td id="xdx_F17_zArqqH50QVM8" style="text-align: justify"&gt;The dollar amounts reported represent the average amount of "compensation actually paid," as computed in accordance with
SEC rules, for our NEOs, other than our CEO. The dollar amounts reported are the average of the total compensation reported for our NEOs,
other than our CEO in the Summary Compensation Table for fiscal years 2023 and 2022, but also include (i) the year-end value of equity
awards granted during the reported year, (ii) the change in the value of equity awards that were unvested at the end of the prior year,
measured through the date the awards vested, or through the end of the reported fiscal year, and (iii) value of equity awards issued and
vested during the reported fiscal year.&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top"&gt;
&lt;td id="xdx_F04_zpOhUEUseEJ3"&gt;5)&lt;/td&gt;&lt;td id="xdx_F13_zMy6tQr7uMRc" style="text-align: justify"&gt;Reflects the cumulative shareholder return over the relevant fiscal year, computed in accordance with SEC rules, assuming an investment
of $100 in our common shares at a price per share equal to the closing price of our common stock on the last trading day before the commencement
of the applicable fiscal year and the measurement end point of the closing price of our common stock on the last trading day in the applicable
fiscal year. For 2023, the closing price of our common stock on December 31, 2022, was $63.20 and the closing price of our common stock
on December 31, 2023 was $5.06. For 2022, the closing price of our common stock on December 31, 2021 was $68.80 and the closing price
of our common stock on December 31, 2022 was $63.20.&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

</ecd:NamedExecutiveOfficersFnTextBlock>
    <ecd:PeoName contextRef="From2023-01-01to2023-12-31" id="Fact000042">Anthony Scott</ecd:PeoName>
    <ecd:AdjToPeoCompFnTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000048">&lt;p id="xdx_847_eecd--AdjToPeoCompFnTextBlock_dU_zg40pMNHuhOe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 31.5pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;To calculate the amounts
in the &#x201c;Compensation Actually Paid to CEO&#x201d; column in the table above, the following amounts were deducted from and added
to (as applicable) our President and CEO&#x2019;s &#x201c;Total&#x201d; compensation as reported in the Summary Compensation Table:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Summary Compensation Table Total for CEO&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Reported Value of Equity Awards for CEO(1)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Fair Value as of Year End for Unvested Awards Granted During the Year&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Fair Value Year Over Year Increase or Decrease in Unvested Awards Granted in Prior Years&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Fair Value Increase or Decrease from Prior Year end for Awards that Vested During the Year&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Compensation Actually Paid&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 6%; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eecd--PeoTotalCompAmt_c20230101__20231231__ecd--IndividualAxis__custom--AnthonyScottMember_zuB054QGdwJ6" style="width: 13%; text-align: right" title="Summary Compensation Total for PEO"&gt;457,907&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eecd--AdjToCompAmt_iN_di_c20230101__20231231__ecd--IndividualAxis__custom--AnthonyScottMember__ecd--AdjToCompAxis__custom--ReportedValueOfEquityAwardsForCeoMember_fKDEp_zjwjeD2IQjyi" style="width: 13%; text-align: right"&gt;139,157&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98D_eecd--AdjToCompAmt_c20230101__20231231__ecd--IndividualAxis__custom--AnthonyScottMember__ecd--AdjToCompAxis__custom--FairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember_zaLCFbtz5rh7" style="width: 13%; text-align: right" title="Adjustment to Compensation Amount"&gt;24,882&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eecd--AdjToCompAmt_d0_c20230101__20231231__ecd--IndividualAxis__custom--AnthonyScottMember__ecd--AdjToCompAxis__custom--FairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember_zELuNwxvhfG9" style="width: 13%; text-align: right" title="Adjustment to Compensation Amount"&gt;&#x2013;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eecd--AdjToCompAmt_c20230101__20231231__ecd--IndividualAxis__custom--AnthonyScottMember__ecd--AdjToCompAxis__custom--FairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember_zS0MbDf508r1" style="width: 13%; text-align: right" title="Adjustment to Compensation Amount"&gt;(23,980&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eecd--PeoActuallyPaidCompAmt_c20230101__20231231__ecd--IndividualAxis__custom--AnthonyScottMember_zAp8YOwT6py6" style="width: 11%; text-align: right" title="PEO Actually Paid Compensation Amount"&gt;319,652&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: center"&gt;2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98A_eecd--PeoTotalCompAmt_c20220101__20221231__ecd--IndividualAxis__custom--AnthonyScottMember_zAAGl8yTdpa8" style="text-align: right"&gt;425,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eecd--AdjToCompAmt_iN_di_c20220101__20221231__ecd--IndividualAxis__custom--AnthonyScottMember__ecd--AdjToCompAxis__custom--ReportedValueOfEquityAwardsForCeoMember_fKDEp_z0LcZYizaHE5" style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eecd--AdjToCompAmt_c20220101__20221231__ecd--IndividualAxis__custom--AnthonyScottMember__ecd--AdjToCompAxis__custom--FairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember_zQbWwlWdUAB7" style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eecd--AdjToCompAmt_c20220101__20221231__ecd--IndividualAxis__custom--AnthonyScottMember__ecd--AdjToCompAxis__custom--FairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember_zzamN6Hv5d54" style="text-align: right"&gt;(2,442&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_988_eecd--AdjToCompAmt_c20220101__20221231__ecd--IndividualAxis__custom--AnthonyScottMember__ecd--AdjToCompAxis__custom--FairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember_zeAqh9H8iJnd" style="text-align: right"&gt;783&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eecd--PeoActuallyPaidCompAmt_c20220101__20221231__ecd--IndividualAxis__custom--AnthonyScottMember_zmO8p0t73DXj" style="text-align: right"&gt;423,341&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;
&lt;tr style="vertical-align: top"&gt;
  &lt;td id="xdx_F04_zC1kl0GphGEl" style="text-align: left; padding-left: 10pt; text-indent: -0.01pt; width: 3%"&gt;1)&#160;&#160;&#160;&#160;&#160;&lt;/td&gt;
  &lt;td id="xdx_F11_zFN4evH1uXa" style="text-align: left; padding-left: 10pt; text-indent: -0.01pt; width: 97%"&gt;Represents the grant date fair value of the equity awards to our CEO, as reported in the Summary Compensation Table.&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


</ecd:AdjToPeoCompFnTextBlock>
    <ecd:PeoTotalCompAmt
      contextRef="From2023-01-012023-12-31_custom_AnthonyScottMember"
      decimals="0"
      id="Fact000050"
      unitRef="USD">457907</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_AnthonyScottMember_custom_ReportedValueOfEquityAwardsForCeoMember"
      decimals="0"
      id="Fact000051"
      unitRef="USD">-139157</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_AnthonyScottMember_custom_FairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember"
      decimals="0"
      id="Fact000053"
      unitRef="USD">24882</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_AnthonyScottMember_custom_FairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember"
      decimals="0"
      id="Fact000055"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_AnthonyScottMember_custom_FairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember"
      decimals="0"
      id="Fact000057"
      unitRef="USD">-23980</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2023-01-012023-12-31_custom_AnthonyScottMember"
      decimals="0"
      id="Fact000059"
      unitRef="USD">319652</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="From2022-01-012022-12-31_custom_AnthonyScottMember"
      decimals="0"
      id="Fact000060"
      unitRef="USD">425000</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_custom_AnthonyScottMember_custom_ReportedValueOfEquityAwardsForCeoMember"
      decimals="0"
      id="Fact000061"
      unitRef="USD">-0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_custom_AnthonyScottMember_custom_FairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember"
      decimals="0"
      id="Fact000062"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_custom_AnthonyScottMember_custom_FairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember"
      decimals="0"
      id="Fact000063"
      unitRef="USD">-2442</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_custom_AnthonyScottMember_custom_FairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember"
      decimals="0"
      id="Fact000064"
      unitRef="USD">783</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2022-01-012022-12-31_custom_AnthonyScottMember"
      decimals="0"
      id="Fact000065"
      unitRef="USD">423341</ecd:PeoActuallyPaidCompAmt>
    <ecd:AdjToNonPeoNeoCompFnTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000068">&lt;p id="xdx_84E_eecd--AdjToNonPeoNeoCompFnTextBlock_dU_zg1juGBsMNSi" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;To calculate the amounts in the
&#x201c;Compensation Actually Paid to Non-CEO NEOs&#x201d; column in the table above, the following amounts were deducted from and added
to (as applicable) the average &#x201c;Total&#x201d; compensation of our Non-CEO NEOs as reported in the Summary Compensation Table:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Year&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Summary Compensation Table Total for Non-CEO NEOs&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Reported Value of Equity Awards for Non-CEO NEOs(1)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Fair Value as of Year End for Unvested Awards Granted During the Year&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Fair Value Year Over Year Increase or Decrease in Unvested Awards Granted in Prior Years&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Fair Value Increase or Decrease from Prior Year end for Awards that Vested During the Year&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Compensation Actually Paid to Non-CEO NEOs&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="width: 6%; text-align: center"&gt;2023&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_985_eecd--NonPeoNeoAvgTotalCompAmt_c20230101__20231231_zsXkziSLtIVd" style="width: 13%; text-align: right" title="Average Total Compensation Amount for Non-PEO NEO"&gt;302,520&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eecd--AdjToCompAmt_iN_di_c20230101__20231231__ecd--AdjToCompAxis__custom--ReportedValueOfEquityAwardsForCeoMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_fKDEp_z2SBbLS2zMM1" style="width: 13%; text-align: right"&gt;48,514&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eecd--AdjToCompAmt_c20230101__20231231__ecd--AdjToCompAxis__custom--FairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zzruFPthspP2" style="width: 13%; text-align: right"&gt;8,674&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_981_eecd--AdjToCompAmt_c20230101__20231231__ecd--AdjToCompAxis__custom--FairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zkhmAjnIPBYh" style="width: 13%; text-align: right"&gt;(22,910&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_983_eecd--AdjToCompAmt_c20230101__20231231__ecd--AdjToCompAxis__custom--FairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zMuoi0zjjfF7" style="width: 13%; text-align: right"&gt;(22,424&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20230101__20231231_zNLfL1WpVoAl" style="width: 11%; text-align: right" title="Non-PEO NEO Average Compensation Actually Paid Amount"&gt;217,347&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(238,238,238)"&gt;
    &lt;td style="text-align: center"&gt;2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eecd--NonPeoNeoAvgTotalCompAmt_c20220101__20221231_zAf8sXS6ECx8" style="text-align: right"&gt;242,368&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eecd--AdjToCompAmt_iN_di_c20220101__20221231__ecd--AdjToCompAxis__custom--ReportedValueOfEquityAwardsForCeoMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_fKDEp_z69fBhZmpkwi" style="text-align: right"&gt;39,089&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_987_eecd--AdjToCompAmt_c20220101__20221231__ecd--AdjToCompAxis__custom--FairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zwSZjIBCaZF3" style="text-align: right"&gt;36,188&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_982_eecd--AdjToCompAmt_c20220101__20221231__ecd--AdjToCompAxis__custom--FairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zwkE4bMRWYW3" style="text-align: right"&gt;(2,424&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_980_eecd--AdjToCompAmt_c20220101__20221231__ecd--AdjToCompAxis__custom--FairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember_zoYTWs5f155j" style="text-align: right"&gt;4,547&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_98F_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20220101__20221231_zhdj9qXCcIb5" style="text-align: right"&gt;241,589&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"&gt;
&lt;tr style="vertical-align: top"&gt;
  &lt;td id="xdx_F0B_zFFcqKH0yPXj" style="text-align: left; padding-left: 10pt; text-indent: -0.01pt; width: 3%"&gt;1)&#160;&#160;&#160;&#160;&#160;&lt;/td&gt;
  &lt;td id="xdx_F17_zQ93uikaVhV7" style="text-align: left; padding-left: 10pt; text-indent: -0.01pt; width: 97%"&gt;Represents the grant date fair value of the equity awards to our Non-CEO NEOs, as reported in the Summary Compensation Table&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


</ecd:AdjToNonPeoNeoCompFnTextBlock>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2023-01-01to2023-12-31"
      decimals="0"
      id="Fact000070"
      unitRef="USD">302520</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_ReportedValueOfEquityAwardsForCeoMember_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000071"
      unitRef="USD">-48514</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_FairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000072"
      unitRef="USD">8674</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_FairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000073"
      unitRef="USD">-22910</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_FairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000074"
      unitRef="USD">-22424</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2023-01-01to2023-12-31"
      decimals="0"
      id="Fact000076"
      unitRef="USD">217347</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000077"
      unitRef="USD">242368</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_custom_ReportedValueOfEquityAwardsForCeoMember_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000078"
      unitRef="USD">-39089</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_custom_FairValueAsOfYearEndForUnvestedAwardsGrantedDuringYearMember_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000079"
      unitRef="USD">36188</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_custom_FairValueYearOverYearIncreaseOrDecreaseInUnvestedAwardsGrantedInPriorYearsMember_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000080"
      unitRef="USD">-2424</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_custom_FairValueIncreaseOrDecreaseFromPriorYearEndForAwardsVestedDuringYearMember_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000081"
      unitRef="USD">4547</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000082"
      unitRef="USD">241589</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:CompActuallyPaidVsNetIncomeTextBlock contextRef="From2023-01-01to2023-12-31" id="Fact000085">&lt;p id="xdx_843_eecd--CompActuallyPaidVsNetIncomeTextBlock_dU_zLBQJucesNW4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;Relationship between Pay and Performance&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"&gt;Our &#x201c;total shareholder
return,&#x201d; as set forth in the above table, during the two-year period ended December 31, 2023 decreased by 91% compared to (a) a
decrease in &#x201c;compensation actually paid&#x201d; to our CEO from $423,341 in 2022 to $319,652 in 2023 and (b) a decrease in average
&#x201c;compensation actually paid&#x201d; to our non-CEO NEOs from $241,589 in 2022 to $217,347 in 2023. In addition, our net loss during
the two-year period ended December 31, 2023 decreased by 14%, from $(16,229) in 2022 to $(13,891) in 2023 compared to the aforementioned
changes in &#x201c;compensation actually paid&#x201d; to our CEO and non-CEO NEOs.&lt;/p&gt;

</ecd:CompActuallyPaidVsNetIncomeTextBlock>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact000016"
          xlink:label="Fact000016"
          xlink:type="locator"/>
        <link:footnote id="Footnote000041" xlink:label="Footnote000041" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The dollar amounts reported are the amounts of total
                                                       compensation reported for our President and Chief Executive Officer, <xhtml:span id="xdx_90C_eecd--PeoName_c20230101__20231231_zmMJqaYis0k1">Anthony Scott</xhtml:span>, in the Summary Compensation Table for fiscal years 2023 and 2022.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000016"
          xlink:to="Footnote000041"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000028"
          xlink:label="Fact000028"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000028"
          xlink:to="Footnote000041"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000018"
          xlink:label="Fact000018"
          xlink:type="locator"/>
        <link:footnote id="Footnote000043" xlink:label="Footnote000043" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The dollar amounts reported represent the amount of "compensation actually paid," as computed in accordance with SEC rules.
The dollar amounts reported are the amounts of total compensation reported for Mr. Scott during the applicable year, but also include
(i) the year-end value of equity awards granted during the reported year, (ii) the change in the value of equity awards that were unvested
at the end of the prior year, measured through the date the awards vested, or through the end of the reported fiscal year, and (iii) value
of equity awards issued and vested during the reported fiscal year. See Table below for further information.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000018"
          xlink:to="Footnote000043"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000030"
          xlink:label="Fact000030"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000030"
          xlink:to="Footnote000043"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000020"
          xlink:label="Fact000020"
          xlink:type="locator"/>
        <link:footnote id="Footnote000044" xlink:label="Footnote000044" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The dollar amounts reported are the average of the total compensation reported for our NEOs, other than our CEO, in the Summary Compensation
Table for fiscal years 2023 and 2022.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000020"
          xlink:to="Footnote000044"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000032"
          xlink:label="Fact000032"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000032"
          xlink:to="Footnote000044"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000022"
          xlink:label="Fact000022"
          xlink:type="locator"/>
        <link:footnote id="Footnote000045" xlink:label="Footnote000045" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The dollar amounts reported represent the average amount of "compensation actually paid," as computed in accordance with
SEC rules, for our NEOs, other than our CEO. The dollar amounts reported are the average of the total compensation reported for our NEOs,
other than our CEO in the Summary Compensation Table for fiscal years 2023 and 2022, but also include (i) the year-end value of equity
awards granted during the reported year, (ii) the change in the value of equity awards that were unvested at the end of the prior year,
measured through the date the awards vested, or through the end of the reported fiscal year, and (iii) value of equity awards issued and
vested during the reported fiscal year.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000022"
          xlink:to="Footnote000045"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000034"
          xlink:label="Fact000034"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000034"
          xlink:to="Footnote000045"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000024"
          xlink:label="Fact000024"
          xlink:type="locator"/>
        <link:footnote id="Footnote000046" xlink:label="Footnote000046" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Reflects the cumulative shareholder return over the relevant fiscal year, computed in accordance with SEC rules, assuming an investment
of $100 in our common shares at a price per share equal to the closing price of our common stock on the last trading day before the commencement
of the applicable fiscal year and the measurement end point of the closing price of our common stock on the last trading day in the applicable
fiscal year. For 2023, the closing price of our common stock on December 31, 2022, was $63.20 and the closing price of our common stock
on December 31, 2023 was $5.06. For 2022, the closing price of our common stock on December 31, 2021 was $68.80 and the closing price
of our common stock on December 31, 2022 was $63.20.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000024"
          xlink:to="Footnote000046"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000036"
          xlink:label="Fact000036"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000036"
          xlink:to="Footnote000046"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000051"
          xlink:label="Fact000051"
          xlink:type="locator"/>
        <link:footnote id="Footnote000066" xlink:label="Footnote000066" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents the grant date fair value of the equity awards to our CEO, as reported in the Summary Compensation Table.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000051"
          xlink:to="Footnote000066"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000061"
          xlink:label="Fact000061"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000061"
          xlink:to="Footnote000066"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000071"
          xlink:label="Fact000071"
          xlink:type="locator"/>
        <link:footnote id="Footnote000083" xlink:label="Footnote000083" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Represents the grant date fair value of the equity awards to our Non-CEO NEOs, as reported in the Summary Compensation Table</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000071"
          xlink:to="Footnote000083"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000078"
          xlink:label="Fact000078"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000078"
          xlink:to="Footnote000083"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
